sample	id	disease_type	case_id	submitter_id	primary_site	cigarettes_per_day.exposures	alcohol_history.exposures	pack_years_smoked.exposures	race.demographic	gender.demographic	ethnicity.demographic	vital_status.demographic	age_at_index.demographic	days_to_birth.demographic	year_of_birth.demographic	days_to_death.demographic	year_of_death.demographic	primary_site.project	project_id.project	disease_type.project	name.project	name.program.project	tissue_source_site_id.tissue_source_site	code.tissue_source_site	name.tissue_source_site	project.tissue_source_site	bcr_id.tissue_source_site	entity_submitter_id.annotations	notes.annotations	submitter_id.annotations	classification.annotations	entity_id.annotations	created_datetime.annotations	annotation_id.annotations	entity_type.annotations	updated_datetime.annotations	case_id.annotations	state.annotations	category.annotations	status.annotations	case_submitter_id.annotations	synchronous_malignancy.diagnoses	ajcc_pathologic_stage.diagnoses	days_to_diagnosis.diagnoses	last_known_disease_status.diagnoses	tissue_or_organ_of_origin.diagnoses	days_to_last_follow_up.diagnoses	age_at_diagnosis.diagnoses	primary_diagnosis.diagnoses	prior_malignancy.diagnoses	year_of_diagnosis.diagnoses	prior_treatment.diagnoses	ajcc_staging_system_edition.diagnoses	ajcc_pathologic_t.diagnoses	morphology.diagnoses	ajcc_pathologic_n.diagnoses	ajcc_pathologic_m.diagnoses	classification_of_tumor.diagnoses	icd_10_code.diagnoses	site_of_resection_or_biopsy.diagnoses	tumor_grade.diagnoses	progression_or_recurrence.diagnoses	ajcc_clinical_t.diagnoses	age_at_earliest_diagnosis.diagnoses.xena_derived	age_at_earliest_diagnosis_in_years.diagnoses.xena_derived	updated_datetime.treatments.diagnoses	treatment_id.treatments.diagnoses	submitter_id.treatments.diagnoses	treatment_type.treatments.diagnoses	state.treatments.diagnoses	treatment_or_therapy.treatments.diagnoses	created_datetime.treatments.diagnoses	sample_type_id.samples	tumor_descriptor.samples	sample_id.samples	sample_type.samples	composition.samples	days_to_collection.samples	initial_weight.samples	preservation_method.samples	pathology_report_uuid.samples	oct_embedded.samples	specimen_type.samples	is_ffpe.samples	tissue_type.samples
TCGA-XF-AAN0-01A	e7e95597-ef88-4442-8c01-8d633822e7b5	Transitional Cell Papillomas and Carcinomas	e7e95597-ef88-4442-8c01-8d633822e7b5	TCGA-XF-AAN0	Bladder	3.0684931506849313	Not Reported	56.0	white	male	not hispanic or latino	Dead	68	-24877.0	1939.0	1718.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		24877.0	Transitional cell carcinoma	no	2007.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24877.0	68.15616438356165	['2019-07-31T17:01:18.680451-05:00', '2019-07-31T17:01:18.680451-05:00']	['02918174-bde4-568f-b5bd-8c6c7256b831', '8b6b5a5f-4944-54cd-9fe0-736fda003df5']	['TCGA-XF-AAN0_treatment', 'TCGA-XF-AAN0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:21.124190-05:00']	01	Primary	bb4fde10-e87d-405f-92a4-282f1595e4d7	Primary Tumor	Not Reported	2551.0	690.0	OCT	0F0F3285-4798-4D8F-95D3-20AB4F0ED269	true	Solid Tissue	False	Tumor
TCGA-GV-A3QI-01A	06f936e9-5a90-40d3-b91a-713f2b4e6e11	Transitional Cell Papillomas and Carcinomas	06f936e9-5a90-40d3-b91a-713f2b4e6e11	TCGA-GV-A3QI	Bladder	1.917808219178082	Not Reported	35.0	white	male	not hispanic or latino	Alive	47	-17383.0	1964.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	1110.0	17383.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		17383.0	47.62465753424657	['2019-07-31T16:43:30.261360-05:00', '2019-07-31T16:43:30.261360-05:00']	['43c77ca8-9aa4-58ab-bed3-ed541bdcec67', '9cc604d4-1d82-50b0-9f6a-d21b6d4c134a']	['TCGA-GV-A3QI_treatment', 'TCGA-GV-A3QI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:48:00.513931-05:00']	01	Primary	45f1a50a-8d05-48c5-8f82-ba4955117d1b	Primary Tumor	Not Reported	105.0	410.0	OCT	3792A65B-C233-4DDF-88F8-8829B73616FE	true	Solid Tissue	False	Tumor
TCGA-BT-A20N-11A	ebedab7c-dd7c-448e-8324-78c86f13be8b	Transitional Cell Papillomas and Carcinomas	ebedab7c-dd7c-448e-8324-78c86f13be8b	TCGA-BT-A20N	Bladder	2.73972602739726	Not Reported	50.0	not reported	male	not reported	Dead	72	-26456.0	1931.0	795.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Trigone of bladder		26456.0	Transitional cell carcinoma	yes	2003.0	No	6th	T3a	8120/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	26456.0	72.48219178082192	['2019-07-31T17:01:30.392297-05:00', '2019-07-31T17:01:30.392297-05:00']	['65668751-80ea-58a2-821a-7ca63a54d40b', 'e74f1e5d-9aa3-59a0-a798-ba90ced221f8']	['TCGA-BT-A20N_treatment', 'TCGA-BT-A20N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:30.756454-05:00']	11	Not Applicable	753c9421-02be-4ecd-9f8e-5dbb4fe72c38	Solid Tissue Normal		2955.0	160.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20N-01A	ebedab7c-dd7c-448e-8324-78c86f13be8b	Transitional Cell Papillomas and Carcinomas	ebedab7c-dd7c-448e-8324-78c86f13be8b	TCGA-BT-A20N	Bladder	2.73972602739726	Not Reported	50.0	not reported	male	not reported	Dead	72	-26456.0	1931.0	795.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Trigone of bladder		26456.0	Transitional cell carcinoma	yes	2003.0	No	6th	T3a	8120/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	26456.0	72.48219178082192	['2019-07-31T17:01:30.392297-05:00', '2019-07-31T17:01:30.392297-05:00']	['65668751-80ea-58a2-821a-7ca63a54d40b', 'e74f1e5d-9aa3-59a0-a798-ba90ced221f8']	['TCGA-BT-A20N_treatment', 'TCGA-BT-A20N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:30.756454-05:00']	01	Primary	89ec2dfd-7a0c-4631-958d-d5492bc89f8d	Primary Tumor		2955.0	530.0	OCT	20F84480-449D-45CD-AEDC-509BE72C6B46	true	Solid Tissue	False	Tumor
TCGA-ZF-AA51-01A	1029514b-a32c-4c43-a440-a5ba2709f717	Transitional Cell Papillomas and Carcinomas	1029514b-a32c-4c43-a440-a5ba2709f717	TCGA-ZF-AA51	Bladder	2.0821917808219177	Not Reported	38.0	white	female	not hispanic or latino	Alive	69	-25484.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1714.0	25484.0	Transitional cell carcinoma	no	2009.0	No	6th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25484.0	69.81917808219178	['2019-07-31T16:44:08.659827-05:00', '2019-07-31T16:44:08.659827-05:00']	['0390b070-3dc5-5de6-9c91-f7f3de45ba3c', 'bb6f7410-aed5-5ac0-88c0-a6dd60713811']	['TCGA-ZF-AA51_treatment_1', 'TCGA-ZF-AA51_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:48:33.493444-05:00', '']	01	Primary	71eb8fff-9d34-4727-9dbe-448297379ee8	Primary Tumor	Not Reported	1479.0	130.0	OCT	F2059BDD-0218-47A9-BBA8-BFE95D1CD55E	true	Solid Tissue	False	Tumor
TCGA-DK-A1AF-01A	f3104468-bf17-434b-8a7e-bc3b253121ea	Transitional Cell Papillomas and Carcinomas	f3104468-bf17-434b-8a7e-bc3b253121ea	TCGA-DK-A1AF	Bladder		Not Reported		white	female	not hispanic or latino	Alive	84	-30914.0	1926.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	536.0	30914.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30914.0	84.69589041095891	['2019-07-31T17:01:59.879186-05:00', '2019-07-31T17:01:59.879186-05:00']	['1375506c-6653-52e9-bc22-ce8c59ddc833', 'c697a15b-1789-59b5-84c1-904250693e0e']	['TCGA-DK-A1AF_treatment', 'TCGA-DK-A1AF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:54.819122-05:00']	01	Primary	7f6ea115-7795-4552-bb1c-33bfd5f9fe8a	Primary Tumor	Not Reported	129.0	200.0	OCT	587A4629-6ADF-46A3-9F02-A167120286D2	true	Solid Tissue	False	Tumor
TCGA-XF-A8HC-01A	17ee3278-dc2a-4021-a903-e4ed11e3218b	Transitional Cell Papillomas and Carcinomas	17ee3278-dc2a-4021-a903-e4ed11e3218b	TCGA-XF-A8HC	Bladder		Not Reported		asian	male	not hispanic or latino	Dead	79	-28996.0	1926.0	200.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		28996.0	Papillary transitional cell carcinoma	no	2005.0	No	6th	T3a	8130/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28996.0	79.44109589041096	['2019-07-31T16:44:31.588836-05:00', '2019-07-31T16:44:31.588836-05:00']	['705733ee-9dc1-5fe4-9afb-a1263f6e7311', '7bece475-32b6-5b67-ba52-0eeee9656beb']	['TCGA-XF-A8HC_treatment_1', 'TCGA-XF-A8HC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:48:51.607982-05:00', '']	01	Primary	19aa5ad0-f253-4837-8f04-a21dacb7cf15	Primary Tumor	Not Reported	3146.0	640.0	OCT	A2FF709D-B1C0-4287-BB27-0F96F81BA2CD	true	Solid Tissue	False	Tumor
TCGA-XF-AAMW-01A	19da59a8-b67a-438d-900a-92a71e03bef3	Transitional Cell Papillomas and Carcinomas	19da59a8-b67a-438d-900a-92a71e03bef3	TCGA-XF-AAMW	Bladder		Not Reported		white	female	not hispanic or latino	Dead	79	-28903.0	1927.0	253.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		28903.0	Transitional cell carcinoma	no	2006.0	No	5th	T2b	8120/3	N0		not reported	C67.9	Bladder, NOS	Not Reported	not reported		28903.0	79.18630136986302	['2019-07-31T16:44:41.145663-05:00', '2019-07-31T16:44:41.145663-05:00']	['4d06447b-5de3-5691-b640-af255ccf338c', '838bb2bd-d6cb-58ca-870f-2b8d2b5ffde2']	['TCGA-XF-AAMW_treatment', 'TCGA-XF-AAMW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:59.354297-05:00']	01	Primary	10fe7dbb-4bf4-486e-ada4-bd311aa967c2	Primary Tumor	Not Reported	2682.0	640.0	OCT	F763F16E-C76C-4A58-9096-8B19B9825C9B	true	Solid Tissue	False	Tumor
TCGA-E5-A4U1-01A	1c28f311-e0b0-4292-b29a-c6757665a4a4	Transitional Cell Papillomas and Carcinomas	1c28f311-e0b0-4292-b29a-c6757665a4a4	TCGA-E5-A4U1	Bladder		Not Reported		not reported	male	not hispanic or latino	Alive	72	-26305.0	1939.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	3b76a3ec-899f-5b8f-b869-4c03bf9a222d	E5	Roswell Park	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1181.0	26305.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	26305.0	72.06849315068493	['2019-07-31T16:44:44.165138-05:00', '2019-07-31T16:44:44.165138-05:00']	['a1843a1c-69af-534f-ba65-221467d5a723', 'c382cc96-283b-5d9a-b191-ad381d1d953c']	['TCGA-E5-A4U1_treatment_1', 'TCGA-E5-A4U1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:49:02.024766-05:00', '']	01	Primary	59e8792a-4a68-419d-b30c-3d16fc42a6ca	Primary Tumor	Not Reported	504.0	200.0	Unknown	0010AA87-DA61-42F2-8A3D-49DCDDB7484C	false	Solid Tissue	False	Tumor
TCGA-DK-A1AG-01A	f8c0a69c-df53-4a0a-a30e-4424c0ce3dd5	Transitional Cell Papillomas and Carcinomas	f8c0a69c-df53-4a0a-a30e-4424c0ce3dd5	TCGA-DK-A1AG	Bladder		Not Reported		white	male	not hispanic or latino	Alive	65	-24095.0	1945.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	475.0	24095.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24095.0	66.01369863013699	['2019-07-31T17:02:33.089858-05:00', '2019-07-31T17:02:33.089858-05:00']	['6a28a052-a3f7-5137-80a7-159b8b984b19', 'dd2cfcd0-5d35-547d-9f42-558e8903481d']	['TCGA-DK-A1AG_treatment', 'TCGA-DK-A1AG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:03:22.286165-05:00']	01	Primary	64668aa0-dde5-4534-8cd0-378881e4a4e4	Primary Tumor	Not Reported	169.0	430.0	OCT	CDF2E5C1-FD42-4703-9803-6C08E2FD48BA	true	Solid Tissue	False	Tumor
TCGA-UY-A9PB-01A	f90cff19-1c16-4514-8bc1-169539d01fca	Transitional Cell Papillomas and Carcinomas	f90cff19-1c16-4514-8bc1-169539d01fca	TCGA-UY-A9PB	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Alive	49	-17885.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	899.0	17885.0	Transitional cell carcinoma	no		No	6th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		17885.0	49.0	['2019-07-31T17:02:36.025019-05:00', '2019-07-31T17:02:36.025019-05:00']	['2b731323-235e-5023-b5dd-567a5723215a', 'f0f1221c-6919-554b-888c-c2b9949eee00']	['TCGA-UY-A9PB_treatment_1', 'TCGA-UY-A9PB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:25.662465-05:00', '']	01	Primary	7ef5e57d-c08f-4749-9656-6d0ceabe824a	Primary Tumor	Not Reported		90.0	OCT	1CCAA482-BC52-4F00-89E4-31D0D9BBEAF9	true	Solid Tissue	False	Tumor
TCGA-XF-A9T5-01A	f9a7ab94-70df-4194-8102-66021d01dadd	Transitional Cell Papillomas and Carcinomas	f9a7ab94-70df-4194-8102-66021d01dadd	TCGA-XF-A9T5	Bladder		Not Reported		white	female	not hispanic or latino	Alive	78	-28578.0	1930.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	2027.0	28578.0	Transitional cell carcinoma	yes	2008.0	No	6th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28578.0	78.2958904109589	['2019-07-31T17:02:44.724549-05:00', '2019-07-31T17:02:44.724549-05:00']	['83bcdf85-101c-5afe-98ee-1017bb4a75be', 'fcc4c15b-455f-5d4b-9a28-20578ad61bf3']	['TCGA-XF-A9T5_treatment', 'TCGA-XF-A9T5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:03:32.846900-05:00']	01	Primary	cb05500b-f83d-4d3a-8da1-eedafb7d02ac	Primary Tumor	Not Reported	2105.0	1050.0	OCT	23A2FC99-03F3-4A72-8F33-14ED56125E65	true	Solid Tissue	False	Tumor
TCGA-DK-AA6T-01A	f9b55748-605a-4313-bb19-dcf5476590c2	Transitional Cell Papillomas and Carcinomas	f9b55748-605a-4313-bb19-dcf5476590c2	TCGA-DK-AA6T	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Alive	63	-23198.0	1950.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Trigone of bladder	572.0	23198.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T2	23198.0	63.556164383561644	['2019-07-31T17:02:51.017644-05:00', '2019-07-31T17:02:51.017644-05:00']	['34ad3ea8-2971-5ce3-9dc3-740f37920946', '91b441b2-47cd-5782-8e09-cfbe246aea9e']	['TCGA-DK-AA6T_treatment', 'TCGA-DK-AA6T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:03:37.803549-05:00']	01	Primary	a886d3cb-5733-4a50-8ddb-1fb7fb8c4f71	Primary Tumor	Not Reported	186.0	80.0	OCT	7424FFA2-7BE6-4268-BAF4-4589C4F210AE	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RF-01A	fa05f7f6-50e9-4878-a834-f655c0877394	Transitional Cell Papillomas and Carcinomas	fa05f7f6-50e9-4878-a834-f655c0877394	TCGA-ZF-A9RF	Bladder	2.8493150684931505	Not Reported	52.0	white	male	not hispanic or latino	Alive	74	-27281.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1949.0	27281.0	Transitional cell carcinoma	no	2009.0	No	6th	T1	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27281.0	74.74246575342465	['2019-07-31T17:02:54.001976-05:00', '2019-07-31T17:02:54.001976-05:00']	['004783c7-56c2-55f9-9002-5246161e9370', '9e00aa1c-174d-54c9-8a58-b8b9613b1c9e']	['TCGA-ZF-A9RF_treatment_1', 'TCGA-ZF-A9RF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:40.511110-05:00', '']	01	Primary	29695237-1ba7-4e7e-a89f-158f53f2c4bc	Primary Tumor	Not Reported	1536.0	80.0	OCT	CBA9E3B1-AD28-4E0B-B851-D70ACAED921A	true	Solid Tissue	False	Tumor
TCGA-UY-A8OD-01A	fa2410b1-4f69-446d-99ee-a10a00034c42	Transitional Cell Papillomas and Carcinomas	fa2410b1-4f69-446d-99ee-a10a00034c42	TCGA-UY-A8OD	Bladder		Not Reported		black or african american	female	not hispanic or latino	Alive	68	-24588.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	3432.0	24588.0	Transitional cell carcinoma	no		No	6th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24588.0	67.36438356164383	['2019-07-31T17:02:57.072412-05:00', '2019-07-31T17:02:57.072412-05:00']	['a73fb758-3345-50df-8716-ba575b46448c', 'cc95dca7-5258-5f8e-80f3-ac0cbb74b243']	['TCGA-UY-A8OD_treatment_1', 'TCGA-UY-A8OD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:43.073589-05:00', '']	01	Primary	c53ef182-b87d-4332-8fce-150e8cb904da	Primary Tumor	Not Reported		40.0	OCT	B74B0DFB-0A6B-4E4C-A843-50130DE79C1A	true	Solid Tissue	False	Tumor
TCGA-E7-A6MF-01A	faf3c230-c661-4d6e-9b73-2b679bc6deff	Transitional Cell Papillomas and Carcinomas	faf3c230-c661-4d6e-9b73-2b679bc6deff	TCGA-E7-A6MF	Bladder	0.136986301369863	Not Reported	2.5	asian	male	not hispanic or latino	Alive	37	-13867.0	1976.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	750.0	13867.0	Papillary transitional cell carcinoma	no	2013.0	No	7th	T2a	8130/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	13867.0	37.99178082191781	['2019-07-31T17:03:03.081212-05:00', '2019-07-31T17:03:03.081212-05:00']	['4dab948b-792b-552b-8aad-d0ccfb321be3', 'e7c04577-2ce9-5f65-8aae-0f96f85cd992']	['TCGA-E7-A6MF_treatment_1', 'TCGA-E7-A6MF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:48.161882-05:00', '']	01	Primary	938c0423-dc2c-4321-861a-56b474358624	Primary Tumor	Not Reported	114.0	490.0	OCT	3431AE0E-2696-4DE7-BBA8-E3CD0185632B	true	Solid Tissue	False	Tumor
TCGA-E7-A4IJ-01A	faf4c71c-c4f3-4513-8c44-9114a5d3729a	Transitional Cell Papillomas and Carcinomas	faf4c71c-c4f3-4513-8c44-9114a5d3729a	TCGA-E7-A4IJ	Bladder		Not Reported		asian	male	not hispanic or latino	Dead	56	-20723.0	1956.0	674.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	408.0	20723.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2b	8130/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20723.0	56.775342465753425	['2019-07-31T17:03:05.492343-05:00', '2019-07-31T17:03:05.492343-05:00']	['92c04c5a-a207-5829-8da6-b9a5f23c142d', 'dbf6b3e5-a979-5e87-b322-785e184fe8f5']	['TCGA-E7-A4IJ_treatment_1', 'TCGA-E7-A4IJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:51.333880-05:00', '']	01	Primary	ad01a372-16a9-4c09-81bb-cd0383d0c24b	Primary Tumor	Not Reported	114.0	1200.0	OCT	E926015A-3299-4F9B-AA80-3D46F3CF96C0	true	Solid Tissue	False	Tumor
TCGA-E7-A7XN-01A	286cf147-b7f7-4a05-8e41-7fbd3717ad71	Transitional Cell Papillomas and Carcinomas	286cf147-b7f7-4a05-8e41-7fbd3717ad71	TCGA-E7-A7XN	Bladder	0.547945205479452	Not Reported	10.0	asian	male	not hispanic or latino	Alive	66	-24466.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	428.0	24466.0	Transitional cell carcinoma	no	2013.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24466.0	67.03013698630137	['2019-07-31T16:45:42.109841-05:00', '2019-07-31T16:45:42.109841-05:00']	['4e47bdcd-b40c-5cb6-abac-b4b3aa7e7017', 'e0e8a17f-38a6-5019-9380-6136db11fa6b']	['TCGA-E7-A7XN_treatment_1', 'TCGA-E7-A7XN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:47.831644-05:00', '']	01	Primary	63eec89c-e81f-420e-a7b5-d63a241415f5	Primary Tumor	Not Reported	90.0	780.0	OCT	FB206F17-A9B7-4EDE-8DA3-62A7C99BBEB2	true	Solid Tissue	False	Tumor
TCGA-E7-A678-01A	29c52372-d3a7-4188-b468-67c3451c4f20	Transitional Cell Papillomas and Carcinomas	29c52372-d3a7-4188-b468-67c3451c4f20	TCGA-E7-A678	Bladder	1.36986301369863	Not Reported	25.0	asian	male	not hispanic or latino	Alive	55	-20169.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	798.0	20169.0	Transitional cell carcinoma	no	2012.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20169.0	55.25753424657534	['2019-07-31T16:45:48.343468-05:00', '2019-07-31T16:45:48.343468-05:00']	['53d3384f-38fc-55fe-9ac7-1763c162955b', 'e6b3c6c7-10d0-5d6d-80b7-a10624d15beb']	['TCGA-E7-A678_treatment_1', 'TCGA-E7-A678_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:53.305184-05:00', '']	01	Primary	64ed8359-fb2a-4403-b863-7d5988df5ffe	Primary Tumor	Not Reported	104.0	950.0	OCT	21E3AC3F-5CD6-4E9F-8583-B21642258D07	true	Solid Tissue	False	Tumor
TCGA-FD-A6TG-01A	0c890030-9bdb-4247-a3d5-a004f992f99c	Transitional Cell Papillomas and Carcinomas	0c890030-9bdb-4247-a3d5-a004f992f99c	TCGA-FD-A6TG	Bladder	0.547945205479452	Not Reported	10.0	white	male	not hispanic or latino	Dead	73	-26893.0	1940.0	93.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	81.0	26893.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	26893.0	73.67945205479452	['2019-07-31T16:43:48.114417-05:00', '2019-07-31T16:43:48.114417-05:00']	['107982d5-65e9-5c03-b811-3fc68f75fcf0', 'f35b5222-b612-5388-82ec-eecaaceec22f']	['TCGA-FD-A6TG_treatment_1', 'TCGA-FD-A6TG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:48:16.304381-05:00', '']	01	Primary	fa9f9744-0123-4d33-be9a-000e8a24bd22	Primary Tumor	Not Reported	69.0	1100.0	OCT	0F4A353C-3292-4C6C-85AC-A621109D3F24	true	Solid Tissue	False	Tumor
TCGA-XF-AAMX-01A	edc290bf-9731-4f03-bc37-64542e78e8bb	Transitional Cell Papillomas and Carcinomas	edc290bf-9731-4f03-bc37-64542e78e8bb	TCGA-XF-AAMX	Bladder		Not Reported		black or african american	female	not hispanic or latino	Dead	87	-31884.0	1919.0	206.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		31884.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31884.0	87.35342465753425	['2019-07-31T17:01:36.199839-05:00', '2019-07-31T17:01:36.199839-05:00']	['aef0808f-0afb-5972-980b-5e032189e27b', 'f01609f0-7bcc-5a0f-a57d-1f2ce8662654']	['TCGA-XF-AAMX_treatment', 'TCGA-XF-AAMX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:02:35.328243-05:00']	01	Primary	c4f39a7a-fc9c-4ed1-b5ba-a6ca641dee58	Primary Tumor	Not Reported	2730.0	1410.0	OCT	22526530-46B1-4DB8-A1EB-2D97AB18FD63	true	Solid Tissue	False	Tumor
TCGA-XF-A8HI-01A	eed3908f-f1bd-4254-bca8-bc1a7427e95c	Transitional Cell Papillomas and Carcinomas	eed3908f-f1bd-4254-bca8-bc1a7427e95c	TCGA-XF-A8HI	Bladder		Not Reported		white	female	not hispanic or latino	Dead	57	-21059.0	1948.0	544.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		21059.0	Papillary transitional cell carcinoma	no	2005.0	No	6th	T2b	8130/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21059.0	57.6958904109589	['2019-07-31T17:01:42.128099-05:00', '2019-07-31T17:01:42.128099-05:00']	['18953517-fa85-56ac-b709-3969f33cc090', '5c67e1c5-c325-5979-b84a-79791057cb6d']	['TCGA-XF-A8HI_treatment_1', 'TCGA-XF-A8HI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:40.048085-05:00', '']	01	Primary	227a8e56-3e04-4244-96ee-f9d2da882079	Primary Tumor	Not Reported	3153.0	270.0	OCT	737E5709-0C1B-488C-B915-84F26A4B86D8	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R1-01A	f1bd8305-5c3f-4c82-9e68-ba9cf4ecdf7b	Transitional Cell Papillomas and Carcinomas	f1bd8305-5c3f-4c82-9e68-ba9cf4ecdf7b	TCGA-ZF-A9R1	Bladder		Not Reported		white	male	not hispanic or latino	Alive	81	-29610.0	1932.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	773.0	29610.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T1	29610.0	81.12328767123287	['2019-07-31T17:01:56.647853-05:00', '2019-07-31T17:01:56.647853-05:00']	['28b88b22-7046-52a2-b801-816884f9fe77', '37e13b4c-398d-59a5-9067-32e750b61408']	['TCGA-ZF-A9R1_treatment_1', 'TCGA-ZF-A9R1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:52.461196-05:00', '']	01	Primary	58a00e33-adbc-499f-bb0d-5c8463ae7a5d	Primary Tumor	Not Reported	317.0	150.0	OCT	D0951273-E0D2-4B6F-8033-4745A2AAD74E	true	Solid Tissue	False	Tumor
TCGA-CF-A47W-01A	122fc134-8915-47db-96c9-ab1853c3cd18	Transitional Cell Papillomas and Carcinomas	122fc134-8915-47db-96c9-ab1853c3cd18	TCGA-CF-A47W	Bladder	0.547945205479452	Not Reported	10.0	asian	male	not hispanic or latino	Alive	42	-15497.0	1970.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	368.0	15497.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	15497.0	42.45753424657534	['2019-07-31T16:44:18.630316-05:00', '2019-07-31T16:44:18.630316-05:00']	['2da49231-d07c-5335-a1b6-3a199e217c73', '8a779972-38a0-5ab5-828e-f8b96da7e161']	['TCGA-CF-A47W_treatment', 'TCGA-CF-A47W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:41.272863-05:00']	01	Primary	3e3f2238-288d-42f4-95ff-1bb8c1a3373b	Primary Tumor	Not Reported	192.0	450.0	OCT	2246A9D0-E96B-4FC1-83D1-D04845B003F9	true	Solid Tissue	False	Tumor
TCGA-DK-A3IL-01A	178b28cd-99c3-48dc-8d09-1ef71b4cee80	Transitional Cell Papillomas and Carcinomas	178b28cd-99c3-48dc-8d09-1ef71b4cee80	TCGA-DK-A3IL	Bladder	5.917808219178082	Not Reported	108.0	white	female	not hispanic or latino	Dead	79	-29047.0	1932.0	413.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	121.0	29047.0	Transitional cell carcinoma	no	2011.0	No	6th	T3	8120/3	N2	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		29047.0	79.58082191780822	['2019-07-31T16:44:28.109776-05:00', '2019-07-31T16:44:28.109776-05:00']	['00e94e2c-d7ad-59ba-87cc-59c97dd7b245', '279fe2e9-3e23-5e25-9d80-95bfb30d9fb8']	['TCGA-DK-A3IL_treatment', 'TCGA-DK-A3IL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:48:49.173765-05:00']	01	Primary	59d6683f-5eb7-493d-8e8e-78b88be2cd70	Primary Tumor	Not Reported	149.0	240.0	OCT	FE31B934-2AE5-4CA6-981D-DF7C0F9E1677	true	Solid Tissue	False	Tumor
TCGA-G2-A2EL-01A	30c7445e-d0c4-4a0f-96a4-27e4259ee10b	Transitional Cell Papillomas and Carcinomas	30c7445e-d0c4-4a0f-96a4-27e4259ee10b	TCGA-G2-A2EL	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	77	-28370.0	1932.0	819.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder		28370.0	Transitional cell carcinoma	no	2009.0	No	6th		8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2a	28370.0	77.72602739726027	['2019-07-31T16:46:05.810704-05:00', '2019-07-31T16:46:05.810704-05:00']	['28c50dc7-75af-5efd-be1f-41ef09d4172d', '7341a904-5563-53a6-924b-42b963bfda46']	['TCGA-G2-A2EL_treatment', 'TCGA-G2-A2EL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:50:07.669753-05:00']	01	Primary	90f1d206-3e97-4c88-922c-fe4773c37caa	Primary Tumor	Not Reported	698.0	120.0	OCT	E021F112-7358-4CD0-870A-A29D0115CAE3	true	Solid Tissue	False	Tumor
TCGA-K4-A5RI-01A	32efe5e2-e037-4547-8ead-619f61647639	Transitional Cell Papillomas and Carcinomas	32efe5e2-e037-4547-8ead-619f61647639	TCGA-K4-A5RI	Bladder	2.191780821917808	Not Reported	40.0	white	female	not hispanic or latino	Dead	67	-24614.0	1945.0	356.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	239.0	24614.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	TX	24614.0	67.43561643835616	['2019-07-31T16:46:25.551063-05:00', '2019-07-31T16:46:25.551063-05:00']	['3a1070e8-5108-59d7-86ab-bb62a29c1f78', '569c1f76-4670-546f-9663-a029a5d04723']	['TCGA-K4-A5RI_treatment', 'TCGA-K4-A5RI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:23.922103-05:00']	01	Primary	6e3f1eb8-b294-4058-b8dd-fc853d13b3f0	Primary Tumor	Not Reported	100.0	320.0	OCT	F61654B9-A305-40B9-97FE-A22B9EE1375D	true	Solid Tissue	False	Tumor
TCGA-K4-A5RI-11A	32efe5e2-e037-4547-8ead-619f61647639	Transitional Cell Papillomas and Carcinomas	32efe5e2-e037-4547-8ead-619f61647639	TCGA-K4-A5RI	Bladder	2.191780821917808	Not Reported	40.0	white	female	not hispanic or latino	Dead	67	-24614.0	1945.0	356.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	239.0	24614.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	TX	24614.0	67.43561643835616	['2019-07-31T16:46:25.551063-05:00', '2019-07-31T16:46:25.551063-05:00']	['3a1070e8-5108-59d7-86ab-bb62a29c1f78', '569c1f76-4670-546f-9663-a029a5d04723']	['TCGA-K4-A5RI_treatment', 'TCGA-K4-A5RI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:23.922103-05:00']	11	Not Applicable	c7d68b77-e250-42e7-8bad-987843191eea	Solid Tissue Normal	Not Reported	100.0	230.0	OCT		true	Solid Tissue	False	Normal
TCGA-GV-A3QH-01A	33bc6a7c-9844-41e3-96b3-1e34bb3fedd5	Transitional Cell Papillomas and Carcinomas	33bc6a7c-9844-41e3-96b3-1e34bb3fedd5	TCGA-GV-A3QH	Bladder	0.547945205479452	Not Reported	10.0	white	male	not hispanic or latino	Dead	67	-24681.0	1944.0	258.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Trigone of bladder	237.0	24681.0	Transitional cell carcinoma	no	2011.0	No	7th		8120/3	NX	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T2	24681.0	67.61917808219178	['2019-07-31T16:46:29.026716-05:00', '2019-07-31T16:46:29.026716-05:00']	['163dd9e9-8d81-5a87-aefb-569d6030fd03', 'a43bba83-08cf-5f01-91fb-76a5f82be6b8']	['TCGA-GV-A3QH_treatment', 'TCGA-GV-A3QH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:50:26.523456-05:00']	01	Primary	deb7311f-e747-44ec-92c3-1e56cd5cacf2	Primary Tumor	Not Reported	162.0	120.0	OCT	7492187D-9243-482E-B2A0-08CAD7EB7DBE	true	Solid Tissue	False	Tumor
TCGA-DK-A1AC-01A	36c14e9d-1863-4c55-bbbb-f8c9dd418932	Transitional Cell Papillomas and Carcinomas	36c14e9d-1863-4c55-bbbb-f8c9dd418932	TCGA-DK-A1AC	Bladder	1.095890410958904	Not Reported	20.0	white	male	not reported	Alive	72	-26307.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	3981.0	26307.0	Transitional cell carcinoma	yes	2000.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26307.0	72.07397260273973	['2019-07-31T16:46:42.181631-05:00', '2019-07-31T16:46:42.181631-05:00']	['b82eba52-38fb-5166-b920-cfcb3c54808b', 'e1e69690-a2c5-5fa4-b982-bb3ab6d09779']	['TCGA-DK-A1AC_treatment_1', 'TCGA-DK-A1AC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:50:37.155368-05:00', '']	01	Primary	cd2fb6b8-5db9-42b4-a407-a5b6f7b8665f	Primary Tumor	Not Reported	3689.0	330.0	OCT	6A32EB34-E83A-4665-8DEA-F4CEB7CBF52D	true	Solid Tissue	False	Tumor
TCGA-CF-A1HR-01A	39ea19e1-4959-4f1b-9934-54bdaf766842	Transitional Cell Papillomas and Carcinomas	39ea19e1-4959-4f1b-9934-54bdaf766842	TCGA-CF-A1HR	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	62	-22777.0	1948.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	389.0	22777.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22777.0	62.4027397260274	['2019-07-31T15:23:11.309605-05:00', '2019-07-31T15:23:11.309605-05:00']	['16ce23d6-796d-5d84-9d0c-c2c049d8f0ed', '4a9f5926-2696-5d46-860c-13fe78459efd']	['TCGA-CF-A1HR_treatment_1', 'TCGA-CF-A1HR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T08:42:56.633243-05:00', '']	01	Primary	6e77ab45-9c53-4a74-9581-043005c3e685	Primary Tumor	Not Reported	64.0	300.0	OCT	A3E36F4A-596B-433A-8898-1BFA6E715816	true	Solid Tissue	False	Tumor
TCGA-DK-A3IS-01A	9f75cc89-cc3f-4ae9-973d-da37c6417bfc	Transitional Cell Papillomas and Carcinomas	9f75cc89-cc3f-4ae9-973d-da37c6417bfc	TCGA-DK-A3IS	Bladder		Not Reported		white	male	not hispanic or latino	Alive	68	-25098.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	['TCGA-DK-A3IS', 'TCGA-DK-A3IS']	['Patient had synchronous prostate cancer and prior basal cell carcinoma. No radiation or systemic chemotherapy.', 'Patient had synchronous prostate cancer and prior basal cell carcinoma. No radiation or systemic chemotherapy']	['15254', '15256']	['Notification', 'Notification']	['9f75cc89-cc3f-4ae9-973d-da37c6417bfc', '9f75cc89-cc3f-4ae9-973d-da37c6417bfc']	['2013-01-31T00:00:00', '2013-01-31T00:00:00']	['0059ca72-5750-5754-bdfa-a470f1534e23', '966a3dce-a056-5eb3-aa13-fb56063d986f']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['9f75cc89-cc3f-4ae9-973d-da37c6417bfc', '9f75cc89-cc3f-4ae9-973d-da37c6417bfc']	['released', 'released']	['Prior malignancy', 'Synchronous malignancy']	['Approved', 'Approved']	['TCGA-DK-A3IS', 'TCGA-DK-A3IS']	Not Reported	Stage II	0	not reported	Bladder, NOS	1529.0	25098.0	Transitional cell carcinoma	yes	2008.0	No	6th	T2a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25098.0	68.76164383561644	['2019-07-31T16:55:57.708211-05:00', '2019-07-31T16:55:57.708211-05:00']	['4fe222e9-732e-511e-adec-075b53684a96', 'e803053e-7d38-5075-853e-b0b8103c83c0']	['TCGA-DK-A3IS_treatment_1', 'TCGA-DK-A3IS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:59.823364-05:00', '']	01	Primary	956dedad-c152-4d04-b191-9a627f291efe	Primary Tumor	Not Reported	1279.0	100.0	OCT	2387C5D6-37CA-40C0-A122-228070BEE480	true	Solid Tissue	False	Tumor
TCGA-BT-A42C-01A	b9808ef9-e917-45f9-9e0f-b86f7834b5ff	Transitional Cell Papillomas and Carcinomas	b9808ef9-e917-45f9-9e0f-b86f7834b5ff	TCGA-BT-A42C	Bladder	7.232876712328767	Not Reported	132.0	white	male	not hispanic or latino	Alive	64	-23584.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH	TCGA-BT-A42C	Patient received BCG treatment for a non-muscle invasive bladder cancer	15241	Notification	b9808ef9-e917-45f9-9e0f-b86f7834b5ff	2013-01-29T00:00:00	008158fd-2a2e-584e-8d47-989929336ab3	case	2018-08-23T16:32:20.747393-05:00	b9808ef9-e917-45f9-9e0f-b86f7834b5ff	released	History of acceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BT-A42C	Not Reported	Stage II	0	not reported	Lateral wall of bladder	873.0	23584.0	Papillary transitional cell carcinoma	yes	2011.0	No	7th		8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2a	23584.0	64.61369863013698	['2019-07-31T16:57:56.628950-05:00', '2019-07-31T16:57:56.628950-05:00']	['3b787f49-053b-5b40-b8cf-3c379e6d755a', '89f05166-e8a1-5126-8828-6adc03f1320c']	['TCGA-BT-A42C_treatment_1', 'TCGA-BT-A42C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:35.139209-05:00', '']	01	Primary	384aea4d-d779-49d2-aa44-9945ab702fa2	Primary Tumor	Not Reported	274.0	190.0	OCT	8716FEB2-A4DD-4EFF-B1A6-D679A5C75C76	true	Solid Tissue	False	Tumor
TCGA-BT-A20V-11A	24f21425-b001-4986-aedf-5b4dd851c6ad	Transitional Cell Papillomas and Carcinomas	24f21425-b001-4986-aedf-5b4dd851c6ad	TCGA-BT-A20V	Bladder		Not Reported		black or african american	female	not hispanic or latino	Dead	59	-21551.0	1949.0	154.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH	TCGA-BT-A20V	Per EPC pathology review this case may be a cervical primary and not a bladder primary.	29864	Observation	24f21425-b001-4986-aedf-5b4dd851c6ad	2016-02-17T00:00:00	04317f48-872d-5650-bd1f-7d8d64959f33	case	2018-08-23T16:32:20.747393-05:00	24f21425-b001-4986-aedf-5b4dd851c6ad	released	Item may not meet study protocol	Approved	TCGA-BT-A20V	No	Stage IV	0	not reported	Lateral wall of bladder		21551.0	Transitional cell carcinoma	no	2008.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T4a	21551.0	59.04383561643836	['2019-07-31T16:45:20.113272-05:00', '2019-07-31T16:45:20.113272-05:00']	['6e506d79-a0bf-5a3e-a2eb-909d322f4acb', '75120752-a2bf-55b0-a8a0-fb414bef9b97']	['TCGA-BT-A20V_treatment_1', 'TCGA-BT-A20V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:30.973311-05:00', '']	11	Not Applicable	1c7630ed-6b1c-4569-a15c-e296772868de	Solid Tissue Normal		1072.0	210.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20V-01A	24f21425-b001-4986-aedf-5b4dd851c6ad	Transitional Cell Papillomas and Carcinomas	24f21425-b001-4986-aedf-5b4dd851c6ad	TCGA-BT-A20V	Bladder		Not Reported		black or african american	female	not hispanic or latino	Dead	59	-21551.0	1949.0	154.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH	TCGA-BT-A20V	Per EPC pathology review this case may be a cervical primary and not a bladder primary.	29864	Observation	24f21425-b001-4986-aedf-5b4dd851c6ad	2016-02-17T00:00:00	04317f48-872d-5650-bd1f-7d8d64959f33	case	2018-08-23T16:32:20.747393-05:00	24f21425-b001-4986-aedf-5b4dd851c6ad	released	Item may not meet study protocol	Approved	TCGA-BT-A20V	No	Stage IV	0	not reported	Lateral wall of bladder		21551.0	Transitional cell carcinoma	no	2008.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T4a	21551.0	59.04383561643836	['2019-07-31T16:45:20.113272-05:00', '2019-07-31T16:45:20.113272-05:00']	['6e506d79-a0bf-5a3e-a2eb-909d322f4acb', '75120752-a2bf-55b0-a8a0-fb414bef9b97']	['TCGA-BT-A20V_treatment_1', 'TCGA-BT-A20V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:30.973311-05:00', '']	01	Primary	967443e3-35c3-4f41-9bb5-dc899d290806	Primary Tumor		1072.0	360.0	OCT	9D40A90D-AD9C-4754-A65C-799C23183534	true	Solid Tissue	False	Tumor
TCGA-DK-A2HX-01A	c728fac9-5452-4759-a4ed-a366e0f757cb	Transitional Cell Papillomas and Carcinomas	c728fac9-5452-4759-a4ed-a366e0f757cb	TCGA-DK-A2HX	Bladder	1.095890410958904	Not Reported	20.0	white	female	not hispanic or latino	Dead	80	-29332.0	1930.0	1420.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A2HX	Patient had synchronous gastrointestinal stromal tumor. No systemic chemotherapy.	15251	Notification	c728fac9-5452-4759-a4ed-a366e0f757cb	2013-01-29T00:00:00	0724214c-bfd3-54f0-b6b8-5c191b701fa3	case	2018-08-23T16:32:20.747393-05:00	c728fac9-5452-4759-a4ed-a366e0f757cb	released	Synchronous malignancy	Approved	TCGA-DK-A2HX	Not Reported	Stage IV	0	not reported	Bladder, NOS	55.0	29332.0	Transitional cell carcinoma	yes	2010.0	No	6th	T3	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29332.0	80.36164383561643	['2019-07-31T16:58:46.525015-05:00', '2019-07-31T16:58:46.525015-05:00']	['a2e49d1d-caaa-51aa-9094-3b75e52bf5c5', 'a8180ba2-9263-51b4-82b0-921563dc6135']	['TCGA-DK-A2HX_treatment_1', 'TCGA-DK-A2HX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T10:00:16.109863-05:00', '']	01	Primary	537f3fe6-4e8e-4570-827a-0f5cab193be0	Primary Tumor	Not Reported	182.0	690.0	OCT	D531397C-85E3-4C46-BB9C-0780CBFE25D6	true	Solid Tissue	False	Tumor
TCGA-GC-A3WC-01A	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	Transitional Cell Papillomas and Carcinomas	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	TCGA-GC-A3WC	Bladder	0.7671232876712328	Not Reported	14.0	white	female	not hispanic or latino	Alive	80	-29295.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3WC	Patient had a prior breast cancer. No radiation or systemic chemotherapy.	15276	Notification	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	2013-02-01T00:00:00	0c6e76d0-c23a-588d-9e8b-bdb124071249	case	2018-08-23T16:32:20.747393-05:00	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	released	Prior malignancy	Approved	TCGA-GC-A3WC	Not Reported	Stage III	0	not reported	Bladder, NOS	540.0	29295.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29295.0	80.26027397260275	['2019-07-31T17:00:38.325674-05:00', '2019-07-31T17:00:38.325674-05:00']	['9df77109-f5d4-568b-90a5-ba1abf530a29', 'f0b1a770-4d33-5616-ba5d-c42b48b305de']	['TCGA-GC-A3WC_treatment_1', 'TCGA-GC-A3WC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:47.372654-05:00', '']	01	Primary	24f9d01b-1210-4716-9466-8fe9f3612b8b	Primary Tumor	Not Reported	119.0	230.0	Unknown	91347009-C0A1-4BB1-8445-D00B769B59AF	false	Solid Tissue	False	Tumor
TCGA-GC-A3WC-11A	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	Transitional Cell Papillomas and Carcinomas	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	TCGA-GC-A3WC	Bladder	0.7671232876712328	Not Reported	14.0	white	female	not hispanic or latino	Alive	80	-29295.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3WC	Patient had a prior breast cancer. No radiation or systemic chemotherapy.	15276	Notification	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	2013-02-01T00:00:00	0c6e76d0-c23a-588d-9e8b-bdb124071249	case	2018-08-23T16:32:20.747393-05:00	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	released	Prior malignancy	Approved	TCGA-GC-A3WC	Not Reported	Stage III	0	not reported	Bladder, NOS	540.0	29295.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29295.0	80.26027397260275	['2019-07-31T17:00:38.325674-05:00', '2019-07-31T17:00:38.325674-05:00']	['9df77109-f5d4-568b-90a5-ba1abf530a29', 'f0b1a770-4d33-5616-ba5d-c42b48b305de']	['TCGA-GC-A3WC_treatment_1', 'TCGA-GC-A3WC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:47.372654-05:00', '']	11	Not Applicable	67ecde91-9420-41f4-ae8a-5da68d3eeabc	Solid Tissue Normal	Not Reported	119.0	80.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FD-A3B6-01A	36054200-3fa4-4541-a25c-47282e4ef88d	Transitional Cell Papillomas and Carcinomas	36054200-3fa4-4541-a25c-47282e4ef88d	TCGA-FD-A3B6	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Dead	75	-27541.0	1936.0	1005.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A3B6	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15259	Notification	36054200-3fa4-4541-a25c-47282e4ef88d	2013-01-31T00:00:00	10eaaee5-490f-52c4-9d99-cc9bbac846dd	case	2018-08-23T16:32:20.747393-05:00	36054200-3fa4-4541-a25c-47282e4ef88d	released	Synchronous malignancy	Approved	TCGA-FD-A3B6	Not Reported	Stage II	0	not reported	Posterior wall of bladder	209.0	27541.0	Papillary transitional cell carcinoma	yes	2011.0	No	7th	T2b	8130/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	27541.0	75.45479452054795	['2019-07-31T16:46:38.802871-05:00', '2019-07-31T16:46:38.802871-05:00']	['01749a96-4353-5bd7-9baf-f3d694c88fc2', '8ec437ba-4bb2-5d2d-9365-19cd5fdeb61b']	['TCGA-FD-A3B6_treatment', 'TCGA-FD-A3B6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:34.319565-05:00']	01	Primary	d6818c85-5857-44b0-ad64-1eeb53b80606	Primary Tumor	Not Reported	133.0	470.0	Unknown	7FC255AC-F494-49EB-B90A-A43409E15CD5	false	Solid Tissue	False	Tumor
TCGA-FD-A3NA-01A	14917461-dae4-44cb-909d-42ac45aef450	Transitional Cell Papillomas and Carcinomas	14917461-dae4-44cb-909d-42ac45aef450	TCGA-FD-A3NA	Bladder	2.4657534246575343	Not Reported	45.0	white	male	not hispanic or latino	Alive	60	-21936.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A3NA	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15263	Notification	14917461-dae4-44cb-909d-42ac45aef450	2013-01-31T00:00:00	223aefe9-bf46-56e9-b00d-bc74cd4fea83	case	2018-08-23T16:32:20.747393-05:00	14917461-dae4-44cb-909d-42ac45aef450	released	Synchronous malignancy	Approved	TCGA-FD-A3NA	Not Reported	Stage II	0	not reported	Posterior wall of bladder	1845.0	21936.0	Transitional cell carcinoma	yes	2009.0	No	6th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		21936.0	60.0986301369863	['2019-07-31T16:44:25.007251-05:00', '2019-07-31T16:44:25.007251-05:00']	['6e51a6b4-bb47-588a-ad54-87a211412c5d', '88917c2e-6c75-5e52-80f7-c1d3fd603072']	['TCGA-FD-A3NA_treatment_1', 'TCGA-FD-A3NA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:48:46.483782-05:00', '']	01	Primary	7bd000ab-6f48-4a9e-98a4-eaf47d6e3c05	Primary Tumor	Not Reported	997.0	320.0	OCT	D738C31B-26D6-4B68-ABFE-01E6FE6A4F55	true	Solid Tissue	False	Tumor
TCGA-GV-A3QG-01A	79f23a0e-5aae-4618-8191-7dd7c0552408	Transitional Cell Papillomas and Carcinomas	79f23a0e-5aae-4618-8191-7dd7c0552408	TCGA-GV-A3QG	Bladder	2.5205479452054793	Not Reported	46.0	white	male	not hispanic or latino	Dead	65	-23847.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH	['TCGA-GV-A3QG', 'TCGA-GV-A3QG']	['Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.', 'Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.']	['15280', '15281']	['Notification', 'Notification']	['79f23a0e-5aae-4618-8191-7dd7c0552408', '79f23a0e-5aae-4618-8191-7dd7c0552408']	['2013-02-01T00:00:00', '2013-02-01T00:00:00']	['22a18d5f-fc4d-546f-bd5e-24fca00bbf99', '2cfc836c-eb7c-5be7-b88f-c665bba8d28d']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['79f23a0e-5aae-4618-8191-7dd7c0552408', '79f23a0e-5aae-4618-8191-7dd7c0552408']	['released', 'released']	['Synchronous malignancy', 'Prior malignancy']	['Approved', 'Approved']	['TCGA-GV-A3QG', 'TCGA-GV-A3QG']	Not Reported	Stage IV	0	not reported	Posterior wall of bladder		23847.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3a	8120/3	N3	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23847.0	65.33424657534246	['2019-07-31T16:53:07.153195-05:00', '2019-07-31T16:53:07.153195-05:00']	['571db996-6eb7-5755-943f-1aa53e48e398', '85e9f634-405c-5619-a625-dfb561828d27']	['TCGA-GV-A3QG_treatment', 'TCGA-GV-A3QG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:43.521762-05:00']	01	Primary	fb9b1639-242f-4019-937f-dd13c40d9c2b	Primary Tumor	Not Reported	64.0	180.0	OCT	60B86A97-E046-40B9-B86E-6498CC6F864B	true	Solid Tissue	False	Tumor
TCGA-C4-A0EZ-01A	05935f1d-77c2-46ca-b87a-7a84bce38afd	Transitional Cell Papillomas and Carcinomas	05935f1d-77c2-46ca-b87a-7a84bce38afd	TCGA-C4-A0EZ	Bladder	1.8630136986301369	Not Reported	34.0	not reported	female	not reported	Dead	69	-25202.0	1937.0	273.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	af546e3d-a713-5d08-88f4-d8a64d54f2a4	C4	Indivumed	Bladder Urothelial Carcinoma	NCH	TCGA-C4-A0EZ	Patient had a melanoma of the lower limb. No radiation or systemic chemotherapy.	15242	Notification	05935f1d-77c2-46ca-b87a-7a84bce38afd	2013-01-29T00:00:00	30920ce4-35a0-5f87-9133-3a130e0ca61c	case	2018-08-23T16:32:20.747393-05:00	05935f1d-77c2-46ca-b87a-7a84bce38afd	released	Prior malignancy	Approved	TCGA-C4-A0EZ	Not Reported	Stage IV	0	not reported	Bladder, NOS		25202.0	Transitional cell carcinoma	yes	2006.0	No	5th	T3a	8120/3	N1	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25202.0	69.04657534246576	['2019-07-31T16:43:20.994281-05:00', '2019-07-31T16:43:20.994281-05:00']	['46c2e0b0-ec30-5828-8315-84839cf28c51', '9b168bcf-eb43-5f86-ae7b-bc452c6ba8ba']	['TCGA-C4-A0EZ_treatment', 'TCGA-C4-A0EZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:47:53.688673-05:00']	01	Primary	75f55447-5584-4a98-a3a3-8e90d50efdbc	Primary Tumor	Not Reported	1299.0	210.0	Unknown	DB053F32-6DBF-45A8-AF18-4DF817CB6444	false	Solid Tissue	False	Tumor
TCGA-CU-A0YR-01A	811b3950-36e7-485f-bc48-aca1eee2ddef	Transitional Cell Papillomas and Carcinomas	811b3950-36e7-485f-bc48-aca1eee2ddef	TCGA-CU-A0YR	Bladder	0.6575342465753424	Not Reported	12.0	white	male	not hispanic or latino	Dead	83	-30674.0	1927.0	460.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	TCGA-CU-A0YR	Patient was previously diagnosed with prostate cancer. No radiation or systemic chemotherapy.	15246	Notification	811b3950-36e7-485f-bc48-aca1eee2ddef	2013-01-29T00:00:00	3a3b49ae-a690-54a8-902f-d1e86b5b8f0d	case	2018-08-23T16:32:20.747393-05:00	811b3950-36e7-485f-bc48-aca1eee2ddef	released	Prior malignancy	Approved	TCGA-CU-A0YR	No	Stage IV	0	not reported	Bladder, NOS	219.0	30674.0	Transitional cell carcinoma	no	2010.0	No		T2	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30674.0	84.03835616438356	['2019-07-31T16:53:28.611014-05:00', '2019-07-31T16:53:28.611014-05:00']	['8168daf0-8cf6-509c-96e1-f910a657abb1', 'd80b9a75-8eb0-5129-959f-0f0189e982d4']	['TCGA-CU-A0YR_treatment', 'TCGA-CU-A0YR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:00.951465-05:00']	01	Primary	b362fcfa-4e31-4321-9e17-11a8bae839c3	Primary Tumor	Not Reported	184.0	80.0	Unknown	F46FA517-9F64-46C0-AE22-36F1453D3266	false	Solid Tissue	False	Tumor
TCGA-CU-A0YR-11A	811b3950-36e7-485f-bc48-aca1eee2ddef	Transitional Cell Papillomas and Carcinomas	811b3950-36e7-485f-bc48-aca1eee2ddef	TCGA-CU-A0YR	Bladder	0.6575342465753424	Not Reported	12.0	white	male	not hispanic or latino	Dead	83	-30674.0	1927.0	460.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	TCGA-CU-A0YR	Patient was previously diagnosed with prostate cancer. No radiation or systemic chemotherapy.	15246	Notification	811b3950-36e7-485f-bc48-aca1eee2ddef	2013-01-29T00:00:00	3a3b49ae-a690-54a8-902f-d1e86b5b8f0d	case	2018-08-23T16:32:20.747393-05:00	811b3950-36e7-485f-bc48-aca1eee2ddef	released	Prior malignancy	Approved	TCGA-CU-A0YR	No	Stage IV	0	not reported	Bladder, NOS	219.0	30674.0	Transitional cell carcinoma	no	2010.0	No		T2	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30674.0	84.03835616438356	['2019-07-31T16:53:28.611014-05:00', '2019-07-31T16:53:28.611014-05:00']	['8168daf0-8cf6-509c-96e1-f910a657abb1', 'd80b9a75-8eb0-5129-959f-0f0189e982d4']	['TCGA-CU-A0YR_treatment', 'TCGA-CU-A0YR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:00.951465-05:00']	11	Not Applicable	c60912e4-2f70-4c1e-91bd-f2f5548e532b	Solid Tissue Normal	Not Reported	184.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BT-A3PJ-01A	cb664eef-be6f-44ef-aa90-6f6da0e6440a	Transitional Cell Papillomas and Carcinomas	cb664eef-be6f-44ef-aa90-6f6da0e6440a	TCGA-BT-A3PJ	Bladder		Not Reported		white	male	not hispanic or latino	Alive	76	-27821.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH	TCGA-BT-A3PJ	Synchronous prostate malignancy. No radiation or systemic chemotherapy.	15240	Notification	cb664eef-be6f-44ef-aa90-6f6da0e6440a	2013-01-29T00:00:00	3e69484a-4e40-5fb7-8486-b17bc9ed6d3d	case	2018-08-23T16:32:20.747393-05:00	cb664eef-be6f-44ef-aa90-6f6da0e6440a	released	Synchronous malignancy	Approved	TCGA-BT-A3PJ	No	Stage III	0	not reported	Lateral wall of bladder	789.0	27821.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		27821.0	76.22191780821917	['2019-07-31T16:59:09.690669-05:00', '2019-07-31T16:59:09.690669-05:00']	['94e6c866-44c4-5d3f-97c9-461405431823', 'b56d4934-143d-5729-a397-e466d146c165']	['TCGA-BT-A3PJ_treatment', 'TCGA-BT-A3PJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:00:35.637375-05:00']	01	Primary	29d79b83-fa80-490e-a8a1-c51c9ad061fe	Primary Tumor	Not Reported	98.0	160.0	OCT	D2E98BC0-ED05-4653-9515-259D0361F2C4	true	Solid Tissue	False	Tumor
TCGA-CU-A3KJ-01A	a75584bc-bef7-48f6-b4b3-c1472a3af768	Transitional Cell Papillomas and Carcinomas	a75584bc-bef7-48f6-b4b3-c1472a3af768	TCGA-CU-A3KJ	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Alive	75	-27692.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	['TCGA-CU-A3KJ', 'TCGA-CU-A3KJ']	['Patient was previously diagnosed with non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.', 'Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.']	['15247', '15248']	['Notification', 'Notification']	['a75584bc-bef7-48f6-b4b3-c1472a3af768', 'a75584bc-bef7-48f6-b4b3-c1472a3af768']	['2013-01-29T00:00:00', '2013-01-29T00:00:00']	['47ff3c68-973c-5a84-8ff4-c87fee43d02c', 'f6d56712-d6bd-5e85-9f75-2369b7ed6bd0']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['a75584bc-bef7-48f6-b4b3-c1472a3af768', 'a75584bc-bef7-48f6-b4b3-c1472a3af768']	['released', 'released']	['Prior malignancy', 'Synchronous malignancy']	['Approved', 'Approved']	['TCGA-CU-A3KJ', 'TCGA-CU-A3KJ']	Not Reported	Stage III	0	not reported	Bladder, NOS	562.0	27692.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27692.0	75.86849315068493	['2019-07-31T16:56:21.198077-05:00', '2019-07-31T16:56:21.198077-05:00']	['ca8c223f-fc39-5514-a13a-25ed449995c1', 'd55fe580-9722-5252-9f22-e79ea0c1d155']	['TCGA-CU-A3KJ_treatment_1', 'TCGA-CU-A3KJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:58:18.129838-05:00', '']	01	Primary	3d92f5a6-949a-4176-9309-4294cca6fc25	Primary Tumor	Not Reported	204.0	360.0	Unknown	DC5E6643-868B-40C6-AC67-B594E2F7BFBA	false	Solid Tissue	False	Tumor
TCGA-DK-A6B2-01A	10c825d7-4e21-43e7-ac95-dda75fbdaf74	Transitional Cell Papillomas and Carcinomas	10c825d7-4e21-43e7-ac95-dda75fbdaf74	TCGA-DK-A6B2	Bladder	3.1232876712328768	Not Reported	57.0	white	male	not hispanic or latino	Alive	70	-25625.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A6B2	TSS found during enrollment the patient had a PT2 prior to the procurement of the TCGA sample. The TSS considered this a progression, but this would not have been allowed in based on TCGA rules.	26881	Notification	10c825d7-4e21-43e7-ac95-dda75fbdaf74	2015-03-05T00:00:00	53c6be75-0849-521e-b03f-079d37deb3e9	case	2018-08-23T16:32:20.747393-05:00	10c825d7-4e21-43e7-ac95-dda75fbdaf74	released	Item does not meet study protocol	Approved	TCGA-DK-A6B2	Not Reported	Stage IV	0	not reported	Posterior wall of bladder	477.0	25625.0	Transitional cell carcinoma	yes	2012.0	No	6th	T3	8120/3	N1	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		25625.0	70.20547945205479	['2019-07-31T17:14:56.251766-05:00', '2019-07-31T17:14:56.251766-05:00']	['c8ca7ea3-dd30-5b33-9016-0df7d606f1fa', 'd2e821e0-9fab-5b23-8129-44d426118e1b']	['TCGA-DK-A6B2_treatment_1', 'TCGA-DK-A6B2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:13:39.732475-05:00', '']	01	Primary	639277ed-3037-489b-a219-f1edba494cd0	Primary Tumor	Not Reported	472.0	590.0	OCT	B8914E0E-6446-4467-9BB3-08593BFBEFCD	true	Solid Tissue	False	Tumor
TCGA-DK-A3IU-01A	f093f043-efd4-4cba-a87f-8cbb5c1acd9e	Transitional Cell Papillomas and Carcinomas	f093f043-efd4-4cba-a87f-8cbb5c1acd9e	TCGA-DK-A3IU	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Dead	58	-21369.0	1953.0	706.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	['TCGA-DK-A3IU', 'TCGA-DK-A3IU']	['Patient had synchronous prostate cancer and prior history of non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.', 'Patient had synchronous prostate cancer and prior history of non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.']	['15261', '15262']	['Notification', 'Notification']	['f093f043-efd4-4cba-a87f-8cbb5c1acd9e', 'f093f043-efd4-4cba-a87f-8cbb5c1acd9e']	['2013-01-31T00:00:00', '2013-01-31T00:00:00']	['5a8910c3-7f02-5af7-98ab-76aed16bf443', 'cbfa81b5-2cf0-5e8f-afa1-fe90b986286a']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['f093f043-efd4-4cba-a87f-8cbb5c1acd9e', 'f093f043-efd4-4cba-a87f-8cbb5c1acd9e']	['released', 'released']	['Synchronous malignancy', 'Prior malignancy']	['Approved', 'Approved']	['TCGA-DK-A3IU', 'TCGA-DK-A3IU']	Not Reported	Stage II	0	not reported	Posterior wall of bladder	609.0	21369.0	Transitional cell carcinoma	yes	2011.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		21369.0	58.54520547945206	['2019-07-31T17:01:53.865456-05:00', '2019-07-31T17:01:53.865456-05:00']	['333db1d5-5965-5227-8299-d72a82e49f34', '53d05051-e936-5026-87e2-4127797343a0']	['TCGA-DK-A3IU_treatment_1', 'TCGA-DK-A3IU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:49.993327-05:00', '']	01	Primary	b9c39e8b-d689-499a-bc06-ce3bffc9996c	Primary Tumor	Not Reported	261.0	370.0	OCT	7BDC2B9E-DB52-4D92-9712-CBE3B6A67706	true	Solid Tissue	False	Tumor
TCGA-HQ-A2OF-01A	691adaa9-196a-4b62-9437-640c4ae6e2b2	Adenomas and Adenocarcinomas	691adaa9-196a-4b62-9437-640c4ae6e2b2	TCGA-HQ-A2OF	Bladder		Not Reported		not reported	female	not reported	Alive	52	-19016.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	92ea63f4-dd85-57be-8c8e-c50c70f40169	HQ	Ontario Institute for Cancer Research (OICR)	Bladder Urothelial Carcinoma	NCH	TCGA-HQ-A2OF	Sample was shipped as a muscle invasive urothelial carcinoma, but according to the path report and expert pathology review it is a papillary carcinoma. Therefore this case, does not meet TCGA BLCA requirements.	29684	Notification	691adaa9-196a-4b62-9437-640c4ae6e2b2	2015-12-07T00:00:00	5fee924c-77e0-5cb0-8a06-a85f4e479f6f	case	2018-08-23T16:32:20.747393-05:00	691adaa9-196a-4b62-9437-640c4ae6e2b2	released	Item does not meet study protocol	Approved	TCGA-HQ-A2OF	No	Stage III	0	not reported	Dome of bladder	1947.0	19016.0	Papillary adenocarcinoma, NOS	no		No	6th	T3b	8260/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		19016.0	52.0986301369863	['2019-07-31T16:51:23.897429-05:00', '2019-07-31T16:51:23.897429-05:00']	['17b517ac-2ae5-53d5-871d-3196702fdeaf', '351dd910-95f3-5c34-9f9f-09988eb0077d']	['TCGA-HQ-A2OF_treatment', 'TCGA-HQ-A2OF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:54:21.608876-05:00']	01	Primary	6a971539-f1c4-4404-b825-6b50bdbd9b11	Primary Tumor	Not Reported		140.0	Unknown	255B8E38-1BBF-4B3B-B3C6-99F5A41779EA	false	Solid Tissue	False	Tumor
TCGA-FD-A43X-01A	4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f	Transitional Cell Papillomas and Carcinomas	4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f	TCGA-FD-A43X	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Alive	84	-30764.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A43X	Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.	15272	Notification	4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f	2013-02-01T00:00:00	62d66ecf-5303-526e-8f32-bd1f1a595dec	case	2018-08-23T16:32:20.747393-05:00	4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f	released	Prior malignancy	Approved	TCGA-FD-A43X	Not Reported	Stage II	0	not reported	Posterior wall of bladder	110.0	30764.0	Papillary transitional cell carcinoma	yes	2012.0	No	7th	T2a	8130/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T1	30764.0	84.28493150684932	['2019-07-31T16:49:10.805099-05:00', '2019-07-31T16:49:10.805099-05:00']	['41c87f14-c558-5240-8230-272c5abc86d5', 'ca7a2220-3f05-5c90-8943-560ad4565df7']	['TCGA-FD-A43X_treatment_1', 'TCGA-FD-A43X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:37.104166-05:00', '']	01	Primary	88c99351-f64d-4310-bc80-44c4399da91e	Primary Tumor	Not Reported	26.0	1000.0	OCT	1DE6AC6C-BA81-4CB1-8595-21D6E9033C7F	true	Solid Tissue	False	Tumor
TCGA-DK-A3IT-01A	58520c66-7688-435a-b09f-653b18768c41	Transitional Cell Papillomas and Carcinomas	58520c66-7688-435a-b09f-653b18768c41	TCGA-DK-A3IT	Bladder		Not Reported		white	male	not hispanic or latino	Alive	62	-22786.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A3IT	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15255	Notification	58520c66-7688-435a-b09f-653b18768c41	2013-01-31T00:00:00	645e4864-256f-54dc-afeb-5df715fbf0c9	case	2018-08-23T16:32:20.747393-05:00	58520c66-7688-435a-b09f-653b18768c41	released	Synchronous malignancy	Approved	TCGA-DK-A3IT	Not Reported	Stage III	0	not reported	Lateral wall of bladder	648.0	22786.0	Transitional cell carcinoma	yes	2011.0	No	6th	T3	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		22786.0	62.42739726027397	['2019-07-31T16:49:46.936578-05:00', '2019-07-31T16:49:46.936578-05:00']	['643854c4-af87-5038-ba9f-ddf5a24340fc', 'c9030191-8c01-50fa-ba00-97d91035c20b']	['TCGA-DK-A3IT_treatment_1', 'TCGA-DK-A3IT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:53:04.237872-05:00', '']	01	Primary	6b48dae5-b757-450a-8248-65c2434a7afc	Primary Tumor	Not Reported	145.0	240.0	OCT	B42C9A76-53B5-46A6-833F-5A63871F92A0	true	Solid Tissue	False	Tumor
TCGA-GV-A3QK-01B	9ee8e704-c61d-413d-b69d-257ef829fdae	Transitional Cell Papillomas and Carcinomas	9ee8e704-c61d-413d-b69d-257ef829fdae	TCGA-GV-A3QK	Bladder	2.4657534246575343	Not Reported	45.0	white	female	not hispanic or latino	Alive	56	-20802.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-GV-A3QK	Patient had a prior colon cancer. No radiation or systemic chemotherapy.	15282	Notification	9ee8e704-c61d-413d-b69d-257ef829fdae	2013-02-01T00:00:00	669fb9dd-7e6b-5111-8c7e-84b4df7701e8	case	2018-08-23T16:32:20.747393-05:00	9ee8e704-c61d-413d-b69d-257ef829fdae	released	Prior malignancy	Approved	TCGA-GV-A3QK	Not Reported	Stage IV	0	not reported	Bladder, NOS	832.0	20802.0	Transitional cell carcinoma	yes	2012.0	No	7th	T4a	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20802.0	56.99178082191781	['2019-07-31T16:55:48.597012-05:00', '2019-07-31T16:55:48.597012-05:00']	['900437da-e8e5-5b83-9d94-d1d3b631a214', 'b84dda83-4c68-57cf-9a4b-87cc179411fd']	['TCGA-GV-A3QK_treatment', 'TCGA-GV-A3QK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:57:52.714199-05:00']	01	Primary	9bf2d470-cbc4-454a-95ab-3109f045684c	Primary Tumor	Not Reported	146.0	260.0	OCT	C6248F9C-58D2-4F68-9D45-B38F38DCCA53	true	Solid Tissue	False	Tumor
TCGA-C4-A0F7-01A	ca554128-da9d-4f37-9560-ca083509e01d	Transitional Cell Papillomas and Carcinomas	ca554128-da9d-4f37-9560-ca083509e01d	TCGA-C4-A0F7	Bladder		Not Reported		not reported	male	not reported	Dead	77	-28428.0	1931.0	62.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	af546e3d-a713-5d08-88f4-d8a64d54f2a4	C4	Indivumed	Bladder Urothelial Carcinoma	NCH	TCGA-C4-A0F7	Patient had an unspecified malignant neoplasm of the testis. No radiation or systemic chemotherapy.	15243	Notification	ca554128-da9d-4f37-9560-ca083509e01d	2013-01-29T00:00:00	6744b667-d5a7-52e0-80b8-28ebda274452	case	2018-08-23T16:32:20.747393-05:00	ca554128-da9d-4f37-9560-ca083509e01d	released	Prior malignancy	Approved	TCGA-C4-A0F7	Not Reported	Stage IV	0	not reported	Bladder, NOS		28428.0	Transitional cell carcinoma	yes	2008.0	No	6th	T4b	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28428.0	77.88493150684931	['2019-07-31T16:59:04.019211-05:00', '2019-07-31T16:59:04.019211-05:00']	['47cb8bb0-8a23-51fd-bfb8-42045ebdc55d', '6ac285a1-c77a-5035-bcda-78d0dd95f68f']	['TCGA-C4-A0F7_treatment', 'TCGA-C4-A0F7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T10:00:30.982488-05:00']	01	Primary	f206c24b-a9c5-4476-a2a2-8dc1c45b5199	Primary Tumor	Not Reported	660.0	120.0	Unknown	27D0A4B2-0CC8-46CB-8048-2AB02805A100	false	Solid Tissue	False	Tumor
TCGA-K4-A3WU-01B	9aa6522a-120a-4691-993e-3f8534f644b5	Transitional Cell Papillomas and Carcinomas	9aa6522a-120a-4691-993e-3f8534f644b5	TCGA-K4-A3WU	Bladder		Not Reported		white	male	not hispanic or latino	Alive	87	-32134.0	1925.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-K4-A3WU	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15286	Notification	9aa6522a-120a-4691-993e-3f8534f644b5	2013-02-01T00:00:00	6b2864e3-00ab-5dc0-8bfe-bcd4b7156afe	case	2018-08-23T16:32:20.747393-05:00	9aa6522a-120a-4691-993e-3f8534f644b5	released	Synchronous malignancy	Approved	TCGA-K4-A3WU	No	Stage III	0	not reported	Bladder, NOS	105.0	32134.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	TX	32134.0	88.03835616438356	['2019-07-31T16:55:17.941000-05:00', '2019-07-31T16:55:17.941000-05:00']	['556abe13-7af9-5e94-85e5-153adf005e21', '8ace4042-6279-595e-a351-efa109dd6d01']	['TCGA-K4-A3WU_treatment_1', 'TCGA-K4-A3WU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:28.824797-05:00', '']	01	Primary	f91a5f96-cd62-4bdb-b4aa-15c24bee80de	Primary Tumor	Not Reported	112.0	270.0	Unknown	57551F09-2ACE-481D-99A0-53A0E7814F70	false	Solid Tissue	False	Tumor
TCGA-GV-A40G-01A	10422fe9-8d70-40a9-9875-3fe9fab68823	Transitional Cell Papillomas and Carcinomas	10422fe9-8d70-40a9-9875-3fe9fab68823	TCGA-GV-A40G	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Alive	77	-28204.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-GV-A40G	Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.	15284	Notification	10422fe9-8d70-40a9-9875-3fe9fab68823	2013-02-01T00:00:00	77d30a15-8a39-5935-8803-517b842389b7	case	2018-08-23T16:32:20.747393-05:00	10422fe9-8d70-40a9-9875-3fe9fab68823	released	Prior malignancy	Approved	TCGA-GV-A40G	Not Reported	Stage II	0	not reported	Bladder, NOS	580.0	28204.0	Transitional cell carcinoma	yes	2012.0	No	7th	T2a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28204.0	77.27123287671233	['2019-07-31T16:44:11.748447-05:00', '2019-07-31T16:44:11.748447-05:00']	['c957db9d-1fd1-579d-b06c-694bc2b99a6c', 'f4c75b70-c1e9-5c40-a7d5-aaad32f115dc']	['TCGA-GV-A40G_treatment', 'TCGA-GV-A40G_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:36.066849-05:00']	01	Primary	fe3f7c73-8e04-48ba-af35-e369f5c62e98	Primary Tumor	Not Reported	99.0	500.0	OCT	28754343-DA2B-4608-A66C-B4E41B52F6FF	true	Solid Tissue	False	Tumor
TCGA-DK-A2I6-01A	de810af0-4c18-4e8f-9836-f8abc425e3eb	Transitional Cell Papillomas and Carcinomas	de810af0-4c18-4e8f-9836-f8abc425e3eb	TCGA-DK-A2I6	Bladder	0.8767123287671232	Not Reported	16.0	white	male	not hispanic or latino	Alive	81	-29789.0	1924.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A2I6	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15252	Notification	de810af0-4c18-4e8f-9836-f8abc425e3eb	2013-01-29T00:00:00	7a141ee8-3712-594a-a801-3566a4f61500	case	2018-08-23T16:32:20.747393-05:00	de810af0-4c18-4e8f-9836-f8abc425e3eb	released	Synchronous malignancy	Approved	TCGA-DK-A2I6	Not Reported	Stage IV	0	not reported	Trigone of bladder	2656.0	29789.0	Transitional cell carcinoma	yes	2005.0	No	6th	T2b	8120/3	N1	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported		29789.0	81.61369863013698	['2019-07-31T17:00:50.048826-05:00', '2019-07-31T17:00:50.048826-05:00']	['bafce29c-e8ca-5d95-b9f8-a88592f820f1', 'db09242d-5328-5b98-adab-52c195dae5c0']	['TCGA-DK-A2I6_treatment', 'TCGA-DK-A2I6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:01:56.954769-05:00']	01	Primary	a536f8f9-3a68-4792-880d-387d78fd0c66	Primary Tumor	Not Reported	2326.0	80.0	OCT	4CDD4632-B977-4B97-BAE5-8442F1D9319A	true	Solid Tissue	False	Tumor
TCGA-GC-A3BM-01A	7840aea9-40c4-473e-be33-8fa0b9f332c9	Transitional Cell Papillomas and Carcinomas	7840aea9-40c4-473e-be33-8fa0b9f332c9	TCGA-GC-A3BM	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	70	-25609.0	1940.0	651.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3BM	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15274	Notification	7840aea9-40c4-473e-be33-8fa0b9f332c9	2013-02-01T00:00:00	7c07ec8c-66ed-5602-9d62-0164f2a1a9a6	case	2018-08-23T16:32:20.747393-05:00	7840aea9-40c4-473e-be33-8fa0b9f332c9	released	Synchronous malignancy	Approved	TCGA-GC-A3BM	No	Stage II	0	not reported	Dome of bladder	88.0	25609.0	Transitional cell carcinoma	no	2010.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		25609.0	70.16164383561645	['2019-07-31T16:52:54.605533-05:00', '2019-07-31T16:52:54.605533-05:00']	['05341ce8-ce75-5417-88cc-5297edc9cef5', '865035fd-cbe8-5af7-853c-07b9112cbdf5']	['TCGA-GC-A3BM_treatment_1', 'TCGA-GC-A3BM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:55:33.917385-05:00', '']	01	Primary	5c631ce8-f96a-4c35-a459-556fc4ab21e1	Primary Tumor	Not Reported	276.0	120.0	Unknown	F3408556-9259-4700-B9A0-F41E516B420C	false	Solid Tissue	False	Tumor
TCGA-GC-A3BM-11A	7840aea9-40c4-473e-be33-8fa0b9f332c9	Transitional Cell Papillomas and Carcinomas	7840aea9-40c4-473e-be33-8fa0b9f332c9	TCGA-GC-A3BM	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	70	-25609.0	1940.0	651.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3BM	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15274	Notification	7840aea9-40c4-473e-be33-8fa0b9f332c9	2013-02-01T00:00:00	7c07ec8c-66ed-5602-9d62-0164f2a1a9a6	case	2018-08-23T16:32:20.747393-05:00	7840aea9-40c4-473e-be33-8fa0b9f332c9	released	Synchronous malignancy	Approved	TCGA-GC-A3BM	No	Stage II	0	not reported	Dome of bladder	88.0	25609.0	Transitional cell carcinoma	no	2010.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		25609.0	70.16164383561645	['2019-07-31T16:52:54.605533-05:00', '2019-07-31T16:52:54.605533-05:00']	['05341ce8-ce75-5417-88cc-5297edc9cef5', '865035fd-cbe8-5af7-853c-07b9112cbdf5']	['TCGA-GC-A3BM_treatment_1', 'TCGA-GC-A3BM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:55:33.917385-05:00', '']	11	Not Applicable	bfba8167-6acc-47f8-b7aa-e9ab2b2f1005	Solid Tissue Normal	Not Reported	276.0	130.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DK-A3IQ-01A	e44f60ec-66c4-45a2-a003-0a1faf1d6e03	Transitional Cell Papillomas and Carcinomas	e44f60ec-66c4-45a2-a003-0a1faf1d6e03	TCGA-DK-A3IQ	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	74	-27194.0	1937.0	539.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A3IQ	Patient was previously diagnosed with kidney papillary renal cell cancer. No radiation or systemic chemotherapy.	15253	Notification	e44f60ec-66c4-45a2-a003-0a1faf1d6e03	2013-01-31T00:00:00	7cd848a6-d5af-5d92-aee8-bdca52764d8a	case	2018-08-23T16:32:20.747393-05:00	e44f60ec-66c4-45a2-a003-0a1faf1d6e03	released	Prior malignancy	Approved	TCGA-DK-A3IQ	Not Reported	Stage III	0	not reported	Posterior wall of bladder	319.0	27194.0	Transitional cell carcinoma	yes	2011.0	No	6th	T3	8120/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27194.0	74.5041095890411	['2019-07-31T17:01:04.563952-05:00', '2019-07-31T17:01:04.563952-05:00']	['17521ad8-0f46-5abd-b6fd-c064c251b69a', 'a0949da4-f565-583c-a7cc-f90c9be0b88b']	['TCGA-DK-A3IQ_treatment_1', 'TCGA-DK-A3IQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:09.122358-05:00', '']	01	Primary	1e375786-db8f-4a8c-ba1c-c6dd7de1a9be	Primary Tumor	Not Reported	230.0	280.0	OCT	11C9802C-072A-4B09-96FB-0CAC21BF43D8	true	Solid Tissue	False	Tumor
TCGA-G2-A2ES-01A	72d8eae8-9efb-45b2-acbd-82c6b5732e38	Transitional Cell Papillomas and Carcinomas	72d8eae8-9efb-45b2-acbd-82c6b5732e38	TCGA-G2-A2ES	Bladder	3.5616438356164384	Not Reported	65.0	white	male	not hispanic or latino	Dead	85	-31293.0	1924.0	1004.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH	TCGA-G2-A2ES	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15273	Notification	72d8eae8-9efb-45b2-acbd-82c6b5732e38	2013-02-01T00:00:00	81f168ec-1d15-5065-93d8-7996b3d70594	case	2018-08-23T16:32:20.747393-05:00	72d8eae8-9efb-45b2-acbd-82c6b5732e38	released	Synchronous malignancy	Approved	TCGA-G2-A2ES	Not Reported	Stage II	0	not reported	Bladder, NOS	525.0	31293.0	Transitional cell carcinoma	yes	2009.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31293.0	85.73424657534247	['2019-07-31T17:18:02.721181-05:00', '2019-07-31T17:18:02.721181-05:00']	['16349c3e-175c-5d31-83b7-aa31f747aed2', 'a99173d5-9a73-546a-b172-4887e5c5c0e5']	['TCGA-G2-A2ES_treatment_1', 'TCGA-G2-A2ES_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:16:16.241785-05:00', '']	01	Primary	c2288290-f17a-435c-90e7-5a4913f0c076	Primary Tumor	Not Reported	694.0	670.0	OCT	A9EE4140-E3B4-4DF3-A898-65CCEAFE4072	true	Solid Tissue	False	Tumor
TCGA-DK-A3IN-01A	fc0032db-b6d8-4da3-bd1b-beec4196abf0	Transitional Cell Papillomas and Carcinomas	fc0032db-b6d8-4da3-bd1b-beec4196abf0	TCGA-DK-A3IN	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	72	-26562.0	1939.0	250.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A3IN	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15257	Notification	fc0032db-b6d8-4da3-bd1b-beec4196abf0	2013-01-31T00:00:00	83777fe2-a8bf-5e38-be42-a8068e3a8785	case	2018-08-23T16:32:20.747393-05:00	fc0032db-b6d8-4da3-bd1b-beec4196abf0	released	Synchronous malignancy	Approved	TCGA-DK-A3IN	Not Reported	Stage III	0	not reported	Lateral wall of bladder		26562.0	Transitional cell carcinoma	yes	2011.0	No	7th	T4a	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		26562.0	72.77260273972603	['2019-07-31T17:18:29.858407-05:00', '2019-07-31T17:18:29.858407-05:00']	['544ab690-17fb-5d34-9a0d-b1a81364b85d', 'fc6b80b4-ae89-5ced-af38-d6d7df7c77f2']	['TCGA-DK-A3IN_treatment_1', 'TCGA-DK-A3IN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:16:39.711620-05:00', '']	01	Primary	f8c14183-3982-44e5-967e-03967eaa8123	Primary Tumor	Not Reported	209.0	1020.0	OCT	750A04D5-2521-4E30-AEE6-E79BA25D6CC1	true	Solid Tissue	False	Tumor
TCGA-FD-A3B7-01A	ef5dd4b3-b77a-444a-b5b0-c999a5a3d129	Transitional Cell Papillomas and Carcinomas	ef5dd4b3-b77a-444a-b5b0-c999a5a3d129	TCGA-FD-A3B7	Bladder	1.36986301369863	Not Reported	25.0	black or african american	male	not hispanic or latino	Dead	66	-24245.0	1945.0	122.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A3B7	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15260	Notification	ef5dd4b3-b77a-444a-b5b0-c999a5a3d129	2013-01-31T00:00:00	84ecb542-8949-550f-9a43-8b2ab4a4ce1f	case	2018-08-23T16:32:20.747393-05:00	ef5dd4b3-b77a-444a-b5b0-c999a5a3d129	released	Synchronous malignancy	Approved	TCGA-FD-A3B7	No	Stage III	0	not reported	Lateral wall of bladder		24245.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	24245.0	66.42465753424658	['2019-07-31T17:01:45.068535-05:00', '2019-07-31T17:01:45.068535-05:00']	['2a99438e-ea03-50f6-8a40-d8b757f59b9d', '7eaf4fc4-2f02-5f8c-ae41-b7097f856c11']	['TCGA-FD-A3B7_treatment_1', 'TCGA-FD-A3B7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:02:42.672889-05:00', '']	01	Primary	a307ca46-3a09-4f0c-84ab-9a9e8954de38	Primary Tumor	Not Reported	152.0	440.0	Unknown	DC81B464-642D-444E-A110-D11E687B36C1	false	Solid Tissue	False	Tumor
TCGA-GU-A42P-01A	ff5b9238-38a7-42b4-9d44-3b8ec9913f6d	Transitional Cell Papillomas and Carcinomas	ff5b9238-38a7-42b4-9d44-3b8ec9913f6d	TCGA-GU-A42P	Bladder	2.0821917808219177	Not Reported	38.0	white	male	not hispanic or latino	Dead	72	-26546.0	1940.0	332.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH	TCGA-GU-A42P	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15278	Notification	ff5b9238-38a7-42b4-9d44-3b8ec9913f6d	2013-02-01T00:00:00	8a9e7d7a-6697-5790-badb-6413df12f609	case	2018-08-23T16:32:20.747393-05:00	ff5b9238-38a7-42b4-9d44-3b8ec9913f6d	released	Synchronous malignancy	Approved	TCGA-GU-A42P	No	Stage IV	0	not reported	Bladder, NOS	195.0	26546.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26546.0	72.72876712328767	['2019-07-31T17:03:14.427015-05:00', '2019-07-31T17:03:14.427015-05:00']	['608b8d9a-4e51-5dd2-8e00-e861b640a4d5', '9ea44359-60b0-5983-a310-bc5c7c7b1328']	['TCGA-GU-A42P_treatment', 'TCGA-GU-A42P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:03:58.751153-05:00']	01	Primary	59c6f5bb-2da7-427c-a319-ae0d4f42eaed	Primary Tumor	Not Reported	176.0	70.0	OCT	EBD243F6-1508-4BDD-A2D4-58E23D812DF0	true	Solid Tissue	False	Tumor
TCGA-FD-A3SN-01A	0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0	Transitional Cell Papillomas and Carcinomas	0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0	TCGA-FD-A3SN	Bladder	0.273972602739726	Not Reported	5.0	white	male	hispanic or latino	Alive	79	-29169.0	1932.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A3SN	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15264	Notification	0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0	2013-01-31T00:00:00	9aca878b-18e4-5fb5-a2c3-50c5025a0b15	case	2018-08-23T16:32:20.747393-05:00	0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0	released	Synchronous malignancy	Approved	TCGA-FD-A3SN	No	Stage III	0	not reported	Trigone of bladder	887.0	29169.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported		29169.0	79.91506849315068	['2019-07-31T16:44:05.724147-05:00', '2019-07-31T16:44:05.724147-05:00']	['08f3c3d9-686d-5034-8aae-59a2639696cc', 'abcd8f50-a570-5353-a792-cbdcfe55df07']	['TCGA-FD-A3SN_treatment', 'TCGA-FD-A3SN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:48:31.285321-05:00']	01	Primary	127892ed-8a7a-41cb-8abe-353e09e6d327	Primary Tumor	Not Reported	105.0	380.0	OCT	E204500A-A1F4-400C-A8C3-B830A832B719	true	Solid Tissue	False	Tumor
TCGA-FD-A3SQ-01A	3071cb51-dcf5-41f7-b047-afc2dcbf0aaf	Transitional Cell Papillomas and Carcinomas	3071cb51-dcf5-41f7-b047-afc2dcbf0aaf	TCGA-FD-A3SQ	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Dead	62	-22687.0	1946.0	1423.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	['TCGA-FD-A3SQ', 'TCGA-FD-A3SQ']	['Patient had synchronous prostate cancer and reported a prior breast cancer. No radiation or systemic chemotherapy.', 'Patient had synchronous prostate cancer and reported a prior breast cancer. No radiation or systemic chemotherapy.']	['15267', '15266']	['Notification', 'Notification']	['3071cb51-dcf5-41f7-b047-afc2dcbf0aaf', '3071cb51-dcf5-41f7-b047-afc2dcbf0aaf']	['2013-01-31T00:00:00', '2013-01-31T00:00:00']	['a328588c-56e8-5bf5-ab23-18d129beae3c', 'a62faf96-584c-5807-84a1-6ae7b2dcb904']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['3071cb51-dcf5-41f7-b047-afc2dcbf0aaf', '3071cb51-dcf5-41f7-b047-afc2dcbf0aaf']	['released', 'released']	['Prior malignancy', 'Synchronous malignancy']	['Approved', 'Approved']	['TCGA-FD-A3SQ', 'TCGA-FD-A3SQ']	Not Reported	Stage IV	0	not reported	Lateral wall of bladder		22687.0	Transitional cell carcinoma	yes	2008.0	No	6th	T3a	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		22687.0	62.156164383561645	['2019-07-31T17:16:26.070652-05:00', '2019-07-31T17:16:26.070652-05:00']	['33f74d95-48dc-5aac-af0b-791701bf1923', 'ea3e8cf5-1a17-5663-a2d1-c6e58bc8458d']	['TCGA-FD-A3SQ_treatment', 'TCGA-FD-A3SQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:14:55.939514-05:00']	01	Primary	a78a8c62-06ed-4562-b529-d30a5d1508e7	Primary Tumor	Not Reported	1375.0	180.0	OCT	CEE5BD08-0FC9-4780-A5CB-A0962A3BE721	true	Solid Tissue	False	Tumor
TCGA-CU-A0YO-01A	4a9ef220-922c-49cf-bbed-d173b214ed31	Transitional Cell Papillomas and Carcinomas	4a9ef220-922c-49cf-bbed-d173b214ed31	TCGA-CU-A0YO	Bladder		Not Reported		white	male	not hispanic or latino	Dead	84	-30817.0	1925.0	149.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	TCGA-CU-A0YO	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15245	Notification	4a9ef220-922c-49cf-bbed-d173b214ed31	2013-01-29T00:00:00	a3b5a277-8500-5dee-ad97-bb3c98fe34ee	case	2018-08-23T16:32:20.747393-05:00	4a9ef220-922c-49cf-bbed-d173b214ed31	released	Synchronous malignancy	Approved	TCGA-CU-A0YO	Not Reported	Stage IV	0	not reported	Bladder, NOS		30817.0	Papillary transitional cell carcinoma	yes	2009.0	No	6th	T3a	8130/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30817.0	84.43013698630136	['2019-07-31T17:17:53.852350-05:00', '2019-07-31T17:17:53.852350-05:00']	['686e9411-2342-5798-9616-3fd5038b4764', 'fcf9f760-53c5-5129-a572-0381ac20d0b0']	['TCGA-CU-A0YO_treatment', 'TCGA-CU-A0YO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:16:08.717700-05:00']	01	Primary	9e190462-39fc-41b2-b1d6-2da150412fcf	Primary Tumor	Not Reported	482.0	90.0	Unknown	2216705A-2F61-47ED-9E0B-619AE7515C0B	false	Solid Tissue	False	Tumor
TCGA-K4-AAQO-01A	383bf27a-9216-492e-b4bd-2b4eef8278de	Transitional Cell Papillomas and Carcinomas	383bf27a-9216-492e-b4bd-2b4eef8278de	TCGA-K4-AAQO	Bladder	2.356164383561644	Not Reported	43.0	white	male	not hispanic or latino	Alive	56	-20683.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-K4-AAQO	Patient received neoadjuvant chemotherapy (gemcitabine and cisplatin).	23657	Notification	383bf27a-9216-492e-b4bd-2b4eef8278de	2014-11-07T00:00:00	a49af471-a577-5846-9849-79774a8e3a54	case	2018-08-23T16:32:20.747393-05:00	383bf27a-9216-492e-b4bd-2b4eef8278de	released	Neoadjuvant therapy	Approved	TCGA-K4-AAQO	No	Stage III	0	not reported	Anterior wall of bladder	359.0	20683.0	Transitional cell carcinoma	no	2013.0	Yes	7th	T3a	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T3	20683.0	56.66575342465753	['2019-07-31T16:46:48.282532-05:00', '2019-07-31T16:46:48.282532-05:00']	['2ad99363-c28a-5e5d-bcd5-f250fe7c8aef', '4b141137-99f5-58d0-922c-164665370d8e']	['TCGA-K4-AAQO_treatment_1', 'TCGA-K4-AAQO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:50:42.230997-05:00', '']	01	Primary	46e17793-8469-406c-9d05-d18ded850721	Primary Tumor	Not Reported	332.0	660.0	OCT	30D1A38A-F0C3-46F6-BDB9-6C629E6E517E	true	Solid Tissue	False	Tumor
TCGA-CU-A0YN-11A	679a6869-2ce9-4472-8db1-8869e2c1a440	Transitional Cell Papillomas and Carcinomas	679a6869-2ce9-4472-8db1-8869e2c1a440	TCGA-CU-A0YN	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	60	-21927.0	1945.0	393.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	TCGA-CU-A0YN	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15244	Notification	679a6869-2ce9-4472-8db1-8869e2c1a440	2013-01-29T00:00:00	adc174e0-b8ed-52f4-9680-44ad71cca554	case	2018-08-23T16:32:20.747393-05:00	679a6869-2ce9-4472-8db1-8869e2c1a440	released	Synchronous malignancy	Approved	TCGA-CU-A0YN	No	Stage III	0	not reported	Bladder, NOS		21927.0	Papillary transitional cell carcinoma	no	2005.0	No	6th	T3a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21927.0	60.07397260273972	['2019-07-31T17:17:59.671744-05:00', '2019-07-31T17:17:59.671744-05:00']	['2d1d5195-975d-5c26-80ba-cb48fdfe2d7f', 'f5b72aca-780b-52b7-8cd9-32caafee920a']	['TCGA-CU-A0YN_treatment_1', 'TCGA-CU-A0YN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:16:13.796213-05:00', '']	11	Not Applicable	caac9355-9bac-41d8-b7a7-8eeb775179fa	Solid Tissue Normal	Not Reported	1827.0	80.0	Unknown		false	Solid Tissue	False	Normal
TCGA-CU-A0YN-01A	679a6869-2ce9-4472-8db1-8869e2c1a440	Transitional Cell Papillomas and Carcinomas	679a6869-2ce9-4472-8db1-8869e2c1a440	TCGA-CU-A0YN	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	60	-21927.0	1945.0	393.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH	TCGA-CU-A0YN	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15244	Notification	679a6869-2ce9-4472-8db1-8869e2c1a440	2013-01-29T00:00:00	adc174e0-b8ed-52f4-9680-44ad71cca554	case	2018-08-23T16:32:20.747393-05:00	679a6869-2ce9-4472-8db1-8869e2c1a440	released	Synchronous malignancy	Approved	TCGA-CU-A0YN	No	Stage III	0	not reported	Bladder, NOS		21927.0	Papillary transitional cell carcinoma	no	2005.0	No	6th	T3a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21927.0	60.07397260273972	['2019-07-31T17:17:59.671744-05:00', '2019-07-31T17:17:59.671744-05:00']	['2d1d5195-975d-5c26-80ba-cb48fdfe2d7f', 'f5b72aca-780b-52b7-8cd9-32caafee920a']	['TCGA-CU-A0YN_treatment_1', 'TCGA-CU-A0YN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:16:13.796213-05:00', '']	01	Primary	dbcc2fcb-a103-46da-9893-6ec689d2f98e	Primary Tumor	Not Reported	1827.0	60.0	Unknown	B3A36579-3E87-408D-AC04-19A8136E1E7A	false	Solid Tissue	False	Tumor
TCGA-GV-A40E-01A	aa6142af-bad7-493c-98a0-fd070de39073	Transitional Cell Papillomas and Carcinomas	aa6142af-bad7-493c-98a0-fd070de39073	TCGA-GV-A40E	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	75	-27569.0	1937.0	261.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-GV-A40E	Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.	15283	Notification	aa6142af-bad7-493c-98a0-fd070de39073	2013-02-01T00:00:00	c2c38cca-782d-5c1b-b3ff-7592634c6884	case	2018-08-23T16:32:20.747393-05:00	aa6142af-bad7-493c-98a0-fd070de39073	released	Prior malignancy	Approved	TCGA-GV-A40E	Not Reported	Stage II	0	not reported	Bladder, NOS	195.0	27569.0	Transitional cell carcinoma	yes	2012.0	No	7th		8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27569.0	75.53150684931506	['2019-07-31T16:56:32.997469-05:00', '2019-07-31T16:56:32.997469-05:00']	['05714d7c-8e70-5962-9532-f02d09d6a7f9', 'bd1b9fe0-b441-5648-8890-16c433821aef']	['TCGA-GV-A40E_treatment_1', 'TCGA-GV-A40E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:58:27.418563-05:00', '']	01	Primary	fe1b2be2-296a-4b78-a009-cfb676357323	Primary Tumor	Not Reported	135.0	140.0	OCT	45815B18-3A6E-4A3D-8D48-0F4653026DFD	true	Solid Tissue	False	Tumor
TCGA-CF-A9FM-01A	aad167ab-4772-4616-afb3-265e00d4a3f0	Transitional Cell Papillomas and Carcinomas	aad167ab-4772-4616-afb3-265e00d4a3f0	TCGA-CF-A9FM	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	50	-18445.0	1963.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH	TCGA-CF-A9FM	The path TNM for the primary was confirmed as T1N0M0.  The surgeon recorded the TNM initially as T2N1M0 which is why the TSS submitted this case.	25399	Notification	aad167ab-4772-4616-afb3-265e00d4a3f0	2015-02-05T00:00:00	c4514ade-edde-5c61-822e-5b3bbe01b5cd	case	2018-08-23T16:32:20.747393-05:00	aad167ab-4772-4616-afb3-265e00d4a3f0	released	Item does not meet study protocol	Approved	TCGA-CF-A9FM	No	Stage I	0	not reported	Bladder, NOS	398.0	18445.0	Papillary transitional cell carcinoma	no	2013.0	No	6th	T1	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		18445.0	50.534246575342465	['2019-07-31T16:56:41.780838-05:00', '2019-07-31T16:56:41.780838-05:00']	['648eba0e-4ce0-5dec-957e-ee8bd97fb226', 'ab063e63-176b-5793-91fc-cff812f6548f']	['TCGA-CF-A9FM_treatment', 'TCGA-CF-A9FM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:34.404991-05:00']	01	Primary	282dcd5c-c35c-4b72-a3ab-571867e304d0	Primary Tumor	Not Reported	122.0	430.0	OCT	D8D401F9-26CE-4A36-9A01-2EC6A02BC35B	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4N-01A	c692e696-37fe-4fc1-90eb-8e34a91a98fc	Epithelial Neoplasms, NOS	c692e696-37fe-4fc1-90eb-8e34a91a98fc	TCGA-ZF-AA4N	Bladder		Not Reported		white	male	not hispanic or latino	Dead	74	-27056.0	1937.0	88.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH	TCGA-ZF-AA4N	the reviewing pathologist could not determine whether the case was urothelial or squamous cell	23678	Observation	c692e696-37fe-4fc1-90eb-8e34a91a98fc	2014-11-18T00:00:00	caef3d7a-a8ae-50e0-85c0-90feef8b06c0	case	2018-08-23T16:32:20.747393-05:00	c692e696-37fe-4fc1-90eb-8e34a91a98fc	released	Item may not meet study protocol	Approved	TCGA-ZF-AA4N	No	Stage II	0	not reported	Bladder, NOS		27056.0	Carcinoma, NOS	no	2011.0	No	7th		8010/3			not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27056.0	74.12602739726027	['2019-07-31T16:58:43.641339-05:00', '2019-07-31T16:58:43.641339-05:00']	['1d4dffc6-1a19-50ca-9ab8-18180933dcc7', 'e9df5217-05eb-5f09-b9ff-695169fbfa89']	['TCGA-ZF-AA4N_treatment_1', 'TCGA-ZF-AA4N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:00:13.500036-05:00', '']	01	Primary	15b108cc-1b8d-4583-bdf0-43c7973b2cb2	Primary Tumor	Not Reported	919.0	220.0	OCT	2330755B-EBE4-46DA-ABAB-A240CD849F36	true	Solid Tissue	False	Tumor
TCGA-FD-A43P-01A	41e8c196-ef93-47c6-ad06-0031f23d4347	Transitional Cell Papillomas and Carcinomas	41e8c196-ef93-47c6-ad06-0031f23d4347	TCGA-FD-A43P	Bladder	2.410958904109589	Not Reported	44.0	black or african american	male	not hispanic or latino	Alive	74	-27201.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	['TCGA-FD-A43P', 'TCGA-FD-A43P']	['Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.', 'Patient had a prior non-muscle invasive bladder cancer. No radiation or systemic chemotherapy.']	['15270', '15271']	['Notification', 'Notification']	['41e8c196-ef93-47c6-ad06-0031f23d4347', '41e8c196-ef93-47c6-ad06-0031f23d4347']	['2013-02-01T00:00:00', '2013-02-01T00:00:00']	['cb171f10-62c2-5216-bd2b-7bc147a9b50b', 'f92494ad-9d6a-504a-b9a2-da8081301ce8']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['41e8c196-ef93-47c6-ad06-0031f23d4347', '41e8c196-ef93-47c6-ad06-0031f23d4347']	['released', 'released']	['Synchronous malignancy', 'Prior malignancy']	['Approved', 'Approved']	['TCGA-FD-A43P', 'TCGA-FD-A43P']	Not Reported	Stage II	0	not reported	Dome of bladder	832.0	27201.0	Transitional cell carcinoma	yes	2012.0	No	7th	T2a	8120/3	N0	MX	not reported	C67.1	Dome of bladder	Not Reported	not reported	T1	27201.0	74.52328767123288	['2019-07-31T16:48:06.116303-05:00', '2019-07-31T16:48:06.116303-05:00']	['080d2a28-81e4-5287-ad0b-1175273ef8ff', '475c73fa-72a4-55d8-a7e9-ccddaf89539c']	['TCGA-FD-A43P_treatment_1', 'TCGA-FD-A43P_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:51:44.971883-05:00', '']	01	Primary	d1b619ca-f17d-4f77-a5c5-1d6b7bfb7574	Primary Tumor	Not Reported	168.0	610.0	OCT	8D2D5019-4C09-4B35-AEB9-4B162A47267A	true	Solid Tissue	False	Tumor
TCGA-GV-A3QF-01A	47990d5e-a0e1-4752-86f5-4f5b84e219df	Transitional Cell Papillomas and Carcinomas	47990d5e-a0e1-4752-86f5-4f5b84e219df	TCGA-GV-A3QF	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Dead	79	-28890.0	1932.0	617.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-GV-A3QF	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15279	Notification	47990d5e-a0e1-4752-86f5-4f5b84e219df	2013-02-01T00:00:00	e1d477a0-0c84-562a-8d6e-6eac8049b013	case	2018-08-23T16:32:20.747393-05:00	47990d5e-a0e1-4752-86f5-4f5b84e219df	released	Synchronous malignancy	Approved	TCGA-GV-A3QF	No	Stage IV	0	not reported	Anterior wall of bladder	232.0	28890.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N2	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		28890.0	79.15068493150685	['2019-07-31T16:48:40.359325-05:00', '2019-07-31T16:48:40.359325-05:00']	['3227c45b-f0b2-549f-b661-29c8e041bf8b', '4b56baab-6e47-5f3e-a5b7-9cfeb51d893f']	['TCGA-GV-A3QF_treatment', 'TCGA-GV-A3QF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:52:12.137040-05:00']	01	Primary	6647c98e-7aa1-49e4-a067-d53aebacff9c	Primary Tumor	Not Reported	149.0	250.0	OCT	DE5B5338-18C3-44AA-AB8E-ADFC18EA5C87	true	Solid Tissue	False	Tumor
TCGA-GC-A3YS-01A	4d323b18-ce5a-4516-862d-7ed1fdf1f008	Transitional Cell Papillomas and Carcinomas	4d323b18-ce5a-4516-862d-7ed1fdf1f008	TCGA-GC-A3YS	Bladder	3.1780821917808217	Not Reported	58.0	white	male	not hispanic or latino	Alive	61	-22515.0	1951.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3YS	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15277	Notification	4d323b18-ce5a-4516-862d-7ed1fdf1f008	2013-02-01T00:00:00	e1e193bb-512c-56aa-b759-6a75075ccfe4	case	2018-08-23T16:32:20.747393-05:00	4d323b18-ce5a-4516-862d-7ed1fdf1f008	released	Synchronous malignancy	Approved	TCGA-GC-A3YS	No	Stage IV	0	not reported	Bladder, NOS	758.0	22515.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22515.0	61.68493150684932	['2019-07-31T16:48:53.439208-05:00', '2019-07-31T16:48:53.439208-05:00']	['0dde2795-f7a9-5056-9862-27142100084f', '1780417c-9fc3-5e0a-9bea-a115518b1362']	['TCGA-GC-A3YS_treatment', 'TCGA-GC-A3YS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:52:21.683151-05:00']	01	Primary	9606581b-1e91-4a91-865d-878b08631782	Primary Tumor	Not Reported	90.0	200.0	Unknown	702DCFCC-C28D-4122-B12F-DED2154826BE	false	Solid Tissue	False	Tumor
TCGA-DK-A3IV-01A	f953dc5d-58bf-4936-b9fe-74b45e8c00e5	Transitional Cell Papillomas and Carcinomas	f953dc5d-58bf-4936-b9fe-74b45e8c00e5	TCGA-DK-A3IV	Bladder	4.383561643835616	Not Reported	80.0	white	male	not hispanic or latino	Dead	60	-22237.0	1951.0	294.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A3IV	Patient was previously diagnosed with prostate cancer. No radiation or systemic chemotherapy.	15258	Notification	f953dc5d-58bf-4936-b9fe-74b45e8c00e5	2013-01-31T00:00:00	e211110c-ee34-557a-8c40-b46c5ef4ecb3	case	2018-08-23T16:32:20.747393-05:00	f953dc5d-58bf-4936-b9fe-74b45e8c00e5	released	Prior malignancy	Approved	TCGA-DK-A3IV	Not Reported	Stage II	0	not reported	Lateral wall of bladder		22237.0	Transitional cell carcinoma	yes	2011.0	No	6th		8120/3	NX	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	22237.0	60.92328767123288	['2019-07-31T17:02:38.967072-05:00', '2019-07-31T17:02:38.967072-05:00']	['2dc2ead0-ef91-54da-8015-d105ef17f47d', 'f3b189d6-e291-59a2-8c08-4ad6188578bf']	['TCGA-DK-A3IV_treatment_1', 'TCGA-DK-A3IV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:28.029940-05:00', '']	01	Primary	bc065247-1179-4fc2-b45c-8efb13aade65	Primary Tumor	Not Reported	226.0	120.0	OCT	258903DE-CB30-4577-9571-C470256E21C6	true	Solid Tissue	False	Tumor
TCGA-FD-A3SS-01A	7b98b829-fdc7-4719-bee9-c83f6154019c	Transitional Cell Papillomas and Carcinomas	7b98b829-fdc7-4719-bee9-c83f6154019c	TCGA-FD-A3SS	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	66	-24408.0	1946.0	391.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH	TCGA-FD-A3SS	Patient was previously diagnosed with basal cell carcinoma. No radiation or systemic chemotherapy.	15265	Notification	7b98b829-fdc7-4719-bee9-c83f6154019c	2013-01-31T00:00:00	e6196e30-e761-52b5-928c-016854f7af95	case	2018-08-23T16:32:20.747393-05:00	7b98b829-fdc7-4719-bee9-c83f6154019c	released	Prior malignancy	Approved	TCGA-FD-A3SS	Not Reported	Stage IV	0	not reported	Trigone of bladder	60.0	24408.0	Transitional cell carcinoma	yes	2012.0	No	7th	T4	8120/3	N3	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported		24408.0	66.87123287671233	['2019-07-31T16:53:12.909041-05:00', '2019-07-31T16:53:12.909041-05:00']	['f2e8b21c-debb-52b9-bfc9-73d2f1403e9a', 'ff771331-427e-5942-aaec-3a832b0845d4']	['TCGA-FD-A3SS_treatment_1', 'TCGA-FD-A3SS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:48.394458-05:00', '']	01	Primary	015e6b08-ab3c-4d1d-99e4-77b5e10bd7fc	Primary Tumor	Not Reported	55.0	840.0	OCT	66492A0C-48DA-4C18-A4A8-905282DCE5DB	true	Solid Tissue	False	Tumor
TCGA-GC-A3RB-01A	a0bcf1b1-4dd4-4d7f-b63e-b49296671451	Transitional Cell Papillomas and Carcinomas	a0bcf1b1-4dd4-4d7f-b63e-b49296671451	TCGA-GC-A3RB	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Alive	54	-20021.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH	TCGA-GC-A3RB	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15275	Notification	a0bcf1b1-4dd4-4d7f-b63e-b49296671451	2013-02-01T00:00:00	ec83c6b5-63ec-5e2e-a5d7-19292fb8099f	case	2018-08-23T16:32:20.747393-05:00	a0bcf1b1-4dd4-4d7f-b63e-b49296671451	released	Synchronous malignancy	Approved	TCGA-GC-A3RB	No	Stage III	0	not reported	Bladder, NOS	582.0	20021.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3b	20021.0	54.85205479452055	['2019-07-31T16:56:00.631615-05:00', '2019-07-31T16:56:00.631615-05:00']	['3feab894-5b08-51a3-a697-d46b96e49007', 'bc22c868-5614-58a8-a18f-00eb00558f9f']	['TCGA-GC-A3RB_treatment_1', 'TCGA-GC-A3RB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:58:02.118619-05:00', '']	01	Primary	b682e1f9-f9c8-41fb-9185-f734ff62917d	Primary Tumor	Not Reported	174.0	80.0	OCT	2783B3D4-83FA-4E66-A424-715CAC7EFD53	true	Solid Tissue	False	Tumor
TCGA-DK-A1A5-01A	904a8757-e0c5-41ef-b583-c8f170caaac1	Transitional Cell Papillomas and Carcinomas	904a8757-e0c5-41ef-b583-c8f170caaac1	TCGA-DK-A1A5	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	79	-29111.0	1931.0	65.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A1A5	Patient was previously diagnosed with basal cell carcinoma. No radiation or systemic chemotherapy.	15249	Notification	904a8757-e0c5-41ef-b583-c8f170caaac1	2013-01-29T00:00:00	ee28a3b3-3429-5b28-944a-2407be0717c3	case	2018-08-23T16:32:20.747393-05:00	904a8757-e0c5-41ef-b583-c8f170caaac1	released	Prior malignancy	Approved	TCGA-DK-A1A5	Not Reported	Stage II	0	not reported	Bladder, NOS		29111.0	Transitional cell carcinoma	yes	2010.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29111.0	79.75616438356164	['2019-07-31T17:18:15.173307-05:00', '2019-07-31T17:18:15.173307-05:00']	['4ab4db07-3016-5383-bd59-a2059cde6d57', '804f5f1a-6311-5a7a-a457-7ab48d1db796']	['TCGA-DK-A1A5_treatment', 'TCGA-DK-A1A5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:16:26.063514-05:00']	01	Primary	a9ef3ec5-b1c1-481f-89cf-1729fab50173	Primary Tumor	Not Reported	120.0	210.0	OCT	07970DA4-6136-48BA-BCA4-3ACC8C3DC1E9	true	Solid Tissue	False	Tumor
TCGA-DK-A1AA-01A	56d8a1b8-1268-4362-a7f1-77b76fbf1b59	Transitional Cell Papillomas and Carcinomas	56d8a1b8-1268-4362-a7f1-77b76fbf1b59	TCGA-DK-A1AA	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Alive	57	-21093.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH	TCGA-DK-A1AA	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15250	Notification	56d8a1b8-1268-4362-a7f1-77b76fbf1b59	2013-01-29T00:00:00	f5d11f6c-02ca-56f9-bd12-9555093fc41d	case	2018-08-23T16:32:20.747393-05:00	56d8a1b8-1268-4362-a7f1-77b76fbf1b59	released	Synchronous malignancy	Approved	TCGA-DK-A1AA	Not Reported	Stage III	0	not reported	Bladder, NOS	578.0	21093.0	Transitional cell carcinoma	yes	2010.0	No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21093.0	57.78904109589041	['2019-07-31T16:49:40.590750-05:00', '2019-07-31T16:49:40.590750-05:00']	['9be012c0-d818-5421-8b9d-36245ef762fb', 'e9a59b6e-b78a-55b3-8c22-dbc1a3134844']	['TCGA-DK-A1AA_treatment', 'TCGA-DK-A1AA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:52:59.427312-05:00']	01	Primary	577700d1-c366-41ef-8a0d-e50deefb5e3c	Primary Tumor	Not Reported	161.0	330.0	OCT	33855148-B5B5-46AE-B92D-61B64D771184	true	Solid Tissue	False	Tumor
TCGA-K4-A3WS-01A	68adacd1-a16e-4489-9e68-792a6bd8811c	Transitional Cell Papillomas and Carcinomas	68adacd1-a16e-4489-9e68-792a6bd8811c	TCGA-K4-A3WS	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Alive	66	-24124.0	1945.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH	TCGA-K4-A3WS	Patient had synchronous prostate cancer. No radiation or systemic chemotherapy.	15285	Notification	68adacd1-a16e-4489-9e68-792a6bd8811c	2013-02-01T00:00:00	fc97e8e3-9c18-5c24-8194-db4ec1a8a6f9	case	2018-08-23T16:32:20.747393-05:00	68adacd1-a16e-4489-9e68-792a6bd8811c	released	Synchronous malignancy	Approved	TCGA-K4-A3WS	Not Reported	Stage III	0	not reported	Bladder, NOS	761.0	24124.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24124.0	66.0931506849315	['2019-07-31T16:51:17.875979-05:00', '2019-07-31T16:51:17.875979-05:00']	['4c29bc84-4cbe-5d6d-8292-bd8e0f2c2abe', '880db3bf-0fb9-5b28-bb4f-5f56abbad3fd']	['TCGA-K4-A3WS_treatment', 'TCGA-K4-A3WS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:16.499842-05:00']	01	Primary	54070ae0-0c10-4c10-b8bb-a7313b80a45f	Primary Tumor	Not Reported	175.0	130.0	OCT	57743D2E-0677-40AD-A1EE-430EFF8F3F2A	true	Solid Tissue	False	Tumor
TCGA-C4-A0F1-01A	ab20d2d5-ea10-4aba-b495-fbe7b18bb394	Transitional Cell Papillomas and Carcinomas	ab20d2d5-ea10-4aba-b495-fbe7b18bb394	TCGA-C4-A0F1	Bladder	4.109589041095891	Not Reported	75.0	not reported	male	not reported	Alive	71	-26178.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	af546e3d-a713-5d08-88f4-d8a64d54f2a4	C4	Indivumed	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	89.0	26178.0	Transitional cell carcinoma	no	2006.0	No	5th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26178.0	71.72054794520548	['2019-07-31T16:56:48.417502-05:00', '2019-07-31T16:56:48.417502-05:00']	['300a54dd-7d5a-57ae-b32d-78503e05665f', 'ffc60cac-3746-5db5-93bd-462ea1a04ab7']	['TCGA-C4-A0F1_treatment', 'TCGA-C4-A0F1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:58:39.069379-05:00']	01	Primary	46b04710-466e-47f5-9c85-08bd686515d7	Primary Tumor	Not Reported	1541.0	230.0	Unknown	8410F811-09E4-40B9-B3CF-5A6F3DE628BD	false	Solid Tissue	False	Tumor
TCGA-FD-A6TK-01A	65295450-36cd-45a7-a4a6-2d52ee11378f	Transitional Cell Papillomas and Carcinomas	65295450-36cd-45a7-a4a6-2d52ee11378f	TCGA-FD-A6TK	Bladder	0.821917808219178	Not Reported	15.0	white	male	not hispanic or latino	Alive	60	-21942.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder	330.0	21942.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	21942.0	60.11506849315069	['2019-07-31T16:51:02.127754-05:00', '2019-07-31T16:51:02.127754-05:00']	['dd9f8d6f-398d-57d6-aa2b-b30d797eef6d', 'e08124ba-349c-5fb3-992a-f988ba2aa0dd']	['TCGA-FD-A6TK_treatment', 'TCGA-FD-A6TK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:04.116438-05:00']	01	Primary	290dcc7f-5957-4fe7-9e6a-32daeb18fe69	Primary Tumor	Not Reported	59.0	390.0	OCT	74DA50BD-1762-42A2-84A3-637C8C1D435B	true	Solid Tissue	False	Tumor
TCGA-4Z-AA84-01A	8b091ac3-d03a-4dd2-bdde-f7f5c6987155	Transitional Cell Papillomas and Carcinomas	8b091ac3-d03a-4dd2-bdde-f7f5c6987155	TCGA-4Z-AA84	Bladder		Not Reported		white	male	not reported	Alive	61	-22397.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	460.0	22397.0	Transitional cell carcinoma	yes	2008.0	No	7th	T3a	8120/3	N2	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T1	22397.0	61.36164383561644	['2019-07-31T16:54:07.801940-05:00', '2019-07-31T16:54:07.801940-05:00']	['2afb3925-53d1-59d7-96c2-c052658923ae', '8786c29d-3809-51b9-a635-8df09ca259e7']	['TCGA-4Z-AA84_treatment', 'TCGA-4Z-AA84_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:31.508044-05:00']	01	Primary	7ab33f7c-e09c-45b2-b951-928778af30d7	Primary Tumor	Not Reported	1880.0	470.0	OCT	528501A3-F7C9-4D93-AC98-7CFFF0C11D0A	true	Solid Tissue	False	Tumor
TCGA-FD-A5BZ-01A	ac187cd1-a5ef-47da-88b2-1d4df27e0e76	Transitional Cell Papillomas and Carcinomas	ac187cd1-a5ef-47da-88b2-1d4df27e0e76	TCGA-FD-A5BZ	Bladder		Not Reported		white	female	not hispanic or latino	Dead	77	-28451.0	1932.0	835.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Anterior wall of bladder		28451.0	Transitional cell carcinoma	no	2009.0	No	6th	T3a	8120/3	N1	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		28451.0	77.94794520547946	['2019-07-31T16:56:57.707003-05:00', '2019-07-31T16:56:57.707003-05:00']	['6e8fb47d-2e1c-5ef0-acf7-f43b90b94f63', '85f2708c-a092-50a8-b020-ad4775a8883a']	['TCGA-FD-A5BZ_treatment', 'TCGA-FD-A5BZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:58:46.500296-05:00']	01	Primary	a9f1edf4-9f35-4c85-95cf-cf32b0b0e073	Primary Tumor	Not Reported	1304.0	290.0	OCT	1FC2AC75-824B-4284-82C6-D664FA8DEB0A	true	Solid Tissue	False	Tumor
TCGA-GC-A6I3-11A	acf6bdf3-6349-49dc-b99a-4eda648eeac5	Transitional Cell Papillomas and Carcinomas	acf6bdf3-6349-49dc-b99a-4eda648eeac5	TCGA-GC-A6I3	Bladder		Not Reported		black or african american	female	not hispanic or latino	Alive	90	-32872.0	1923.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	0.0	32872.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3a	32872.0	90.06027397260274	['2019-07-31T16:57:00.561509-05:00', '2019-07-31T16:57:00.561509-05:00']	['17889429-c84b-5834-8475-ef0a82631ad2', '93e78e5e-d69d-5b7b-87d2-f525007abfe1']	['TCGA-GC-A6I3_treatment_1', 'TCGA-GC-A6I3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-30T16:18:03.933995-05:00', '']	11	Not Applicable	a6bd07c0-2568-42a3-8433-5f2ebfec34b2	Solid Tissue Normal	Not Reported	87.0	50.0	Unknown		false	Solid Tissue	False	Normal
TCGA-GC-A6I3-01A	acf6bdf3-6349-49dc-b99a-4eda648eeac5	Transitional Cell Papillomas and Carcinomas	acf6bdf3-6349-49dc-b99a-4eda648eeac5	TCGA-GC-A6I3	Bladder		Not Reported		black or african american	female	not hispanic or latino	Alive	90	-32872.0	1923.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	0.0	32872.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3a	32872.0	90.06027397260274	['2019-07-31T16:57:00.561509-05:00', '2019-07-31T16:57:00.561509-05:00']	['17889429-c84b-5834-8475-ef0a82631ad2', '93e78e5e-d69d-5b7b-87d2-f525007abfe1']	['TCGA-GC-A6I3_treatment_1', 'TCGA-GC-A6I3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-30T16:18:03.933995-05:00', '']	01	Primary	e1a1b0fa-4cae-4542-9dfb-0a7569bd60f3	Primary Tumor	Not Reported	87.0	60.0	Unknown	84221F34-EFA9-4ADD-A483-6B419D8A025B	false	Solid Tissue	False	Tumor
TCGA-G2-A3IE-01A	c65ba2b8-e867-42e8-bbd0-c2cdf5130cfb	Transitional Cell Papillomas and Carcinomas	c65ba2b8-e867-42e8-bbd0-c2cdf5130cfb	TCGA-G2-A3IE	Bladder	0.0821917808219178	Not Reported	1.5	white	male	not hispanic or latino	Dead	51	-18983.0	1956.0	612.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		18983.0	Transitional cell carcinoma	no	2007.0	No	6th		8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	18983.0	52.00821917808219	['2019-07-31T16:58:40.445249-05:00', '2019-07-31T16:58:40.445249-05:00']	['79c6a754-0838-5933-895d-4adfbf567139', 'a147b39a-19e0-5917-9c7d-d6ab34b2d1ab']	['TCGA-G2-A3IE_treatment_1', 'TCGA-G2-A3IE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:00:11.063176-05:00', '']	01	Primary	fc529667-d055-4fc3-806d-c0431d9a6cff	Primary Tumor	Not Reported	1539.0	130.0	OCT	7412115B-6EA2-43B6-970B-F0ACDB77EAFC	true	Solid Tissue	False	Tumor
TCGA-E7-A97Q-01A	ada19f65-5256-4c79-b3b9-7b9da69be437	Transitional Cell Papillomas and Carcinomas	ada19f65-5256-4c79-b3b9-7b9da69be437	TCGA-E7-A97Q	Bladder	1.095890410958904	Not Reported	20.0	white	female	not hispanic or latino	Dead	60	-22249.0	1953.0	246.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	82.0	22249.0	Transitional cell carcinoma	no	2013.0	No	7th	T4a	8120/3	N3	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22249.0	60.95616438356164	['2019-07-31T16:57:03.446617-05:00', '2019-07-31T16:57:03.446617-05:00']	['5e5a8fa4-2250-5031-93da-4c2bc49735bf', '9f1466b7-c15f-5d6f-846c-151de1440da1']	['TCGA-E7-A97Q_treatment_1', 'TCGA-E7-A97Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:58:50.908174-05:00', '']	01	Primary	6a126e5d-c433-4e51-bb11-7c6ca68e108b	Primary Tumor	Not Reported	171.0	90.0	OCT	E7CE7632-FA80-4509-AC4D-C0EC646E6CB7	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RL-01A	386f51e4-d03a-4606-bf2e-6168f2122c5f	Transitional Cell Papillomas and Carcinomas	386f51e4-d03a-4606-bf2e-6168f2122c5f	TCGA-ZF-A9RL	Bladder	2.0821917808219177	Not Reported	38.0	white	male	not hispanic or latino	Alive	61	-22480.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	2703.0	22480.0	Transitional cell carcinoma	yes	2007.0	No	6th		8120/3		MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22480.0	61.58904109589041	['2019-07-31T16:46:51.248326-05:00', '2019-07-31T16:46:51.248326-05:00']	['4d638fd1-07ef-50b7-bf32-ad8dd951d2d2', '6301d2c4-d8fa-5ede-b927-6a144dcf065e']	['TCGA-ZF-A9RL_treatment', 'TCGA-ZF-A9RL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:50:44.539488-05:00']	01	Primary	743c1949-46c8-4a6e-83d8-5e05f09d9337	Primary Tumor	Not Reported	2221.0	10.0	OCT	EC382266-E28D-4F67-B363-84425688F82F	true	Solid Tissue	False	Tumor
TCGA-CU-A72E-01A	ae080e88-82da-480c-bd13-ae214da0463c	Transitional Cell Papillomas and Carcinomas	ae080e88-82da-480c-bd13-ae214da0463c	TCGA-CU-A72E	Bladder	3.7260273972602738	Not Reported	68.0	white	male	not hispanic or latino	Dead	76	-27963.0	1937.0	413.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	284.0	27963.0	Transitional cell carcinoma	yes	2013.0	Yes	7th	T3b	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27963.0	76.6109589041096	['2019-07-31T16:57:09.215065-05:00', '2019-07-31T16:57:09.215065-05:00']	['96a6b501-d481-5aad-a2e9-7e165f0d50ed', 'accdbd75-e8fa-51b4-babb-620bb96b843e']	['TCGA-CU-A72E_treatment_1', 'TCGA-CU-A72E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:58:55.611035-05:00', '']	01	Primary	26543a29-59ab-4eba-b00f-e45c4c6e9a3e	Primary Tumor	Not Reported	197.0	240.0	Unknown	8D56AE41-2A0C-4D82-971E-989CB5762FFF	false	Solid Tissue	False	Tumor
TCGA-HQ-A2OE-01A	353c5fcc-9c6a-4ac6-99dc-fb4573b2ae6c	Transitional Cell Papillomas and Carcinomas	353c5fcc-9c6a-4ac6-99dc-fb4573b2ae6c	TCGA-HQ-A2OE	Bladder		Not Reported		not reported	male	not reported	Alive	69		1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	92ea63f4-dd85-57be-8c8e-c50c70f40169	HQ	Ontario Institute for Cancer Research (OICR)	Bladder Urothelial Carcinoma	NCH															No		0	not reported	Bladder, NOS	1174.0		Transitional cell carcinoma	no	2007.0	No	6th	T2a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported				['2019-07-31T16:46:32.440418-05:00', '2019-07-31T16:46:32.440418-05:00']	['1b48c1a9-9ffc-59ec-b109-8201313e0cb8', 'cffc28ce-8bfa-5d50-83e9-d7d263204fa4']	['TCGA-HQ-A2OE_treatment', 'TCGA-HQ-A2OE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:50:29.341548-05:00']	01	Primary	65dbbe08-4645-4552-9a1a-e6f79a621013	Primary Tumor	Not Reported		170.0	Unknown	FFCA27E4-3A1F-4626-AB67-2DE62CAD713F	false	Solid Tissue	False	Tumor
TCGA-CU-A3QU-01A	ae6d853b-a7f0-4465-b7bf-5a45006ab3b3	Transitional Cell Papillomas and Carcinomas	ae6d853b-a7f0-4465-b7bf-5a45006ab3b3	TCGA-CU-A3QU	Bladder	0.821917808219178	Not Reported	15.0	white	male	not hispanic or latino	Alive	58	-21233.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	158.0	21233.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21233.0	58.172602739726024	['2019-07-31T16:57:12.559862-05:00', '2019-07-31T16:57:12.559862-05:00']	['5f53fa88-de51-579d-8383-765512c24e16', '831f6d4a-d80d-5eb4-b5d4-bc0826fd7b93']	['TCGA-CU-A3QU_treatment', 'TCGA-CU-A3QU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:57.910105-05:00']	01	Primary	75448068-ded8-42f0-bb99-6d1c4b3ffa4e	Primary Tumor	Not Reported	182.0	940.0	Unknown	3197D149-9CF0-4644-B192-F7BB6028AF45	false	Solid Tissue	False	Tumor
TCGA-H4-A2HO-01A	86d1e388-b30f-48fd-9647-3848eb6134f1	Transitional Cell Papillomas and Carcinomas	86d1e388-b30f-48fd-9647-3848eb6134f1	TCGA-H4-A2HO	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Alive	53	-19630.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	fc847642-8a8a-5c82-be82-e8f6966b98df	H4	Medical College of Georgia	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	46.0	19630.0	Papillary transitional cell carcinoma	no	2010.0	No	7th	T4a	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19630.0	53.78082191780822	['2019-07-31T16:54:01.885136-05:00', '2019-07-31T16:54:01.885136-05:00']	['00af1a6a-f783-5757-9b8d-2f04ae2f0a14', '9d4a85c5-04b5-5044-9478-f84455ce086b']	['TCGA-H4-A2HO_treatment_1', 'TCGA-H4-A2HO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:26.801682-05:00', '']	01	Primary	708501d2-b376-49ea-94ed-3e0ab73af619	Primary Tumor	Not Reported	421.0	470.0	Unknown	24DECC4E-928C-40D2-9269-FE2ABD53E289	false	Solid Tissue	False	Tumor
TCGA-GU-AATQ-01A	aff1533b-486e-40b5-a35a-cfaac5823706	Transitional Cell Papillomas and Carcinomas	aff1533b-486e-40b5-a35a-cfaac5823706	TCGA-GU-AATQ	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	68	-25185.0	1945.0	213.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		25185.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25185.0	69.0	['2019-07-31T16:57:21.217739-05:00', '2019-07-31T16:57:21.217739-05:00']	['cb9fcf61-d43c-511f-9fe7-7758f1e4daae', 'e8d3351d-0e80-5e86-9b80-ef25071ecead']	['TCGA-GU-AATQ_treatment_1', 'TCGA-GU-AATQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:05.327750-05:00', '']	01	Primary	ad2067c7-9fba-4db9-ad14-877bc0c4e20b	Primary Tumor	Not Reported	95.0	240.0	OCT	FF69B05C-B041-4CBA-A481-66AB2510A4AC	true	Solid Tissue	False	Tumor
TCGA-XF-A9SJ-01A	b319798a-3f35-4902-8ecf-5be529d99312	Transitional Cell Papillomas and Carcinomas	b319798a-3f35-4902-8ecf-5be529d99312	TCGA-XF-A9SJ	Bladder	3.0136986301369864	Not Reported	55.0	white	male	not hispanic or latino	Dead	83	-30362.0	1921.0	98.0	2004.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		30362.0	Transitional cell carcinoma	yes	2004.0	No	6th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30362.0	83.18356164383562	['2019-07-31T16:57:27.364549-05:00', '2019-07-31T16:57:27.364549-05:00']	['4349e9d8-8e05-5431-94e9-f4ebf1653ca7', '66507ef4-cbfc-55fc-990d-792cbaa4fadb']	['TCGA-XF-A9SJ_treatment', 'TCGA-XF-A9SJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:10.036772-05:00']	01	Primary	fd042907-f6ca-4c8b-8e6d-aa24678f444a	Primary Tumor	Not Reported	3298.0	510.0	OCT	0093D096-4A35-4543-9FDB-838AE59F0833	true	Solid Tissue	False	Tumor
TCGA-FD-A62N-01A	b7439edc-b7ab-407e-810a-c60864a915bf	Transitional Cell Papillomas and Carcinomas	b7439edc-b7ab-407e-810a-c60864a915bf	TCGA-FD-A62N	Bladder	0.547945205479452	Not Reported	10.0	asian	male	not hispanic or latino	Alive	69	-25297.0	1943.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	82.0	25297.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25297.0	69.30684931506849	['2019-07-31T16:57:44.828258-05:00', '2019-07-31T16:57:44.828258-05:00']	['540ee94c-1bc4-5fe3-87fa-5093fc2bc545', 'e292fc93-ba72-54aa-9c86-cdf9e8d36540']	['TCGA-FD-A62N_treatment', 'TCGA-FD-A62N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:59:25.007625-05:00']	01	Primary	08a5e125-28b4-41cd-9a7a-60fe8377cc1e	Primary Tumor	Not Reported	188.0	1090.0	OCT	16D179ED-9A97-4CB8-BC78-0D4D20AE6B8E	true	Solid Tissue	False	Tumor
TCGA-CF-A3MH-01A	b8a8d2fc-421b-4393-8d5a-946cf72cb496	Transitional Cell Papillomas and Carcinomas	b8a8d2fc-421b-4393-8d5a-946cf72cb496	TCGA-CF-A3MH	Bladder	1.36986301369863	Not Reported	25.0	asian	male	not hispanic or latino	Alive	75	-27458.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	398.0	27458.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27458.0	75.22739726027397	['2019-07-31T16:57:50.762216-05:00', '2019-07-31T16:57:50.762216-05:00']	['086a41de-0092-5431-8631-0be5c557965c', '4f93cbf5-1c89-5d39-8995-c1a621007389']	['TCGA-CF-A3MH_treatment_1', 'TCGA-CF-A3MH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:59:30.121010-05:00', '']	01	Primary	8cf68bb1-5966-40cd-a038-e9e91e608766	Primary Tumor	Not Reported	64.0	460.0	OCT	5C446B3A-D6FB-4301-97E9-D713F985FEBE	true	Solid Tissue	False	Tumor
TCGA-FJ-A871-01A	bb38805e-2ccc-4169-ba01-34b98adf5bd0	Transitional Cell Papillomas and Carcinomas	bb38805e-2ccc-4169-ba01-34b98adf5bd0	TCGA-FJ-A871	Bladder	0.00821917808219178	Not Reported	0.15	white	male	not hispanic or latino	Dead	49	-18051.0	1964.0	272.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4581f940-fb84-5a4a-ab36-d998d0575df0	FJ	BLN - Baylor	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder		18051.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	NX	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	18051.0	49.45479452054794	['2019-07-31T16:58:02.573023-05:00', '2019-07-31T16:58:02.573023-05:00']	['4868f977-f23b-542a-8607-1198db08c221', 'df5c6a6b-e623-5635-93e3-8862f1980461']	['TCGA-FJ-A871_treatment', 'TCGA-FJ-A871_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:59:39.864485-05:00']	01	Primary	3b4729fc-02a4-4e6a-b24c-34bc68943300	Primary Tumor	Not Reported	43.0	60.0	OCT	6F7FA0D6-7A3A-48D2-A45A-326F730E6926	true	Solid Tissue	False	Tumor
TCGA-GC-A3RC-01A	bd7f2c90-863e-4380-ad31-8755bcb2f975	Transitional Cell Papillomas and Carcinomas	bd7f2c90-863e-4380-ad31-8755bcb2f975	TCGA-GC-A3RC	Bladder		Not Reported		white	male	not hispanic or latino	Alive	59	-21668.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	484.0	21668.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2b	21668.0	59.364383561643834	['2019-07-31T16:58:11.182887-05:00', '2019-07-31T16:58:11.182887-05:00']	['05b0fbb8-0c16-5ee8-9f87-bf8dada5a866', '6de25391-079b-5ead-8b64-da1dcaeed875']	['TCGA-GC-A3RC_treatment', 'TCGA-GC-A3RC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:46.960039-05:00']	01	Primary	af6db5e4-2286-4123-9e49-ee03359fd09f	Primary Tumor	Not Reported	80.0	6.0	OCT	77A23BED-7B17-4854-A6E3-D6E8ECD460F8	true	Solid Tissue	False	Tumor
TCGA-BT-A20X-01A	be8b3f36-aaa1-4302-b28e-de1996faceaf	Transitional Cell Papillomas and Carcinomas	be8b3f36-aaa1-4302-b28e-de1996faceaf	TCGA-BT-A20X	Bladder		Not Reported		white	male	not hispanic or latino	Dead	56	-20519.0	1953.0	251.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Dome of bladder		20519.0	Transitional cell carcinoma	no	2009.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T4a	20519.0	56.21643835616438	['2019-07-31T16:58:16.524673-05:00', '2019-07-31T16:58:16.524673-05:00']	['457f1562-11b5-561b-9d54-a582a16ae670', '8cd42817-c98f-57dc-8fa3-ff22c455159e']	['TCGA-BT-A20X_treatment', 'TCGA-BT-A20X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:51.837953-05:00']	01	Primary	4d7d3354-6588-4e02-9354-ab5044ba1ab3	Primary Tumor		555.0	390.0	OCT	60D4B255-2F73-4F45-83D5-68B8CC422D1C	true	Solid Tissue	False	Tumor
TCGA-BT-A20X-11A	be8b3f36-aaa1-4302-b28e-de1996faceaf	Transitional Cell Papillomas and Carcinomas	be8b3f36-aaa1-4302-b28e-de1996faceaf	TCGA-BT-A20X	Bladder		Not Reported		white	male	not hispanic or latino	Dead	56	-20519.0	1953.0	251.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Dome of bladder		20519.0	Transitional cell carcinoma	no	2009.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T4a	20519.0	56.21643835616438	['2019-07-31T16:58:16.524673-05:00', '2019-07-31T16:58:16.524673-05:00']	['457f1562-11b5-561b-9d54-a582a16ae670', '8cd42817-c98f-57dc-8fa3-ff22c455159e']	['TCGA-BT-A20X_treatment', 'TCGA-BT-A20X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:51.837953-05:00']	11	Not Applicable	f949b635-1bf1-457f-b72a-02f59753e467	Solid Tissue Normal		555.0	190.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20O-01A	c0e7fbe7-b9cb-4e65-941b-cd7d581c54ec	Transitional Cell Papillomas and Carcinomas	c0e7fbe7-b9cb-4e65-941b-cd7d581c54ec	TCGA-BT-A20O	Bladder		Not Reported		white	male	not hispanic or latino	Dead	75	-27534.0	1928.0	370.0	2004.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder		27534.0	Transitional cell carcinoma	no	2003.0	No	6th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T3a	27534.0	75.43561643835616	['2019-07-31T16:58:26.069795-05:00', '2019-07-31T16:58:26.069795-05:00']	['47be0a9b-1e4c-5a65-a50b-0105f30ecc2e', 'ccdec459-61df-5af2-8ac5-4a3111a00e74']	['TCGA-BT-A20O_treatment_1', 'TCGA-BT-A20O_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:59:59.396960-05:00', '']	01	Primary	5ecd84ad-44fd-4599-bf3d-ab725e0404ec	Primary Tumor		2702.0	330.0	OCT	B2E8ABBC-33FF-4B89-AE29-34097296CB39	true	Solid Tissue	False	Tumor
TCGA-G2-A2EJ-01A	c6227d39-d9e8-4e28-9e70-d7f720ab25e4	Transitional Cell Papillomas and Carcinomas	c6227d39-d9e8-4e28-9e70-d7f720ab25e4	TCGA-G2-A2EJ	Bladder	1.095890410958904	Not Reported	20.0	white	female	not hispanic or latino	Alive	56	-20649.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1460.0	20649.0	Transitional cell carcinoma	no	2009.0	No	6th		8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	20649.0	56.57260273972603	['2019-07-31T16:58:37.509314-05:00', '2019-07-31T16:58:37.509314-05:00']	['5ed32d71-3b98-5f89-8ba1-3e5d1ebdb5f8', '7819186e-8658-5f82-a40e-c6e48afe3929']	['TCGA-G2-A2EJ_treatment', 'TCGA-G2-A2EJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:00:08.465654-05:00']	01	Primary	fbad20ba-ee08-4d46-825b-870126aad539	Primary Tumor	Not Reported	741.0	250.0	OCT	2C46A6D2-74EE-4389-9D8F-4737CE4832FB	true	Solid Tissue	False	Tumor
TCGA-FT-A3EE-01A	cce62116-3dcd-400d-ada0-9839ca02466e	Transitional Cell Papillomas and Carcinomas	cce62116-3dcd-400d-ada0-9839ca02466e	TCGA-FT-A3EE	Bladder		Not Reported		white	female	not hispanic or latino	Dead	80	-29293.0	1931.0	99.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	02efc747-0acd-56a7-9da3-e8c2358cd50b	FT	BLN - University of Miami	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder neck		29293.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.5	Bladder neck	Not Reported	not reported		29293.0	80.25479452054795	['2019-07-31T16:59:26.202606-05:00', '2019-07-31T16:59:26.202606-05:00']	['484ce690-02e4-53d1-bf1b-8d05d9467fb6', 'cad03a7f-7075-5c79-bdf9-7117e76e191b']	['TCGA-FT-A3EE_treatment_1', 'TCGA-FT-A3EE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T10:00:48.060995-05:00', '']	01	Primary	2356f78c-0653-468f-83db-6cf6107bd259	Primary Tumor	Not Reported	251.0	50.0	OCT	5F7AEE5D-7F5F-495F-B497-31BDDCF1D338	true	Solid Tissue	False	Tumor
TCGA-UY-A9PH-01A	cd10dc46-356a-420b-b3f5-9e4ed4e7ecab	Transitional Cell Papillomas and Carcinomas	cd10dc46-356a-420b-b3f5-9e4ed4e7ecab	TCGA-UY-A9PH	Bladder		Not Reported		white	male	not hispanic or latino	Alive	73	-26654.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	1561.0	26654.0	Transitional cell carcinoma	yes		Yes	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26654.0	73.02465753424657	['2019-07-31T16:59:29.151051-05:00', '2019-07-31T16:59:29.151051-05:00']	['49f5bd00-3d7e-5f54-8b0f-c1c8d386cd8e', 'edb1f50d-30f6-5a7e-ad10-f3e6c5d9d2c1']	['TCGA-UY-A9PH_treatment_1', 'TCGA-UY-A9PH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:00:50.638465-05:00', '']	01	Primary	89f7f38a-8228-40ec-9043-e2eca1d1d44d	Primary Tumor	Not Reported		70.0	OCT	0F1A84D7-7EB5-4FDD-BB99-FC4DBB712814	true	Solid Tissue	False	Tumor
TCGA-GU-AATO-01A	cd20b968-b348-44eb-9cdb-f557af8fb468	Transitional Cell Papillomas and Carcinomas	cd20b968-b348-44eb-9cdb-f557af8fb468	TCGA-GU-AATO	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	75	-27684.0	1938.0	324.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		27684.0	Transitional cell carcinoma	no	2013.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27684.0	75.84657534246575	['2019-07-31T16:59:32.001214-05:00', '2019-07-31T16:59:32.001214-05:00']	['365d77da-2bb9-542d-aa65-281f465a5632', 'd41523bd-ca32-5ad3-9862-7b9dedbf4b3c']	['TCGA-GU-AATO_treatment', 'TCGA-GU-AATO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:00:53.074748-05:00']	01	Primary	98fe54ec-98a0-4257-a805-fe1840eab39d	Primary Tumor	Not Reported	193.0	130.0	OCT	3C79B07E-8985-4F42-BEE6-56D308603409	true	Solid Tissue	False	Tumor
TCGA-FD-A43Y-01A	d349fae0-dd40-4292-908c-ac86a9938240	Transitional Cell Papillomas and Carcinomas	d349fae0-dd40-4292-908c-ac86a9938240	TCGA-FD-A43Y	Bladder	2.73972602739726	Not Reported	50.0	white	male	not hispanic or latino	Dead	65	-23889.0	1947.0	474.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder	369.0	23889.0	Transitional cell carcinoma	no	2012.0	No	7th	T4	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	23889.0	65.44931506849315	['2019-07-31T17:00:02.595985-05:00', '2019-07-31T17:00:02.595985-05:00']	['6b7d1f3e-9e1c-5b0b-a8f5-05860ba7a978', '8f2fe168-7f3d-5103-9ba9-5aa8536eda9b']	['TCGA-FD-A43Y_treatment_1', 'TCGA-FD-A43Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:18.204525-05:00', '']	01	Primary	792e76bf-6fa5-4861-a311-8d848374ff21	Primary Tumor	Not Reported	201.0	1040.0	OCT	DD36E5EA-D22A-47F7-AF4D-743FBDEBA629	true	Solid Tissue	False	Tumor
TCGA-DK-AA6M-01A	d8b07fdd-5580-4bcc-9619-b5e0c9f0aa3d	Transitional Cell Papillomas and Carcinomas	d8b07fdd-5580-4bcc-9619-b5e0c9f0aa3d	TCGA-DK-AA6M	Bladder		Not Reported		white	female	not hispanic or latino	Alive	64	-23574.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Lateral wall of bladder	1582.0	23574.0	Transitional cell carcinoma	yes	2010.0	No	7th	T2	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	23574.0	64.58630136986301	['2019-07-31T17:00:29.333319-05:00', '2019-07-31T17:00:29.333319-05:00']	['3811fc2e-ddee-5372-a80c-21a6fcd32d04', 'e96fb55e-5a84-52b5-aa6f-7f79641b6e82']	['TCGA-DK-AA6M_treatment', 'TCGA-DK-AA6M_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:39.800433-05:00']	01	Primary	10f2ed03-4e58-41aa-ae19-4d44f57cbdf5	Primary Tumor	Not Reported	1176.0	290.0	OCT	C1106CFA-9382-4748-927C-E46BA18D4991	true	Solid Tissue	False	Tumor
TCGA-BT-A42B-01A	db84c62d-6904-4ea8-8e51-1262b8d6ff90	Transitional Cell Papillomas and Carcinomas	db84c62d-6904-4ea8-8e51-1262b8d6ff90	TCGA-BT-A42B	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	59	-21788.0	1952.0	534.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	469.0	21788.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T3a	8130/3	N1	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T3b	21788.0	59.69315068493151	['2019-07-31T17:00:41.223348-05:00', '2019-07-31T17:00:41.223348-05:00']	['516bc38b-d81a-5781-b21a-b878e617d2fa', '5d1de895-4d41-520d-b438-4e7deeee0483']	['TCGA-BT-A42B_treatment', 'TCGA-BT-A42B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:49.830463-05:00']	01	Primary	9d689e1b-3366-4b34-b287-31df87661957	Primary Tumor	Not Reported	316.0	210.0	OCT	ECB8BC78-5051-4B74-B85C-1D89344E8A37	true	Solid Tissue	False	Tumor
TCGA-DK-A6AW-01A	01c815ba-7bda-4f7e-865c-0c5776febf2c	Transitional Cell Papillomas and Carcinomas	01c815ba-7bda-4f7e-865c-0c5776febf2c	TCGA-DK-A6AW	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Alive	70	-25644.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Trigone of bladder	1621.0	25644.0	Transitional cell carcinoma	yes	2010.0	No	6th	T2a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported		25644.0	70.25753424657535	['2019-07-31T16:33:40.756484-05:00', '2019-07-31T16:33:40.756484-05:00']	['9f0abcaa-19fd-58c0-8d7a-71a2a7ea04d7', 'd54f3c55-56ae-5546-a6c7-dfdad0bb3f84']	['TCGA-DK-A6AW_treatment', 'TCGA-DK-A6AW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:40:20.094427-05:00']	01	Primary	71ae41dc-20da-440f-a04a-c2516b79db19	Primary Tumor	Not Reported	1183.0	110.0	OCT	FFC32668-B801-48EB-BBAC-0E624AEED12D	true	Solid Tissue	False	Tumor
TCGA-XF-A8HD-01A	dfc67e7b-3986-4129-ae02-4d8f57e776e3	Transitional Cell Papillomas and Carcinomas	dfc67e7b-3986-4129-ae02-4d8f57e776e3	TCGA-XF-A8HD	Bladder	0.6575342465753424	Not Reported	12.0	white	male	not hispanic or latino	Alive	77	-28305.0	1929.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	2964.0	28305.0	Transitional cell carcinoma	no	2006.0	No	6th	T3a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	28305.0	77.54794520547945	['2019-07-31T17:00:52.966206-05:00', '2019-07-31T17:00:52.966206-05:00']	['5eb64578-293d-564a-9e68-5a5d37fd3ea7', 'ce1ef467-ba4a-5b57-aaac-4b17de4b10b9']	['TCGA-XF-A8HD_treatment_1', 'TCGA-XF-A8HD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:59.254805-05:00', '']	01	Primary	652e7049-0114-4dba-ab6d-2bfb8df5bed3	Primary Tumor	Not Reported	2820.0	760.0	OCT	CB491DC7-F20F-496F-A416-AA32105D32D7	true	Solid Tissue	False	Tumor
TCGA-XF-A8HH-01A	02964d82-cc94-4286-a66f-03567101950c	Transitional Cell Papillomas and Carcinomas	02964d82-cc94-4286-a66f-03567101950c	TCGA-XF-A8HH	Bladder		Not Reported		white	female	not hispanic or latino	Dead	61	-22393.0	1943.0	57.0	2004.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		22393.0	Transitional cell carcinoma	no	2004.0	No	6th	T3b	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22393.0	61.35068493150685	['2019-07-31T16:33:47.027563-05:00', '2019-07-31T16:33:47.027563-05:00']	['0e1d5339-176d-5437-b636-20fae59ff6f2', '4652ba7f-4eac-5080-97a3-449479b41210']	['TCGA-XF-A8HH_treatment', 'TCGA-XF-A8HH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:40:25.091920-05:00']	01	Primary	4c811177-e110-44a7-8c3f-729d5948fce3	Primary Tumor	Not Reported	3312.0	420.0	OCT	33C8B2EA-980D-4CDC-B8A9-B8583E04BCCA	true	Solid Tissue	False	Tumor
TCGA-G2-AA3D-01A	e1540865-69c2-4b60-a78e-97d0ce2957dc	Transitional Cell Papillomas and Carcinomas	e1540865-69c2-4b60-a78e-97d0ce2957dc	TCGA-G2-AA3D	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Alive	60	-22205.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	2139.0	22205.0	Transitional cell carcinoma	no	2009.0	No	6th	T3	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22205.0	60.83561643835616	['2019-07-31T17:01:01.594354-05:00', '2019-07-31T17:01:01.594354-05:00']	['886e1747-3fac-5966-b7da-dd8c1e656cc1', 'a73bf44c-52cf-576d-9ccf-6bba96221c97']	['TCGA-G2-AA3D_treatment', 'TCGA-G2-AA3D_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:06.467923-05:00']	01	Primary	678f654e-8792-4041-8cfb-09fe2c3ba7f4	Primary Tumor	Not Reported	1726.0	50.0	OCT	F4A8627A-5551-4E1D-A49E-370FD0F39D02	true	Solid Tissue	False	Tumor
TCGA-PQ-A6FI-01A	04b9090a-e8ef-4f52-bc52-af90caa84168	Transitional Cell Papillomas and Carcinomas	04b9090a-e8ef-4f52-bc52-af90caa84168	TCGA-PQ-A6FI	Bladder	3.1780821917808217	Not Reported	58.0	white	male	not hispanic or latino	Alive	70	-25672.0	1941.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	2b2b5abf-f65c-5e03-9fee-258ac742453e	PQ	University of Colorado Denver	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	372.0	25672.0	Transitional cell carcinoma	no	2011.0	No	7th	T2a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25672.0	70.33424657534246	['2019-07-31T16:43:17.701952-05:00', '2019-07-31T16:43:17.701952-05:00']	['528fb6dc-1bd3-52eb-a9e6-b220632aed9e', 'f852797f-6af8-54b0-9f42-a1e119793de1']	['TCGA-PQ-A6FI_treatment_1', 'TCGA-PQ-A6FI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:47:51.159597-05:00', '']	01	Primary	760ad8fe-5f5b-4eed-9147-67780330e08c	Primary Tumor	Not Reported	721.0	130.0	OCT	9B3FA7CE-F924-4DD5-9E2E-13F889A2B3AA	true	Solid Tissue	False	Tumor
TCGA-FD-A62S-01A	05a1402e-5a79-4d54-9430-065844ed1505	Transitional Cell Papillomas and Carcinomas	05a1402e-5a79-4d54-9430-065844ed1505	TCGA-FD-A62S	Bladder		Not Reported		black or african american	female	not hispanic or latino	Dead	60	-22000.0	1953.0	406.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	368.0	22000.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22000.0	60.273972602739725	['2019-07-31T16:43:24.202045-05:00', '2019-07-31T16:43:24.202045-05:00']	['19c974d8-126b-55ef-adc8-61f8c58701a5', '83e9e3ba-d2ce-509f-9feb-bad3f16900cd']	['TCGA-FD-A62S_treatment_1', 'TCGA-FD-A62S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:47:55.900578-05:00', '']	01	Primary	3d473acb-5c41-4d9f-a4a9-41846f445b48	Primary Tumor	Not Reported	49.0	1150.0	OCT	690C8ADC-7F33-4E3A-A616-990B588F0029	true	Solid Tissue	False	Tumor
TCGA-GU-A42R-01A	0691b8c5-6244-407c-8601-fa1bda01ff2a	Transitional Cell Papillomas and Carcinomas	0691b8c5-6244-407c-8601-fa1bda01ff2a	TCGA-GU-A42R	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	68	-25134.0	1944.0	577.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	344.0	25134.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2b	25134.0	68.86027397260274	['2019-07-31T17:13:57.876932-05:00', '2019-07-31T17:13:57.876932-05:00']	['858848be-9762-52b3-bb3d-a74131c93e1e', 'a7886568-eddf-5858-bb2b-ed1ee58422bb']	['TCGA-GU-A42R_treatment_1', 'TCGA-GU-A42R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:12:50.460577-05:00', '']	01	Primary	979c176f-5c5c-45ad-a430-beb929d47035	Primary Tumor	Not Reported	16.0	160.0	OCT	A916842B-DCE7-42FE-82BC-277D09DFC698	true	Solid Tissue	False	Tumor
TCGA-DK-A6B1-01A	0d2cd56c-09c6-467d-b3aa-1f7fe0cc60e1	Transitional Cell Papillomas and Carcinomas	0d2cd56c-09c6-467d-b3aa-1f7fe0cc60e1	TCGA-DK-A6B1	Bladder		Not Reported		white	male	not hispanic or latino	Alive	67	-24607.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Anterior wall of bladder	2049.0	24607.0	Transitional cell carcinoma	yes	2007.0	No	6th	T2a	8120/3	N0	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		24607.0	67.41643835616438	['2019-07-31T16:43:51.063971-05:00', '2019-07-31T16:43:51.063971-05:00']	['23562093-2cf8-5cd0-9c12-4c01b0f9d933', '61e3a4a0-d93d-519a-ba05-451b3c343af7']	['TCGA-DK-A6B1_treatment', 'TCGA-DK-A6B1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:18.499014-05:00']	01	Primary	7da631ce-b5f9-480d-a420-ebbe76a0927c	Primary Tumor	Not Reported	2059.0	230.0	OCT	D475F198-6FFF-4869-922E-5E0F5BC564C9	true	Solid Tissue	False	Tumor
TCGA-ZF-AA58-01A	0da6502c-058d-47f5-9996-8aa1d511d7e4	Transitional Cell Papillomas and Carcinomas	0da6502c-058d-47f5-9996-8aa1d511d7e4	TCGA-ZF-AA58	Bladder	2.136986301369863	Not Reported	39.0	white	female	not hispanic or latino	Alive	61	-22549.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	1649.0	22549.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22549.0	61.778082191780825	['2019-07-31T16:43:54.097962-05:00', '2019-07-31T16:43:54.097962-05:00']	['a5dc2c22-7f1c-55d4-a28c-8f840b6c1df3', 'e094f720-5267-5509-8e1e-2d5916d58c54']	['TCGA-ZF-AA58_treatment_1', 'TCGA-ZF-AA58_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:48:21.174634-05:00', '']	01	Primary	56f1ae65-b100-4340-8afe-854e4de7b584	Primary Tumor	Not Reported	1252.0	220.0	OCT	31EED29A-65A9-4DB1-8E78-799A927D59F3	true	Solid Tissue	False	Tumor
TCGA-CF-A47T-01A	0db0f02f-94f5-492f-8840-5254792f6879	Transitional Cell Papillomas and Carcinomas	0db0f02f-94f5-492f-8840-5254792f6879	TCGA-CF-A47T	Bladder		Not Reported		asian	female	not hispanic or latino	Dead	58	-21347.0	1953.0	385.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	205.0	21347.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	21347.0	58.484931506849314	['2019-07-31T16:43:57.120551-05:00', '2019-07-31T16:43:57.120551-05:00']	['4d38c118-6274-5719-84d8-dc495c15be3d', '9761f567-89a0-5368-8751-c1eb5ccbde02']	['TCGA-CF-A47T_treatment', 'TCGA-CF-A47T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:48:23.760299-05:00']	01	Primary	6365aa9b-ccdd-40af-aa59-0396905dcb3e	Primary Tumor	Not Reported	276.0	520.0	OCT	BAAF2D41-6A16-48A3-B758-DC5CDF369C94	true	Solid Tissue	False	Tumor
TCGA-XF-AAMZ-01A	ed36d054-53c4-465c-bd84-6ec5227097bf	Transitional Cell Papillomas and Carcinomas	ed36d054-53c4-465c-bd84-6ec5227097bf	TCGA-XF-AAMZ	Bladder		Not Reported		white	female	not hispanic or latino	Dead	81	-29667.0	1926.0	1348.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		29667.0	Papillary transitional cell carcinoma	yes	2007.0	No	6th	T3a	8130/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29667.0	81.27945205479452	['2019-07-31T17:01:33.306181-05:00', '2019-07-31T17:01:33.306181-05:00']	['c365f6e8-fd27-5e6d-8a8a-791d084b7e15', 'e27c464c-73df-52fc-a54f-e718dd06e932']	['TCGA-XF-AAMZ_treatment', 'TCGA-XF-AAMZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:02:33.072150-05:00']	01	Primary	0c9c512c-0d91-4f83-b706-cac1127cdab0	Primary Tumor	Not Reported	2557.0	370.0	OCT	45680E92-721E-4332-9E45-7F134D7AFCAE	true	Solid Tissue	False	Tumor
TCGA-K4-A5RH-01A	eeca58fe-b5cb-4d13-a93f-a5a2ca00b6e2	Transitional Cell Papillomas and Carcinomas	eeca58fe-b5cb-4d13-a93f-a5a2ca00b6e2	TCGA-K4-A5RH	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Alive	69	-25305.0	1943.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder	276.0	25305.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	TX	25305.0	69.32876712328768	['2019-07-31T17:01:39.154319-05:00', '2019-07-31T17:01:39.154319-05:00']	['2fe945af-e2c9-5c95-b94b-5ab41bc1010f', 'e7194958-481e-5e40-bb68-34cc3cc7e0bc']	['TCGA-K4-A5RH_treatment', 'TCGA-K4-A5RH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:02:37.757193-05:00']	01	Primary	a4acab2e-d8f9-41ab-8e03-d3580221d2af	Primary Tumor	Not Reported	221.0	720.0	OCT	60531FDD-78B7-4DAF-8B6F-ED9C4D6AA2BB	true	Solid Tissue	False	Tumor
TCGA-DK-A1AB-01A	f027d254-ec01-4882-a8a7-964ae90b7d49	Transitional Cell Papillomas and Carcinomas	f027d254-ec01-4882-a8a7-964ae90b7d49	TCGA-DK-A1AB	Bladder		Not Reported		white	female	not hispanic or latino	Dead	74	-27126.0	1936.0	508.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	271.0	27126.0	Transitional cell carcinoma	no	2010.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27126.0	74.31780821917808	['2019-07-31T17:01:51.008573-05:00', '2019-07-31T17:01:51.008573-05:00']	['1f384c41-8e6c-554d-8d0d-675d1b4f9590', '503aeb01-9dcf-59dc-872f-35466347bda7']	['TCGA-DK-A1AB_treatment', 'TCGA-DK-A1AB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:02:47.567800-05:00']	01	Primary	253f84ab-fce2-4e2d-955b-0b8d13a9e4f0	Primary Tumor	Not Reported	162.0	310.0	OCT	5FCDE7D1-8263-465D-B0A6-C660B152D86F	true	Solid Tissue	False	Tumor
TCGA-DK-AA6U-01A	104c8e20-1b29-4d77-9633-359a35be48fb	Transitional Cell Papillomas and Carcinomas	104c8e20-1b29-4d77-9633-359a35be48fb	TCGA-DK-AA6U	Bladder	0.821917808219178	Not Reported	15.0	white	male	not hispanic or latino	Alive	64	-23611.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	578.0	23611.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	23611.0	64.68767123287671	['2019-07-31T16:44:14.715121-05:00', '2019-07-31T16:44:14.715121-05:00']	['51cda8aa-8fa7-5e55-933b-c57e0aa601ce', '816b28c2-cabc-586a-a951-98c1200c90a9']	['TCGA-DK-AA6U_treatment', 'TCGA-DK-AA6U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:48:38.796898-05:00']	01	Primary	ccfee146-e91d-413a-8466-33efb4502990	Primary Tumor	Not Reported	172.0	30.0	OCT	BC479C80-74F1-417F-BEE4-6C69975C0BF6	true	Solid Tissue	False	Tumor
TCGA-CF-A3MI-01A	f1ebf96b-8df9-4e59-acef-7ad433e40214	Transitional Cell Papillomas and Carcinomas	f1ebf96b-8df9-4e59-acef-7ad433e40214	TCGA-CF-A3MI	Bladder	2.191780821917808	Not Reported	40.0	asian	male	not hispanic or latino	Alive	62	-22716.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	370.0	22716.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22716.0	62.23561643835617	['2019-07-31T17:02:11.655909-05:00', '2019-07-31T17:02:11.655909-05:00']	['60eb015a-e66f-504a-b56b-67c7006aea18', '995ffbc2-3049-5436-87be-0abbf5803b10']	['TCGA-CF-A3MI_treatment', 'TCGA-CF-A3MI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:03:05.227534-05:00']	01	Primary	a373568a-bbd3-4d67-92d6-96e8378065cf	Primary Tumor	Not Reported	57.0	500.0	OCT	F492F839-CD0D-43EC-9037-247EAE5B796C	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4T-01A	1859a4c5-78bc-4b1a-a26e-3d2b4cb221c2	Transitional Cell Papillomas and Carcinomas	1859a4c5-78bc-4b1a-a26e-3d2b4cb221c2	TCGA-ZF-AA4T	Bladder		Not Reported		white	male	not hispanic or latino	Dead	65	-23974.0	1943.0	599.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		23974.0	Transitional cell carcinoma	yes	2008.0	No	6th	T4	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	23974.0	65.68219178082192	['2019-07-31T16:44:34.705972-05:00', '2019-07-31T16:44:34.705972-05:00']	['5ac009fd-c07d-598b-b6ae-2154c7a9ef7a', 'fe6d6c1b-1e21-52ae-a902-e6bad84190d0']	['TCGA-ZF-AA4T_treatment_1', 'TCGA-ZF-AA4T_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:48:54.158675-05:00', '']	01	Primary	8a3c17f4-bfbc-43ef-b28c-a340d67e84cf	Primary Tumor	Not Reported	1834.0	160.0	OCT	9BB5D705-F2CF-4BD3-8E55-7F8BCB2A0DE5	true	Solid Tissue	False	Tumor
TCGA-GU-A764-01A	20ebeff1-e5a7-423a-be93-e7ebb82438ac	Transitional Cell Papillomas and Carcinomas	20ebeff1-e5a7-423a-be93-e7ebb82438ac	TCGA-GU-A764	Bladder	1.0410958904109588	Not Reported	19.0	white	male	not hispanic or latino	Alive	66	-24343.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Anterior wall of bladder	610.0	24343.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		24343.0	66.69315068493151	['2019-07-31T16:45:02.708940-05:00', '2019-07-31T16:45:02.708940-05:00']	['55010079-d445-5890-bd5f-a6dca7e94404', '732acc2c-2fd4-5d76-a2c8-d53793224261']	['TCGA-GU-A764_treatment_1', 'TCGA-GU-A764_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:16.214356-05:00', '']	01	Primary	3d503261-c0d3-473a-b9cc-498e78f00da1	Primary Tumor	Not Reported	232.0	140.0	OCT	55AD4C75-61D8-4377-A4F0-1311CFD6ACA8	true	Solid Tissue	False	Tumor
TCGA-DK-AA71-01A	22dbea93-3e1b-4e1b-ba40-55f08b99e73b	Transitional Cell Papillomas and Carcinomas	22dbea93-3e1b-4e1b-ba40-55f08b99e73b	TCGA-DK-AA71	Bladder		Not Reported		white	male	not hispanic or latino	Alive	71	-25950.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Lateral wall of bladder	415.0	25950.0	Transitional cell carcinoma	yes	2013.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25950.0	71.0958904109589	['2019-07-31T16:45:11.417965-05:00', '2019-07-31T16:45:11.417965-05:00']	['2f5dba16-9f3e-5c14-8862-f1e17b58c857', 'd996a550-c1a1-5288-9203-489d7e487db4']	['TCGA-DK-AA71_treatment', 'TCGA-DK-AA71_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:49:23.731036-05:00']	01	Primary	ac4bbd07-dd86-460a-870a-648b5dabda57	Primary Tumor	Not Reported	337.0	820.0	OCT	5C8A75F5-A08D-4CA9-A3D3-67F77C4A65EB	true	Solid Tissue	False	Tumor
TCGA-DK-A2I2-01A	234086dd-5a74-4ff1-94ab-bad43ee69d5c	Transitional Cell Papillomas and Carcinomas	234086dd-5a74-4ff1-94ab-bad43ee69d5c	TCGA-DK-A2I2	Bladder		Not Reported		white	female	not hispanic or latino	Dead	63	-23116.0	1947.0	237.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		23116.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N3	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23116.0	63.33150684931507	['2019-07-31T16:45:32.080403-05:00', '2019-07-31T16:45:32.080403-05:00']	['66018105-fd47-5b7d-96ff-c45a66731561', '9b9d8e38-5e39-5fdc-b718-5cdec534ae2a']	['TCGA-DK-A2I2_treatment_1', 'TCGA-DK-A2I2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:40.657561-05:00', '']	01	Primary	45f8e4b6-5d36-47d7-a77d-e5e4c15848b3	Primary Tumor	Not Reported	217.0	530.0	OCT	40F557A8-987A-422A-B28B-A11F2119EE3F	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RE-01A	284e175c-3229-4fee-a627-a49eac538e3a	Transitional Cell Papillomas and Carcinomas	284e175c-3229-4fee-a627-a49eac538e3a	TCGA-ZF-A9RE	Bladder		Not Reported		white	female	not hispanic or latino	Dead	78	-28622.0	1932.0	106.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		28622.0	Transitional cell carcinoma	no	2010.0	No	7th		8120/3		MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	28622.0	78.41643835616438	['2019-07-31T16:45:29.283318-05:00', '2019-07-31T16:45:29.283318-05:00']	['8dd5f7f0-f862-5766-b4a3-55d9167fa4e5', 'c0d02537-ff2d-5d37-bd51-74db6fa8320b']	['TCGA-ZF-A9RE_treatment', 'TCGA-ZF-A9RE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:49:38.113390-05:00']	01	Primary	7a2362d1-3f48-472a-aad8-d822fdafff0d	Primary Tumor	Not Reported	1364.0	30.0	OCT	9AF70357-D696-4AEB-B338-7A711A39DAE5	true	Solid Tissue	False	Tumor
TCGA-GD-A3OS-01A	2a41b7d4-132f-4fb6-87b5-487c445379c7	Transitional Cell Papillomas and Carcinomas	2a41b7d4-132f-4fb6-87b5-487c445379c7	TCGA-GD-A3OS	Bladder	0.958904109589041	Not Reported	17.5	white	female	not hispanic or latino	Alive	54	-19776.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	638.0	19776.0	Transitional cell carcinoma	no	2011.0	No	7th		8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	19776.0	54.18082191780822	['2019-07-31T16:45:54.282712-05:00', '2019-07-31T16:45:54.282712-05:00']	['28ae936c-c2a3-5b0c-9c89-42e4c36e2208', 'ee4f5d77-8840-5ba2-8f36-e582ef73ef56']	['TCGA-GD-A3OS_treatment_1', 'TCGA-GD-A3OS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:49:58.200677-05:00', '']	01	Primary	c629cd55-54d7-4e31-ab90-955ebff0b20a	Primary Tumor	Not Reported	205.0	350.0	Unknown	FB313E2A-4B08-44FA-A872-00EF40064FB7	false	Solid Tissue	False	Tumor
TCGA-GD-A6C6-01A	aadcf26b-c398-489f-a86a-e8db1b5db456	Transitional Cell Papillomas and Carcinomas	aadcf26b-c398-489f-a86a-e8db1b5db456	TCGA-GD-A6C6	Bladder	2.4657534246575343	Not Reported	45.0	white	male	not hispanic or latino	Alive	64	-23631.0	1948.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	67.0	23631.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	23631.0	64.74246575342465	['2019-07-31T16:56:45.167794-05:00', '2019-07-31T16:56:45.167794-05:00']	['28972543-967b-5d07-8fd3-7bf4f7ad48ce', 'e0d14254-2247-5f1f-8311-9bd91ac7f67d']	['TCGA-GD-A6C6_treatment', 'TCGA-GD-A6C6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:36.764737-05:00']	01	Primary	cc838dca-08f1-43e4-b483-35af5899bda3	Primary Tumor	Not Reported	328.0	200.0	Unknown	C8289619-F986-45C1-A5B3-D88DB3CFC138	false	Solid Tissue	False	Tumor
TCGA-BL-A0C8-01B	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	Transitional Cell Papillomas and Carcinomas	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	TCGA-BL-A0C8	Bladder	0.547945205479452	Not Reported	10.0	white	male	not hispanic or latino	Alive	73	-26819.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH	TCGA-BL-A0C8	This is a non-muscle invasive pT1 bladder cancer submitted before the pT2 requirement	15125	Notification	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	2013-01-22T00:00:00	fd66301a-d155-557c-9c28-3aabcd63cee9	case	2018-08-23T16:32:20.747393-05:00	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	released	Item does not meet study protocol	Approved	TCGA-BL-A0C8	No	Stage I	0	not reported	Dome of bladder	1219.0	26819.0	Transitional cell carcinoma	no	2009.0	No		T1	8120/3	NX	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		26819.0	73.47671232876712	['2019-07-31T15:23:28.267237-05:00', '2019-07-31T15:23:28.267237-05:00']	['04001d39-fe03-51fc-bbd4-85e050d41997', 'd93cde56-03c3-5823-850d-bab213286b6a']	['TCGA-BL-A0C8_treatment_1', 'TCGA-BL-A0C8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T08:43:11.231812-05:00', '']	01	Primary	5365eef9-56ca-4e3f-a187-3316158c4a32	Primary Tumor	Not Reported	806.0		FFPE	5077D8C6-57D2-4C6A-9316-71BE40224195	false	Solid Tissue	True	Tumor
TCGA-BL-A0C8-01A	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	Transitional Cell Papillomas and Carcinomas	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	TCGA-BL-A0C8	Bladder	0.547945205479452	Not Reported	10.0	white	male	not hispanic or latino	Alive	73	-26819.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH	TCGA-BL-A0C8	This is a non-muscle invasive pT1 bladder cancer submitted before the pT2 requirement	15125	Notification	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	2013-01-22T00:00:00	fd66301a-d155-557c-9c28-3aabcd63cee9	case	2018-08-23T16:32:20.747393-05:00	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	released	Item does not meet study protocol	Approved	TCGA-BL-A0C8	No	Stage I	0	not reported	Dome of bladder	1219.0	26819.0	Transitional cell carcinoma	no	2009.0	No		T1	8120/3	NX	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		26819.0	73.47671232876712	['2019-07-31T15:23:28.267237-05:00', '2019-07-31T15:23:28.267237-05:00']	['04001d39-fe03-51fc-bbd4-85e050d41997', 'd93cde56-03c3-5823-850d-bab213286b6a']	['TCGA-BL-A0C8_treatment_1', 'TCGA-BL-A0C8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T08:43:11.231812-05:00', '']	01	Primary	5feed572-07c0-4da0-8649-ca8f8682657a	Primary Tumor	Not Reported	213.0	790.0	Unknown	5077D8C6-57D2-4C6A-9316-71BE40224195	false	Solid Tissue	False	Tumor
TCGA-DK-A6B6-01A	ab6580e4-5de9-4361-b06a-1d20e5571890	Transitional Cell Papillomas and Carcinomas	ab6580e4-5de9-4361-b06a-1d20e5571890	TCGA-DK-A6B6	Bladder	0.3835616438356164	Not Reported	7.0	white	male	not hispanic or latino	Alive	57	-21007.0	1954.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder	1115.0	21007.0	Transitional cell carcinoma	no	2011.0	No	6th		8120/3	NX	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	21007.0	57.553424657534244	['2019-07-31T16:56:51.493859-05:00', '2019-07-31T16:56:51.493859-05:00']	['27d65428-458e-5e26-bf1b-132c20195ba5', 'd915c195-59eb-5f68-bf0b-a4186d1ff0e2']	['TCGA-DK-A6B6_treatment', 'TCGA-DK-A6B6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:41.636434-05:00']	01	Primary	897b2691-b681-4a6f-9163-528c1ae5b228	Primary Tumor	Not Reported	549.0	100.0	OCT	D7E1CBFA-6E00-48AF-804D-6AD61CA65506	true	Solid Tissue	False	Tumor
TCGA-UY-A78L-01A	d46f7976-6061-4ca9-8294-6c215703662b	Transitional Cell Papillomas and Carcinomas	d46f7976-6061-4ca9-8294-6c215703662b	TCGA-UY-A78L	Bladder		Not Reported		white	male	not hispanic or latino	Alive	62	-22717.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	1127.0	22717.0	Papillary transitional cell carcinoma	no		No	6th		8130/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22717.0	62.23835616438356	['2019-07-31T17:00:08.200415-05:00', '2019-07-31T17:00:08.200415-05:00']	['1fc0ced1-f6ee-5ecd-a455-d4ccb385cce1', '46ac8e3d-1a3d-586e-8d40-c7ba602a1c0f']	['TCGA-UY-A78L_treatment_1', 'TCGA-UY-A78L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:01:22.976348-05:00', '']	01	Primary	e5198cce-ef9d-4f17-be93-36016270f6de	Primary Tumor	Not Reported		150.0	OCT	34137AE9-26C3-4CCC-8172-C8DEDF9689A7	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R3-01A	ab77b411-4df2-4e3a-bfad-946e8bb1fa70	Transitional Cell Papillomas and Carcinomas	ab77b411-4df2-4e3a-bfad-946e8bb1fa70	TCGA-ZF-A9R3	Bladder	1.5890410958904109	Not Reported	29.0	white	female	not hispanic or latino	Dead	53	-19384.0	1959.0	949.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	734.0	19384.0	Transitional cell carcinoma	no	2012.0	No	7th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	19384.0	53.106849315068494	['2019-07-31T16:56:54.703981-05:00', '2019-07-31T16:56:54.703981-05:00']	['3b352f6d-577f-5702-8e0f-20f0899a7ad9', 'cd7669b4-4f82-5562-b63a-d035c724630c']	['TCGA-ZF-A9R3_treatment', 'TCGA-ZF-A9R3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:44.057005-05:00']	01	Primary	67f0eda5-8a34-4a44-9b22-474875607617	Primary Tumor	Not Reported	499.0	90.0	OCT	1B5918AB-3C48-405C-BE7F-348E3907060C	true	Solid Tissue	False	Tumor
TCGA-XF-A9SK-01A	03f588d6-832e-47d8-a9c4-af6640a1a635	Transitional Cell Papillomas and Carcinomas	03f588d6-832e-47d8-a9c4-af6640a1a635	TCGA-XF-A9SK	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	65	-24019.0	1939.0	486.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		24019.0	Transitional cell carcinoma	yes	2004.0	No	6th	T3b	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24019.0	65.8054794520548	['2019-07-31T16:43:08.444863-05:00', '2019-07-31T16:43:08.444863-05:00']	['03d24508-4ff6-5ef2-9fd8-6d54bdab5ade', '1deb8253-ea72-5f69-8864-d4fe90aeacf1']	['TCGA-XF-A9SK_treatment_1', 'TCGA-XF-A9SK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:47:42.853813-05:00', '']	01	Primary	03e0aba8-e26c-4a61-a090-262ffeaf6523	Primary Tumor	Not Reported	3598.0	470.0	OCT	473BCE6C-7925-4E58-9257-B94046C707AC	true	Solid Tissue	False	Tumor
TCGA-YF-AA3M-01A	30ad8081-daa7-4e2b-96f8-07f5ad12e774	Transitional Cell Papillomas and Carcinomas	30ad8081-daa7-4e2b-96f8-07f5ad12e774	TCGA-YF-AA3M	Bladder	3.1780821917808217	Not Reported	58.0	not reported	male	hispanic or latino	Alive	57	-21097.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	8bafbaaf-ad60-55f2-a665-7b30f5c99909	YF	University of Puerto Rico	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Lateral wall of bladder	415.0	21097.0	Transitional cell carcinoma	yes	2013.0	Yes	7th	T2a	8120/3	NX	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		21097.0	57.8	['2019-07-31T16:46:03.193671-05:00', '2019-07-31T16:46:03.193671-05:00']	['349af15b-bbcb-576e-822f-d10e6b5dbf87', 'b0e6ed56-9a35-5873-ba41-77841be79bd4']	['TCGA-YF-AA3M_treatment_1', 'TCGA-YF-AA3M_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:50:05.253995-05:00', '']	01	Primary	88980406-0ed9-4154-8e0e-57abe8da254c	Primary Tumor	Not Reported	133.0	360.0	Unknown	D0F09A8C-8431-4A41-B7A6-BE6E9621CC58	false	Solid Tissue	False	Tumor
TCGA-XF-AAMT-01A	ada95115-275f-4229-aa00-f298a5ff931c	Transitional Cell Papillomas and Carcinomas	ada95115-275f-4229-aa00-f298a5ff931c	TCGA-XF-AAMT	Bladder	0.547945205479452	Not Reported	10.0	white	female	not hispanic or latino	Dead	75	-27397.0	1931.0	90.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		27397.0	Transitional cell carcinoma	no	2006.0	No	5th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27397.0	75.06027397260274	['2019-07-31T16:57:06.327432-05:00', '2019-07-31T16:57:06.327432-05:00']	['c1bb5cab-b4bb-55d2-bad4-d0f5781ff7fe', 'fa8088f2-f389-5e2b-8e4b-1fd0275127e2']	['TCGA-XF-AAMT_treatment', 'TCGA-XF-AAMT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:53.126738-05:00']	01	Primary	ea2028dc-8a2f-4eca-84a5-cd403ce100d4	Primary Tumor	Not Reported	2680.0	800.0	OCT	DDAC8877-7594-4939-B98F-0BAB7D3CDBB9	true	Solid Tissue	False	Tumor
TCGA-DK-AA74-01A	0198d8e5-a14b-44ee-b1c4-d248994845ad	Transitional Cell Papillomas and Carcinomas	0198d8e5-a14b-44ee-b1c4-d248994845ad	TCGA-DK-AA74	Bladder	1.8630136986301369	Not Reported	34.0	white	male	not hispanic or latino	Alive	75	-27730.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Dome of bladder	1708.0	27730.0	Transitional cell carcinoma	yes	2010.0	No	7th	T3	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		27730.0	75.97260273972603	['2019-07-31T16:33:37.642006-05:00', '2019-07-31T16:33:37.642006-05:00']	['3d412a5d-4118-5475-ad85-f4a619adca94', '5c79b1fb-046f-53b3-bddb-0cc137cce544']	['TCGA-DK-AA74_treatment_1', 'TCGA-DK-AA74_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:40:17.581222-05:00', '']	01	Primary	3c6f20b8-63a3-4992-a53f-c56d76153c5b	Primary Tumor	Not Reported	1258.0	620.0	OCT	4734B88D-F4C1-433E-A13F-BE4994766B90	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R2-01A	aeb08986-a802-43dd-a5b4-17f4ec018790	Transitional Cell Papillomas and Carcinomas	aeb08986-a802-43dd-a5b4-17f4ec018790	TCGA-ZF-A9R2	Bladder	3.1780821917808217	Not Reported	58.0	white	male	not hispanic or latino	Alive	75	-27537.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	642.0	27537.0	Papillary transitional cell carcinoma	yes	2013.0	No	7th	T2b	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T1	27537.0	75.44383561643835	['2019-07-31T16:57:15.394309-05:00', '2019-07-31T16:57:15.394309-05:00']	['bb4e973d-353d-5325-bb9f-c10893a7bfff', 'f1b31a6d-a16f-5ba1-8f54-f79210cbeeeb']	['TCGA-ZF-A9R2_treatment', 'TCGA-ZF-A9R2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:00.569407-05:00']	01	Primary	d0027b26-44ea-4276-9ad4-e0c47a4564e9	Primary Tumor	Not Reported	307.0	240.0	OCT	B5679648-237C-4F65-87BB-CD92D0C53393	true	Solid Tissue	False	Tumor
TCGA-G2-A3IB-01A	af53d51e-0b5c-437f-a1c0-ec5f55c49364	Transitional Cell Papillomas and Carcinomas	af53d51e-0b5c-437f-a1c0-ec5f55c49364	TCGA-G2-A3IB	Bladder		Not Reported		black or african american	male	not hispanic or latino	Dead	66	-24149.0	1942.0	220.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	214.0	24149.0	Transitional cell carcinoma	no	2008.0	No	6th		8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	24149.0	66.16164383561645	['2019-07-31T16:57:18.161099-05:00', '2019-07-31T16:57:18.161099-05:00']	['023c93e7-ad45-5c6a-a08e-86969faa7ac3', '66e03045-f66b-5380-beb5-6456bd5699e7']	['TCGA-G2-A3IB_treatment', 'TCGA-G2-A3IB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:59:02.950207-05:00']	01	Primary	791e4058-e872-4af8-a431-f5782811f02a	Primary Tumor	Not Reported	1248.0	160.0	OCT	AD5273EB-8A12-4000-A0EB-99CED937D6D8	true	Solid Tissue	False	Tumor
TCGA-XF-A9SM-01A	b027f4e2-f260-4d60-a1f4-444bc49c4a0b	Transitional Cell Papillomas and Carcinomas	b027f4e2-f260-4d60-a1f4-444bc49c4a0b	TCGA-XF-A9SM	Bladder	0.6575342465753424	Not Reported	12.0	white	male	not hispanic or latino	Alive	76	-27826.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	1048.0	27826.0	Transitional cell carcinoma	yes	2004.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27826.0	76.23561643835616	['2019-07-31T16:57:24.524852-05:00', '2019-07-31T16:57:24.524852-05:00']	['3cee6436-6e7d-565f-80c3-f93d141d4033', 'a6a6eb58-8ffe-52d1-b0d8-f4fde824e7eb']	['TCGA-XF-A9SM_treatment', 'TCGA-XF-A9SM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:07.680131-05:00']	01	Primary	072bd7a0-264f-4239-84d1-d8a85497e06f	Primary Tumor	Not Reported	3364.0	710.0	OCT	77D2B628-13A0-486E-866E-C10DDF141B2B	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4R-01A	b36e3b5f-8904-4722-adae-b00812efec65	Transitional Cell Papillomas and Carcinomas	b36e3b5f-8904-4722-adae-b00812efec65	TCGA-ZF-AA4R	Bladder		Not Reported		white	male	not hispanic or latino	Dead	67	-24537.0	1941.0	1036.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		24537.0	Transitional cell carcinoma	yes	2008.0	No	6th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	24537.0	67.22465753424657	['2019-07-31T16:57:30.222754-05:00', '2019-07-31T16:57:30.222754-05:00']	['0f4ab4e8-43be-5617-980f-4a7cdbf55af4', '788d8424-ef9d-518c-bdac-d45c337a8e88']	['TCGA-ZF-AA4R_treatment', 'TCGA-ZF-AA4R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:59:12.431793-05:00']	01	Primary	b06b5035-a792-4afa-baa0-307f665a7bdd	Primary Tumor	Not Reported	1834.0	60.0	OCT	6E9D0F98-3697-46E7-96E6-1CDAAE63DFC5	true	Solid Tissue	False	Tumor
TCGA-DK-A6AV-01A	b41df0b0-572e-4ddb-9f1d-1b69dd1ad290	Transitional Cell Papillomas and Carcinomas	b41df0b0-572e-4ddb-9f1d-1b69dd1ad290	TCGA-DK-A6AV	Bladder	0.6575342465753424	Not Reported	12.0	asian	female	not hispanic or latino	Alive	82	-30089.0	1926.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Dome of bladder	1952.0	30089.0	Transitional cell carcinoma	no	2008.0	No	6th	T2a	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T2	30089.0	82.43561643835616	['2019-07-31T16:57:33.153039-05:00', '2019-07-31T16:57:33.153039-05:00']	['530a0da0-5547-5a7a-8f45-2fff22bdde30', '8e62b9d9-1769-5df7-8eaf-716ba40c255f']	['TCGA-DK-A6AV_treatment', 'TCGA-DK-A6AV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:15.348360-05:00']	01	Primary	efef376f-7619-4319-888b-7fedbda73597	Primary Tumor	Not Reported	1836.0	80.0	OCT	B327B015-3D3E-400C-A172-8144085F6359	true	Solid Tissue	False	Tumor
TCGA-CF-A5UA-01A	b52c870c-bfb8-4e68-86c0-64d57e5c9ae3	Transitional Cell Papillomas and Carcinomas	b52c870c-bfb8-4e68-86c0-64d57e5c9ae3	TCGA-CF-A5UA	Bladder	1.643835616438356	Not Reported	30.0	asian	male	not hispanic or latino	Alive	67	-24625.0	1945.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	365.0	24625.0	Transitional cell carcinoma	no	2012.0	No	6th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24625.0	67.46575342465754	['2019-07-31T16:57:36.067285-05:00', '2019-07-31T16:57:36.067285-05:00']	['542b0162-8880-5934-9399-8d440f2eccda', '55c793bb-3fe8-5e06-9f2c-2e17116f137f']	['TCGA-CF-A5UA_treatment_1', 'TCGA-CF-A5UA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:17.818073-05:00', '']	01	Primary	1245bfa9-f7c3-4d74-976a-26338aa55ef1	Primary Tumor	Not Reported	84.0	320.0	OCT	6D1029C3-2277-488A-A02D-0048DBDFABE0	true	Solid Tissue	False	Tumor
TCGA-FD-A5BS-01A	b581e799-93d1-4f1c-bcb7-7e7ae86a869e	Transitional Cell Papillomas and Carcinomas	b581e799-93d1-4f1c-bcb7-7e7ae86a869e	TCGA-FD-A5BS	Bladder		Not Reported		white	male	not hispanic or latino	Alive	68	-24963.0	1941.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder	1639.0	24963.0	Transitional cell carcinoma	yes	2009.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		24963.0	68.3917808219178	['2019-07-31T16:57:39.056069-05:00', '2019-07-31T16:57:39.056069-05:00']	['a2e62a67-b48a-580a-84b6-ec2386cfd1bd', 'ba423676-f9fa-5480-adb2-836e66435fc5']	['TCGA-FD-A5BS_treatment', 'TCGA-FD-A5BS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:59:20.208195-05:00']	01	Primary	083eb339-613b-44ad-8937-a457b158ef4c	Primary Tumor	Not Reported	1107.0	650.0	OCT	09B55176-4149-4D38-B5D9-F3F98DDA02C3	true	Solid Tissue	False	Tumor
TCGA-XF-AAN4-01A	b6c36037-56b1-4957-8df8-fda72b0d3c39	Transitional Cell Papillomas and Carcinomas	b6c36037-56b1-4957-8df8-fda72b0d3c39	TCGA-XF-AAN4	Bladder	1.36986301369863	Not Reported	25.0	white	female	not hispanic or latino	Dead	77	-28302.0	1930.0	823.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		28302.0	Transitional cell carcinoma	no	2007.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28302.0	77.53972602739726	['2019-07-31T16:57:41.693350-05:00', '2019-07-31T16:57:41.693350-05:00']	['baa14d31-5c12-5797-b141-336c88899418', 'f635a6eb-152c-5e49-a067-0572efae52a4']	['TCGA-XF-AAN4_treatment_1', 'TCGA-XF-AAN4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:22.414027-05:00', '']	01	Primary	da8f7fc5-8b5e-449a-a9c4-04e029dd4cb6	Primary Tumor	Not Reported	2457.0	900.0	OCT	4BE36D8A-9841-4CC7-9331-A2A14D5C2C30	true	Solid Tissue	False	Tumor
TCGA-XF-A9SH-01A	b838a4db-ef0a-4d88-a220-bf57e31e0b3c	Transitional Cell Papillomas and Carcinomas	b838a4db-ef0a-4d88-a220-bf57e31e0b3c	TCGA-XF-A9SH	Bladder		Not Reported		asian	female	not hispanic or latino	Dead	65	-24060.0	1940.0	1971.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		24060.0	Transitional cell carcinoma	no	2005.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24060.0	65.91780821917808	['2019-07-31T16:57:47.714616-05:00', '2019-07-31T16:57:47.714616-05:00']	['7db3f93b-1a43-5f94-b2fa-d417f568dc08', 'b79e4b89-e26f-5c26-b7f4-3faf65959aa8']	['TCGA-XF-A9SH_treatment', 'TCGA-XF-A9SH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:59:27.713746-05:00']	01	Primary	53a09ed7-04cb-4ccc-98e7-09b1f20597ec	Primary Tumor	Not Reported	3256.0	200.0	OCT	E84E385B-B56A-48AC-AD5B-EA7BE9E69CDE	true	Solid Tissue	False	Tumor
TCGA-UY-A78P-01A	b8f3d552-2d4b-4dd8-b0e8-6a38e1baa2f3	Transitional Cell Papillomas and Carcinomas	b8f3d552-2d4b-4dd8-b0e8-6a38e1baa2f3	TCGA-UY-A78P	Bladder	0.821917808219178	Not Reported	15.0	white	female	not hispanic or latino	Alive	78	-28719.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2380.0	28719.0	Transitional cell carcinoma	no		No	6th	T2	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28719.0	78.68219178082192	['2019-07-31T16:57:53.776968-05:00', '2019-07-31T16:57:53.776968-05:00']	['59030b29-e9b1-5c72-aad8-fb87cb3b297b', 'ba7e440f-fff5-519a-bae8-c5e68c721236']	['TCGA-UY-A78P_treatment', 'TCGA-UY-A78P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:59:32.642254-05:00']	01	Primary	be09731d-cb80-4cdf-bc66-872334b00b8e	Primary Tumor	Not Reported		80.0	OCT	89019149-B6D2-4540-9BFE-BACCA9F5DA14	true	Solid Tissue	False	Tumor
TCGA-XF-A8HG-01A	b9b61cf9-8711-4c3a-8511-659070cfe36b	Transitional Cell Papillomas and Carcinomas	b9b61cf9-8711-4c3a-8511-659070cfe36b	TCGA-XF-A8HG	Bladder	0.4383561643835616	Not Reported	8.0	white	male	not hispanic or latino	Dead	69	-25421.0	1936.0	467.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		25421.0	Transitional cell carcinoma	no	2005.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25421.0	69.64657534246575	['2019-07-31T16:57:59.514445-05:00', '2019-07-31T16:57:59.514445-05:00']	['14b20fa5-a0bd-5a5e-aafc-57011a1d6071', '49673cb8-be58-5128-af35-138b3b12cb1a']	['TCGA-XF-A8HG_treatment_1', 'TCGA-XF-A8HG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:59:37.519207-05:00', '']	01	Primary	f9eb39b8-2c51-4c13-b434-d11944ed3ccc	Primary Tumor	Not Reported	2900.0	550.0	OCT	BBBBC7D7-4994-4B78-9C65-22B4E8C61261	true	Solid Tissue	False	Tumor
TCGA-2F-A9KT-01A	bc6c516b-591e-4950-b6b0-decafa666f4e	Transitional Cell Papillomas and Carcinomas	bc6c516b-591e-4950-b6b0-decafa666f4e	TCGA-2F-A9KT	Bladder		Not Reported		white	male	not hispanic or latino	Alive	83	-30520.0	1923.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Posterior wall of bladder	2352.0	30520.0	Transitional cell carcinoma	yes	2006.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	30520.0	83.61643835616438	['2019-07-31T16:58:05.444865-05:00', '2019-07-31T16:58:05.444865-05:00']	['b6e0600a-af7c-5958-8d42-9f0d9110ad18', 'e5ab1aab-bac1-56a9-a28d-f0e4fd3affa5']	['TCGA-2F-A9KT_treatment_1', 'TCGA-2F-A9KT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:42.147732-05:00', '']	01	Primary	1be43154-67ab-4019-8987-5135ee4af419	Primary Tumor	Not Reported	2898.0	130.0	Unknown	EC566A42-E711-458F-8082-1C113AECDF60	false	Solid Tissue	False	Tumor
TCGA-ZF-AA54-01A	bca645ae-a0c9-4005-b672-85d8920b6afb	Transitional Cell Papillomas and Carcinomas	bca645ae-a0c9-4005-b672-85d8920b6afb	TCGA-ZF-AA54	Bladder		Not Reported		white	male	not hispanic or latino	Dead	71	-26128.0	1938.0	590.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder		26128.0	Transitional cell carcinoma	no	2009.0	No	6th	T3	8120/3	NX	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	26128.0	71.58356164383562	['2019-07-31T16:58:08.125860-05:00', '2019-07-31T16:58:08.125860-05:00']	['3848321b-937f-5ca9-8df7-06ed746bd70a', 'a72e7618-ba23-5a6f-997e-531f821884f3']	['TCGA-ZF-AA54_treatment', 'TCGA-ZF-AA54_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:59:44.556457-05:00']	01	Primary	52097937-cbcb-43f8-a505-9b4da32d5c6a	Primary Tumor	Not Reported	1472.0	180.0	OCT	6B1A202D-C715-4495-9F28-0235F69BF983	true	Solid Tissue	False	Tumor
TCGA-GU-A767-01A	bfaba069-0914-46b4-927d-b5ea3a4a341f	Transitional Cell Papillomas and Carcinomas	bfaba069-0914-46b4-927d-b5ea3a4a341f	TCGA-GU-A767	Bladder		Not Reported		white	male	not hispanic or latino	Dead	81	-29739.0	1931.0	144.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		29739.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29739.0	81.47671232876712	['2019-07-31T16:58:19.550421-05:00', '2019-07-31T16:58:19.550421-05:00']	['8aa0c96d-fa3b-56b7-80e4-60c2cf9fce68', 'a616a511-6a50-5ee6-8fc4-23115292e483']	['TCGA-GU-A767_treatment_1', 'TCGA-GU-A767_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:59:54.687112-05:00', '']	01	Primary	95c5614a-96ad-4252-bb62-dc2abfd6786b	Primary Tumor	Not Reported	365.0	80.0	OCT	4D04BC45-D78F-41DB-8E3B-70763300611A	true	Solid Tissue	False	Tumor
TCGA-G2-AA3C-01A	c04cc413-95b0-4b56-af55-9596a5ead4a6	Transitional Cell Papillomas and Carcinomas	c04cc413-95b0-4b56-af55-9596a5ead4a6	TCGA-G2-AA3C	Bladder	0.2191780821917808	Not Reported	4.0	white	male	not hispanic or latino	Dead	66	-24267.0	1943.0	211.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		24267.0	Transitional cell carcinoma	no	2009.0	No	6th	T3b	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	24267.0	66.48493150684932	['2019-07-31T16:58:23.270500-05:00', '2019-07-31T16:58:23.270500-05:00']	['018d260d-f0ac-52ca-b64b-5f92c3ad12da', '8bbeca03-3717-55c5-8a43-2236eed50852']	['TCGA-G2-AA3C_treatment_1', 'TCGA-G2-AA3C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:59:57.155176-05:00', '']	01	Primary	83d4e9e9-7910-4686-9ed4-17c7d85127eb	Primary Tumor	Not Reported	1740.0	430.0	OCT	B1E681AE-43AC-4E17-B334-3ACC476DC289	true	Solid Tissue	False	Tumor
TCGA-XF-AAN5-01A	c1591625-e794-4155-8ae4-b74d6264659f	Transitional Cell Papillomas and Carcinomas	c1591625-e794-4155-8ae4-b74d6264659f	TCGA-XF-AAN5	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Alive	61	-22411.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	2293.0	22411.0	Transitional cell carcinoma	no	2008.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22411.0	61.4	['2019-07-31T16:58:28.743031-05:00', '2019-07-31T16:58:28.743031-05:00']	['190ec659-aa39-53f4-97b9-fff607a27518', '9622e0c4-5b8b-5c77-85fd-657556cdad1e']	['TCGA-XF-AAN5_treatment_1', 'TCGA-XF-AAN5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:00:01.729976-05:00', '']	01	Primary	120124c2-da96-44bc-869e-07c3489b4d39	Primary Tumor	Not Reported	2172.0	350.0	OCT	43F485E6-346F-483A-826F-6960F00025C9	true	Solid Tissue	False	Tumor
TCGA-BL-A5ZZ-01A	c1afc5eb-8c1d-4b6c-8453-48728fc023ba	Transitional Cell Papillomas and Carcinomas	c1afc5eb-8c1d-4b6c-8453-48728fc023ba	TCGA-BL-A5ZZ	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Alive	80	-29247.0	1932.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder	377.0	29247.0	Transitional cell carcinoma	yes	2012.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		29247.0	80.12876712328767	['2019-07-31T16:58:31.665728-05:00', '2019-07-31T16:58:31.665728-05:00']	['659da376-78d7-53a5-9b74-eff839f52bb2', 'aef7e07b-d9a9-579e-949c-8d6399a2e018']	['TCGA-BL-A5ZZ_treatment', 'TCGA-BL-A5ZZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:00:03.845773-05:00']	01	Primary	336aca2f-d2ce-458b-be44-a40878d06973	Primary Tumor	Not Reported	133.0	750.0	Unknown	DDA3DBFA-0ECA-4D47-8E8D-5C33F6E4D448	false	Solid Tissue	False	Tumor
TCGA-DK-A1A3-01A	c5b20ccc-523d-491c-8536-008e05c57212	Transitional Cell Papillomas and Carcinomas	c5b20ccc-523d-491c-8536-008e05c57212	TCGA-DK-A1A3	Bladder	1.3150684931506849	Not Reported	24.0	white	male	not hispanic or latino	Dead	60	-22235.0	1950.0	665.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	77.0	22235.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22235.0	60.917808219178085	['2019-07-31T16:58:34.579010-05:00', '2019-07-31T16:58:34.579010-05:00']	['43ae6505-e163-5ce2-ad3a-77326c1909ba', 'd0381096-2931-546a-9879-1f074f490888']	['TCGA-DK-A1A3_treatment_1', 'TCGA-DK-A1A3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T10:00:06.106387-05:00', '']	01	Primary	954e46ba-514f-4708-ad3c-ecbf8cef005a	Primary Tumor	Not Reported	240.0	120.0	OCT	2FDD45DD-21FB-492B-8458-6D96FBF46509	true	Solid Tissue	False	Tumor
TCGA-FD-A6TD-01A	c80e71b3-7c6c-4e16-8446-6dfda780bc18	Transitional Cell Papillomas and Carcinomas	c80e71b3-7c6c-4e16-8446-6dfda780bc18	TCGA-FD-A6TD	Bladder		Not Reported		white	male	not hispanic or latino	Dead	77	-28328.0	1935.0	386.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Anterior wall of bladder	204.0	28328.0	Transitional cell carcinoma	yes	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T1	28328.0	77.6109589041096	['2019-07-31T16:58:49.158261-05:00', '2019-07-31T16:58:49.158261-05:00']	['2d46355e-ae87-51e9-8854-ace36e1a8b04', 'cf422fc9-adbc-500d-9d17-02a44f2a6032']	['TCGA-FD-A6TD_treatment_1', 'TCGA-FD-A6TD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:00:18.502720-05:00', '']	01	Primary	cb958d50-5538-4f82-987d-3fb103cd75c7	Primary Tumor	Not Reported	224.0	1230.0	OCT	11A1BF15-67A7-4D7F-B4F2-67EE00685E82	true	Solid Tissue	False	Tumor
TCGA-XF-AAME-01A	c8388ac0-975d-4f1e-8324-8cabdc75738d	Transitional Cell Papillomas and Carcinomas	c8388ac0-975d-4f1e-8324-8cabdc75738d	TCGA-XF-AAME	Bladder		Not Reported		white	female	not hispanic or latino	Dead	64	-23448.0	1942.0	2828.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		23448.0	Transitional cell carcinoma	no	2006.0	No	6th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23448.0	64.24109589041096	['2019-07-31T16:58:52.259692-05:00', '2019-07-31T16:58:52.259692-05:00']	['4336f7be-7e2b-5a87-8fbf-bf3a21395f87', '5a2920ed-ace2-557c-bd60-a45f202f4269']	['TCGA-XF-AAME_treatment_1', 'TCGA-XF-AAME_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:00:20.983859-05:00', '']	01	Primary	2447a5c6-3afc-428b-9162-c76024631af1	Primary Tumor	Not Reported	2877.0	250.0	OCT	F59EB865-9B98-4A22-9237-513CADD28F65	true	Solid Tissue	False	Tumor
TCGA-DK-AA6L-01A	cbe6c328-f7e1-44b2-b4e5-b495f46a7fb7	Transitional Cell Papillomas and Carcinomas	cbe6c328-f7e1-44b2-b4e5-b495f46a7fb7	TCGA-DK-AA6L	Bladder	40.0	Not Reported	730.0	white	male	not hispanic or latino	Dead	48	-17635.0	1962.0	1163.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Dome of bladder		17635.0	Transitional cell carcinoma	yes	2010.0	No	7th	T3	8120/3	N1	MX	not reported	C67.1	Dome of bladder	Not Reported	not reported		17635.0	48.31506849315068	['2019-07-31T16:59:12.876974-05:00', '2019-07-31T16:59:12.876974-05:00']	['86e078f4-5c31-504a-9a4f-f9e72fd433a5', 'b320a48a-7cae-5254-a8ff-01c03ffc285b']	['TCGA-DK-AA6L_treatment_1', 'TCGA-DK-AA6L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:00:38.139135-05:00', '']	01	Primary	86cfbaf2-9db7-479e-964e-f3e69cd1dd7c	Primary Tumor	Not Reported	1418.0		OCT	4F76D253-8752-4787-8B1C-CEE72FF7EE54	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4V-01A	ccd65bc8-82ef-453e-b4bc-a005cc2262d5	Transitional Cell Papillomas and Carcinomas	ccd65bc8-82ef-453e-b4bc-a005cc2262d5	TCGA-ZF-AA4V	Bladder	1.5342465753424657	Not Reported	28.0	white	male	not hispanic or latino	Alive	66	-24448.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1806.0	24448.0	Transitional cell carcinoma	no	2008.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	24448.0	66.98082191780821	['2019-07-31T16:59:22.436384-05:00', '2019-07-31T16:59:22.436384-05:00']	['251428c3-bbc1-562c-8b8c-436de5212b46', 'f35566ef-884e-58cb-97a8-e6f025bb0a73']	['TCGA-ZF-AA4V_treatment_1', 'TCGA-ZF-AA4V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:00:45.458663-05:00', '']	01	Primary	20a5ad24-3caf-478d-8bd0-b45a785f0624	Primary Tumor	Not Reported	1850.0	290.0	OCT	52B54951-E580-49D6-BBB5-4F2329A271B0	true	Solid Tissue	False	Tumor
TCGA-G2-A3VY-01A	cd50c69f-0f45-4c57-b61a-8c6b41ab4f7e	Transitional Cell Papillomas and Carcinomas	cd50c69f-0f45-4c57-b61a-8c6b41ab4f7e	TCGA-G2-A3VY	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	66	-24112.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	536.0	24112.0	Transitional cell carcinoma	yes	2012.0	No	7th		8120/3			not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	24112.0	66.06027397260274	['2019-07-31T16:59:34.983325-05:00', '2019-07-31T16:59:34.983325-05:00']	['4d213c76-2ca9-5629-a6bc-8233634c3c5b', '9b8c1a3b-093b-5c35-b32b-5e183c1c4609']	['TCGA-G2-A3VY_treatment', 'TCGA-G2-A3VY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:00:56.183400-05:00']	01	Primary	5a66149f-8fb0-41bc-880c-56d5541e3d94	Primary Tumor	Not Reported	42.0	450.0	OCT	329F5DB7-9FC7-4856-8B15-1DBC9D6C42F6	true	Solid Tissue	False	Tumor
TCGA-XF-A9SV-01A	cdfd86db-15e2-4d38-a717-2207e8de2d8f	Transitional Cell Papillomas and Carcinomas	cdfd86db-15e2-4d38-a717-2207e8de2d8f	TCGA-XF-A9SV	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	82	-30265.0	1924.0	388.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		30265.0	Papillary transitional cell carcinoma	yes	2006.0	No	6th	T4a	8130/3	N2	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30265.0	82.91780821917808	['2019-07-31T16:59:37.846537-05:00', '2019-07-31T16:59:37.846537-05:00']	['4aace4ac-49e3-5326-b71b-239947f4db0b', 'd0a99e32-a99b-5c6c-910f-222398332205']	['TCGA-XF-A9SV_treatment', 'TCGA-XF-A9SV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:00:58.885704-05:00']	01	Primary	098e5b61-7125-4f72-b2a4-e0fdc4327ac9	Primary Tumor	Not Reported	2848.0	740.0	OCT	5C45E09E-9B8A-4CD4-92CC-873CF78D2524	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R7-01A	ce4e4549-befc-447f-9b79-ed46e302e6d7	Transitional Cell Papillomas and Carcinomas	ce4e4549-befc-447f-9b79-ed46e302e6d7	TCGA-ZF-A9R7	Bladder		Not Reported		white	female	not hispanic or latino	Alive	76	-28063.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	665.0	28063.0	Transitional cell carcinoma	no	2011.0	No	7th		8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	28063.0	76.88493150684931	['2019-07-31T16:59:40.792671-05:00', '2019-07-31T16:59:40.792671-05:00']	['312b007d-c898-5301-9641-01458cbe508b', 'eef3a6d6-635e-56cf-ae73-24d6a3b257a6']	['TCGA-ZF-A9R7_treatment_1', 'TCGA-ZF-A9R7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:01.413021-05:00', '']	01	Primary	616b3b82-df11-428b-8882-6b830125ae4b	Primary Tumor	Not Reported	910.0	50.0	OCT	4AC6F4EE-B501-4C35-B35A-576C03866311	true	Solid Tissue	False	Tumor
TCGA-CF-A47S-01A	d2df20d4-6704-41e6-b33d-616225bd737c	Transitional Cell Papillomas and Carcinomas	d2df20d4-6704-41e6-b33d-616225bd737c	TCGA-CF-A47S	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	41	-15225.0	1970.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	333.0	15225.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	15225.0	41.71232876712329	['2019-07-31T16:59:56.161074-05:00', '2019-07-31T16:59:56.161074-05:00']	['3c3f3500-d114-5d09-a642-899e0869d0b1', '5c60679f-4b87-5003-8d61-1ed1dacc70b5']	['TCGA-CF-A47S_treatment', 'TCGA-CF-A47S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:01:13.398501-05:00']	01	Primary	33b36c09-79eb-48d4-bb56-36a2e502cd05	Primary Tumor	Not Reported	283.0	530.0	OCT	2B7A84EA-F94C-411A-95BD-220615D821CE	true	Solid Tissue	False	Tumor
TCGA-E7-A677-01A	d492383f-5449-4845-bfb3-b2cb4eb49c4e	Transitional Cell Papillomas and Carcinomas	d492383f-5449-4845-bfb3-b2cb4eb49c4e	TCGA-E7-A677	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	81	-29613.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	820.0	29613.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29613.0	81.13150684931507	['2019-07-31T17:00:10.970854-05:00', '2019-07-31T17:00:10.970854-05:00']	['6955627a-8f54-59a5-b17f-25afd96475a4', 'aaa55cca-c45a-5fc8-b3ed-04eb68b4b418']	['TCGA-E7-A677_treatment_1', 'TCGA-E7-A677_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:25.239666-05:00', '']	01	Primary	9620a30c-6760-4f22-bdd0-cfa1c9000d02	Primary Tumor	Not Reported	126.0	700.0	OCT	C721E01B-0C35-41AE-952C-5D2AB8373BC0	true	Solid Tissue	False	Tumor
TCGA-E7-A541-01A	d51abc3a-a652-4b13-9a41-ce52be87218b	Transitional Cell Papillomas and Carcinomas	d51abc3a-a652-4b13-9a41-ce52be87218b	TCGA-E7-A541	Bladder		Not Reported		white	male	not hispanic or latino	Dead	66	-24206.0	1946.0	778.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	529.0	24206.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24206.0	66.31780821917808	['2019-07-31T17:00:13.970054-05:00', '2019-07-31T17:00:13.970054-05:00']	['28fe615f-fbbd-58b6-978e-9f89b01e90f3', '3c5f1e0e-e8f6-5a7c-8dba-85d81258f7fe']	['TCGA-E7-A541_treatment_1', 'TCGA-E7-A541_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:27.661971-05:00', '']	01	Primary	ea8d5230-c27d-4cf4-9964-6bab8a68e933	Primary Tumor	Not Reported	265.0	1670.0	OCT	2363E39A-F372-406C-B41B-E2260D50611D	true	Solid Tissue	False	Tumor
TCGA-K4-A3WV-01A	d53eade8-a845-4252-aece-92f3573486a7	Transitional Cell Papillomas and Carcinomas	d53eade8-a845-4252-aece-92f3573486a7	TCGA-K4-A3WV	Bladder	4.383561643835616	Not Reported	80.0	white	female	hispanic or latino	Alive	77	-28444.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	646.0	28444.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28444.0	77.92876712328767	['2019-07-31T17:00:16.865165-05:00', '2019-07-31T17:00:16.865165-05:00']	['3c101dd3-2135-5524-ab42-a052f123b04a', 'b7b2322f-f7b8-5f87-945b-339e27c622e2']	['TCGA-K4-A3WV_treatment_1', 'TCGA-K4-A3WV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:30.080418-05:00', '']	01	Primary	3adfa409-a9f8-4edb-aaf7-c5285ae5f895	Primary Tumor	Not Reported	143.0	100.0	OCT	A3D8B88A-51FB-44D2-8E24-096107D60058	true	Solid Tissue	False	Tumor
TCGA-K4-A3WV-11A	d53eade8-a845-4252-aece-92f3573486a7	Transitional Cell Papillomas and Carcinomas	d53eade8-a845-4252-aece-92f3573486a7	TCGA-K4-A3WV	Bladder	4.383561643835616	Not Reported	80.0	white	female	hispanic or latino	Alive	77	-28444.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	646.0	28444.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28444.0	77.92876712328767	['2019-07-31T17:00:16.865165-05:00', '2019-07-31T17:00:16.865165-05:00']	['3c101dd3-2135-5524-ab42-a052f123b04a', 'b7b2322f-f7b8-5f87-945b-339e27c622e2']	['TCGA-K4-A3WV_treatment_1', 'TCGA-K4-A3WV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:30.080418-05:00', '']	11	Not Applicable	c8b4ed6d-69c0-4052-bec2-9fe6a3cfc481	Solid Tissue Normal	Not Reported	143.0	100.0	OCT		true	Solid Tissue	False	Normal
TCGA-HQ-A5NE-01A	e053a911-2202-4c1f-bc93-904e26564e79	Transitional Cell Papillomas and Carcinomas	e053a911-2202-4c1f-bc93-904e26564e79	TCGA-HQ-A5NE	Bladder	4.383561643835616	Not Reported	80.0	not reported	male	not reported	Dead	57	-20647.0		370.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	92ea63f4-dd85-57be-8c8e-c50c70f40169	HQ	Ontario Institute for Cancer Research (OICR)	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	250.0	20647.0	Transitional cell carcinoma	no		No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	20647.0	56.56712328767123	['2019-07-31T17:00:58.700166-05:00', '2019-07-31T17:00:58.700166-05:00']	['4e880206-393f-5bb7-80de-396342445e91', 'b9bfc6f1-fcdc-5cac-8116-58c6fb83b2c8']	['TCGA-HQ-A5NE_treatment', 'TCGA-HQ-A5NE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:02:04.086498-05:00']	01	Primary	73a76b8a-ba29-459a-8395-3068a3a9b5ce	Primary Tumor	Not Reported		330.0	Unknown	464FAAEC-5FEB-4544-8B28-46559A81A09A	false	Solid Tissue	False	Tumor
TCGA-FD-A5C0-01A	0628e443-3d7f-4a38-9d2a-ebc7f4f7e11d	Transitional Cell Papillomas and Carcinomas	0628e443-3d7f-4a38-9d2a-ebc7f4f7e11d	TCGA-FD-A5C0	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	61	-22500.0	1951.0	550.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder	407.0	22500.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22500.0	61.64383561643836	['2019-07-31T16:43:27.168412-05:00', '2019-07-31T16:43:27.168412-05:00']	['3a999fb6-ed87-585d-a6bf-67e792aea1e5', '5bdc0927-b878-567c-9f32-40dcd0d02ec4']	['TCGA-FD-A5C0_treatment', 'TCGA-FD-A5C0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:47:58.363415-05:00']	01	Primary	e3429307-4ff7-450a-a9dd-5ca2f863a87a	Primary Tumor	Not Reported	70.0	1030.0	OCT	55259128-2D24-433B-A556-632B9D1D0E6F	true	Solid Tissue	False	Tumor
TCGA-FD-A5C1-01A	070c66fa-ef48-46cb-af4f-357d2c641118	Transitional Cell Papillomas and Carcinomas	070c66fa-ef48-46cb-af4f-357d2c641118	TCGA-FD-A5C1	Bladder		Not Reported		white	female	not hispanic or latino	Alive	61	-22505.0	1948.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder	1792.0	22505.0	Transitional cell carcinoma	yes	2009.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22505.0	61.657534246575345	['2019-07-31T16:43:33.207208-05:00', '2019-07-31T16:43:33.207208-05:00']	['0b12319b-fbe6-50d9-af92-dcf8ab0b6825', '3eb35945-2a07-503a-854f-c6b1fbd5cc4c']	['TCGA-FD-A5C1_treatment', 'TCGA-FD-A5C1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:48:03.173420-05:00']	01	Primary	d84e38e2-cd76-46ed-9ab7-454c16ebaa1b	Primary Tumor	Not Reported	1387.0	850.0	OCT	C65141F1-754F-4BE1-B19B-4D4C0B0E2BED	true	Solid Tissue	False	Tumor
TCGA-BL-A13I-01B	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	Transitional Cell Papillomas and Carcinomas	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	TCGA-BL-A13I	Bladder	0.821917808219178	Not Reported	15.0	white	female	not hispanic or latino	Dead	57	-20885.0	1953.0	223.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		20885.0	Transitional cell carcinoma	no	2010.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20885.0	57.21917808219178	['2019-07-31T15:15:49.426257-05:00', '2019-07-31T15:15:49.426257-05:00']	['91bd2aa1-fe84-59d5-9733-6d6fb91a2e81', 'dbe66ff2-4969-5523-8044-ad4730dc163f']	['TCGA-BL-A13I_treatment_1', 'TCGA-BL-A13I_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T08:36:37.497537-05:00', '']	01	Primary	5bd2e340-f1a9-4fd9-9620-5b202a88fbe9	Primary Tumor	Not Reported	503.0		FFPE	976FBDBF-55C5-4957-986B-D2DE85FF7540	false	Solid Tissue	True	Tumor
TCGA-BL-A13I-01A	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	Transitional Cell Papillomas and Carcinomas	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	TCGA-BL-A13I	Bladder	0.821917808219178	Not Reported	15.0	white	female	not hispanic or latino	Dead	57	-20885.0	1953.0	223.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		20885.0	Transitional cell carcinoma	no	2010.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20885.0	57.21917808219178	['2019-07-31T15:15:49.426257-05:00', '2019-07-31T15:15:49.426257-05:00']	['91bd2aa1-fe84-59d5-9733-6d6fb91a2e81', 'dbe66ff2-4969-5523-8044-ad4730dc163f']	['TCGA-BL-A13I_treatment_1', 'TCGA-BL-A13I_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T08:36:37.497537-05:00', '']	01	Primary	62c2ba8f-02e3-4100-86bc-5958038b4983	Primary Tumor	Not Reported	127.0	410.0	Unknown	976FBDBF-55C5-4957-986B-D2DE85FF7540	false	Solid Tissue	False	Tumor
TCGA-LT-A5Z6-01A	ec7fc492-53cc-4b71-a66a-1cef1adeba33	Transitional Cell Papillomas and Carcinomas	ec7fc492-53cc-4b71-a66a-1cef1adeba33	TCGA-LT-A5Z6	Bladder		Not Reported		white	male	not hispanic or latino	Alive	56	-20746.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	2ad17b10-e87e-5a1d-91bc-bd4856c1f3c3	LT	Gundersen Lutheran Health System	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	474.0	20746.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	20746.0	56.83835616438356	['2019-07-31T17:18:24.125787-05:00', '2019-07-31T17:18:24.125787-05:00']	['1b6633bb-7e6d-5bef-adf7-4746fc1a3adc', '5b3fcd9e-17cd-5967-9fb9-028c8adb95de']	['TCGA-LT-A5Z6_treatment_1', 'TCGA-LT-A5Z6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:16:34.394425-05:00', '']	01	Primary	60701f6c-48e8-4576-a0a5-c9748d192085	Primary Tumor	Not Reported	14.0	350.0	OCT	1249D02D-48D2-477E-AAAE-51B1D625C8F7	true	Solid Tissue	False	Tumor
TCGA-XF-AAMH-01A	0ec37c2c-8d90-48c1-9cbc-69fe6473c980	Transitional Cell Papillomas and Carcinomas	0ec37c2c-8d90-48c1-9cbc-69fe6473c980	TCGA-XF-AAMH	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	80	-29547.0	1925.0	344.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		29547.0	Transitional cell carcinoma	no	2005.0	No	6th	T3b	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29547.0	80.95068493150686	['2019-07-31T17:14:53.346777-05:00', '2019-07-31T17:14:53.346777-05:00']	['69c8afcc-f925-5a70-8c0b-2930e1a881bd', 'd9737cbf-6d90-5279-89cb-40c310ea9d82']	['TCGA-XF-AAMH_treatment_1', 'TCGA-XF-AAMH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:13:37.318754-05:00', '']	01	Primary	917a011e-65bd-44fc-879d-6d710693db1f	Primary Tumor	Not Reported	3271.0	150.0	OCT	5262C4FA-045C-4F50-8C82-D5CA53A406F1	true	Solid Tissue	False	Tumor
TCGA-BL-A3JM-01A	0f4fb205-b13c-4a85-97b3-779429e6ccdd	Transitional Cell Papillomas and Carcinomas	0f4fb205-b13c-4a85-97b3-779429e6ccdd	TCGA-BL-A3JM	Bladder	2.684931506849315	Not Reported	49.0	white	male	not hispanic or latino	Dead	62	-23000.0	1948.0	205.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		23000.0	Transitional cell carcinoma	no	2010.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23000.0	63.013698630136986	['2019-07-31T15:19:19.607997-05:00', '2019-07-31T15:19:19.607997-05:00']	['0e639ab6-3051-5000-902c-52b403e7fc23', '9d92c72f-40fe-50de-87bb-9ee56ffda78b']	['TCGA-BL-A3JM_treatment_1', 'TCGA-BL-A3JM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T08:39:39.785321-05:00', '']	01	Primary	110acee1-915f-43a2-b382-5d0af1fc167f	Primary Tumor	Not Reported	513.0	240.0	Unknown	D6831C2D-C567-4649-9C51-75E1B202D8F9	false	Solid Tissue	False	Tumor
TCGA-BT-A20P-11A	f48937ed-e294-41f0-8872-7010391167a9	Transitional Cell Papillomas and Carcinomas	f48937ed-e294-41f0-8872-7010391167a9	TCGA-BT-A20P	Bladder		Not Reported		white	female	not hispanic or latino	Dead	81	-29634.0	1924.0	544.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder		29634.0	Transitional cell carcinoma	no	2005.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	29634.0	81.18904109589042	['2019-07-31T17:02:02.787079-05:00', '2019-07-31T17:02:02.787079-05:00']	['07c70b2a-e4cd-56f1-bcc2-fbdf9d35a247', '46d8f3ae-c793-5c7e-842e-e94d411e92d8']	['TCGA-BT-A20P_treatment', 'TCGA-BT-A20P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:02:57.542641-05:00']	11	Not Applicable	2a07dbf4-d44c-4643-8a37-80e013dbe20b	Solid Tissue Normal		2270.0	250.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20P-01A	f48937ed-e294-41f0-8872-7010391167a9	Transitional Cell Papillomas and Carcinomas	f48937ed-e294-41f0-8872-7010391167a9	TCGA-BT-A20P	Bladder		Not Reported		white	female	not hispanic or latino	Dead	81	-29634.0	1924.0	544.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder		29634.0	Transitional cell carcinoma	no	2005.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	29634.0	81.18904109589042	['2019-07-31T17:02:02.787079-05:00', '2019-07-31T17:02:02.787079-05:00']	['07c70b2a-e4cd-56f1-bcc2-fbdf9d35a247', '46d8f3ae-c793-5c7e-842e-e94d411e92d8']	['TCGA-BT-A20P_treatment', 'TCGA-BT-A20P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:02:57.542641-05:00']	01	Primary	6b43eeec-4feb-4062-827a-e63ed8ce3820	Primary Tumor		2270.0	220.0	OCT	C35A6F61-D5C4-4F8C-B82B-1349E6CDCA43	true	Solid Tissue	False	Tumor
TCGA-GU-A763-01A	f632bc31-3aa0-4783-b10b-818ecb26d40b	Transitional Cell Papillomas and Carcinomas	f632bc31-3aa0-4783-b10b-818ecb26d40b	TCGA-GU-A763	Bladder	2.4657534246575343	Not Reported	45.0	white	male	not hispanic or latino	Alive	72	-26527.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Lateral wall of bladder	997.0	26527.0	Transitional cell carcinoma	yes	2012.0	No	7th	T4	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		26527.0	72.67671232876712	['2019-07-31T17:02:17.857544-05:00', '2019-07-31T17:02:17.857544-05:00']	['37a213a4-76c7-5d6e-a8a6-ea4eba09276e', 'ddd02c15-2cab-56bd-ae21-0b64971be40c']	['TCGA-GU-A763_treatment_1', 'TCGA-GU-A763_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:03:10.017353-05:00', '']	01	Primary	248b4e29-74de-40b8-b006-69c6bdac640e	Primary Tumor	Not Reported	447.0	90.0	OCT	91819D13-8938-4216-966F-930D9E0BF4E7	true	Solid Tissue	False	Tumor
TCGA-ZF-AA5N-01A	f78cb4fa-5548-40f8-b71b-663dde47f539	Transitional Cell Papillomas and Carcinomas	f78cb4fa-5548-40f8-b71b-663dde47f539	TCGA-ZF-AA5N	Bladder	0.547945205479452	Not Reported	10.0	white	female	not hispanic or latino	Dead	62	-22741.0	1951.0	168.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		22741.0	Transitional cell carcinoma	no	2013.0	No	7th	T2	8120/3	NX	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22741.0	62.3041095890411	['2019-07-31T17:02:24.186949-05:00', '2019-07-31T17:02:24.186949-05:00']	['1b91e0f6-b606-55d4-a373-d117a4a59432', '5b3beb86-220d-5154-a510-a94490fb36b5']	['TCGA-ZF-AA5N_treatment_1', 'TCGA-ZF-AA5N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:03:14.806698-05:00', '']	01	Primary	8a928ba7-1211-4d9a-b060-b603206559f6	Primary Tumor	Not Reported	29.0	60.0	OCT	C115F113-1A42-4DB6-A6AA-7717C6DE227C	true	Solid Tissue	False	Tumor
TCGA-CF-A3MF-01A	1e308b12-0590-4dae-94d0-a539fcf25df7	Transitional Cell Papillomas and Carcinomas	1e308b12-0590-4dae-94d0-a539fcf25df7	TCGA-CF-A3MF	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	34	-12557.0	1977.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	383.0	12557.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T3	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		12557.0	34.4027397260274	['2019-07-31T16:44:51.035310-05:00', '2019-07-31T16:44:51.035310-05:00']	['1b7be257-495e-54a6-bd15-d4c17c2ae063', '6c59181d-b6ed-5ed2-abcd-63b0108caa6b']	['TCGA-CF-A3MF_treatment', 'TCGA-CF-A3MF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:49:06.668935-05:00']	01	Primary	e9889071-4c6e-4761-9d65-06c6b5989fb7	Primary Tumor	Not Reported	165.0	430.0	OCT	D7C5EE9B-98F3-46C1-A568-F989E97ABFCC	true	Solid Tissue	False	Tumor
TCGA-BT-A20R-01A	f8780a4b-7f55-41d1-bf92-8513955d150e	Transitional Cell Papillomas and Carcinomas	f8780a4b-7f55-41d1-bf92-8513955d150e	TCGA-BT-A20R	Bladder		Not Reported		white	female	not hispanic or latino	Dead	79	-28987.0	1927.0	154.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder		28987.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N1	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3b	28987.0	79.41643835616438	['2019-07-31T17:02:30.047797-05:00', '2019-07-31T17:02:30.047797-05:00']	['3f6bb63a-0c1e-5f26-9650-a69cc299f3b9', 'e8ef11c4-39ad-589b-83db-caad8cc5e42f']	['TCGA-BT-A20R_treatment_1', 'TCGA-BT-A20R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:19.874219-05:00', '']	01	Primary	20231b7f-cb6a-4cd0-9c46-10d4e959d483	Primary Tumor		1794.0	220.0	OCT	F974D857-0AA3-4BAA-9C65-A71F27A72877	true	Solid Tissue	False	Tumor
TCGA-BT-A20R-11A	f8780a4b-7f55-41d1-bf92-8513955d150e	Transitional Cell Papillomas and Carcinomas	f8780a4b-7f55-41d1-bf92-8513955d150e	TCGA-BT-A20R	Bladder		Not Reported		white	female	not hispanic or latino	Dead	79	-28987.0	1927.0	154.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder		28987.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N1	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3b	28987.0	79.41643835616438	['2019-07-31T17:02:30.047797-05:00', '2019-07-31T17:02:30.047797-05:00']	['3f6bb63a-0c1e-5f26-9650-a69cc299f3b9', 'e8ef11c4-39ad-589b-83db-caad8cc5e42f']	['TCGA-BT-A20R_treatment_1', 'TCGA-BT-A20R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:19.874219-05:00', '']	11	Not Applicable	4f6353e2-fb61-48b7-b784-3c0d391d708b	Solid Tissue Normal		1794.0	270.0	OCT		true	Solid Tissue	False	Normal
TCGA-XF-A9T4-01A	f9a03eaa-a228-429c-99c5-8e877379db0f	Transitional Cell Papillomas and Carcinomas	f9a03eaa-a228-429c-99c5-8e877379db0f	TCGA-XF-A9T4	Bladder		Not Reported		white	male	not hispanic or latino	Dead	48	-17728.0	1960.0	495.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		17728.0	Transitional cell carcinoma	no	2008.0	No	6th	T2b	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		17728.0	48.56986301369863	['2019-07-31T17:02:41.925792-05:00', '2019-07-31T17:02:41.925792-05:00']	['5b6bcfee-b737-57aa-aa6b-47a36fa3823d', '6ef306ad-aeb4-5091-9b09-7ff07b1dc06d']	['TCGA-XF-A9T4_treatment_1', 'TCGA-XF-A9T4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:03:30.358599-05:00', '']	01	Primary	d87953c9-fb82-4c22-9d64-71d1d40071ce	Primary Tumor	Not Reported	2146.0	740.0	OCT	82129FB4-5062-4878-931D-C09C336EAE4A	true	Solid Tissue	False	Tumor
TCGA-XF-AAN3-01A	24ad2168-b25a-4de8-a021-dfe1c74fcc6e	Transitional Cell Papillomas and Carcinomas	24ad2168-b25a-4de8-a021-dfe1c74fcc6e	TCGA-XF-AAN3	Bladder		Not Reported		white	male	not hispanic or latino	Alive	76	-27909.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	2625.0	27909.0	Transitional cell carcinoma	no	2007.0	No	6th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27909.0	76.46301369863014	['2019-07-31T16:45:14.076134-05:00', '2019-07-31T16:45:14.076134-05:00']	['2dac90fc-29d9-5012-8a25-7088ceb45b8c', '6ab31e39-7e60-52e0-8ab9-25e1cd6ce618']	['TCGA-XF-AAN3_treatment_1', 'TCGA-XF-AAN3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:49:26.190095-05:00', '']	01	Primary	633b412a-5681-47ce-bd5e-3d0a37f76bd2	Primary Tumor	Not Reported	2445.0	590.0	OCT	A0641D3F-1AB4-446B-B5AB-BB5882E82730	true	Solid Tissue	False	Tumor
TCGA-UY-A8OB-01A	fe33e5e0-a54d-481a-897c-e32b4708da69	Transitional Cell Papillomas and Carcinomas	fe33e5e0-a54d-481a-897c-e32b4708da69	TCGA-UY-A8OB	Bladder	1.36986301369863	Not Reported	25.0	white	male	hispanic or latino	Alive	63	-23360.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	2109.0	23360.0	Transitional cell carcinoma	no		No	6th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23360.0	64.0	['2019-07-31T17:03:08.200297-05:00', '2019-07-31T17:03:08.200297-05:00']	['51531baa-611f-5690-a120-5834b36c86e0', 'c508fbb6-623f-5749-a8b0-7e7c6f05a40f']	['TCGA-UY-A8OB_treatment', 'TCGA-UY-A8OB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:03:53.770530-05:00']	01	Primary	db9be25a-e321-4fbd-a6eb-1d7521c16ece	Primary Tumor	Not Reported		250.0	OCT	1D6D35DC-D4B8-4186-9EA4-97F53314D01B	true	Solid Tissue	False	Tumor
TCGA-G2-A2EC-01A	28e25ffb-8b0c-4839-a735-ed7b78e3213a	Transitional Cell Papillomas and Carcinomas	28e25ffb-8b0c-4839-a735-ed7b78e3213a	TCGA-G2-A2EC	Bladder		Not Reported		black or african american	female	not hispanic or latino	Dead	58	-21215.0	1952.0	696.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	679.0	21215.0	Transitional cell carcinoma	no	2010.0	No	2nd		8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	21215.0	58.12328767123287	['2019-07-31T16:45:45.354279-05:00', '2019-07-31T16:45:45.354279-05:00']	['a4176a47-ece8-539b-aa06-f886a15c954f', 'c5aedb26-1567-5635-9114-c3e71fa9b619']	['TCGA-G2-A2EC_treatment', 'TCGA-G2-A2EC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:49:50.593548-05:00']	01	Primary	2da969e6-9a63-4c03-8347-01a51496c224	Primary Tumor	Not Reported	481.0	60.0	OCT	77EEB2BE-B13B-41FD-B503-8C107D16FE38	true	Solid Tissue	False	Tumor
TCGA-G2-A2EF-01A	2a142731-119c-495d-ad30-eb0b48bacb46	Transitional Cell Papillomas and Carcinomas	2a142731-119c-495d-ad30-eb0b48bacb46	TCGA-G2-A2EF	Bladder	1.917808219178082	Not Reported	35.0	white	male	not hispanic or latino	Alive	50	-18467.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1884.0	18467.0	Transitional cell carcinoma	no	2007.0	No	6th		8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	18467.0	50.59452054794521	['2019-07-31T16:45:51.148369-05:00', '2019-07-31T16:45:51.148369-05:00']	['6e679563-bdd3-5622-a969-4ce4f8141216', 'e7355349-02f2-54e5-835b-96265f2786fa']	['TCGA-G2-A2EF_treatment', 'TCGA-G2-A2EF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:49:55.756301-05:00']	01	Primary	981f581e-32af-486b-9b60-0c8f1047c879	Primary Tumor	Not Reported	1485.0	120.0	OCT	6C7C3694-0D25-476F-BCAF-83BCC10C7C3B	true	Solid Tissue	False	Tumor
TCGA-GD-A3OQ-01A	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	Transitional Cell Papillomas and Carcinomas	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	TCGA-GD-A3OQ	Bladder	1.6986301369863013	Not Reported	31.0	white	male	not hispanic or latino	Alive	48	-17682.0	1963.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	95.0	17682.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	17682.0	48.443835616438356	['2019-07-31T15:19:22.278828-05:00', '2019-07-31T15:19:22.278828-05:00']	['2b12a9f0-d64c-56b8-b8a9-4904e3c55e09', 'bfe3ffeb-5263-50dd-8fa1-2dff3b591255']	['TCGA-GD-A3OQ_treatment_1', 'TCGA-GD-A3OQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T08:39:42.095286-05:00', '']	01	Primary	e3d22638-c0ae-48aa-a523-8c9a6cfbf063	Primary Tumor	Not Reported	297.0	280.0	Unknown	E507237E-8A43-45E8-88CC-0AA7C62029E6	false	Solid Tissue	False	Tumor
TCGA-GD-A3OQ-11A	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	Transitional Cell Papillomas and Carcinomas	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	TCGA-GD-A3OQ	Bladder	1.6986301369863013	Not Reported	31.0	white	male	not hispanic or latino	Alive	48	-17682.0	1963.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	95.0	17682.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	17682.0	48.443835616438356	['2019-07-31T15:19:22.278828-05:00', '2019-07-31T15:19:22.278828-05:00']	['2b12a9f0-d64c-56b8-b8a9-4904e3c55e09', 'bfe3ffeb-5263-50dd-8fa1-2dff3b591255']	['TCGA-GD-A3OQ_treatment_1', 'TCGA-GD-A3OQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T08:39:42.095286-05:00', '']	11	Not Applicable	fa1b5772-8254-49ba-a385-af8c9ac7fa4f	Solid Tissue Normal	Not Reported	297.0	490.0	Unknown		false	Solid Tissue	False	Normal
TCGA-E7-A3X6-01A	c871ea6b-fbd2-4e6f-ab29-f43f6e3ddcbb	Transitional Cell Papillomas and Carcinomas	c871ea6b-fbd2-4e6f-ab29-f43f6e3ddcbb	TCGA-E7-A3X6	Bladder		Not Reported		white	male	not hispanic or latino	Dead	70	-25584.0	1941.0	904.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	750.0	25584.0	Transitional cell carcinoma	no	2011.0	No	7th	T2	8120/3	NX	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25584.0	70.0931506849315	['2019-07-31T16:58:58.161410-05:00', '2019-07-31T16:58:58.161410-05:00']	['8fe526cd-444a-5e5b-8a66-88c6d6d83427', 'ec517dc0-2504-5763-b7f5-4afa3752f2a8']	['TCGA-E7-A3X6_treatment', 'TCGA-E7-A3X6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:00:26.070318-05:00']	01	Primary	554ae735-9991-4cb3-afe8-4951490bd709	Primary Tumor	Not Reported	280.0	590.0	OCT	BC75580D-4F4D-408C-9E9C-116A260DDED3	true	Solid Tissue	False	Tumor
TCGA-E7-A85H-01A	c8adce3d-4914-4851-9952-846b0c9c32de	Transitional Cell Papillomas and Carcinomas	c8adce3d-4914-4851-9952-846b0c9c32de	TCGA-E7-A85H	Bladder	0.273972602739726	Not Reported	5.0	asian	male	not hispanic or latino	Alive	64	-23497.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	394.0	23497.0	Transitional cell carcinoma	no	2013.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23497.0	64.37534246575342	['2019-07-31T16:59:01.107771-05:00', '2019-07-31T16:59:01.107771-05:00']	['2e101ca9-ca18-5316-8fcf-727a0b62a7b5', '61359cc4-3989-55a9-87c2-dab1ebc6b526']	['TCGA-E7-A85H_treatment_1', 'TCGA-E7-A85H_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'no']	['2019-04-28T10:00:28.544970-05:00', '']	01	Primary	3e301929-fcfd-4bf1-8314-595b4d8d382d	Primary Tumor	Not Reported	106.0	1670.0	OCT	4AAC565F-AE74-46E9-87D1-055DD38EFEBD	true	Solid Tissue	False	Tumor
TCGA-E5-A4TZ-01A	ca6403dd-3bd5-4023-8ea1-9957ec44dba5	Transitional Cell Papillomas and Carcinomas	ca6403dd-3bd5-4023-8ea1-9957ec44dba5	TCGA-E5-A4TZ	Bladder	4.657534246575342	Not Reported	85.0	white	male	not hispanic or latino	Dead	64	-23566.0	1946.0	467.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	3b76a3ec-899f-5b8f-b869-4c03bf9a222d	E5	Roswell Park	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		23566.0	Transitional cell carcinoma	yes	2010.0	Yes	7th	T4b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23566.0	64.56438356164384	['2019-07-31T16:59:06.885565-05:00', '2019-07-31T16:59:06.885565-05:00']	['1ab8d19c-cc73-55b6-a3d2-cd12bb938d04', '82b49c3d-cdd8-5e4c-9e88-e330238b68c5']	['TCGA-E5-A4TZ_treatment_1', 'TCGA-E5-A4TZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:00:33.297377-05:00', '']	01	Primary	38ca6485-9a8e-40ba-8172-25dfe79aaabb	Primary Tumor	Not Reported	1003.0	80.0	Unknown	07FC68D0-114F-4840-836C-53B2A8A18CEC	false	Solid Tissue	False	Tumor
TCGA-FD-A5BT-01A	cc2350ca-9220-400d-8b76-cc36d26f68d6	Transitional Cell Papillomas and Carcinomas	cc2350ca-9220-400d-8b76-cc36d26f68d6	TCGA-FD-A5BT	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	84	-30686.0	1927.0	328.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Lateral wall of bladder		30686.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		30686.0	84.07123287671233	['2019-07-31T16:59:15.903542-05:00', '2019-07-31T16:59:15.903542-05:00']	['42121bb5-71d1-5782-945e-6b4daf5ade89', '5af1762d-fcb4-5f76-a902-352adbcb89da']	['TCGA-FD-A5BT_treatment_1', 'TCGA-FD-A5BT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:00:40.545016-05:00', '']	01	Primary	3fb8f48e-ccfd-4feb-b247-d6710dfaeca1	Primary Tumor	Not Reported	447.0	910.0	OCT	B5902DC7-953C-4944-B555-534BEDE6A248	true	Solid Tissue	False	Tumor
TCGA-KQ-A41S-01A	cc8602bb-78e2-4732-9784-83c3388b999e	Transitional Cell Papillomas and Carcinomas	cc8602bb-78e2-4732-9784-83c3388b999e	TCGA-KQ-A41S	Bladder		Not Reported		white	female	not reported	Alive	87	-32041.0	1924.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	35.0	32041.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	NX	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		32041.0	87.78356164383561	['2019-07-31T16:59:19.074186-05:00', '2019-07-31T16:59:19.074186-05:00']	['8a0a60b9-54c0-541f-9c7e-29058de899ba', 'a4e418a6-0e3f-5978-8cc1-cf625b261731']	['TCGA-KQ-A41S_treatment_1', 'TCGA-KQ-A41S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:00:43.041034-05:00', '']	01	Primary	546e9ec3-7745-4a94-bb1d-b5f40203669a	Primary Tumor	Not Reported	321.0	450.0	OCT	75B6EA6C-3EC8-4283-883C-25DD6A6A6E59	true	Solid Tissue	False	Tumor
TCGA-DK-AA75-01A	cea28eac-4442-4436-b737-536e45b89989	Transitional Cell Papillomas and Carcinomas	cea28eac-4442-4436-b737-536e45b89989	TCGA-DK-AA75	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	82	-30090.0	1931.0	340.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder		30090.0	Transitional cell carcinoma	no	2013.0	No	7th	T3	8120/3	N0	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		30090.0	82.43835616438356	['2019-07-31T16:59:44.057028-05:00', '2019-07-31T16:59:44.057028-05:00']	['a92b9309-56c2-502b-b7e1-ee29d780cb62', 'ec91e249-584b-58e3-9847-4260697eb16c']	['TCGA-DK-AA75_treatment', 'TCGA-DK-AA75_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:01:03.875153-05:00']	01	Primary	5346c3ec-3060-40c5-8ad4-c6e4d37c8909	Primary Tumor	Not Reported	272.0	240.0	OCT	7BC5ECDC-33EB-42AA-AD88-71185A483309	true	Solid Tissue	False	Tumor
TCGA-H4-A2HQ-01A	cede5274-279d-4021-8aca-5ecc4bf94d66	Transitional Cell Papillomas and Carcinomas	cede5274-279d-4021-8aca-5ecc4bf94d66	TCGA-H4-A2HQ	Bladder	0.3835616438356164	Not Reported	7.0	black or african american	female	not hispanic or latino	Alive	64	-23538.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	fc847642-8a8a-5c82-be82-e8f6966b98df	H4	Medical College of Georgia	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	590.0	23538.0	Transitional cell carcinoma	no	2010.0	No	7th		8120/3	NX	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2b	23538.0	64.4876712328767	['2019-07-31T16:59:47.047796-05:00', '2019-07-31T16:59:47.047796-05:00']	['1b1eeed1-d89c-5f3b-8453-acebfed130b1', 'abc3aa11-2dc1-516d-a1c9-b8b1e1fae380']	['TCGA-H4-A2HQ_treatment', 'TCGA-H4-A2HQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:06.145402-05:00']	01	Primary	cbedc0db-39fd-4661-9531-cc24d422fac4	Primary Tumor	Not Reported	200.0	120.0	Unknown	87991E38-AE15-4163-BC44-6AEA8105A203	false	Solid Tissue	False	Tumor
TCGA-MV-A51V-01A	d2f329b3-5b44-414b-bccd-7b2d1345d21e	Transitional Cell Papillomas and Carcinomas	d2f329b3-5b44-414b-bccd-7b2d1345d21e	TCGA-MV-A51V	Bladder		Not Reported		white	male	not hispanic or latino	Alive	75	-27430.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	25d68f48-3057-512a-a3fc-995ab0660aea	MV	University of Minnesota	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	410.0	27430.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T3a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27430.0	75.15068493150685	['2019-07-31T16:59:59.342390-05:00', '2019-07-31T16:59:59.342390-05:00']	['276b228d-5c06-5d01-a549-1f3b66973b88', 'c20f10bc-c164-5d9c-a114-9a8eb1754512']	['TCGA-MV-A51V_treatment_1', 'TCGA-MV-A51V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:15.676679-05:00', '']	01	Primary	c0da46cf-81eb-4f1f-8f95-07bccee9f7de	Primary Tumor	Not Reported	171.0	230.0	OCT	E6737FA1-2DEE-4CF3-AE45-6866FF1F7FF4	true	Solid Tissue	False	Tumor
TCGA-DK-A6B5-01A	d5e8d936-40ae-4fd3-b40e-cac54763d71f	Transitional Cell Papillomas and Carcinomas	d5e8d936-40ae-4fd3-b40e-cac54763d71f	TCGA-DK-A6B5	Bladder		Not Reported		white	male	not hispanic or latino	Alive	45	-16453.0	1965.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Anterior wall of bladder	1542.0	16453.0	Transitional cell carcinoma	yes	2010.0	No	6th	T4a	8120/3	N2	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		16453.0	45.07671232876712	['2019-07-31T17:00:19.924870-05:00', '2019-07-31T17:00:19.924870-05:00']	['3254b3b2-25c3-5619-a5e5-42d52b8a2551', 'd564f5fc-a580-595b-8205-9e2e687e5bed']	['TCGA-DK-A6B5_treatment', 'TCGA-DK-A6B5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:32.545864-05:00']	01	Primary	b3694163-a186-4cf0-90b6-545cef6248bf	Primary Tumor	Not Reported	984.0	320.0	OCT	8265F65D-C5A6-4290-AE46-7A9A114C82C9	true	Solid Tissue	False	Tumor
TCGA-DK-A3WX-01A	d63c186d-add6-492e-8250-e83f46d39d00	Transitional Cell Papillomas and Carcinomas	d63c186d-add6-492e-8250-e83f46d39d00	TCGA-DK-A3WX	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Dead	67	-24553.0	1944.0	321.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder		24553.0	Transitional cell carcinoma	no	2011.0	No	6th	T3	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	24553.0	67.26849315068493	['2019-07-31T17:00:22.943918-05:00', '2019-07-31T17:00:22.943918-05:00']	['1cbe837a-4f51-572c-88de-0a6351892297', '82f99123-9b17-5ea3-a27b-f5113231e3c7']	['TCGA-DK-A3WX_treatment', 'TCGA-DK-A3WX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:01:35.069336-05:00']	01	Primary	fed73c89-75f1-45c9-b14b-7840c52c305f	Primary Tumor	Not Reported	223.0	280.0	OCT	9E6A2855-20DB-4EFD-ADFF-8B82CD356533	true	Solid Tissue	False	Tumor
TCGA-GV-A3JX-01A	d9dcbb57-f6c2-4465-8a60-afe876e113ca	Transitional Cell Papillomas and Carcinomas	d9dcbb57-f6c2-4465-8a60-afe876e113ca	TCGA-GV-A3JX	Bladder	4.383561643835616	Not Reported	80.0	white	male	not hispanic or latino	Alive	59	-21888.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	581.0	21888.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21888.0	59.967123287671235	['2019-07-31T17:00:32.249710-05:00', '2019-07-31T17:00:32.249710-05:00']	['715e5282-d91a-5a0b-bb90-f39c59eb1a54', 'cdad3f3b-d1d5-55ee-bbaa-2c24b1f27e47']	['TCGA-GV-A3JX_treatment_1', 'TCGA-GV-A3JX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:42.434024-05:00', '']	01	Primary	ce32612d-f504-4164-ae50-04c4ac2999fb	Primary Tumor	Not Reported	161.0	80.0	OCT	754BC231-6859-478C-8874-66CB06F2596C	true	Solid Tissue	False	Tumor
TCGA-BT-A42F-01A	da98be9d-7acf-43ce-aa24-38d1d2604506	Transitional Cell Papillomas and Carcinomas	da98be9d-7acf-43ce-aa24-38d1d2604506	TCGA-BT-A42F	Bladder		Not Reported		white	male	not hispanic or latino	Alive	64	-23713.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder	864.0	23713.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N1	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T4a	23713.0	64.96712328767123	['2019-07-31T17:00:35.226368-05:00', '2019-07-31T17:00:35.226368-05:00']	['73430661-4790-5b74-80b2-72dc56a8e780', 'ac1bdbad-ba6b-57bf-bf9b-4bdfb03e0251']	['TCGA-BT-A42F_treatment_1', 'TCGA-BT-A42F_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:01:44.748427-05:00', '']	01	Primary	d5f2a552-91c3-4750-a66f-30c3c854d6e1	Primary Tumor	Not Reported	282.0	50.0	OCT	2A58F62D-F2F7-454A-A9E3-F7AE46DF70C5	true	Solid Tissue	False	Tumor
TCGA-FD-A6TC-01A	00d8e96f-f231-4475-9e9f-c1f8aec28e4e	Transitional Cell Papillomas and Carcinomas	00d8e96f-f231-4475-9e9f-c1f8aec28e4e	TCGA-FD-A6TC	Bladder	0.547945205479452	Not Reported	10.0	white	female	not hispanic or latino	Alive	79	-28963.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder	187.0	28963.0	Transitional cell carcinoma	yes	2013.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	28963.0	79.35068493150685	['2019-07-31T16:33:34.580822-05:00', '2019-07-31T16:33:34.580822-05:00']	['135d6557-eea8-5bc4-96b4-48558ce0283d', '2c130eaa-7f4e-5bb2-ad5a-8fe32227f8f9']	['TCGA-FD-A6TC_treatment', 'TCGA-FD-A6TC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:40:14.805562-05:00']	01	Primary	cbb32aa6-5088-43dc-8e7f-bcdac17e33ff	Primary Tumor	Not Reported	139.0	380.0	OCT	035F00F9-9B4B-4628-829B-D4C1E3219C90	true	Solid Tissue	False	Tumor
TCGA-2F-A9KO-01A	dd3a6357-9087-44b2-9956-f981e0de6f1c	Transitional Cell Papillomas and Carcinomas	dd3a6357-9087-44b2-9956-f981e0de6f1c	TCGA-2F-A9KO	Bladder	3.780821917808219	Not Reported	69.0	white	male	not hispanic or latino	Dead	63	-23323.0	1945.0	734.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder	678.0	23323.0	Transitional cell carcinoma	no	2008.0	No	6th	T3	8120/3	N1	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23323.0	63.8986301369863	['2019-07-31T17:00:47.165388-05:00', '2019-07-31T17:00:47.165388-05:00']	['231a62ba-6315-57fd-8db0-e4b33a724514', 'ab6d5281-7afe-51d0-9088-22fd4d24d880']	['TCGA-2F-A9KO_treatment', 'TCGA-2F-A9KO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:01:54.609066-05:00']	01	Primary	6e63e194-e41f-4f0d-979b-1e0439da1bfc	Primary Tumor	Not Reported	2168.0	160.0	Unknown	FA1D30C7-E486-48DD-989F-E774B42EA1B1	false	Solid Tissue	False	Tumor
TCGA-GV-A3JV-01A	01ee41ef-1894-4408-9e96-a22a1f068190	Transitional Cell Papillomas and Carcinomas	01ee41ef-1894-4408-9e96-a22a1f068190	TCGA-GV-A3JV	Bladder	4.931506849315069	Not Reported	90.0	white	male	not hispanic or latino	Dead	66	-24243.0	1945.0	434.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	134.0	24243.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	24243.0	66.41917808219178	['2019-07-31T16:33:43.897514-05:00', '2019-07-31T16:33:43.897514-05:00']	['9fc3fe45-bf79-551c-9ee3-f14b6c8d51b7', 'a1db269e-da25-579b-b0c5-5381c62fe0db']	['TCGA-GV-A3JV_treatment', 'TCGA-GV-A3JV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:40:22.824045-05:00']	01	Primary	55072935-cd20-4355-897b-f60f77a18847	Primary Tumor	Not Reported	281.0	390.0	OCT	098BAA98-ACDF-4E3B-9383-03ECFB214CB3	true	Solid Tissue	False	Tumor
TCGA-FD-A5BR-01A	dfdaebd6-e0ab-49d1-9ae9-3a57b3c318b5	Transitional Cell Papillomas and Carcinomas	dfdaebd6-e0ab-49d1-9ae9-3a57b3c318b5	TCGA-FD-A5BR	Bladder		Not Reported		white	male	not hispanic or latino	Alive	57	-20964.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	813.0	20964.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		20964.0	57.43561643835616	['2019-07-31T17:00:55.854667-05:00', '2019-07-31T17:00:55.854667-05:00']	['5d5432f2-661c-5175-a816-b6b09290f158', 'b91cea10-28b6-55a0-920f-dcec87b6640b']	['TCGA-FD-A5BR_treatment_1', 'TCGA-FD-A5BR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:02:01.732483-05:00', '']	01	Primary	02351552-109a-48b6-a2e5-8d2a7e4b6c96	Primary Tumor	Not Reported	307.0	600.0	OCT	2C24A4C8-5866-4077-8497-5294CA674C36	true	Solid Tissue	False	Tumor
TCGA-DK-A2I1-01A	036b9681-ab58-4734-a8fd-e0d5d078bf5a	Transitional Cell Papillomas and Carcinomas	036b9681-ab58-4734-a8fd-e0d5d078bf5a	TCGA-DK-A2I1	Bladder		Not Reported		white	female	not hispanic or latino	Alive	73	-26726.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	546.0	26726.0	Papillary transitional cell carcinoma	no	2010.0	No	6th	T2b	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26726.0	73.22191780821917	['2019-07-31T16:43:05.715831-05:00', '2019-07-31T16:43:05.715831-05:00']	['8bd864ca-06cc-5d34-9a4d-118ddc24ac9b', 'ba850f29-52e5-5186-bbd3-5344b0df4c08']	['TCGA-DK-A2I1_treatment', 'TCGA-DK-A2I1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:47:40.497690-05:00']	01	Primary	f9bd70b2-6cde-48e5-9f0d-55d86ccfeba8	Primary Tumor	Not Reported	245.0	350.0	OCT	4E78ED88-FF1B-406C-98B8-A836D6AEA1E9	true	Solid Tissue	False	Tumor
TCGA-E7-A7PW-01A	045fe498-6a07-41ff-9956-dc0fb0483e7f	Transitional Cell Papillomas and Carcinomas	045fe498-6a07-41ff-9956-dc0fb0483e7f	TCGA-E7-A7PW	Bladder	0.273972602739726	Not Reported	5.0	asian	male	not hispanic or latino	Alive	63	-23057.0	1950.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	416.0	23057.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23057.0	63.16986301369863	['2019-07-31T16:43:14.343440-05:00', '2019-07-31T16:43:14.343440-05:00']	['2daae445-7590-5411-90c1-67ecb6f5953f', 'bee5ad4a-28db-595d-b819-4823bd4a3d02']	['TCGA-E7-A7PW_treatment_1', 'TCGA-E7-A7PW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:47:48.706514-05:00', '']	01	Primary	06dfea18-68e6-460d-a03f-02a92d49c171	Primary Tumor	Not Reported	117.0	1780.0	OCT	7C70BB37-3B12-4980-A232-20E47478BE78	true	Solid Tissue	False	Tumor
TCGA-CF-A47V-01A	e5086eab-c920-4e3e-a965-90f3f495363a	Transitional Cell Papillomas and Carcinomas	e5086eab-c920-4e3e-a965-90f3f495363a	TCGA-CF-A47V	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	52	-19265.0	1960.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	379.0	19265.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	19265.0	52.78082191780822	['2019-07-31T17:01:10.205956-05:00', '2019-07-31T17:01:10.205956-05:00']	['f63fdc29-2662-55b5-a906-31d1720a2587', 'fc5425d5-18d4-567b-82d2-787b5cc72895']	['TCGA-CF-A47V_treatment_1', 'TCGA-CF-A47V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T10:02:14.051891-05:00', '']	01	Primary	50d76f90-60be-43ac-9de0-0242c1c2a13c	Primary Tumor	Not Reported	206.0	420.0	OCT	D395DB4F-3DDF-48D2-97DE-0472E6B51A88	true	Solid Tissue	False	Tumor
TCGA-UY-A78M-01A	069b6e47-012c-483e-bee4-36a2a21a3486	Transitional Cell Papillomas and Carcinomas	069b6e47-012c-483e-bee4-36a2a21a3486	TCGA-UY-A78M	Bladder		Not Reported		asian	female	not hispanic or latino	Dead	81	-29706.0		690.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		29706.0	Transitional cell carcinoma	no		No	6th	T2	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29706.0	81.38630136986302	['2019-07-31T17:14:00.775490-05:00', '2019-07-31T17:14:00.775490-05:00']	['2df2d229-6c3c-5a30-9aa4-d3653c116fcb', '64db6360-29c5-5889-baf3-6870ced37720']	['TCGA-UY-A78M_treatment', 'TCGA-UY-A78M_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T10:12:52.845224-05:00']	01	Primary	eadbc728-7f25-474e-82f4-e863d79c8dd6	Primary Tumor	Not Reported		220.0	OCT	04F6BAED-CAA0-4396-9332-3EB8BA902895	true	Solid Tissue	False	Tumor
TCGA-CU-A3YL-01A	087a7f70-2fa8-4a16-b130-4df10a70c662	Transitional Cell Papillomas and Carcinomas	087a7f70-2fa8-4a16-b130-4df10a70c662	TCGA-CU-A3YL	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Alive	67	-24524.0	1944.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	906.0	24524.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T4a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24524.0	67.18904109589042	['2019-07-31T15:19:25.527153-05:00', '2019-07-31T15:19:25.527153-05:00']	['6ae3b974-f11b-5249-afa6-c348cfd8285e', 'ac13a4a2-0f52-5e56-8b91-5ea30aa65a4b']	['TCGA-CU-A3YL_treatment', 'TCGA-CU-A3YL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T08:39:44.552337-05:00']	01	Primary	f66ad788-e2d8-4688-820f-49a609701533	Primary Tumor	Not Reported	191.0	510.0	Unknown	A1AF7975-132E-469A-B4C8-A0A3F19EA0D0	false	Solid Tissue	False	Tumor
TCGA-ZF-A9R9-01A	ebad8bc9-f196-4f53-bfea-de38488eb4e1	Transitional Cell Papillomas and Carcinomas	ebad8bc9-f196-4f53-bfea-de38488eb4e1	TCGA-ZF-A9R9	Bladder	0.1643835616438356	Not Reported	3.0	white	male	not hispanic or latino	Dead	58	-21491.0	1952.0	864.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		21491.0	Transitional cell carcinoma	no	2010.0	No	7th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	21491.0	58.87945205479452	['2019-07-31T17:01:27.549544-05:00', '2019-07-31T17:01:27.549544-05:00']	['4b9c4b12-8895-548d-8767-d7f4aef84ecf', '9a0c80cc-6a09-59ad-9ff2-9580f17a24b6']	['TCGA-ZF-A9R9_treatment', 'TCGA-ZF-A9R9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:02:28.110858-05:00']	01	Primary	d4a7e1ea-870b-4bdd-9935-3284af040138	Primary Tumor	Not Reported	1239.0	140.0	OCT	164EE426-8661-404C-9E0F-4216A76253C8	true	Solid Tissue	False	Tumor
TCGA-FD-A6TI-01A	0f956645-35aa-4a68-98d3-ea589459be00	Transitional Cell Papillomas and Carcinomas	0f956645-35aa-4a68-98d3-ea589459be00	TCGA-FD-A6TI	Bladder		Not Reported		white	male	not hispanic or latino	Dead	73	-26874.0	1940.0	294.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Anterior wall of bladder	122.0	26874.0	Transitional cell carcinoma	no	2013.0	No	7th	T4b	8120/3	N1	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	26874.0	73.62739726027397	['2019-07-31T16:44:03.101943-05:00', '2019-07-31T16:44:03.101943-05:00']	['ef62c97a-2e9e-5f35-89d8-839e02519749', 'fb0b9f11-64c7-58ee-8b96-42911a345ee1']	['TCGA-FD-A6TI_treatment_1', 'TCGA-FD-A6TI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:48:29.070065-05:00', '']	01	Primary	8a145be8-1299-4837-b5da-83865d8ab461	Primary Tumor	Not Reported	68.0	1110.0	OCT	9262DABE-98EE-4544-8907-124CDE5197C0	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7S-01A	f001cc02-8119-4726-b41c-14ac1e6a4216	Transitional Cell Papillomas and Carcinomas	f001cc02-8119-4726-b41c-14ac1e6a4216	TCGA-4Z-AA7S	Bladder		Not Reported		black or african american	male	not reported	Dead	66	-24111.0	1944.0	1064.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		24111.0	Transitional cell carcinoma	no	2010.0	No	7th	T4a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	24111.0	66.05753424657534	['2019-07-31T17:01:48.236138-05:00', '2019-07-31T17:01:48.236138-05:00']	['43f82f45-1a05-57ff-a923-2886d93a0a26', '9df9cc69-4edf-5dc0-b336-5b435e8decbb']	['TCGA-4Z-AA7S_treatment_1', 'TCGA-4Z-AA7S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:02:45.106326-05:00', '']	01	Primary	6d7d103d-08a9-4acd-aefa-ea7580bdf6b0	Primary Tumor	Not Reported	1190.0	420.0	OCT	A406A3F6-80CB-48D6-A129-2837504B5DE2	true	Solid Tissue	False	Tumor
TCGA-FD-A43U-01A	140b83db-badd-4b8d-b0f5-0f8c8060a228	Transitional Cell Papillomas and Carcinomas	140b83db-badd-4b8d-b0f5-0f8c8060a228	TCGA-FD-A43U	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Alive	70	-25841.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	636.0	25841.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T4	25841.0	70.7972602739726	['2019-07-31T16:44:21.850118-05:00', '2019-07-31T16:44:21.850118-05:00']	['30481e81-5fb0-5546-9c08-74387a7d0c9b', 'b2d77437-e23b-5179-8930-e4a4f0a453c5']	['TCGA-FD-A43U_treatment', 'TCGA-FD-A43U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:48:43.832103-05:00']	01	Primary	1336ab5a-0103-4fab-b057-1d387ddf0ded	Primary Tumor	Not Reported	119.0	910.0	OCT	FB7CF869-AA10-4C3E-9BDA-5686130DB4C6	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RD-01A	f57122dd-a6f1-484d-b08a-cb1194de2f9d	Transitional Cell Papillomas and Carcinomas	f57122dd-a6f1-484d-b08a-cb1194de2f9d	TCGA-ZF-A9RD	Bladder	0.547945205479452	Not Reported	10.0	white	female	not hispanic or latino	Dead	75	-27496.0	1933.0	408.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		27496.0	Transitional cell carcinoma	no	2008.0	No	6th	T3a	8120/3	N2	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	27496.0	75.33150684931506	['2019-07-31T17:02:05.520601-05:00', '2019-07-31T17:02:05.520601-05:00']	['5ec2241e-a7c3-5c2a-9720-d8563e2fe51a', '736eae88-d40d-54c1-b04f-0882d3ac3a72']	['TCGA-ZF-A9RD_treatment', 'TCGA-ZF-A9RD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:03:00.052999-05:00']	01	Primary	3c7de6de-68e0-443b-946d-437b8aece057	Primary Tumor	Not Reported	2074.0	220.0	OCT	6B721B6B-AD81-422E-8390-D615EA75EF64	true	Solid Tissue	False	Tumor
TCGA-XF-A9SW-01A	f5e03536-26e1-480d-a7bb-010eb8210cd6	Transitional Cell Papillomas and Carcinomas	f5e03536-26e1-480d-a7bb-010eb8210cd6	TCGA-XF-A9SW	Bladder		Not Reported		white	male	not hispanic or latino	Dead	85	-31049.0	1921.0	362.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		31049.0	Transitional cell carcinoma	yes	2006.0	No	6th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31049.0	85.06575342465753	['2019-07-31T17:18:27.055105-05:00', '2019-07-31T17:18:27.055105-05:00']	['1b8de496-caab-5996-804f-b2b141d11334', 'b48d456d-a8b8-5537-b5ad-d804ec85ab40']	['TCGA-XF-A9SW_treatment_1', 'TCGA-XF-A9SW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:16:37.168870-05:00', '']	01	Primary	bb24b09a-7230-4e2c-92fd-f820981c65e9	Primary Tumor	Not Reported	2721.0	480.0	OCT	FC0E8C4B-EC30-47FA-8582-5AE007A9F697	true	Solid Tissue	False	Tumor
TCGA-2F-A9KR-01A	f6d916b0-8e4c-49cb-a0d4-883908f3284f	Transitional Cell Papillomas and Carcinomas	f6d916b0-8e4c-49cb-a0d4-883908f3284f	TCGA-2F-A9KR	Bladder	1.2328767123287672	Not Reported	22.5	not reported	female	not reported	Dead	59	-21848.0	1941.0	3183.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	3148.0	21848.0	Papillary transitional cell carcinoma	no	2000.0	No	5th	T3a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	21848.0	59.85753424657534	['2019-07-31T17:02:20.789098-05:00', '2019-07-31T17:02:20.789098-05:00']	['31308d34-1eed-5cd2-bd37-16d6b4c2ca7b', 'd8d68053-df4f-5c6a-90fd-85445e999b49']	['TCGA-2F-A9KR_treatment', 'TCGA-2F-A9KR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:03:12.322344-05:00']	01	Primary	b83bab59-8667-4920-9593-575997621b34	Primary Tumor	Not Reported	4919.0	650.0	Unknown	EC17D988-194A-4C20-9BF8-D7CC75D9DF55	false	Solid Tissue	False	Tumor
TCGA-E7-A8O7-01A	1e15cb17-cf22-4f06-a3d9-e528e77d1876	Transitional Cell Papillomas and Carcinomas	1e15cb17-cf22-4f06-a3d9-e528e77d1876	TCGA-E7-A8O7	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	52	-19063.0	1961.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	466.0	19063.0	Transitional cell carcinoma	no	2013.0	No	7th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	19063.0	52.227397260273975	['2019-07-31T16:44:47.398500-05:00', '2019-07-31T16:44:47.398500-05:00']	['b1300f10-1467-5fdd-b221-88b4338ecc61', 'e7c3dc78-3643-58c9-b09e-8a64ab19c437']	['TCGA-E7-A8O7_treatment_1', 'TCGA-E7-A8O7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'no']	['2019-04-28T09:49:04.400223-05:00', '']	01	Primary	627cfa74-c61b-4401-8242-7c74d65f9c9f	Primary Tumor	Not Reported	97.0	1100.0	OCT	6EF2834F-F28C-4E95-AC82-568590C9444D	true	Solid Tissue	False	Tumor
TCGA-E7-A3Y1-01A	f7c891eb-3b09-4e01-bb8a-53d570518cbe	Transitional Cell Papillomas and Carcinomas	f7c891eb-3b09-4e01-bb8a-53d570518cbe	TCGA-E7-A3Y1	Bladder		Not Reported		white	male	not hispanic or latino	Alive	57	-20917.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	163.0	20917.0	Transitional cell carcinoma	no	2012.0	No	7th		8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	20917.0	57.30684931506849	['2019-07-31T17:02:27.179656-05:00', '2019-07-31T17:02:27.179656-05:00']	['5b8d832b-9cd5-57f7-a541-3b9c54b2340b', 'b7777dcd-b953-56e4-bd17-8eb0a4308c98']	['TCGA-E7-A3Y1_treatment_1', 'TCGA-E7-A3Y1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T10:03:17.373863-05:00', '']	01	Primary	fabe5b98-4586-445d-9513-598bb7fd1909	Primary Tumor	Not Reported	101.0	850.0	OCT	015FB5A9-F21F-48CC-9EDA-43952CE358B7	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7M-01A	1ecfdf16-f5e9-4a08-8834-37f4b474179d	Transitional Cell Papillomas and Carcinomas	1ecfdf16-f5e9-4a08-8834-37f4b474179d	TCGA-4Z-AA7M	Bladder	0.547945205479452	Not Reported	10.0	white	male	not reported	Alive	65	-23817.0	1948.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	495.0	23817.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	23817.0	65.25205479452055	['2019-07-31T16:44:56.834334-05:00', '2019-07-31T16:44:56.834334-05:00']	['93740dae-0265-5382-8670-458d022c0956', '9b33cb92-3cd8-5e84-8e02-09f423e03176']	['TCGA-4Z-AA7M_treatment_1', 'TCGA-4Z-AA7M_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:11.173894-05:00', '']	01	Primary	837e7e71-56f8-4438-887c-406b5eeacc71	Primary Tumor	Not Reported	172.0	170.0	OCT	C14C42D1-6359-4625-90E1-B3E43646DB64	true	Solid Tissue	False	Tumor
TCGA-K4-A4AC-01A	2088ac24-a8b4-49af-a954-2b78b88a6f66	Transitional Cell Papillomas and Carcinomas	2088ac24-a8b4-49af-a954-2b78b88a6f66	TCGA-K4-A4AC	Bladder		Not Reported		white	male	not hispanic or latino	Dead	83	-30655.0	1929.0	278.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	197.0	30655.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30655.0	83.98630136986301	['2019-07-31T16:44:59.760634-05:00', '2019-07-31T16:44:59.760634-05:00']	['c5f7a435-8a5f-55d3-add9-5264b5c7de01', 'cede8cb1-fe66-5c7a-81f6-c775b4e04953']	['TCGA-K4-A4AC_treatment', 'TCGA-K4-A4AC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:49:13.675712-05:00']	01	Primary	15ee18e3-8da7-4eea-83f7-7e49d15914c1	Primary Tumor	Not Reported	81.0	600.0	OCT	6925099A-6C31-478E-A7A2-78472DC0BD46	true	Solid Tissue	False	Tumor
TCGA-G2-AA3B-01A	22424a05-0546-44c2-8ab7-abb8e49c3363	Transitional Cell Papillomas and Carcinomas	22424a05-0546-44c2-8ab7-abb8e49c3363	TCGA-G2-AA3B	Bladder	1.4246575342465753	Not Reported	26.0	white	female	not hispanic or latino	Alive	75	-27646.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2008.0	27646.0	Transitional cell carcinoma	no	2009.0	No	6th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27646.0	75.74246575342465	['2019-07-31T16:45:05.490913-05:00', '2019-07-31T16:45:05.490913-05:00']	['3c7991a5-328e-5cdb-83ce-7328a14f5a89', '8bcbc4b6-0d3a-5b0d-bcd6-886716a41ec4']	['TCGA-G2-AA3B_treatment', 'TCGA-G2-AA3B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:49:18.884973-05:00']	01	Primary	991fa342-863b-4708-9a95-f0c8590c7a63	Primary Tumor	Not Reported	1754.0	110.0	OCT	F2410C77-1B33-47AA-A820-8A0E637234FC	true	Solid Tissue	False	Tumor
TCGA-CF-A7I0-01A	25ac9acd-328b-4fae-a448-4f3957b1b212	Transitional Cell Papillomas and Carcinomas	25ac9acd-328b-4fae-a448-4f3957b1b212	TCGA-CF-A7I0	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	54	-20059.0	1959.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	368.0	20059.0	Papillary transitional cell carcinoma	no	2013.0	No	6th	T2	8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		20059.0	54.95616438356164	['2019-07-31T16:45:23.065785-05:00', '2019-07-31T16:45:23.065785-05:00']	['0d591876-8e62-5c76-ac94-f05c6ccee0d3', 'e01a3f24-21fc-5a64-994f-7ffcaf8e4383']	['TCGA-CF-A7I0_treatment_1', 'TCGA-CF-A7I0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:33.282638-05:00', '']	01	Primary	10fbdca9-5665-4441-a908-7c318100a5dc	Primary Tumor	Not Reported	223.0	340.0	OCT	25D0EA9B-2E2B-40D3-A340-2CA9F0BBD48E	true	Solid Tissue	False	Tumor
TCGA-FD-A6TA-01A	fcda9873-3a93-40b2-913d-4df1e6a27efb	Transitional Cell Papillomas and Carcinomas	fcda9873-3a93-40b2-913d-4df1e6a27efb	TCGA-FD-A6TA	Bladder		Not Reported		white	male	not hispanic or latino	Alive	58	-21196.0	1951.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	1912.0	21196.0	Papillary transitional cell carcinoma	no	2009.0	No	7th	T3b	8130/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		21196.0	58.07123287671233	['2019-07-31T17:18:33.131530-05:00', '2019-07-31T17:18:33.131530-05:00']	['1672805b-1926-5662-ae46-d860e7322ef9', '50fe17f7-cb20-555c-8026-9dc3ef2e902b']	['TCGA-FD-A6TA_treatment', 'TCGA-FD-A6TA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:16:42.099085-05:00']	01	Primary	5840fc62-5ac2-4794-8ce9-cdd7bce8019b	Primary Tumor	Not Reported	1620.0	320.0	OCT	876F967E-2CC2-4AFA-9BE7-23D77F6531E3	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7Q-01A	ffafcbfd-0eb3-4e14-acd0-4407b641a4a5	Transitional Cell Papillomas and Carcinomas	ffafcbfd-0eb3-4e14-acd0-4407b641a4a5	TCGA-4Z-AA7Q	Bladder		Not Reported		white	male	not reported	Dead	79	-28981.0	1933.0	510.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		28981.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3a	28981.0	79.4	['2019-07-31T17:03:16.941177-05:00', '2019-07-31T17:03:16.941177-05:00']	['225ae57a-f405-5434-877b-b65d9a7432cc', 'b2555385-bb8d-5bd7-9d55-b9034299ba87']	['TCGA-4Z-AA7Q_treatment_1', 'TCGA-4Z-AA7Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:04:01.209514-05:00', '']	01	Primary	c9131c2e-4230-482a-8847-566b2f4f9254	Primary Tumor	Not Reported	518.0	240.0	OCT	5715E28F-8C16-48DD-B92B-568EFCD0CA8D	true	Solid Tissue	False	Tumor
TCGA-DK-A3WW-01A	2ab0fb7b-ad2a-403d-9411-712974ccd878	Transitional Cell Papillomas and Carcinomas	2ab0fb7b-ad2a-403d-9411-712974ccd878	TCGA-DK-A3WW	Bladder		Not Reported		white	male	not hispanic or latino	Alive	57	-20909.0	1954.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	633.0	20909.0	Transitional cell carcinoma	no	2011.0	No	7th	T3	8120/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		20909.0	57.28493150684932	['2019-07-31T16:45:56.929762-05:00', '2019-07-31T16:45:56.929762-05:00']	['ae27b72a-bd6b-5c0f-a90e-2c38da4fb54d', 'ffda01f3-ec68-5b65-a0d2-6eca5bda379a']	['TCGA-DK-A3WW_treatment', 'TCGA-DK-A3WW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:50:00.611257-05:00']	01	Primary	5f78ba36-59d4-475e-9582-df5e361876b5	Primary Tumor	Not Reported	210.0	880.0	OCT	5EA5657B-39DE-49F8-BFFF-AC48B4491370	true	Solid Tissue	False	Tumor
TCGA-BT-A2LB-11A	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	Transitional Cell Papillomas and Carcinomas	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	TCGA-BT-A2LB	Bladder		Not Reported		white	female	not hispanic or latino	Dead	73	-26846.0	1937.0	492.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Dome of bladder	170.0	26846.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T3a	26846.0	73.55068493150685	['2019-07-31T16:59:53.121110-05:00', '2019-07-31T16:59:53.121110-05:00']	['06444461-e5e3-5733-828c-f6247b5a413b', '33fbfb5d-f3cc-5984-8ed7-8e62e02f90cb']	['TCGA-BT-A2LB_treatment', 'TCGA-BT-A2LB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:01:10.984552-05:00']	11	Not Applicable	085da7a1-e01d-4273-b5f2-7aab5d4d942a	Solid Tissue Normal	Not Reported	317.0	200.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A2LB-01A	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	Transitional Cell Papillomas and Carcinomas	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	TCGA-BT-A2LB	Bladder		Not Reported		white	female	not hispanic or latino	Dead	73	-26846.0	1937.0	492.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Dome of bladder	170.0	26846.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T3a	26846.0	73.55068493150685	['2019-07-31T16:59:53.121110-05:00', '2019-07-31T16:59:53.121110-05:00']	['06444461-e5e3-5733-828c-f6247b5a413b', '33fbfb5d-f3cc-5984-8ed7-8e62e02f90cb']	['TCGA-BT-A2LB_treatment', 'TCGA-BT-A2LB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:01:10.984552-05:00']	01	Primary	7c6178a6-6d4c-4def-b4ac-a064ab4a6c8a	Primary Tumor	Not Reported	317.0	160.0	OCT	CD9D52D3-87E7-4AC0-BBEA-E22C57F2E10A	true	Solid Tissue	False	Tumor
TCGA-DK-AA76-01A	d37b0460-efa4-4cf5-8082-f27ff2cf2f28	Transitional Cell Papillomas and Carcinomas	d37b0460-efa4-4cf5-8082-f27ff2cf2f28	TCGA-DK-AA76	Bladder	2.191780821917808	Not Reported	40.0	white	female	not hispanic or latino	Alive	64	-23542.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Anterior wall of bladder	366.0	23542.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	N0	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	23542.0	64.4986301369863	['2019-07-31T17:00:05.458491-05:00', '2019-07-31T17:00:05.458491-05:00']	['46092259-eb81-5c8d-9c6e-e2b4d4c3b345', '6b0edfa8-8b90-5878-b0df-1bb5d7587326']	['TCGA-DK-AA76_treatment', 'TCGA-DK-AA76_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:20.561876-05:00']	01	Primary	e98b7d82-0274-4fbe-829b-552552799ad9	Primary Tumor	Not Reported	216.0	380.0	OCT	3271070D-5B10-4243-BEE5-AFDD60B7CDDA	true	Solid Tissue	False	Tumor
TCGA-KQ-A41P-01A	d7af7e2c-f742-46ed-814b-1967d7e8c2d2	Transitional Cell Papillomas and Carcinomas	d7af7e2c-f742-46ed-814b-1967d7e8c2d2	TCGA-KQ-A41P	Bladder		Not Reported		white	male	not hispanic or latino	Alive	76	-27816.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder	1094.0	27816.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N3	M1	not reported	C67.0	Trigone of bladder	Not Reported	not reported		27816.0	76.20821917808219	['2019-07-31T17:00:26.199601-05:00', '2019-07-31T17:00:26.199601-05:00']	['9a7ca91b-038c-5a5e-a7f5-e03ac7ee1127', '9f160417-4f6e-5d96-9436-65b8a2fe9891']	['TCGA-KQ-A41P_treatment', 'TCGA-KQ-A41P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:37.460441-05:00']	01	Primary	4e500021-3c23-46a8-b60b-9952e5c91434	Primary Tumor	Not Reported	554.0	290.0	OCT	454B14C5-DD25-4249-85A6-71638DD756F7	true	Solid Tissue	False	Tumor
TCGA-ZF-AA53-01A	92c6856a-b26f-4512-bbb1-8a8aff4636ab	Transitional Cell Papillomas and Carcinomas	92c6856a-b26f-4512-bbb1-8a8aff4636ab	TCGA-ZF-AA53	Bladder		Not Reported		white	male	not hispanic or latino	Alive	60	-22035.0	1950.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	1761.0	22035.0	Transitional cell carcinoma	yes	2010.0	No	7th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	22035.0	60.36986301369863	['2019-07-31T16:54:33.443722-05:00', '2019-07-31T16:54:33.443722-05:00']	['5ef05d81-d4eb-54ee-a78c-a472947e9945', 'd010f37a-e9a4-58bd-aa92-2c3a4ccbaa71']	['TCGA-ZF-AA53_treatment_1', 'TCGA-ZF-AA53_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:56:53.320378-05:00', '']	01	Primary	aa672ec6-de2c-4020-857f-f99abd029aea	Primary Tumor	Not Reported	1434.0	270.0	OCT	07A1F163-55AF-4D64-AFD9-DE8DFF7CB2C6	true	Solid Tissue	False	Tumor
TCGA-HQ-A5ND-01A	001944e5-af34-4061-9c09-bb9ea346f6fd	Transitional Cell Papillomas and Carcinomas	001944e5-af34-4061-9c09-bb9ea346f6fd	TCGA-HQ-A5ND	Bladder	2.191780821917808	Not Reported	40.0	not reported	male	not reported	Dead	78	-28555.0		274.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	92ea63f4-dd85-57be-8c8e-c50c70f40169	HQ	Ontario Institute for Cancer Research (OICR)	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		28555.0	Transitional cell carcinoma	no		No	6th	T3b	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28555.0	78.23287671232876	['2019-07-31T16:33:31.101642-05:00', '2019-07-31T16:33:31.101642-05:00']	['83136421-54d5-5b88-bfe7-73f3f08e6719', 'f516cc0b-6cc3-5b34-8347-631fbbd5a265']	['TCGA-HQ-A5ND_treatment_1', 'TCGA-HQ-A5ND_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:40:11.879825-05:00', '']	01	Primary	8fef5013-4e57-4043-8770-a56135aeac9b	Primary Tumor	Not Reported		560.0	Unknown	90EBB6AD-C8DC-44FE-AE88-674F15041327	false	Solid Tissue	False	Tumor
TCGA-XF-A9SZ-01A	dc321b92-7275-48c9-adeb-7670db3195ef	Transitional Cell Papillomas and Carcinomas	dc321b92-7275-48c9-adeb-7670db3195ef	TCGA-XF-A9SZ	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	79	-29100.0	1928.0	859.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		29100.0	Transitional cell carcinoma	no	2007.0	No	5th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29100.0	79.72602739726027	['2019-07-31T17:00:44.314241-05:00', '2019-07-31T17:00:44.314241-05:00']	['3257623d-1d59-59d3-bbf1-cc00538cc7e4', 'cb417703-fd32-5031-8335-0ebf4ec1be42']	['TCGA-XF-A9SZ_treatment', 'TCGA-XF-A9SZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:01:52.225622-05:00']	01	Primary	f3f9e379-d7e3-4657-825d-45f4d16a89f0	Primary Tumor	Not Reported	2352.0	1080.0	OCT	BBDDB909-1AE0-4F10-948A-DAA989CF87D2	true	Solid Tissue	False	Tumor
TCGA-ZF-AA5H-01A	04477379-6c51-45d9-b9b9-d05d53b53945	Transitional Cell Papillomas and Carcinomas	04477379-6c51-45d9-b9b9-d05d53b53945	TCGA-ZF-AA5H	Bladder	0.4383561643835616	Not Reported	8.0	white	female	not hispanic or latino	Alive	60	-22122.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	897.0	22122.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22122.0	60.608219178082194	['2019-07-31T16:43:11.264678-05:00', '2019-07-31T16:43:11.264678-05:00']	['65aee747-4f5f-582b-b9ac-c2b340da0721', '95026320-6ddf-58e5-b521-b26f015b055e']	['TCGA-ZF-AA5H_treatment', 'TCGA-ZF-AA5H_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:47:45.695589-05:00']	01	Primary	e693d75f-e58e-4f53-a402-6936226fbc32	Primary Tumor	Not Reported	437.0	40.0	OCT	34430EB2-DC78-41EC-A4BD-9452B1B01C92	true	Solid Tissue	False	Tumor
TCGA-KQ-A41R-01A	e492d5a9-7ec5-454b-ae89-077c90f67489	Transitional Cell Papillomas and Carcinomas	e492d5a9-7ec5-454b-ae89-077c90f67489	TCGA-KQ-A41R	Bladder	1.095890410958904	Not Reported	20.0	white	female	not hispanic or latino	Alive	80	-29351.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1350.0	29351.0	Transitional cell carcinoma	no	2011.0	No	7th	T2	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29351.0	80.41369863013699	['2019-07-31T17:01:07.472583-05:00', '2019-07-31T17:01:07.472583-05:00']	['252864c0-8cb3-5a46-a7f1-aa3f324ff376', 'b8cc3b96-a1e8-5fc8-8757-d9f9991c7810']	['TCGA-KQ-A41R_treatment_1', 'TCGA-KQ-A41R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:02:11.775210-05:00', '']	01	Primary	d25c4cba-553c-459a-9249-433726b84c3a	Primary Tumor	Not Reported	294.0	240.0	OCT	D54B3725-D134-4F18-9FFC-8074F8942BC6	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4X-01A	e6f7bf6c-92b1-4795-94fc-b189d0c7877f	Transitional Cell Papillomas and Carcinomas	e6f7bf6c-92b1-4795-94fc-b189d0c7877f	TCGA-ZF-AA4X	Bladder		Not Reported		white	male	not hispanic or latino	Alive	56	-20579.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2044.0	20579.0	Transitional cell carcinoma	no	2009.0	No	6th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	20579.0	56.38082191780822	['2019-07-31T17:01:13.302918-05:00', '2019-07-31T17:01:13.302918-05:00']	['547c8655-0ffc-590f-9ad4-efb2399bec27', 'b19d03ba-a299-5d4e-85b0-37ab264ef9e4']	['TCGA-ZF-AA4X_treatment', 'TCGA-ZF-AA4X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:02:16.438791-05:00']	01	Primary	e332926d-4997-4beb-8f39-97aee0408809	Primary Tumor	Not Reported	1603.0	60.0	OCT	56AEE38E-1301-436B-91CE-BCDB523A56E5	true	Solid Tissue	False	Tumor
TCGA-GU-A766-01A	e7680a8e-1c0e-426b-abd8-d0d8e7d0e5aa	Transitional Cell Papillomas and Carcinomas	e7680a8e-1c0e-426b-abd8-d0d8e7d0e5aa	TCGA-GU-A766	Bladder		Not Reported		white	male	not hispanic or latino	Alive	62	-22774.0	1951.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	480.0	22774.0	Transitional cell carcinoma	no	2013.0	No	7th	T2a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22774.0	62.394520547945206	['2019-07-31T17:01:15.956536-05:00', '2019-07-31T17:01:15.956536-05:00']	['425965b0-1172-50c8-81f9-b07f6ddfa641', 'fdf7eeed-bc66-5821-9fef-c24c01bbfa59']	['TCGA-GU-A766_treatment_1', 'TCGA-GU-A766_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:18.808043-05:00', '']	01	Primary	15255077-f06b-45df-84c0-cab7850a729c	Primary Tumor	Not Reported	99.0	380.0	OCT	295B55E8-4220-4342-96E3-C4A8065B3D58	true	Solid Tissue	False	Tumor
TCGA-ZF-AA56-01A	eb30ae33-2076-475d-aac9-804a8f1119a0	Transitional Cell Papillomas and Carcinomas	eb30ae33-2076-475d-aac9-804a8f1119a0	TCGA-ZF-AA56	Bladder		Not Reported		white	female	not hispanic or latino	Dead	79	-28937.0	1931.0	259.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder		28937.0	Transitional cell carcinoma	no	2010.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2a	28937.0	79.27945205479452	['2019-07-31T17:01:21.673907-05:00', '2019-07-31T17:01:21.673907-05:00']	['1f915c6a-80db-5a45-b83c-71105ea15a6d', 'dd2ed8bb-0643-55cd-b21b-2c1708da2630']	['TCGA-ZF-AA56_treatment_1', 'TCGA-ZF-AA56_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:02:23.519315-05:00', '']	01	Primary	72f50bb3-c7a3-49b5-8262-185eb830e17e	Primary Tumor	Not Reported	1344.0	230.0	OCT	835DF5D1-5F61-4C7A-860B-265F1209DDC9	true	Solid Tissue	False	Tumor
TCGA-DK-AA6X-01A	071b350d-8745-4795-8194-a8c6491f0931	Transitional Cell Papillomas and Carcinomas	071b350d-8745-4795-8194-a8c6491f0931	TCGA-DK-AA6X	Bladder		Not Reported		white	male	not hispanic or latino	Alive	63	-23208.0	1950.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	467.0	23208.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	23208.0	63.583561643835615	['2019-07-31T16:43:36.029112-05:00', '2019-07-31T16:43:36.029112-05:00']	['473174d1-ff7e-5515-9bcd-05413f9dcf9e', '8c2ebd84-96e8-5c0d-855c-d7b61d2d1752']	['TCGA-DK-AA6X_treatment_1', 'TCGA-DK-AA6X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:48:05.528558-05:00', '']	01	Primary	03523592-740d-4a06-ac8c-f921bf3f7952	Primary Tumor	Not Reported	60.0	90.0	OCT	669554D5-C608-4028-B24E-1F2129FA0925	true	Solid Tissue	False	Tumor
TCGA-DK-AA77-01A	eb4f8c76-08d9-4ba4-846e-969fded63a87	Transitional Cell Papillomas and Carcinomas	eb4f8c76-08d9-4ba4-846e-969fded63a87	TCGA-DK-AA77	Bladder		Not Reported		white	male	not hispanic or latino	Alive	61	-22365.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder	618.0	22365.0	Transitional cell carcinoma	no	2013.0	No	7th	T2a	8120/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22365.0	61.273972602739725	['2019-07-31T17:01:24.718328-05:00', '2019-07-31T17:01:24.718328-05:00']	['05014f89-9893-5a46-80b0-d5aa0df56518', '6ed3a2d0-1373-5af6-a9a5-c09e5864ff79']	['TCGA-DK-AA77_treatment_1', 'TCGA-DK-AA77_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:02:25.843473-05:00', '']	01	Primary	d9b66125-cf32-4928-9488-8efb146684f9	Primary Tumor	Not Reported	168.0	950.0	OCT	382A39E0-F94D-4828-8B30-22A4080724BB	true	Solid Tissue	False	Tumor
TCGA-FD-A6TH-01A	08d13748-0946-49a1-8eb3-5afd1deebc84	Transitional Cell Papillomas and Carcinomas	08d13748-0946-49a1-8eb3-5afd1deebc84	TCGA-FD-A6TH	Bladder	2.4657534246575343	Not Reported	45.0	white	male	not hispanic or latino	Dead	63	-23236.0	1950.0	131.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Trigone of bladder	67.0	23236.0	Transitional cell carcinoma	yes	2013.0	Yes	7th	T3	8120/3	N2	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T2	23236.0	63.66027397260274	['2019-07-31T16:43:41.819474-05:00', '2019-07-31T16:43:41.819474-05:00']	['63774fb1-b774-5501-932d-f4425fc744e2', '8fc853c6-5c30-5940-b113-d2903969b357']	['TCGA-FD-A6TH_treatment', 'TCGA-FD-A6TH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:11.113091-05:00']	01	Primary	73be4eab-ce32-4a3e-8252-6f0a0bdc13db	Primary Tumor	Not Reported	80.0	700.0	OCT	874A45C3-3707-4EDD-80C4-140655FAE95A	true	Solid Tissue	False	Tumor
TCGA-BT-A20T-01A	096b4f32-10c1-4737-a0dd-cae04c54ee33	Transitional Cell Papillomas and Carcinomas	096b4f32-10c1-4737-a0dd-cae04c54ee33	TCGA-BT-A20T	Bladder		Not Reported		white	male	not hispanic or latino	Dead	63	-23220.0	1944.0	453.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Anterior wall of bladder		23220.0	Transitional cell carcinoma	no	2007.0	No	6th	T3b	8120/3	N1	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T3	23220.0	63.61643835616438	['2019-07-31T16:43:44.886474-05:00', '2019-07-31T16:43:44.886474-05:00']	['8c8ac181-b82e-5221-82e9-3812d0987529', '9f163616-5816-51a2-ae67-f5cc971bef4a']	['TCGA-BT-A20T_treatment_1', 'TCGA-BT-A20T_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:48:13.792065-05:00', '']	01	Primary	52f538ef-b05d-4c76-9976-ce6d49158016	Primary Tumor		1464.0	190.0	OCT	6DCDDE73-580E-46FF-9A06-39A85EB4830A	true	Solid Tissue	False	Tumor
TCGA-GV-A6ZA-01A	f5c187ef-dc08-4466-932a-43aa33285673	Transitional Cell Papillomas and Carcinomas	f5c187ef-dc08-4466-932a-43aa33285673	TCGA-GV-A6ZA	Bladder		Not Reported		white	male	not hispanic or latino	Alive	54	-19871.0	1958.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	691.0	19871.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19871.0	54.441095890410956	['2019-07-31T17:02:08.508310-05:00', '2019-07-31T17:02:08.508310-05:00']	['0dd59467-24ed-509e-bc28-7a1978e7a4e1', 'ff1aa7d0-ac44-50bb-8abe-9445689e557f']	['TCGA-GV-A6ZA_treatment_1', 'TCGA-GV-A6ZA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T10:03:02.767125-05:00', '']	01	Primary	927ac1a0-08c1-4d62-86c3-0df801fadbb9	Primary Tumor	Not Reported	322.0	660.0	OCT	7FF8C90D-50A3-435B-B3C9-306DC4973DC9	true	Solid Tissue	False	Tumor
TCGA-E7-A97P-01A	18e6bdb0-b62d-4367-86e9-befbbf5e458c	Transitional Cell Papillomas and Carcinomas	18e6bdb0-b62d-4367-86e9-befbbf5e458c	TCGA-E7-A97P	Bladder		Not Reported		asian	male	not hispanic or latino	Dead	73	-26956.0	1940.0	437.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	13.0	26956.0	Transitional cell carcinoma	no	2013.0	No	7th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	26956.0	73.85205479452055	['2019-07-31T16:44:38.242348-05:00', '2019-07-31T16:44:38.242348-05:00']	['4ab66a9a-b4fb-5244-b0a1-daa3f6070e68', 'b4025d2c-e1b4-55a8-b95b-4ce2470f54f8']	['TCGA-E7-A97P_treatment', 'TCGA-E7-A97P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:48:56.822453-05:00']	01	Primary	8f094241-95a3-4940-bb07-9c096d27818f	Primary Tumor	Not Reported	90.0	750.0	OCT	F93869FD-9F81-4BB1-B0A4-489E5293C31F	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RG-01A	1eb0adbf-dbe8-4736-97f6-2dc4ee30e943	Transitional Cell Papillomas and Carcinomas	1eb0adbf-dbe8-4736-97f6-2dc4ee30e943	TCGA-ZF-A9RG	Bladder		Not Reported		white	female	not hispanic or latino	Alive	70	-25656.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	1786.0	25656.0	Transitional cell carcinoma	no	2010.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	25656.0	70.2904109589041	['2019-07-31T16:44:53.993734-05:00', '2019-07-31T16:44:53.993734-05:00']	['38e267c2-d142-563c-b75e-6774e9b15fca', '9f8615c4-9472-5c58-b59c-a621bb3916f0']	['TCGA-ZF-A9RG_treatment', 'TCGA-ZF-A9RG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:49:08.972749-05:00']	01	Primary	72f71f3b-b0a7-48d7-8b79-b59aed35c556	Primary Tumor	Not Reported	1421.0	250.0	OCT	FAA3F68D-0FB9-44E4-AFEF-7DC1662BE783	true	Solid Tissue	False	Tumor
TCGA-GC-A3OO-01A	1ff60fd9-3ca3-43be-92a8-8dba2cd4d4df	Transitional Cell Papillomas and Carcinomas	1ff60fd9-3ca3-43be-92a8-8dba2cd4d4df	TCGA-GC-A3OO	Bladder		Not Reported		white	male	not hispanic or latino	Alive	79	-29065.0	1932.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	481.0	29065.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2b	29065.0	79.63013698630137	['2019-07-31T17:15:38.072191-05:00', '2019-07-31T17:15:38.072191-05:00']	['29c3b136-54e4-5cb9-860c-3c47cb68e6e0', '5d467917-146c-5646-8f5a-4ec8f978ae4e']	['TCGA-GC-A3OO_treatment', 'TCGA-GC-A3OO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:14:14.769525-05:00']	01	Primary	91e7f41c-17b3-4724-96ef-d3c207b964e1	Primary Tumor	Not Reported	111.0	10.0	Unknown	F4DFFC0E-5A8F-4BC0-8CF2-011F13468ABD	false	Solid Tissue	False	Tumor
TCGA-BT-A0YX-01A	22473ad4-df39-4716-b558-3c1409d5fa0e	Transitional Cell Papillomas and Carcinomas	22473ad4-df39-4716-b558-3c1409d5fa0e	TCGA-BT-A0YX	Bladder		Not Reported		white	female	not hispanic or latino	Dead	70	-25570.0	1939.0	400.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	363.0	25570.0	Transitional cell carcinoma	no	2009.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3b	25570.0	70.05479452054794	['2019-07-31T16:45:08.309904-05:00', '2019-07-31T16:45:08.309904-05:00']	['b1ad9344-c292-5a91-acb0-7307cfce2bde', 'b53368fe-e5e8-5970-9f26-5188a58d756e']	['TCGA-BT-A0YX_treatment_1', 'TCGA-BT-A0YX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:49:21.167059-05:00', '']	01	Primary	da614214-f84c-43ab-983c-d9d76cf2d6ae	Primary Tumor	Not Reported	296.0	320.0	OCT	C628DA27-9908-48F3-B191-99C9248774C9	true	Solid Tissue	False	Tumor
TCGA-FJ-A3ZF-01A	fae38579-5fe2-4d81-9729-39fde866d18c	Transitional Cell Papillomas and Carcinomas	fae38579-5fe2-4d81-9729-39fde866d18c	TCGA-FJ-A3ZF	Bladder	2.7945205479452055	Not Reported	51.0	white	male	not hispanic or latino	Alive	73	-26825.0	1939.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4581f940-fb84-5a4a-ab36-d998d0575df0	FJ	BLN - Baylor	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	524.0	26825.0	Papillary transitional cell carcinoma	yes	2012.0	Yes	7th		8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3b	26825.0	73.4931506849315	['2019-07-31T17:03:00.242854-05:00', '2019-07-31T17:03:00.242854-05:00']	['417da1f3-8d68-5207-b2fa-c3f51015df3f', 'd1b1978a-6689-5d10-a49e-124a8c78a8bd']	['TCGA-FJ-A3ZF_treatment_1', 'TCGA-FJ-A3ZF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:03:45.793842-05:00', '']	01	Primary	bf3850ef-e650-4727-bcd5-6608bfca2ae2	Primary Tumor	Not Reported	27.0	370.0	OCT	5057B461-361A-4BF8-BF8E-59E49AF47A1F	true	Solid Tissue	False	Tumor
TCGA-ZF-AA5P-01A	24d56331-4bca-4ab8-9fb7-a95a30b4c8fe	Transitional Cell Papillomas and Carcinomas	24d56331-4bca-4ab8-9fb7-a95a30b4c8fe	TCGA-ZF-AA5P	Bladder	3.3972602739726026	Not Reported	62.0	white	male	not hispanic or latino	Alive	65	-23971.0	1948.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder	372.0	23971.0	Transitional cell carcinoma	no	2013.0	No	7th	T2b	8120/3	N2	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	23971.0	65.67397260273972	['2019-07-31T16:45:16.974879-05:00', '2019-07-31T16:45:16.974879-05:00']	['748010b6-8b95-5da7-be6c-a343a566cd49', 'f10cfffe-c23e-5412-9396-bcf790ed7de8']	['TCGA-ZF-AA5P_treatment', 'TCGA-ZF-AA5P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:49:28.673410-05:00']	01	Primary	f90c92b0-9251-4ef5-972c-3e6d6824b6ac	Primary Tumor	Not Reported	85.0	160.0	OCT	BB68912E-1368-47BF-BC76-0C1C8532E6BF	true	Solid Tissue	False	Tumor
TCGA-2F-A9KQ-01A	25eaf3f9-c364-423c-aaae-925e7b393afc	Transitional Cell Papillomas and Carcinomas	25eaf3f9-c364-423c-aaae-925e7b393afc	TCGA-2F-A9KQ	Bladder		Not Reported		white	male	not hispanic or latino	Alive	69	-25259.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	2886.0	25259.0	Transitional cell carcinoma	no	2007.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	TX	25259.0	69.2027397260274	['2019-07-31T16:45:26.220204-05:00', '2019-07-31T16:45:26.220204-05:00']	['41cbe0f6-21ea-5687-bd47-5deb7e5b461d', '7eda994a-7ac9-5689-9b4c-a1f4060770f6']	['TCGA-2F-A9KQ_treatment_1', 'TCGA-2F-A9KQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:49:35.705357-05:00', '']	01	Primary	32d94d14-818a-4ae5-b290-73170fa2a3ef	Primary Tumor	Not Reported	2470.0	160.0	Unknown	F35113C2-F4CC-43EC-8C52-B71B357DDA46	false	Solid Tissue	False	Tumor
TCGA-UY-A9PE-01A	fed69898-a229-4b81-bbd9-cdcb164dae7b	Transitional Cell Papillomas and Carcinomas	fed69898-a229-4b81-bbd9-cdcb164dae7b	TCGA-UY-A9PE	Bladder	2.4657534246575343	Not Reported	45.0	white	male	not hispanic or latino	Alive	86	-31755.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	189.0	31755.0	Transitional cell carcinoma	no		No	7th	T2b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31755.0	87.0	['2019-07-31T17:03:11.049496-05:00', '2019-07-31T17:03:11.049496-05:00']	['6d37c9bd-4427-5fc6-a14f-cfbb590ce941', 'dde9a48b-7dd9-513d-ad6e-ad37824d554b']	['TCGA-UY-A9PE_treatment', 'TCGA-UY-A9PE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'not reported']	['', '2019-04-28T10:03:56.314203-05:00']	01	Primary	287baaa7-3a6b-44e0-865d-f268cf414c5a	Primary Tumor	Not Reported		80.0	OCT	4B7A7988-B259-4630-86A6-522EAFAFF078	true	Solid Tissue	False	Tumor
TCGA-XF-A9T8-01A	317e1db6-df93-4793-a4df-2fa234d8a81a	Transitional Cell Papillomas and Carcinomas	317e1db6-df93-4793-a4df-2fa234d8a81a	TCGA-XF-A9T8	Bladder	0.821917808219178	Not Reported	15.0	white	male	not hispanic or latino	Dead	64	-23403.0	1944.0	418.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		23403.0	Transitional cell carcinoma	yes	2008.0	No	4th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23403.0	64.11780821917809	['2019-07-31T16:46:08.673860-05:00', '2019-07-31T16:46:08.673860-05:00']	['4ef8281f-79b7-5a05-80d3-6c0134468402', 'f043d6e8-1c6c-5b13-be55-8528ea186b37']	['TCGA-XF-A9T8_treatment_1', 'TCGA-XF-A9T8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:50:10.268560-05:00', '']	01	Primary	74caea53-239b-453b-a4e6-c8be49fc9bc2	Primary Tumor	Not Reported	1972.0	1140.0	OCT	7F4BAF33-CF00-4B19-914A-5AA8CFB3D797	true	Solid Tissue	False	Tumor
TCGA-XF-AAML-01A	329d372c-c44e-4595-b8ac-474c5a1321a5	Transitional Cell Papillomas and Carcinomas	329d372c-c44e-4595-b8ac-474c5a1321a5	TCGA-XF-AAML	Bladder		Not Reported		white	male	not hispanic or latino	Dead	75	-27422.0	1932.0	232.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Lateral wall of bladder		27422.0	Papillary transitional cell carcinoma	yes	2007.0	No	6th	T2b	8130/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		27422.0	75.12876712328767	['2019-07-31T16:46:15.358936-05:00', '2019-07-31T16:46:15.358936-05:00']	['03adcfe9-caa7-5a37-abde-9d1805059a6f', '3d712dbd-fbf3-5d76-b9af-5ed0d6acfa12']	['TCGA-XF-AAML_treatment', 'TCGA-XF-AAML_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:15.013301-05:00']	01	Primary	90f7397e-7264-4a41-b5f0-e9725a84de3e	Primary Tumor	Not Reported	2288.0	300.0	OCT	919C33FD-44F5-440A-8A7B-B8EBACBCCC55	true	Solid Tissue	False	Tumor
TCGA-LC-A66R-01A	39fdc742-8bdb-4e77-b20b-0f967a75e659	Transitional Cell Papillomas and Carcinomas	39fdc742-8bdb-4e77-b20b-0f967a75e659	TCGA-LC-A66R	Bladder		Not Reported		white	male	not hispanic or latino	Alive	78	-28793.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	2fafc2c6-df5b-5d4c-8987-466878ed16ad	LC	Hartford Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	466.0	28793.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	28793.0	78.88493150684931	['2019-07-31T16:47:02.815300-05:00', '2019-07-31T16:47:02.815300-05:00']	['cc0d1b2c-9c6b-506d-8b42-565ced5ffb1f', 'ef7a6d08-8457-5a98-80aa-aa5420bb35fd']	['TCGA-LC-A66R_treatment_1', 'TCGA-LC-A66R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:50:55.154611-05:00', '']	01	Primary	94379846-7eaf-4fe6-81c5-1520f2fb4ee4	Primary Tumor	Not Reported	136.0	600.0	OCT	4E013D66-E9BD-49D1-8CA5-CABFE070D7BE	true	Solid Tissue	False	Tumor
TCGA-2F-A9KW-01A	3b464065-b2e9-4fb2-a7da-09e963fd43b3	Transitional Cell Papillomas and Carcinomas	3b464065-b2e9-4fb2-a7da-09e963fd43b3	TCGA-2F-A9KW	Bladder		Not Reported		white	female	not hispanic or latino	Dead	67	-24703.0	1946.0	254.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	147.0	24703.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	24703.0	67.67945205479452	['2019-07-31T16:47:08.623507-05:00', '2019-07-31T16:47:08.623507-05:00']	['374440d2-021a-5889-bb21-1d63d0cddc7f', '965808fe-3077-51b5-9efb-6e2c75a4d9c1']	['TCGA-2F-A9KW_treatment_1', 'TCGA-2F-A9KW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:50:59.853568-05:00', '']	01	Primary	0ed8d2ee-d9bb-488c-ab40-1e9b43d5b9c9	Primary Tumor	Not Reported	56.0	40.0	Unknown	C4DACE91-4ED5-4259-9C31-F1C118E40AAE	false	Solid Tissue	False	Tumor
TCGA-FD-A43N-01A	3cccffea-bd7d-4548-bb38-fe5eda630de6	Transitional Cell Papillomas and Carcinomas	3cccffea-bd7d-4548-bb38-fe5eda630de6	TCGA-FD-A43N	Bladder	6.136986301369863	Not Reported	112.0	white	male	not hispanic or latino	Alive	76	-27833.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	699.0	27833.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	27833.0	76.25479452054795	['2019-07-31T16:47:14.785208-05:00', '2019-07-31T16:47:14.785208-05:00']	['1f676321-6b77-5c5f-90e4-5945dcd566e0', '267d79d7-a87a-544a-9f94-50b9e15c6da3']	['TCGA-FD-A43N_treatment', 'TCGA-FD-A43N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:51:04.837735-05:00']	01	Primary	a191db88-2aad-4571-9b93-ff16cc2ccbe9	Primary Tumor	Not Reported	322.0	1040.0	OCT	1F3E42FB-862D-4B8C-BAC0-9B69011D28F9	true	Solid Tissue	False	Tumor
TCGA-DK-A3X2-01A	40551d53-388b-4067-9341-76e94d023703	Transitional Cell Papillomas and Carcinomas	40551d53-388b-4067-9341-76e94d023703	TCGA-DK-A3X2	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	85	-31160.0	1925.0	547.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Lateral wall of bladder		31160.0	Transitional cell carcinoma	yes	2010.0	No	6th	T3	8120/3	N2	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		31160.0	85.36986301369863	['2019-07-31T16:47:54.066976-05:00', '2019-07-31T16:47:54.066976-05:00']	['45564e9d-8c43-5fa7-9366-de189ce215c2', '96af75a4-ff70-5ed3-95b5-2cbda0f190c3']	['TCGA-DK-A3X2_treatment', 'TCGA-DK-A3X2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:51:35.334271-05:00']	01	Primary	3b816277-91cb-413e-bc7c-ba33cd72b67d	Primary Tumor	Not Reported	548.0	830.0	OCT	8360D3E9-526D-4E99-86E0-C33F785DCF15	true	Solid Tissue	False	Tumor
TCGA-SY-A9G0-01A	423b7fc5-3970-4c96-990d-96ad0842f1eb	Transitional Cell Papillomas and Carcinomas	423b7fc5-3970-4c96-990d-96ad0842f1eb	TCGA-SY-A9G0	Bladder	0.5342465753424658	Not Reported	9.75	white	male	not hispanic or latino	Dead	82	-30205.0	1929.0	1008.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6761081a-af3f-57f8-bd98-4243cfb8c9e9	SY	Mayo Clinic Arizona	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Posterior wall of bladder	378.0	30205.0	Transitional cell carcinoma	yes	2011.0	No	7th	T4	8120/3	N1	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T4	30205.0	82.75342465753425	['2019-07-31T16:48:09.831735-05:00', '2019-07-31T16:48:09.831735-05:00']	['4e47cacd-5bac-56d2-b241-f45a2c388b28', 'c5f9ad52-07b3-58e7-a38f-e3287cc024e7']	['TCGA-SY-A9G0_treatment', 'TCGA-SY-A9G0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:51:47.470925-05:00']	01	Primary	14e1cb71-07e9-46af-84da-e35a360a2bbc	Primary Tumor	Not Reported	752.0	50.0	OCT	D586B06E-08E2-4C46-89B3-121BF0FFF693	true	Solid Tissue	False	Tumor
TCGA-CF-A8HX-01A	43f9b602-683a-4fa1-b044-8fc5794b1453	Transitional Cell Papillomas and Carcinomas	43f9b602-683a-4fa1-b044-8fc5794b1453	TCGA-CF-A8HX	Bladder		Not Reported		asian	female	not hispanic or latino	Alive	55	-20259.0	1958.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	345.0	20259.0	Transitional cell carcinoma	no	2013.0	No	6th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20259.0	55.50410958904109	['2019-07-31T16:48:16.360669-05:00', '2019-07-31T16:48:16.360669-05:00']	['8753c594-7925-5247-ad0a-dce48d8cc880', 'b8eb5124-ed1e-565a-bc8b-a67e838654fa']	['TCGA-CF-A8HX_treatment_1', 'TCGA-CF-A8HX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:51:52.547190-05:00', '']	01	Primary	8ddad133-cd3d-49d9-b144-f11e6e93431e	Primary Tumor	Not Reported	119.0	170.0	OCT	347944A8-FA38-477F-B68C-5851B2097790	true	Solid Tissue	False	Tumor
TCGA-4Z-AA87-01A	45b4b153-e4aa-4080-b0dc-ee81a966978a	Transitional Cell Papillomas and Carcinomas	45b4b153-e4aa-4080-b0dc-ee81a966978a	TCGA-4Z-AA87	Bladder		Not Reported		black or african american	male	not reported	Alive	72	-26430.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1454.0	26430.0	Transitional cell carcinoma	no	2010.0	No	7th	T4a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	26430.0	72.41095890410959	['2019-07-31T16:48:22.863475-05:00', '2019-07-31T16:48:22.863475-05:00']	['84c62e75-5eb5-54f9-a51e-01c3987b95c4', 'fa9ad886-90b8-5442-b161-580d859b9d92']	['TCGA-4Z-AA87_treatment_1', 'TCGA-4Z-AA87_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:51:57.206536-05:00', '']	01	Primary	7335875d-9a3c-47b3-80c0-9bd4576a4ea4	Primary Tumor	Not Reported	1159.0	230.0	OCT	0B1A1E8B-78FD-43B8-A6B1-2E7EB251FD52	true	Solid Tissue	False	Tumor
TCGA-UY-A9PA-01A	45f5af14-060a-49a3-b51d-25ab8a88feb7	Transitional Cell Papillomas and Carcinomas	45f5af14-060a-49a3-b51d-25ab8a88feb7	TCGA-UY-A9PA	Bladder		Not Reported		white	male	not hispanic or latino	Alive	48	-17520.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	1072.0	17520.0	Transitional cell carcinoma	no		No	6th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		17520.0	48.0	['2019-07-31T16:48:28.513902-05:00', '2019-07-31T16:48:28.513902-05:00']	['b5aa6710-bddf-506f-af03-e54ae56aca53', 'c83c5584-d69e-5900-8e29-c9aff82ee092']	['TCGA-UY-A9PA_treatment', 'TCGA-UY-A9PA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:02.412483-05:00']	01	Primary	64a966f2-6bab-4b17-a377-2eb3b1a1124d	Primary Tumor	Not Reported		50.0	OCT	73CA1D6C-0158-4324-9D82-4442254EF8A4	true	Solid Tissue	False	Tumor
TCGA-FD-A62O-01A	472502eb-ad99-4a1a-8445-1a11dc02a6d9	Transitional Cell Papillomas and Carcinomas	472502eb-ad99-4a1a-8445-1a11dc02a6d9	TCGA-FD-A62O	Bladder		Not Reported		white	male	not hispanic or latino	Dead	74	-27310.0	1938.0	216.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder	147.0	27310.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported		27310.0	74.82191780821918	['2019-07-31T16:48:34.542486-05:00', '2019-07-31T16:48:34.542486-05:00']	['612703fe-7b37-5adf-b560-df6929229891', 'c7d119ff-4fe1-586b-b3d3-abc9b14f6ea1']	['TCGA-FD-A62O_treatment_1', 'TCGA-FD-A62O_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:52:07.200737-05:00', '']	01	Primary	ab5607a4-8851-4797-abdd-df58facbe33b	Primary Tumor	Not Reported	141.0	490.0	OCT	41E61CCB-5006-491B-94B7-BE81FB559D0E	true	Solid Tissue	False	Tumor
TCGA-GU-AATP-01A	3b16881a-88c2-4048-b78f-e3e183503f70	Transitional Cell Papillomas and Carcinomas	3b16881a-88c2-4048-b78f-e3e183503f70	TCGA-GU-AATP	Bladder	0.7671232876712328	Not Reported	14.0	white	male	not hispanic or latino	Alive	74	-27049.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Lateral wall of bladder	1003.0	27049.0	Transitional cell carcinoma	yes	2012.0	No	7th	T2	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T1	27049.0	74.10684931506849	['2019-07-31T16:47:05.522513-05:00', '2019-07-31T16:47:05.522513-05:00']	['a8b3706f-04af-504e-a82e-e9246cbdacd6', 'aba5ed09-d1e4-5f35-b819-0e7d37c7785d']	['TCGA-GU-AATP_treatment_1', 'TCGA-GU-AATP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:50:57.431480-05:00', '']	01	Primary	c9320b64-3928-4a33-a20d-c491a9fb8872	Primary Tumor	Not Reported	594.0	140.0	OCT	6E966861-6052-4F99-8BD5-0835BAE0179D	true	Solid Tissue	False	Tumor
TCGA-E7-A7DV-01A	3effd691-570c-478a-8903-3771a1b43f2e	Transitional Cell Papillomas and Carcinomas	3effd691-570c-478a-8903-3771a1b43f2e	TCGA-E7-A7DV	Bladder		Not Reported		white	male	not hispanic or latino	Alive	44	-16145.0	1969.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	37.0	16145.0	Papillary transitional cell carcinoma	yes	2013.0	No	7th	T4	8130/3	N3	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		16145.0	44.23287671232877	['2019-07-31T16:47:44.555746-05:00', '2019-07-31T16:47:44.555746-05:00']	['67866f15-3576-5214-95be-518239a15d47', 'b4a17b63-a6f2-50dc-a9da-479fe813bd1d']	['TCGA-E7-A7DV_treatment_1', 'TCGA-E7-A7DV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'no']	['2019-04-28T09:51:27.364296-05:00', '']	01	Primary	d8f4c926-cc18-4d72-9e3d-ae7f58d846cf	Primary Tumor	Not Reported	164.0	1610.0	OCT	7226D91A-DF25-4FAE-B300-5E33F29C0E61	true	Solid Tissue	False	Tumor
TCGA-DK-A3IK-01A	3f0a0748-9acc-4d0b-ba18-7c08bd183f86	Transitional Cell Papillomas and Carcinomas	3f0a0748-9acc-4d0b-ba18-7c08bd183f86	TCGA-DK-A3IK	Bladder		Not Reported		white	male	not hispanic or latino	Dead	87	-32076.0	1924.0	146.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	67.0	32076.0	Transitional cell carcinoma	no	2011.0	No	6th	T3	8120/3	N2	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		32076.0	87.87945205479453	['2019-07-31T16:47:47.754495-05:00', '2019-07-31T16:47:47.754495-05:00']	['31ef9cf4-9486-510d-b7cb-c0c8760c7b5a', '9c8b2662-5787-5b6f-9122-706e67862589']	['TCGA-DK-A3IK_treatment_1', 'TCGA-DK-A3IK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:51:29.961614-05:00', '']	01	Primary	4ff20c48-29ee-4101-b409-c4573e38cf92	Primary Tumor	Not Reported	124.0	720.0	OCT	4BB6EAAF-643A-43F8-A54C-0103A45AD684	true	Solid Tissue	False	Tumor
TCGA-C4-A0F0-01A	40398c03-a9cc-476b-9ee9-aecf161be43f	Transitional Cell Papillomas and Carcinomas	40398c03-a9cc-476b-9ee9-aecf161be43f	TCGA-C4-A0F0	Bladder	3.3424657534246576	Not Reported	61.0	not reported	male	not reported	Alive	60	-22068.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	af546e3d-a713-5d08-88f4-d8a64d54f2a4	C4	Indivumed	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	59.0	22068.0	Transitional cell carcinoma	no	2007.0	No	5th	T2b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22068.0	60.46027397260274	['2019-07-31T16:47:51.131284-05:00', '2019-07-31T16:47:51.131284-05:00']	['6b76b173-f3e8-507d-9f9e-e153c0c7ecab', 'e1f5a26c-1d8c-599e-a0f4-c0f6034c5c1e']	['TCGA-C4-A0F0_treatment_1', 'TCGA-C4-A0F0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:51:32.804466-05:00', '']	01	Primary	54234a11-8674-4b01-b2ef-a4c6d772aa43	Primary Tumor	Not Reported	1207.0	380.0	Unknown	0A00B798-B309-4D11-8E16-3D7EE4AC1122	false	Solid Tissue	False	Tumor
TCGA-E5-A2PC-01A	4107ae6f-502c-4bdc-bf14-e4b3711cba38	Transitional Cell Papillomas and Carcinomas	4107ae6f-502c-4bdc-bf14-e4b3711cba38	TCGA-E5-A2PC	Bladder		Not Reported		white	female	not hispanic or latino	Alive	61	-22308.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	3b76a3ec-899f-5b8f-b869-4c03bf9a222d	E5	Roswell Park	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	1326.0	22308.0	Transitional cell carcinoma	no	2008.0	No	6th	T2b	8120/3	N1	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		22308.0	61.11780821917808	['2019-07-31T16:47:56.973603-05:00', '2019-07-31T16:47:56.973603-05:00']	['9e0af80d-64b3-54f8-a328-95d34f95f159', 'd113b9a7-6359-5b82-89e1-3c327f7a0656']	['TCGA-E5-A2PC_treatment', 'TCGA-E5-A2PC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:51:37.603272-05:00']	01	Primary	2195b75e-157f-4547-9705-1e7e75666ca8	Primary Tumor	Not Reported	1052.0	120.0	OCT	7E6EAFBD-51DD-4E4A-86F7-20CAA317F849	true	Solid Tissue	False	Tumor
TCGA-DK-A3IM-01A	41b59716-116f-4942-8b63-409870a87e26	Transitional Cell Papillomas and Carcinomas	41b59716-116f-4942-8b63-409870a87e26	TCGA-DK-A3IM	Bladder	0.4383561643835616	Not Reported	8.0	white	male	not hispanic or latino	Dead	76	-28106.0	1935.0	248.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	238.0	28106.0	Transitional cell carcinoma	no	2011.0	No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28106.0	77.0027397260274	['2019-07-31T16:48:03.065112-05:00', '2019-07-31T16:48:03.065112-05:00']	['28ad0755-f571-54f1-95b8-dcdb82836bc9', 'bca95f13-51df-5c08-ae0f-86579e6662b7']	['TCGA-DK-A3IM_treatment_1', 'TCGA-DK-A3IM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:51:42.648724-05:00', '']	01	Primary	7a37ae7c-6b46-410d-ae2b-12fd868c25b3	Primary Tumor	Not Reported	254.0	480.0	OCT	860A2391-F5B1-4E5B-AEDB-FD318817F1F1	true	Solid Tissue	False	Tumor
TCGA-XF-A9SU-01A	42bcf1a7-2f3a-4ed8-a41d-cdd67e65b928	Transitional Cell Papillomas and Carcinomas	42bcf1a7-2f3a-4ed8-a41d-cdd67e65b928	TCGA-XF-A9SU	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Dead	74	-27068.0	1932.0	182.0	2006.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		27068.0	Papillary transitional cell carcinoma	no	2006.0	No	6th	T3b	8130/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27068.0	74.15890410958905	['2019-07-31T15:58:58.232309-05:00', '2019-07-31T15:58:58.232309-05:00']	['2f3e775d-f533-5e67-8ad3-36297d1d7ee7', 'f3942d58-a91f-5436-9713-84ccc8d32db4']	['TCGA-XF-A9SU_treatment_1', 'TCGA-XF-A9SU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:13:11.214031-05:00', '']	01	Primary	abe273cd-9f0d-45ca-b72b-a154685708c1	Primary Tumor	Not Reported	2887.0	860.0	OCT	B2C3CDC0-DC42-4971-9203-30B712F89553	true	Solid Tissue	False	Tumor
TCGA-DK-AA6S-01A	45eea556-e97b-4912-8aa9-7e5c709eb52b	Transitional Cell Papillomas and Carcinomas	45eea556-e97b-4912-8aa9-7e5c709eb52b	TCGA-DK-AA6S	Bladder		Not Reported		white	male	not hispanic or latino	Alive	60	-22027.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Lateral wall of bladder	5050.0	22027.0	Transitional cell carcinoma	yes	2000.0	No	5th	T3b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		22027.0	60.347945205479455	['2019-07-31T16:48:25.685769-05:00', '2019-07-31T16:48:25.685769-05:00']	['131d3cca-3213-5886-962f-3d159e3206af', '97b60c5f-8ef5-5987-8c9a-7ee45fdcb047']	['TCGA-DK-AA6S_treatment_1', 'TCGA-DK-AA6S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:51:59.865013-05:00', '']	01	Primary	61cf45dc-21ec-40a3-a72b-3edd21895f6b	Primary Tumor	Not Reported	4782.0	390.0	OCT	64478CAB-EA92-4334-AC37-3A0906057203	true	Solid Tissue	False	Tumor
TCGA-GD-A3OP-11A	31da07bb-6752-49a3-a7ea-5427c04a9458	Transitional Cell Papillomas and Carcinomas	31da07bb-6752-49a3-a7ea-5427c04a9458	TCGA-GD-A3OP	Bladder		Not Reported		white	female	not hispanic or latino	Alive	84	-30956.0	1927.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	64.0	30956.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30956.0	84.81095890410958	['2019-07-31T16:46:11.949582-05:00', '2019-07-31T16:46:11.949582-05:00']	['79638d7c-f35b-5da5-87b8-4a4edd409862', 'a51e720f-9ca8-59cb-bccd-c68fe848f424']	['TCGA-GD-A3OP_treatment_1', 'TCGA-GD-A3OP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:50:12.646973-05:00', '']	11	Not Applicable	22340b82-9219-49c6-b511-fda79f24f36e	Solid Tissue Normal	Not Reported	133.0	120.0	Unknown		false	Solid Tissue	False	Normal
TCGA-GD-A3OP-01A	31da07bb-6752-49a3-a7ea-5427c04a9458	Transitional Cell Papillomas and Carcinomas	31da07bb-6752-49a3-a7ea-5427c04a9458	TCGA-GD-A3OP	Bladder		Not Reported		white	female	not hispanic or latino	Alive	84	-30956.0	1927.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	64.0	30956.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30956.0	84.81095890410958	['2019-07-31T16:46:11.949582-05:00', '2019-07-31T16:46:11.949582-05:00']	['79638d7c-f35b-5da5-87b8-4a4edd409862', 'a51e720f-9ca8-59cb-bccd-c68fe848f424']	['TCGA-GD-A3OP_treatment_1', 'TCGA-GD-A3OP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:50:12.646973-05:00', '']	01	Primary	c0773229-5a20-4451-9db5-f757e34921ae	Primary Tumor	Not Reported	133.0	340.0	Unknown	6C700249-6A70-45C6-834B-DF271740FC33	false	Solid Tissue	False	Tumor
TCGA-4Z-AA82-01A	32e79b35-a33a-4ca0-bfb7-7ea7e4e26568	Transitional Cell Papillomas and Carcinomas	32e79b35-a33a-4ca0-bfb7-7ea7e4e26568	TCGA-4Z-AA82	Bladder		Not Reported		black or african american	male	not reported	Dead	59	-21893.0	1951.0	1556.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder	1538.0	21893.0	Transitional cell carcinoma	no	2010.0	No	7th	T2a	8120/3	N1	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	21893.0	59.98082191780822	['2019-07-31T16:46:22.292250-05:00', '2019-07-31T16:46:22.292250-05:00']	['0e4c6b3f-2448-5e2b-af82-d6e33263a0c0', '23d24aa8-6133-5806-ad89-956b34c6b42e']	['TCGA-4Z-AA82_treatment_1', 'TCGA-4Z-AA82_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:50:21.480803-05:00', '']	01	Primary	2dc2d753-15c7-4f3b-918a-8155bc03b91e	Primary Tumor	Not Reported	1384.0	120.0	OCT	E5DA265D-FBA6-4EA0-9383-96C365A9679A	true	Solid Tissue	False	Tumor
TCGA-XF-A9ST-01A	33708951-0a0d-4ad0-b472-23151c9f76f6	Transitional Cell Papillomas and Carcinomas	33708951-0a0d-4ad0-b472-23151c9f76f6	TCGA-XF-A9ST	Bladder	3.287671232876712	Not Reported	60.0	white	male	not hispanic or latino	Dead	68	-25080.0	1937.0	128.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		25080.0	Papillary transitional cell carcinoma	yes	2005.0	No	6th	T3b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25080.0	68.71232876712328	['2019-07-31T15:58:55.370983-05:00', '2019-07-31T15:58:55.370983-05:00']	['7a831c6e-923d-5fb6-8bf7-afaa30db8fc7', 'f8cbf549-55ea-5110-90a0-f4adc9372bc2']	['TCGA-XF-A9ST_treatment_1', 'TCGA-XF-A9ST_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:13:08.597831-05:00', '']	01	Primary	a995dd33-498e-45f6-b928-edbf0929186b	Primary Tumor	Not Reported	2992.0	900.0	OCT	DD442B47-AE60-4492-AE4A-0BCD1AC15A0C	true	Solid Tissue	False	Tumor
TCGA-4Z-AA81-01A	35c7bb8a-7b5c-488d-9d3a-725b24d14478	Transitional Cell Papillomas and Carcinomas	35c7bb8a-7b5c-488d-9d3a-725b24d14478	TCGA-4Z-AA81	Bladder		Not Reported		white	male	not reported	Dead	80	-29457.0	1930.0	1270.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder	710.0	29457.0	Papillary transitional cell carcinoma	no	2010.0	No	7th	T2b	8130/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	29457.0	80.7041095890411	['2019-07-31T16:46:35.522219-05:00', '2019-07-31T16:46:35.522219-05:00']	['4f6a0652-bb09-5968-a30e-9639e5e24a68', 'c30eb50a-4f6b-583e-bdde-87f3cb8ae00c']	['TCGA-4Z-AA81_treatment_1', 'TCGA-4Z-AA81_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:50:31.734165-05:00', '']	01	Primary	75b242d6-392c-478f-b787-9e1da640ac33	Primary Tumor	Not Reported	1400.0	300.0	OCT	715A2080-BE4D-4A75-B7A7-C68FD032997E	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R4-01A	371b5d70-9797-4dae-b523-247f5eaeb4ab	Transitional Cell Papillomas and Carcinomas	371b5d70-9797-4dae-b523-247f5eaeb4ab	TCGA-ZF-A9R4	Bladder		Not Reported		white	male	not hispanic or latino	Alive	83	-30398.0	1929.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	921.0	30398.0	Transitional cell carcinoma	yes	2012.0	No	7th	T2	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	30398.0	83.28219178082192	['2019-07-31T16:46:45.351133-05:00', '2019-07-31T16:46:45.351133-05:00']	['a3faae85-fa7e-575e-b50b-f3672ace8a58', 'b94f6f71-9610-5653-bbac-36117100159c']	['TCGA-ZF-A9R4_treatment', 'TCGA-ZF-A9R4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:39.627987-05:00']	01	Primary	733b0ca7-7350-459c-b7c6-9d3c7745417c	Primary Tumor	Not Reported	588.0	40.0	OCT	8E623BA9-F937-4DFC-97F5-7B8E5FE8498B	true	Solid Tissue	False	Tumor
TCGA-FD-A6TB-01A	389d1e21-5b97-4231-a3d7-71fecb918beb	Transitional Cell Papillomas and Carcinomas	389d1e21-5b97-4231-a3d7-71fecb918beb	TCGA-FD-A6TB	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Alive	82	-30185.0	1930.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Lateral wall of bladder	572.0	30185.0	Transitional cell carcinoma	yes	2012.0	Yes	7th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T1	30185.0	82.6986301369863	['2019-07-31T16:46:53.925104-05:00', '2019-07-31T16:46:53.925104-05:00']	['2bdd0366-39c1-581e-bded-32a5f0a11119', 'ddec3b87-1814-544b-82a7-2e068564a9da']	['TCGA-FD-A6TB_treatment_1', 'TCGA-FD-A6TB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:50:46.840875-05:00', '']	01	Primary	133a4be0-26a6-4f42-9ebf-52d3e48d35a9	Primary Tumor	Not Reported	273.0	750.0	OCT	D324203B-97F7-4EDF-B1D2-217F63ACAF92	true	Solid Tissue	False	Tumor
TCGA-XF-AAMG-01A	390a29fe-2cfd-43c4-a247-69e692763e17	Transitional Cell Papillomas and Carcinomas	390a29fe-2cfd-43c4-a247-69e692763e17	TCGA-XF-AAMG	Bladder		Not Reported		white	male	hispanic or latino	Alive	49	-18021.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	3364.0	18021.0	Transitional cell carcinoma	no	2004.0	No	6th	T4a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		18021.0	49.37260273972603	['2019-07-31T16:46:56.853262-05:00', '2019-07-31T16:46:56.853262-05:00']	['354f02b4-f551-5ea0-ab4a-0b8996d9a3fa', 'f0f7e6ad-3f76-51a5-961f-a7f83734877e']	['TCGA-XF-AAMG_treatment_1', 'TCGA-XF-AAMG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:50:49.335849-05:00', '']	01	Primary	d8ab144a-616b-45ca-b54b-d7106f707155	Primary Tumor	Not Reported	3366.0	540.0	OCT	3B9E30D8-1671-465F-9425-951912C1ECF5	true	Solid Tissue	False	Tumor
TCGA-CF-A3MG-01A	39efa06a-ffe5-40b3-8f8a-a2d7071bc9e3	Transitional Cell Papillomas and Carcinomas	39efa06a-ffe5-40b3-8f8a-a2d7071bc9e3	TCGA-CF-A3MG	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	48	-17600.0	1963.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	369.0	17600.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		17600.0	48.21917808219178	['2019-07-31T16:46:59.932872-05:00', '2019-07-31T16:46:59.932872-05:00']	['766ac92f-d696-50c2-8f66-6275556d8a1c', '7692bf06-4abb-50ed-a951-bda7805a8540']	['TCGA-CF-A3MG_treatment', 'TCGA-CF-A3MG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:50:51.709234-05:00']	01	Primary	1acf91c8-4971-4893-ac27-64ea4a4c3023	Primary Tumor	Not Reported	158.0	500.0	OCT	DB1F9F51-DFAE-4A1E-9976-E63EE782149C	true	Solid Tissue	False	Tumor
TCGA-UY-A9PF-01A	3bd918a8-3b92-4042-b4a1-f9dfcd6fe405	Transitional Cell Papillomas and Carcinomas	3bd918a8-3b92-4042-b4a1-f9dfcd6fe405	TCGA-UY-A9PF	Bladder	0.273972602739726	Not Reported	5.0	white	male	not hispanic or latino	Alive	77	-28470.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	117.0	28470.0	Papillary transitional cell carcinoma	no		No	7th	T3a	8130/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		28470.0	78.0	['2019-07-31T16:47:11.926504-05:00', '2019-07-31T16:47:11.926504-05:00']	['4776d316-d752-53ba-ac0d-09086e9c8757', 'f8865a1f-abcd-586b-9f7f-5eefd7018012']	['TCGA-UY-A9PF_treatment', 'TCGA-UY-A9PF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'not reported']	['', '2019-04-28T09:51:02.440316-05:00']	01	Primary	0b4b4931-c6d5-484d-9951-979636275b55	Primary Tumor	Not Reported		90.0	OCT	9521187B-B7A8-48F8-860A-57A28664BD26	true	Solid Tissue	False	Tumor
TCGA-GV-A3JW-01A	3d644eaf-82fc-4bc7-93b7-3e600e8c6511	Transitional Cell Papillomas and Carcinomas	3d644eaf-82fc-4bc7-93b7-3e600e8c6511	TCGA-GV-A3JW	Bladder		Not Reported		white	male	not hispanic or latino	Alive	74	-27091.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	649.0	27091.0	Transitional cell carcinoma	no	2011.0	No	7th	T2	8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	27091.0	74.22191780821917	['2019-07-31T16:47:20.826145-05:00', '2019-07-31T16:47:20.826145-05:00']	['4991972c-d15c-559f-bce5-12d18b75ea03', 'a9dedcfe-4ae9-5bca-8ede-2dab98dd81f9']	['TCGA-GV-A3JW_treatment', 'TCGA-GV-A3JW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:51:10.004642-05:00']	01	Primary	b02c03b6-24aa-42d3-9310-741de1ef0d30	Primary Tumor	Not Reported	168.0	260.0	OCT	AC922A7D-2261-4322-99B5-BA845CC77C85	true	Solid Tissue	False	Tumor
TCGA-DK-A1A7-01A	3ed614e7-f356-4d87-985b-d3bbbae3bb40	Transitional Cell Papillomas and Carcinomas	3ed614e7-f356-4d87-985b-d3bbbae3bb40	TCGA-DK-A1A7	Bladder		Not Reported		white	female	not hispanic or latino	Alive	67	-24499.0	1943.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	560.0	24499.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24499.0	67.12054794520547	['2019-07-31T16:47:17.856622-05:00', '2019-07-31T16:47:17.856622-05:00']	['5be9c5bc-2d01-54e8-a45f-1bb199476aa7', 'e415a498-3762-54f2-867d-358a039c07fd']	['TCGA-DK-A1A7_treatment_1', 'TCGA-DK-A1A7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:51:07.490458-05:00', '']	01	Primary	d68d16f7-6117-4d3d-8347-cf5cd3f23ae4	Primary Tumor	Not Reported	164.0	20.0	OCT	B64F829C-9624-4F01-BD7A-9E223D81BEE1	true	Solid Tissue	False	Tumor
TCGA-BT-A20Q-11A	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	Transitional Cell Papillomas and Carcinomas	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	TCGA-BT-A20Q	Bladder		Not Reported		white	male	not hispanic or latino	Dead	73	-26778.0	1933.0	593.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder		26778.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N2	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3b	26778.0	73.36438356164383	['2019-07-31T16:47:59.769236-05:00', '2019-07-31T16:47:59.769236-05:00']	['7e44b7fd-c728-5b40-923a-59946e48eba9', '93c86cdf-cfd1-5f6d-b7f9-902f54db7c05']	['TCGA-BT-A20Q_treatment', 'TCGA-BT-A20Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:51:40.005893-05:00']	11	Not Applicable	df346965-b972-445d-9aac-35605b908f4d	Solid Tissue Normal		1898.0	370.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20Q-01A	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	Transitional Cell Papillomas and Carcinomas	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	TCGA-BT-A20Q	Bladder		Not Reported		white	male	not hispanic or latino	Dead	73	-26778.0	1933.0	593.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder		26778.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N2	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3b	26778.0	73.36438356164383	['2019-07-31T16:47:59.769236-05:00', '2019-07-31T16:47:59.769236-05:00']	['7e44b7fd-c728-5b40-923a-59946e48eba9', '93c86cdf-cfd1-5f6d-b7f9-902f54db7c05']	['TCGA-BT-A20Q_treatment', 'TCGA-BT-A20Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:51:40.005893-05:00']	01	Primary	f3906cd4-31c7-48a8-935b-5b7fafec1ae7	Primary Tumor		1898.0	320.0	OCT	E686B42F-3A8C-4181-836E-79D4443DC0CD	true	Solid Tissue	False	Tumor
TCGA-UY-A78O-01A	4319aa02-6d8b-4cb8-b4e4-c4eed1cb2ac7	Transitional Cell Papillomas and Carcinomas	4319aa02-6d8b-4cb8-b4e4-c4eed1cb2ac7	TCGA-UY-A78O	Bladder		Not Reported		white	female	not hispanic or latino	Alive	75	-27234.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2312.0	27234.0	Transitional cell carcinoma	no		No	6th	T2	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27234.0	74.61369863013698	['2019-07-31T16:48:13.178835-05:00', '2019-07-31T16:48:13.178835-05:00']	['3de1df9d-92bc-5273-9821-af0feba3ea48', 'd481ce22-4896-571d-b63a-c8b783c27ddf']	['TCGA-UY-A78O_treatment_1', 'TCGA-UY-A78O_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:51:50.236111-05:00', '']	01	Primary	9b7bb0f3-020c-422e-959d-ce87e94e5f82	Primary Tumor	Not Reported		240.0	OCT	139E5F15-194A-451A-83D7-919C657C08A3	true	Solid Tissue	False	Tumor
TCGA-FD-A3SL-01A	4570b6e2-d430-41ca-aab1-ce4d14c36463	Transitional Cell Papillomas and Carcinomas	4570b6e2-d430-41ca-aab1-ce4d14c36463	TCGA-FD-A3SL	Bladder		Not Reported		white	male	not hispanic or latino	Dead	60	-22020.0	1951.0	712.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Posterior wall of bladder	683.0	22020.0	Transitional cell carcinoma	yes	2011.0	No	7th	T4a	8120/3	N2	M1	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22020.0	60.32876712328767	['2019-07-31T16:48:20.141883-05:00', '2019-07-31T16:48:20.141883-05:00']	['8733e633-8da6-58e2-b652-59d941aa2102', '9d0d86f0-5405-598f-b0c3-58c9bf450682']	['TCGA-FD-A3SL_treatment', 'TCGA-FD-A3SL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:51:54.802293-05:00']	01	Primary	0a1e88e0-3593-40ba-86e5-751074885578	Primary Tumor	Not Reported	322.0	920.0	OCT	60008E3E-7CD4-4DB5-83C0-3273B7F962F6	true	Solid Tissue	False	Tumor
TCGA-FD-A3B5-01A	462d5a6b-9f39-4aae-a35b-d06a7811d053	Transitional Cell Papillomas and Carcinomas	462d5a6b-9f39-4aae-a35b-d06a7811d053	TCGA-FD-A3B5	Bladder	1.36986301369863	Not Reported	25.0	black or african american	male	not hispanic or latino	Dead	86	-31442.0	1925.0	272.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		31442.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N1	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	31442.0	86.14246575342466	['2019-07-31T16:48:31.392444-05:00', '2019-07-31T16:48:31.392444-05:00']	['a298c1c4-46d0-5651-908c-e6bfa7600eee', 'aac7ff25-ac86-5933-ae71-d4a918e0770e']	['TCGA-FD-A3B5_treatment_1', 'TCGA-FD-A3B5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:04.707977-05:00', '']	01	Primary	f9dedc8c-327d-456a-9c0b-e1ec58ae3169	Primary Tumor	Not Reported	218.0	320.0	Unknown	683132FE-FCA5-4D03-A018-45D36B12FFD4	false	Solid Tissue	False	Tumor
TCGA-FD-A3SM-01A	474582f2-8dec-4fbc-803f-4fd9ba2e0957	Transitional Cell Papillomas and Carcinomas	474582f2-8dec-4fbc-803f-4fd9ba2e0957	TCGA-FD-A3SM	Bladder	4.383561643835616	Not Reported	80.0	white	male	not hispanic or latino	Dead	70	-25852.0	1941.0	547.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Lateral wall of bladder	186.0	25852.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3a	8120/3	N2	M1	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25852.0	70.82739726027397	['2019-07-31T16:48:37.574699-05:00', '2019-07-31T16:48:37.574699-05:00']	['0423b6c2-3d5c-5f73-b625-885359301730', '49e58227-3bdd-5d08-b79b-6b93cf1c0123']	['TCGA-FD-A3SM_treatment', 'TCGA-FD-A3SM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:52:09.726105-05:00']	01	Primary	5f7de481-c011-43a8-844b-f47569499f0d	Primary Tumor	Not Reported	195.0	1830.0	OCT	CAA50B17-CBA3-4AE7-BBF7-BED1DD7A3040	true	Solid Tissue	False	Tumor
TCGA-DK-A1AE-01A	493a4ff2-37a5-4b79-928d-83dbfe534556	Transitional Cell Papillomas and Carcinomas	493a4ff2-37a5-4b79-928d-83dbfe534556	TCGA-DK-A1AE	Bladder	0.547945205479452	Not Reported	10.0	white	male	not hispanic or latino	Alive	84	-30707.0	1926.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	491.0	30707.0	Transitional cell carcinoma	no	2010.0	No	6th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		30707.0	84.12876712328767	['2019-07-31T16:48:43.304615-05:00', '2019-07-31T16:48:43.304615-05:00']	['096604e2-cce8-5964-8dc1-d36c12dce248', '6fe7bde0-e2c3-5c2c-88f3-a6d5011463a6']	['TCGA-DK-A1AE_treatment', 'TCGA-DK-A1AE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:52:14.536965-05:00']	01	Primary	67865453-d515-4d63-84e8-cfb2686a211d	Primary Tumor	Not Reported	107.0	600.0	OCT	C248FA15-7190-448F-9298-CBEA48C155CB	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7Y-01A	49ea6676-ae27-4ca0-a7b3-48423d606d48	Transitional Cell Papillomas and Carcinomas	49ea6676-ae27-4ca0-a7b3-48423d606d48	TCGA-4Z-AA7Y	Bladder		Not Reported		white	male	not reported	Alive	60	-22056.0	1950.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	1522.0	22056.0	Papillary transitional cell carcinoma	no	2010.0	No	7th	T2a	8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2a	22056.0	60.42739726027397	['2019-07-31T16:48:46.742296-05:00', '2019-07-31T16:48:46.742296-05:00']	['0e0cb23b-9316-5f97-baa4-ee63ecf1dd72', 'd566b3b9-a92f-508a-b403-908d4e332906']	['TCGA-4Z-AA7Y_treatment', 'TCGA-4Z-AA7Y_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:16.972371-05:00']	01	Primary	e6657dc9-da7f-4cc9-97f2-f26eaa31666c	Primary Tumor	Not Reported	1172.0	530.0	OCT	E0AF3F47-9EBB-4E83-B664-6C139C75D402	true	Solid Tissue	False	Tumor
TCGA-FD-A3B3-01A	4b5d873b-bfda-482e-92a0-bf84c0f9032a	Transitional Cell Papillomas and Carcinomas	4b5d873b-bfda-482e-92a0-bf84c0f9032a	TCGA-FD-A3B3	Bladder	1.7534246575342465	Not Reported	32.0	white	female	not hispanic or latino	Dead	74	-27068.0	1937.0	974.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder	392.0	27068.0	Papillary transitional cell carcinoma	no	2011.0	No	7th	T3	8130/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T2	27068.0	74.15890410958905	['2019-07-31T15:23:25.479668-05:00', '2019-07-31T15:23:25.479668-05:00']	['0b8b0e4c-f2c2-53d1-b324-021a7e0b49ce', '12f9f599-534f-57d2-a7f6-bf710c438f6e']	['TCGA-FD-A3B3_treatment', 'TCGA-FD-A3B3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T08:43:08.681439-05:00']	01	Primary	769ee027-5ed7-4ec2-86b5-fe40f9d6fb5a	Primary Tumor	Not Reported	182.0	270.0	Unknown	F0E3A01E-2B43-4BE1-BAE5-85340943A422	false	Solid Tissue	False	Tumor
TCGA-CF-A5U8-01A	4cc25adb-6db4-46aa-9fc9-c2c6339fb6d3	Transitional Cell Papillomas and Carcinomas	4cc25adb-6db4-46aa-9fc9-c2c6339fb6d3	TCGA-CF-A5U8	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	59	-21734.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	399.0	21734.0	Transitional cell carcinoma	no	2012.0	No	6th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21734.0	59.54520547945206	['2019-07-31T16:48:50.429396-05:00', '2019-07-31T16:48:50.429396-05:00']	['7d5d3fb3-f924-55ec-a98d-fcc69be5731e', 'eabb93b6-46d2-53c4-b041-3250ea8e6c99']	['TCGA-CF-A5U8_treatment', 'TCGA-CF-A5U8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:19.318152-05:00']	01	Primary	7b29b034-86e4-4266-8657-036e96e04430	Primary Tumor	Not Reported	120.0	240.0	OCT	-A9CA-D5039E0450B1.pdf	true	Solid Tissue	False	Tumor
TCGA-BT-A20W-11A	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	Transitional Cell Papillomas and Carcinomas	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	TCGA-BT-A20W	Bladder		Not Reported		white	male	not hispanic or latino	Dead	71	-26078.0	1938.0	254.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder		26078.0	Transitional cell carcinoma	no	2009.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2b	26078.0	71.44657534246575	['2019-07-31T16:48:56.160719-05:00', '2019-07-31T16:48:56.160719-05:00']	['3cfce4ba-f89f-5113-a346-7a7b24c7664f', 'f6b37f89-cd70-5b08-8954-f98a347dae28']	['TCGA-BT-A20W_treatment', 'TCGA-BT-A20W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:24.598370-05:00']	11	Not Applicable	5ff660d2-10de-4d72-bde0-93840309b5e5	Solid Tissue Normal		751.0		OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20W-01A	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	Transitional Cell Papillomas and Carcinomas	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	TCGA-BT-A20W	Bladder		Not Reported		white	male	not hispanic or latino	Dead	71	-26078.0	1938.0	254.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder		26078.0	Transitional cell carcinoma	no	2009.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2b	26078.0	71.44657534246575	['2019-07-31T16:48:56.160719-05:00', '2019-07-31T16:48:56.160719-05:00']	['3cfce4ba-f89f-5113-a346-7a7b24c7664f', 'f6b37f89-cd70-5b08-8954-f98a347dae28']	['TCGA-BT-A20W_treatment', 'TCGA-BT-A20W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:24.598370-05:00']	01	Primary	ca14f475-1be4-450c-80c3-7094d23d0b3d	Primary Tumor		751.0	270.0	OCT	4BCE7132-F235-4C57-9DAB-0C51C8737E87	true	Solid Tissue	False	Tumor
TCGA-DK-AA6P-01A	4e702ca1-c0e0-4b9c-b9c7-7d7946818561	Transitional Cell Papillomas and Carcinomas	4e702ca1-c0e0-4b9c-b9c7-7d7946818561	TCGA-DK-AA6P	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Alive	72	-26560.0	1941.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	457.0	26560.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	26560.0	72.76712328767124	['2019-07-31T16:48:58.865292-05:00', '2019-07-31T16:48:58.865292-05:00']	['3d8a0ac8-02f6-5c18-b0fd-3acab8daf94f', '81b8c448-ab21-5200-8361-7ad78ed804d6']	['TCGA-DK-AA6P_treatment', 'TCGA-DK-AA6P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:52:27.095100-05:00']	01	Primary	3c71158d-98ff-4ef5-923f-ba31a25036ec	Primary Tumor	Not Reported	329.0	340.0	OCT	2D499EC2-59F5-462D-A60C-BD19B4BE8E46	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RC-01A	4ed34db5-ddb5-4efd-a49b-84bf26789aee	Transitional Cell Papillomas and Carcinomas	4ed34db5-ddb5-4efd-a49b-84bf26789aee	TCGA-ZF-A9RC	Bladder		Not Reported		white	male	not hispanic or latino	Alive	77	-28275.0	1930.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	2868.0	28275.0	Transitional cell carcinoma	no	2007.0	No	6th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	28275.0	77.46575342465754	['2019-07-31T16:49:02.024438-05:00', '2019-07-31T16:49:02.024438-05:00']	['abdbee54-779e-522d-8c16-8b64e349d49e', 'b3a98a1c-9c49-55f5-b630-bddfc88e2338']	['TCGA-ZF-A9RC_treatment_1', 'TCGA-ZF-A9RC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:29.708303-05:00', '']	01	Primary	d9c9d1c0-9e14-4fdc-9463-fa8b223fa441	Primary Tumor	Not Reported	2386.0	70.0	OCT	B7DD19FB-FF13-44CB-88FF-B42A6E20962B	true	Solid Tissue	False	Tumor
TCGA-FD-A5BV-01A	4fa31971-15e2-4c9b-b49a-b3b7096262e4	Transitional Cell Papillomas and Carcinomas	4fa31971-15e2-4c9b-b49a-b3b7096262e4	TCGA-FD-A5BV	Bladder	1.5342465753424657	Not Reported	28.0	white	female	not hispanic or latino	Dead	47	-17501.0	1965.0	163.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder		17501.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported		17501.0	47.94794520547945	['2019-07-31T16:49:04.863979-05:00', '2019-07-31T16:49:04.863979-05:00']	['6f8c21f0-9152-5b09-81e1-12f36ac60ae5', 'ddc18a8a-02d4-5725-97a9-d318604ad907']	['TCGA-FD-A5BV_treatment', 'TCGA-FD-A5BV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:32.468462-05:00']	01	Primary	ea8a6b07-16b1-4879-ae7d-082e2c5f1c34	Primary Tumor	Not Reported	156.0	660.0	OCT	9CD8EA72-6DF6-4DD6-9F32-610AB97C9E0D	true	Solid Tissue	False	Tumor
TCGA-5N-A9KI-01A	4fece3d0-649c-4771-b9c4-a3397cea0feb	Transitional Cell Papillomas and Carcinomas	4fece3d0-649c-4771-b9c4-a3397cea0feb	TCGA-5N-A9KI	Bladder	3.287671232876712	Not Reported	60.0	white	female	not hispanic or latino	Dead	76	-27777.0	1935.0	76.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	740c5228-5133-53ab-a6c0-75a167b9f894	5N	University Hospital Erlangen	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		27777.0	Transitional cell carcinoma	no	2011.0	No	7th	T4	8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	27777.0	76.1013698630137	['2019-07-31T16:49:07.852236-05:00', '2019-07-31T16:49:07.852236-05:00']	['09067b36-b2f4-5f27-a81c-2f79e9928d23', '650be4a0-ba80-5722-899a-32149522f2db']	['TCGA-5N-A9KI_treatment', 'TCGA-5N-A9KI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:34.816949-05:00']	01	Primary	d45fa399-718f-48e4-9b59-c58293d47829	Primary Tumor	Not Reported	903.0	162.0	Unknown	9F2417E9-F7F7-480E-86C8-A5CD1D54CD73	false	Solid Tissue	False	Tumor
TCGA-C4-A0F6-01A	4ff9b4f2-6d04-4fed-8796-155902a8bf28	Transitional Cell Papillomas and Carcinomas	4ff9b4f2-6d04-4fed-8796-155902a8bf28	TCGA-C4-A0F6	Bladder	1.917808219178082	Not Reported	35.0	not reported	female	not reported	Alive	82	-29951.0	1926.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	af546e3d-a713-5d08-88f4-d8a64d54f2a4	C4	Indivumed	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	700.0	29951.0	Transitional cell carcinoma	no	2008.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29951.0	82.05753424657534	['2019-07-31T16:49:14.329045-05:00', '2019-07-31T16:49:14.329045-05:00']	['2e5a7e79-c6ee-5de1-bda3-5fa946763677', 'd63d486d-aa41-5832-84aa-a6e1573793de']	['TCGA-C4-A0F6_treatment', 'TCGA-C4-A0F6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:52:39.531745-05:00']	01	Primary	905d2bf1-08cb-4260-8188-00b60d881cf2	Primary Tumor	Not Reported	568.0	140.0	Unknown	6141ED7C-45EC-4157-9064-47EA7C945CE0	false	Solid Tissue	False	Tumor
TCGA-E7-A5KE-01A	514dcd02-0b33-40ef-8ef1-05272045fc39	Transitional Cell Papillomas and Carcinomas	514dcd02-0b33-40ef-8ef1-05272045fc39	TCGA-E7-A5KE	Bladder		Not Reported		asian	female	not hispanic or latino	Alive	78	-28714.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	17.0	28714.0	Transitional cell carcinoma	no	2012.0	No	7th	T2a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28714.0	78.66849315068494	['2019-07-31T16:49:17.135228-05:00', '2019-07-31T16:49:17.135228-05:00']	['7c5b6947-cba9-5dae-ac34-d77ec5595c55', '8d0896e7-364c-54b2-9db8-f87256bc9153']	['TCGA-E7-A5KE_treatment_1', 'TCGA-E7-A5KE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'no']	['2019-04-28T09:52:42.319523-05:00', '']	01	Primary	a281ea63-5db3-4db4-9294-89392a6c65a6	Primary Tumor	Not Reported	119.0	310.0	OCT	6B72BC7B-5419-4B29-AAB1-AC15111183DC	true	Solid Tissue	False	Tumor
TCGA-XF-A9SL-01A	51fdb034-5d05-427b-b6b8-b6eecd65d976	Transitional Cell Papillomas and Carcinomas	51fdb034-5d05-427b-b6b8-b6eecd65d976	TCGA-XF-A9SL	Bladder	3.0136986301369864	Not Reported	55.0	white	male	not hispanic or latino	Dead	69	-25460.0	1935.0	2020.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		25460.0	Transitional cell carcinoma	no	2004.0	No	6th	T3a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25460.0	69.75342465753425	['2019-07-31T16:49:20.611119-05:00', '2019-07-31T16:49:20.611119-05:00']	['c236acc1-21c7-543a-be75-5ffbe4dc1e8d', 'c606500a-6977-59f8-9f3d-b2ac95d6e355']	['TCGA-XF-A9SL_treatment_1', 'TCGA-XF-A9SL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:44.964615-05:00', '']	01	Primary	f298b46c-ce8b-4ce6-870e-ea6f3e139f46	Primary Tumor	Not Reported	3423.0	650.0	OCT	D8FA25D2-8119-47BA-8ECD-A2EA6E56E7B3	true	Solid Tissue	False	Tumor
TCGA-K4-A54R-01A	52fddd92-fa5e-4fac-8e44-e64c98c84f86	Transitional Cell Papillomas and Carcinomas	52fddd92-fa5e-4fac-8e44-e64c98c84f86	TCGA-K4-A54R	Bladder		Not Reported		white	male	not hispanic or latino	Alive	59	-21601.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Dome of bladder	842.0	21601.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.1	Dome of bladder	Not Reported	not reported		21601.0	59.18082191780822	['2019-07-31T16:49:23.941813-05:00', '2019-07-31T16:49:23.941813-05:00']	['0d158d59-d3ac-52df-b618-2f23884e8b55', '40167fe7-9131-5a02-b2ea-30eecbbd5a50']	['TCGA-K4-A54R_treatment_1', 'TCGA-K4-A54R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:47.264751-05:00', '']	01	Primary	89b2a25d-6626-4ca8-9dfb-4b8ac8dda1de	Primary Tumor	Not Reported	224.0	90.0	OCT	176B5C21-B423-41BE-AFAB-565E58E5404C	true	Solid Tissue	False	Tumor
TCGA-K4-A54R-11A	52fddd92-fa5e-4fac-8e44-e64c98c84f86	Transitional Cell Papillomas and Carcinomas	52fddd92-fa5e-4fac-8e44-e64c98c84f86	TCGA-K4-A54R	Bladder		Not Reported		white	male	not hispanic or latino	Alive	59	-21601.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Dome of bladder	842.0	21601.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.1	Dome of bladder	Not Reported	not reported		21601.0	59.18082191780822	['2019-07-31T16:49:23.941813-05:00', '2019-07-31T16:49:23.941813-05:00']	['0d158d59-d3ac-52df-b618-2f23884e8b55', '40167fe7-9131-5a02-b2ea-30eecbbd5a50']	['TCGA-K4-A54R_treatment_1', 'TCGA-K4-A54R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:47.264751-05:00', '']	11	Not Applicable	f65c2e6d-8ae0-4413-bba1-44146bec7bac	Solid Tissue Normal	Not Reported	224.0	50.0	OCT		true	Solid Tissue	False	Normal
TCGA-XF-AAN1-01A	5378f375-aa04-4eca-bc35-190b3efb52bc	Transitional Cell Papillomas and Carcinomas	5378f375-aa04-4eca-bc35-190b3efb52bc	TCGA-XF-AAN1	Bladder	2.5753424657534247	Not Reported	47.0	not reported	female	not hispanic or latino	Dead	75	-27687.0	1931.0	941.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		27687.0	Papillary transitional cell carcinoma	yes	2006.0	No	6th	T4a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27687.0	75.85479452054794	['2019-07-31T16:49:27.320931-05:00', '2019-07-31T16:49:27.320931-05:00']	['086191a3-a803-559f-9602-b28ae5ef086a', '19dc0452-e2d5-5ea3-8b95-e045c816d674']	['TCGA-XF-AAN1_treatment', 'TCGA-XF-AAN1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:52:49.789379-05:00']	01	Primary	724b5713-b867-4cff-9f1b-7ce3f667dfd1	Primary Tumor	Not Reported	2644.0	710.0	OCT	7BD47644-AADB-40AE-A5BA-997B74F6AD80	true	Solid Tissue	False	Tumor
TCGA-FD-A3B8-01A	537ca5d1-5b26-496f-b7b4-05fea7b46353	Transitional Cell Papillomas and Carcinomas	537ca5d1-5b26-496f-b7b4-05fea7b46353	TCGA-FD-A3B8	Bladder	2.191780821917808	Not Reported	40.0	white	male	hispanic or latino	Alive	56	-20555.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	384.0	20555.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	20555.0	56.31506849315068	['2019-07-31T16:49:30.967400-05:00', '2019-07-31T16:49:30.967400-05:00']	['9c5bd2de-4e6e-518b-8e81-63856f7dcfb1', 'e487596c-d011-5ff6-9ae9-833d15405d44']	['TCGA-FD-A3B8_treatment_1', 'TCGA-FD-A3B8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:52.352682-05:00', '']	01	Primary	9a27aa84-d541-4fa3-a798-d7559a5ae70c	Primary Tumor	Not Reported	232.0	400.0	Unknown	1F9298B4-73AC-4B72-946B-443278540E6A	false	Solid Tissue	False	Tumor
TCGA-GC-A6I1-01A	54c04bcc-ebd5-461e-bbd5-b4d791b00c95	Transitional Cell Papillomas and Carcinomas	54c04bcc-ebd5-461e-bbd5-b4d791b00c95	TCGA-GC-A6I1	Bladder		Not Reported		white	female	not hispanic or latino	Dead	90	-32872.0	1922.0	0.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	0.0	32872.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2b	32872.0	90.06027397260274	['2019-07-31T16:49:34.280346-05:00', '2019-07-31T16:49:34.280346-05:00']	['aaaa708b-f405-55aa-9649-8d9b21b796b8', 'b7238960-e431-5c70-b69d-5e7dec9222a1']	['TCGA-GC-A6I1_treatment_1', 'TCGA-GC-A6I1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-30T16:18:00.347356-05:00', '']	01	Primary	016eb791-6835-49a0-add9-612716fe431c	Primary Tumor	Not Reported	168.0	50.0	Unknown	30B23BF3-A3EC-444C-A43A-F080EEDFB6CC	false	Solid Tissue	False	Tumor
TCGA-BL-A13J-11A	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	556fcbc8-172a-4af1-8822-ae036e8d68e8	TCGA-BL-A13J	Bladder	1.3150684931506849	Not Reported	24.0	white	male	not hispanic or latino	Dead	65	-23927.0	1945.0	81.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		23927.0	Transitional cell carcinoma	no	2010.0	No		T4	8120/3	N2	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23927.0	65.55342465753425	['2019-07-31T16:49:37.529457-05:00', '2019-07-31T16:49:37.529457-05:00']	['04e5320c-e9af-52f4-af45-77a50901166e', '691d6cde-1889-5398-be89-5d0b9c88851b']	['TCGA-BL-A13J_treatment_1', 'TCGA-BL-A13J_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:57.016776-05:00', '']	11	Not Applicable	2a834a44-9490-4c60-b587-ebe890c3fb0a	Solid Tissue Normal	Not Reported	246.0		Unknown		false	Solid Tissue	False	Normal
TCGA-BL-A13J-01B	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	556fcbc8-172a-4af1-8822-ae036e8d68e8	TCGA-BL-A13J	Bladder	1.3150684931506849	Not Reported	24.0	white	male	not hispanic or latino	Dead	65	-23927.0	1945.0	81.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		23927.0	Transitional cell carcinoma	no	2010.0	No		T4	8120/3	N2	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23927.0	65.55342465753425	['2019-07-31T16:49:37.529457-05:00', '2019-07-31T16:49:37.529457-05:00']	['04e5320c-e9af-52f4-af45-77a50901166e', '691d6cde-1889-5398-be89-5d0b9c88851b']	['TCGA-BL-A13J_treatment_1', 'TCGA-BL-A13J_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:57.016776-05:00', '']	01	Primary	a696305c-e8c6-40d3-aa4c-1738d0987885	Primary Tumor	Not Reported	622.0		FFPE	3ABF8C6B-606C-41A9-B050-E115834A7616	false	Solid Tissue	True	Tumor
TCGA-BL-A13J-01A	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	556fcbc8-172a-4af1-8822-ae036e8d68e8	TCGA-BL-A13J	Bladder	1.3150684931506849	Not Reported	24.0	white	male	not hispanic or latino	Dead	65	-23927.0	1945.0	81.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	a18eca9a-2444-54a7-9015-d3d912404070	BL	Christiana Healthcare	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		23927.0	Transitional cell carcinoma	no	2010.0	No		T4	8120/3	N2	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23927.0	65.55342465753425	['2019-07-31T16:49:37.529457-05:00', '2019-07-31T16:49:37.529457-05:00']	['04e5320c-e9af-52f4-af45-77a50901166e', '691d6cde-1889-5398-be89-5d0b9c88851b']	['TCGA-BL-A13J_treatment_1', 'TCGA-BL-A13J_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:52:57.016776-05:00', '']	01	Primary	cf23846d-a7d2-40a9-8b51-49a27967d101	Primary Tumor	Not Reported	246.0	280.0	Unknown	3ABF8C6B-606C-41A9-B050-E115834A7616	false	Solid Tissue	False	Tumor
TCGA-UY-A78N-01A	573e124f-98cb-4014-b9d2-0499f7fbdb7a	Transitional Cell Papillomas and Carcinomas	573e124f-98cb-4014-b9d2-0499f7fbdb7a	TCGA-UY-A78N	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Dead	80	-29132.0		2641.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		29132.0	Transitional cell carcinoma	yes		No	6th	T2	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29132.0	79.81369863013698	['2019-07-31T16:49:43.587557-05:00', '2019-07-31T16:49:43.587557-05:00']	['b20c2af2-f65c-5ac4-bca1-26c8fb843452', 'e56f59f8-34ff-528f-ab2a-8a4b8982169d']	['TCGA-UY-A78N_treatment', 'TCGA-UY-A78N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:53:01.833497-05:00']	01	Primary	fa16f098-4c30-4d95-9534-605399027088	Primary Tumor	Not Reported		340.0	OCT	9DE74A4B-6785-40FE-8117-496F4A32DFE5	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4U-01A	585dfb25-5013-4ae1-a26b-5fed08e6cdb3	Transitional Cell Papillomas and Carcinomas	585dfb25-5013-4ae1-a26b-5fed08e6cdb3	TCGA-ZF-AA4U	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Dead	70	-25682.0	1938.0	262.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		25682.0	Transitional cell carcinoma	no	2008.0	No	6th	T4a	8120/3	NX	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25682.0	70.36164383561643	['2019-07-31T16:50:00.590562-05:00', '2019-07-31T16:50:00.590562-05:00']	['75642f43-f512-52f3-a781-813060b143bb', 'e8390f30-213b-5545-a387-fc4c2c73fd5d']	['TCGA-ZF-AA4U_treatment_1', 'TCGA-ZF-AA4U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:53:13.962108-05:00', '']	01	Primary	a30bceda-99e4-4b73-9cb6-0a080865f214	Primary Tumor	Not Reported	1842.0	90.0	OCT	72EA5495-3D5D-4547-B2BE-54C138294216	true	Solid Tissue	False	Tumor
TCGA-UY-A8OC-01A	5a0e4dc3-4ec6-4d27-bb7e-1d2221d06d33	Transitional Cell Papillomas and Carcinomas	5a0e4dc3-4ec6-4d27-bb7e-1d2221d06d33	TCGA-UY-A8OC	Bladder		Not Reported		white	male	not hispanic or latino	Dead	90	-32872.0		0.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		32872.0	Transitional cell carcinoma	no		No	6th	T4	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		32872.0	90.06027397260274	['2019-07-31T16:50:03.565987-05:00', '2019-07-31T16:50:03.565987-05:00']	['d11663d8-7cd0-54b8-9d63-852f2467ce23', 'dce33585-8868-5835-9493-8b3fedbe056f']	['TCGA-UY-A8OC_treatment', 'TCGA-UY-A8OC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:53:16.491598-05:00']	01	Primary	2a83d2ac-f8b9-4c24-9af1-4149ad400a21	Primary Tumor	Not Reported		280.0	OCT	A3441B74-07BB-4A9F-9B66-0071AD46CB21	true	Solid Tissue	False	Tumor
TCGA-K4-A5RJ-01A	5a25658c-2436-4a47-8902-8a2cf4a1c20d	Transitional Cell Papillomas and Carcinomas	5a25658c-2436-4a47-8902-8a2cf4a1c20d	TCGA-K4-A5RJ	Bladder		Not Reported		white	male	not hispanic or latino	Alive	75	-27518.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder	539.0	27518.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2b	8130/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27518.0	75.3917808219178	['2019-07-31T16:50:06.607795-05:00', '2019-07-31T16:50:06.607795-05:00']	['0a5f3408-9902-5009-b3e0-bf4c16f8a7bb', 'e0cc5305-80a1-57ec-bc2a-e1a8780a8b8b']	['TCGA-K4-A5RJ_treatment', 'TCGA-K4-A5RJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:53:18.842196-05:00']	01	Primary	5cc33b47-d462-4417-aceb-3b5fd9f5189e	Primary Tumor	Not Reported	101.0	190.0	OCT	19AA5671-7AE1-49F3-8CF0-03D2871AFCCA	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R0-01A	5b39a0dc-8ab2-46c6-95c7-65df919ebc76	Transitional Cell Papillomas and Carcinomas	5b39a0dc-8ab2-46c6-95c7-65df919ebc76	TCGA-ZF-A9R0	Bladder	0.273972602739726	Not Reported	5.0	white	male	not hispanic or latino	Dead	82	-30222.0	1931.0	680.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	567.0	30222.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	NX	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	30222.0	82.8	['2019-07-31T16:50:10.040650-05:00', '2019-07-31T16:50:10.040650-05:00']	['504e6426-02c9-5864-a2b9-787de4c82da5', 'ef5d8296-e33a-524a-8221-edf286cf1c99']	['TCGA-ZF-A9R0_treatment', 'TCGA-ZF-A9R0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:53:21.295289-05:00']	01	Primary	770c9b75-a491-4223-8038-6e0c9def9761	Primary Tumor	Not Reported	309.0	270.0	OCT	A69288AE-85B5-4041-A601-A7ACDBCBBEB2	true	Solid Tissue	False	Tumor
TCGA-DK-A2I4-01A	5c4aebeb-fb6f-4d66-b24a-89ef20de971e	Transitional Cell Papillomas and Carcinomas	5c4aebeb-fb6f-4d66-b24a-89ef20de971e	TCGA-DK-A2I4	Bladder		Not Reported		white	male	not hispanic or latino	Alive	79	-29037.0	1922.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder	3835.0	29037.0	Papillary transitional cell carcinoma	no	2001.0	No	6th	T3b	8130/3	N0	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		29037.0	79.55342465753425	['2019-07-31T16:50:13.657454-05:00', '2019-07-31T16:50:13.657454-05:00']	['99589c36-6fe8-5e0e-a542-73831d658701', 'd09d4d7e-e1db-5648-b4ff-041cf649e05f']	['TCGA-DK-A2I4_treatment_1', 'TCGA-DK-A2I4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:53:23.734508-05:00', '']	01	Primary	aa0cccc2-14b3-4b88-b42c-25adf1764fe3	Primary Tumor	Not Reported	3656.0	320.0	OCT	C521242F-494B-4399-AF73-302A96F3BC48	true	Solid Tissue	False	Tumor
TCGA-FD-A6TE-01A	5c771ee8-2aea-498d-ba8c-cdbaebfd57ac	Transitional Cell Papillomas and Carcinomas	5c771ee8-2aea-498d-ba8c-cdbaebfd57ac	TCGA-FD-A6TE	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Alive	54	-19874.0	1959.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder	376.0	19874.0	Transitional cell carcinoma	no	2013.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported		19874.0	54.44931506849315	['2019-07-31T16:50:16.718142-05:00', '2019-07-31T16:50:16.718142-05:00']	['70047b3f-6520-5e60-b6a7-56d3564dd9c7', '8ee93528-c323-53af-83e9-c2192595b085']	['TCGA-FD-A6TE_treatment', 'TCGA-FD-A6TE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:53:26.207734-05:00']	01	Primary	d16650c9-487c-4668-9927-f982227c4b2b	Primary Tumor	Not Reported	147.0	720.0	OCT	648DDD7D-6C27-4CA1-BBB2-891A9F7839FE	true	Solid Tissue	False	Tumor
TCGA-E7-A5KF-01A	5d06cc19-8b10-4ed1-b6d4-8e044f1f8a8c	Transitional Cell Papillomas and Carcinomas	5d06cc19-8b10-4ed1-b6d4-8e044f1f8a8c	TCGA-E7-A5KF	Bladder	1.36986301369863	Not Reported	25.0	asian	male	not hispanic or latino	Alive	67	-24528.0	1945.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	20.0	24528.0	Transitional cell carcinoma	no	2012.0	No	7th	T2a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24528.0	67.2	['2019-07-31T16:50:19.532180-05:00', '2019-07-31T16:50:19.532180-05:00']	['0e6d18a6-c4ef-5f64-988f-75a8908f8148', '2fd053c5-dbb8-5d69-8ba8-d954191b21b2']	['TCGA-E7-A5KF_treatment_1', 'TCGA-E7-A5KF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:53:28.842703-05:00', '']	01	Primary	ba110c03-750f-4b30-89b3-e1b1b41e8144	Primary Tumor	Not Reported	107.0	670.0	OCT	4EE096A0-381D-468C-AA30-F914F4F6589E	true	Solid Tissue	False	Tumor
TCGA-GD-A2C5-01A	5d54c742-5a8e-4c40-8d62-95e75e210ab8	Transitional Cell Papillomas and Carcinomas	5d54c742-5a8e-4c40-8d62-95e75e210ab8	TCGA-GD-A2C5	Bladder	1.6986301369863013	Not Reported	31.0	white	female	not hispanic or latino	Alive	53	-19498.0	1958.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	812.0	19498.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19498.0	53.41917808219178	['2019-07-31T16:50:22.771196-05:00', '2019-07-31T16:50:22.771196-05:00']	['51cdd7a1-2def-5ae5-a12c-dfce613d8d60', 'a07c757d-75fc-5f75-b4b7-6d259dafcc33']	['TCGA-GD-A2C5_treatment', 'TCGA-GD-A2C5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:53:31.582151-05:00']	01	Primary	2cd62676-762c-461d-b111-1f81e7cd5877	Primary Tumor	Not Reported	76.0	260.0	Unknown	1522A38C-0867-4275-AB24-FF21B8E988B5	false	Solid Tissue	False	Tumor
TCGA-GD-A2C5-11A	5d54c742-5a8e-4c40-8d62-95e75e210ab8	Transitional Cell Papillomas and Carcinomas	5d54c742-5a8e-4c40-8d62-95e75e210ab8	TCGA-GD-A2C5	Bladder	1.6986301369863013	Not Reported	31.0	white	female	not hispanic or latino	Alive	53	-19498.0	1958.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	812.0	19498.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19498.0	53.41917808219178	['2019-07-31T16:50:22.771196-05:00', '2019-07-31T16:50:22.771196-05:00']	['51cdd7a1-2def-5ae5-a12c-dfce613d8d60', 'a07c757d-75fc-5f75-b4b7-6d259dafcc33']	['TCGA-GD-A2C5_treatment', 'TCGA-GD-A2C5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:53:31.582151-05:00']	11	Not Applicable	892eb338-9c49-4378-a934-623f4edacf7d	Solid Tissue Normal	Not Reported	76.0	120.0	Unknown		false	Solid Tissue	False	Normal
TCGA-G2-A2EK-01A	5da1cb68-c438-4ddc-999f-90aed0c4bd7a	Transitional Cell Papillomas and Carcinomas	5da1cb68-c438-4ddc-999f-90aed0c4bd7a	TCGA-G2-A2EK	Bladder		Not Reported		white	male	not hispanic or latino	Alive	57	-20995.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	485.0	20995.0	Transitional cell carcinoma	no	2010.0	No	7th		8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	20995.0	57.52054794520548	['2019-07-31T16:50:26.020841-05:00', '2019-07-31T16:50:26.020841-05:00']	['97474c8e-9b73-5e77-9f2a-5774db705ffb', 'c81d8d6c-188a-5919-8317-7226ffa17462']	['TCGA-G2-A2EK_treatment_1', 'TCGA-G2-A2EK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:53:34.076950-05:00', '']	01	Primary	ff1691f2-df11-4068-8d8d-a778f384ec60	Primary Tumor	Not Reported	147.0	120.0	OCT	935F1F7B-F048-4B44-81F0-1E56842A73B1	true	Solid Tissue	False	Tumor
TCGA-DK-AA6R-01A	5db4b168-a6ba-482c-b067-2274eba96aad	Transitional Cell Papillomas and Carcinomas	5db4b168-a6ba-482c-b067-2274eba96aad	TCGA-DK-AA6R	Bladder	3.0136986301369864	Not Reported	55.0	white	male	not hispanic or latino	Alive	68	-25196.0	1933.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Lateral wall of bladder	5041.0	25196.0	Transitional cell carcinoma	yes	2001.0	No	5th	T4	8120/3	N1	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25196.0	69.03013698630137	['2019-07-31T16:50:28.913838-05:00', '2019-07-31T16:50:28.913838-05:00']	['610d5fa1-daea-5433-a350-c24327669b3c', '66288269-9500-5ec9-885a-5ecd83efd1eb']	['TCGA-DK-AA6R_treatment_1', 'TCGA-DK-AA6R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:53:36.505601-05:00', '']	01	Primary	82bc393c-5391-497a-a0dc-41c077ae9c40	Primary Tumor	Not Reported	4591.0	340.0	OCT	4A588484-5C6C-4ACF-8AA6-8BE9F1AE804C	true	Solid Tissue	False	Tumor
TCGA-4Z-AA80-01A	5df620fa-44d9-4361-91d0-f242e3e5e595	Transitional Cell Papillomas and Carcinomas	5df620fa-44d9-4361-91d0-f242e3e5e595	TCGA-4Z-AA80	Bladder		Not Reported		white	male	not reported	Dead	73	-26873.0	1939.0	19.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		26873.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T1	26873.0	73.62465753424658	['2019-07-31T17:17:56.692040-05:00', '2019-07-31T17:17:56.692040-05:00']	['006e16c7-3b9f-5092-aef7-4b29010c5777', '62249ea5-5c38-5c2f-b4f6-f9da56a87c32']	['TCGA-4Z-AA80_treatment', 'TCGA-4Z-AA80_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:16:11.082329-05:00']	01	Primary	c4b78493-09e1-4509-bea2-a86ebc601eb1	Primary Tumor	Not Reported	612.0	160.0	OCT	B2F4C3E3-1740-4C76-86A3-51103954FA72	true	Solid Tissue	False	Tumor
TCGA-UY-A78K-01A	5f587f1b-f835-4869-9e6d-8cb3b9e0610b	Transitional Cell Papillomas and Carcinomas	5f587f1b-f835-4869-9e6d-8cb3b9e0610b	TCGA-UY-A78K	Bladder		Not Reported		white	male	not hispanic or latino	Dead	60	-22020.0		536.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		22020.0	Papillary transitional cell carcinoma	no		No	6th		8130/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22020.0	60.32876712328767	['2019-07-31T16:50:31.757905-05:00', '2019-07-31T16:50:31.757905-05:00']	['012b49d6-93f0-5030-8b20-8bde74f63608', 'f762be0e-43e6-5475-b94f-d799281c4ac1']	['TCGA-UY-A78K_treatment_1', 'TCGA-UY-A78K_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:53:38.995964-05:00', '']	01	Primary	5a08f98a-0f35-49b2-991b-ef2764246e18	Primary Tumor	Not Reported		160.0	OCT	5A6AB084-6B3E-4C9F-9DD6-E055376EF290	true	Solid Tissue	False	Tumor
TCGA-XF-A9T0-01A	5f5c1775-a908-483d-8a77-b902c5b7570e	Transitional Cell Papillomas and Carcinomas	5f5c1775-a908-483d-8a77-b902c5b7570e	TCGA-XF-A9T0	Bladder		Not Reported		white	male	not hispanic or latino	Alive	68	-25190.0	1939.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	799.0	25190.0	Transitional cell carcinoma	yes	2007.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25190.0	69.01369863013699	['2019-07-31T16:50:40.232928-05:00', '2019-07-31T16:50:40.232928-05:00']	['43d5070f-403c-535d-a2e8-9efce3a88922', 'e224b767-7116-5fed-a043-b42ab514e800']	['TCGA-XF-A9T0_treatment', 'TCGA-XF-A9T0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:53:47.041478-05:00']	01	Primary	b97891bc-bf12-4c81-a2bb-b15e341b4bdf	Primary Tumor	Not Reported	2323.0	770.0	OCT	BD4F0E43-3FE5-4059-875E-70E998BEF60F	true	Solid Tissue	False	Tumor
TCGA-XF-A9T3-01A	5f7c3b2d-9a5b-470f-bd12-9c7787a543f0	Transitional Cell Papillomas and Carcinomas	5f7c3b2d-9a5b-470f-bd12-9c7787a543f0	TCGA-XF-A9T3	Bladder	2.8493150684931505	Not Reported	52.0	white	female	not hispanic or latino	Alive	69	-25532.0	1939.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	68.0	25532.0	Transitional cell carcinoma	yes	2008.0	No	4th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25532.0	69.95068493150686	['2019-07-31T15:59:01.323942-05:00', '2019-07-31T15:59:01.323942-05:00']	['96697f00-ad48-521a-b39f-efd7725fdd30', 'ad70d20c-8a7b-58b8-83b4-543bc46e4c48']	['TCGA-XF-A9T3_treatment_1', 'TCGA-XF-A9T3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T09:13:13.647088-05:00', '']	01	Primary	41bcf107-12ad-4732-8e88-35347137a05f	Primary Tumor	Not Reported	2140.0	130.0	OCT	F782DE7F-4DE3-476D-BDF6-549CD871EE9C	true	Solid Tissue	False	Tumor
TCGA-FD-A3SP-01A	5f99dcff-d809-4c87-8024-c9b30bd565e9	Transitional Cell Papillomas and Carcinomas	5f99dcff-d809-4c87-8024-c9b30bd565e9	TCGA-FD-A3SP	Bladder	0.6575342465753424	Not Reported	12.0	white	male	not hispanic or latino	Alive	60	-22005.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	783.0	22005.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		22005.0	60.28767123287671	['2019-07-31T16:50:43.294692-05:00', '2019-07-31T16:50:43.294692-05:00']	['5f0efbbe-440e-5737-9e4a-1a3650e1a27d', '87cb7719-f492-572b-97cb-8ac462a0faaf']	['TCGA-FD-A3SP_treatment', 'TCGA-FD-A3SP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:53:49.346916-05:00']	01	Primary	3592a9c5-124e-428f-b1f9-40429c591429	Primary Tumor	Not Reported	57.0	390.0	OCT	F20CA7B6-3109-4A49-9355-5DCED1AD7136	true	Solid Tissue	False	Tumor
TCGA-DK-AA6Q-01A	60419f8c-92c2-4e8f-b2fa-a767d30c9d59	Transitional Cell Papillomas and Carcinomas	60419f8c-92c2-4e8f-b2fa-a767d30c9d59	TCGA-DK-AA6Q	Bladder		Not Reported		white	female	not hispanic or latino	Dead	61	-22314.0	1951.0	413.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Posterior wall of bladder		22314.0	Transitional cell carcinoma	no	2012.0	No	7th	T3	8120/3	N1	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	22314.0	61.134246575342466	['2019-07-31T16:50:46.461545-05:00', '2019-07-31T16:50:46.461545-05:00']	['a1173265-645b-50ff-893a-c24798d6c32f', 'f77847b5-ff51-53f4-9689-60a8730d7966']	['TCGA-DK-AA6Q_treatment', 'TCGA-DK-AA6Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:53:51.731415-05:00']	01	Primary	daba59a9-8839-4b02-bbf8-4de9c6595a7c	Primary Tumor	Not Reported	516.0	110.0	OCT	1D50AD73-3AE6-427F-92D8-518FE4BD4B51	true	Solid Tissue	False	Tumor
TCGA-4Z-AA89-01A	604c0d60-6ba9-4d2f-98db-e310c58bc8ca	Transitional Cell Papillomas and Carcinomas	604c0d60-6ba9-4d2f-98db-e310c58bc8ca	TCGA-4Z-AA89	Bladder	2.191780821917808	Not Reported	40.0	white	male	not reported	Alive	60	-22271.0	1951.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Trigone of bladder	1029.0	22271.0	Papillary transitional cell carcinoma	yes	2011.0	No	7th	T4b	8130/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	TX	22271.0	61.016438356164386	['2019-07-31T15:20:30.198459-05:00', '2019-07-31T15:20:30.198459-05:00']	['499c3a3f-6aa9-5cbc-8976-efbf7e8fba55', 'b3b3ee90-5506-5148-86b0-80f866d084b3']	['TCGA-4Z-AA89_treatment_1', 'TCGA-4Z-AA89_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T08:40:38.012744-05:00', '']	01	Primary	692a6349-8712-4b9a-82fe-5d08e9cf5ccf	Primary Tumor	Not Reported	763.0	340.0	OCT	5D5A2A97-F2B3-4EBE-BD57-C035D1710874	true	Solid Tissue	False	Tumor
TCGA-K4-A6FZ-01A	610811d5-e45e-4a4f-bdc1-8d700efd6e43	Transitional Cell Papillomas and Carcinomas	610811d5-e45e-4a4f-bdc1-8d700efd6e43	TCGA-K4-A6FZ	Bladder		Not Reported		white	female	not hispanic or latino	Alive	75	-27686.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	55.0	27686.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27686.0	75.85205479452055	['2019-07-31T16:50:49.667005-05:00', '2019-07-31T16:50:49.667005-05:00']	['0173d730-75fb-5602-a30d-6f67cedf3b9f', '35ba9fb4-977e-53b0-9808-2240b14820c0']	['TCGA-K4-A6FZ_treatment_1', 'TCGA-K4-A6FZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:53:54.184169-05:00', '']	01	Primary	81dcb3af-128a-4934-8781-cc60310b258f	Primary Tumor	Not Reported	154.0	150.0	OCT	16FB3E38-2BB2-4DE2-8DCF-AF6C9225DFC4	true	Solid Tissue	False	Tumor
TCGA-FD-A6TF-01A	6134f549-6876-4c07-8e58-49ec87eaf4c0	Transitional Cell Papillomas and Carcinomas	6134f549-6876-4c07-8e58-49ec87eaf4c0	TCGA-FD-A6TF	Bladder		Not Reported		white	female	not hispanic or latino	Dead	80	-29317.0	1933.0	69.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder	63.0	29317.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N2	M1	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	29317.0	80.32054794520548	['2019-07-31T16:50:52.776028-05:00', '2019-07-31T16:50:52.776028-05:00']	['8d4c89ee-3cc0-5e00-9419-af63c6f26b31', '9f9e0593-5960-5702-ac4b-3dd26d3c0ac2']	['TCGA-FD-A6TF_treatment_1', 'TCGA-FD-A6TF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:53:56.637948-05:00', '']	01	Primary	7f933632-2dc4-44f6-835e-1a9865f26349	Primary Tumor	Not Reported	80.0	670.0	OCT	BDE506A5-17A5-459C-87DD-6FFBF0D713F6	true	Solid Tissue	False	Tumor
TCGA-ZF-AA4W-01A	63443198-4fcf-40bd-befb-4a6920d29ca4	Transitional Cell Papillomas and Carcinomas	63443198-4fcf-40bd-befb-4a6920d29ca4	TCGA-ZF-AA4W	Bladder		Not Reported		white	male	not hispanic or latino	Alive	56	-20611.0	1953.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1830.0	20611.0	Transitional cell carcinoma	no	2009.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	20611.0	56.46849315068493	['2019-07-31T16:50:55.969291-05:00', '2019-07-31T16:50:55.969291-05:00']	['222e948f-70b2-5e9c-b1aa-2c2c56f6d8c3', '3598bcb2-36d9-5f5d-8f30-43278d965173']	['TCGA-ZF-AA4W_treatment', 'TCGA-ZF-AA4W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:53:59.203137-05:00']	01	Primary	579dd91d-d4ac-40bc-b406-5a799dacce39	Primary Tumor	Not Reported	1742.0	200.0	OCT	CEDD5865-4B14-4F0C-9BBD-CBE89E68C2C3	true	Solid Tissue	False	Tumor
TCGA-DK-AA6W-01A	63fa8434-4a6f-4c32-9c5d-89dcc913900b	Transitional Cell Papillomas and Carcinomas	63fa8434-4a6f-4c32-9c5d-89dcc913900b	TCGA-DK-AA6W	Bladder		Not Reported		white	male	not hispanic or latino	Dead	78	-28853.0	1935.0	415.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Lateral wall of bladder	263.0	28853.0	Transitional cell carcinoma	yes	2013.0	No	7th	T2	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	28853.0	79.04931506849314	['2019-07-31T16:50:58.883834-05:00', '2019-07-31T16:50:58.883834-05:00']	['324fcb7c-95c1-574f-ad22-1da5c903fee0', '567aa2ee-fa41-5457-bdf8-1a41a2f67358']	['TCGA-DK-AA6W_treatment_1', 'TCGA-DK-AA6W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:54:01.714115-05:00', '']	01	Primary	e6db8232-33b3-4449-a2fc-cde3b7d3d72b	Primary Tumor	Not Reported	68.0	80.0	OCT	6ED3ACF0-57B3-4E7C-92DF-EA92499CA9CD	true	Solid Tissue	False	Tumor
TCGA-2F-A9KP-01A	65d1eaec-28db-4a41-a4db-1a710fcb24ad	Transitional Cell Papillomas and Carcinomas	65d1eaec-28db-4a41-a4db-1a710fcb24ad	TCGA-2F-A9KP	Bladder	3.3972602739726026	Not Reported	62.0	white	male	not hispanic or latino	Dead	66	-24428.0	1945.0	364.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	00c13427-c6e8-5633-8d7e-0c06132ce858	2F	Erasmus MC	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder		24428.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	24428.0	66.92602739726027	['2019-07-31T16:51:05.055069-05:00', '2019-07-31T16:51:05.055069-05:00']	['38775ab0-8b7e-5591-b3e6-8a0e5873adb0', 'b8001728-0010-51bd-8d62-e0629c7c7e00']	['TCGA-2F-A9KP_treatment_1', 'TCGA-2F-A9KP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:54:06.541875-05:00', '']	01	Primary	96e66b43-ffbf-4ad8-95ef-1b9165ad751e	Primary Tumor	Not Reported	916.0	90.0	Unknown	19580F74-7FD9-4366-9FFB-D66D2BC33336	false	Solid Tissue	False	Tumor
TCGA-YF-AA3L-01A	661967e5-94b3-4f98-9402-6ab137893c16	Transitional Cell Papillomas and Carcinomas	661967e5-94b3-4f98-9402-6ab137893c16	TCGA-YF-AA3L	Bladder	3.287671232876712	Not Reported	60.0	not reported	female	hispanic or latino	Alive	47	-17268.0	1966.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	8bafbaaf-ad60-55f2-a665-7b30f5c99909	YF	University of Puerto Rico	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	364.0	17268.0	Transitional cell carcinoma	no	2013.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		17268.0	47.30958904109589	['2019-07-31T16:51:07.851673-05:00', '2019-07-31T16:51:07.851673-05:00']	['8dcc4d5c-cced-593a-ab1c-c0dd06ee044d', 'c3e0c12c-3bd8-5d6d-aad1-70f162bf4736']	['TCGA-YF-AA3L_treatment_1', 'TCGA-YF-AA3L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:54:08.962742-05:00', '']	01	Primary	40849937-c37d-4625-a7d7-38286046621f	Primary Tumor	Not Reported	88.0	80.0	Unknown	B30B0CE0-2C49-4970-A67A-1F777A4E00BB	false	Solid Tissue	False	Tumor
TCGA-K4-A6MB-01A	661d7b4a-a2b2-4251-b464-292421665948	Transitional Cell Papillomas and Carcinomas	661d7b4a-a2b2-4251-b464-292421665948	TCGA-K4-A6MB	Bladder		Not Reported		white	male	not hispanic or latino	Alive	64	-23664.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder	469.0	23664.0	Transitional cell carcinoma	no	2013.0	No	7th	T3b	8120/3	N1	MX	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3	23664.0	64.83287671232877	['2019-07-31T16:51:11.380207-05:00', '2019-07-31T16:51:11.380207-05:00']	['5fd144ae-473d-5314-a9a8-fe0eaf2be144', '86d53b6f-571e-5c43-acf8-2e837295ae54']	['TCGA-K4-A6MB_treatment_1', 'TCGA-K4-A6MB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:54:11.413717-05:00', '']	01	Primary	27fc991d-95c7-4ab1-bd42-cbaf91b199d0	Primary Tumor	Not Reported	84.0	130.0	OCT	1CAB3206-121C-44C6-AD32-6DBCCAA94C94	true	Solid Tissue	False	Tumor
TCGA-KQ-A41N-01A	67cadffc-460b-4a2a-b182-3794421992b4	Transitional Cell Papillomas and Carcinomas	67cadffc-460b-4a2a-b182-3794421992b4	TCGA-KQ-A41N	Bladder	2.73972602739726	Not Reported	50.0	black or african american	male	not hispanic or latino	Alive	73	-26837.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Ureteric orifice	1604.0	26837.0	Transitional cell carcinoma	no	2011.0	No	7th	T3b	8120/3	N0	M0	not reported	C67.6	Ureteric orifice	Not Reported	not reported	T2b	26837.0	73.52602739726028	['2019-07-31T16:51:14.543915-05:00', '2019-07-31T16:51:14.543915-05:00']	['10c29ce4-46c0-54ef-ace5-3eca67b49512', 'f1cd5049-d3d0-519a-9665-16828b9a7d9b']	['TCGA-KQ-A41N_treatment', 'TCGA-KQ-A41N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:13.943518-05:00']	01	Primary	85d9b3ae-d14a-445f-83bf-e4a9f9b076b8	Primary Tumor	Not Reported	555.0	760.0	OCT	3C2A6E9E-9C14-40F5-BD61-7BF5FF26ECC3	true	Solid Tissue	False	Tumor
TCGA-BT-A0S7-01A	68bc786e-07c7-4964-bc88-5e2a8633626a	Transitional Cell Papillomas and Carcinomas	68bc786e-07c7-4964-bc88-5e2a8633626a	TCGA-BT-A0S7	Bladder		Not Reported		white	male	not hispanic or latino	Dead	75	-27533.0	1932.0	200.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		27533.0	Transitional cell carcinoma	no	2007.0	No	6th	T4a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27533.0	75.43287671232876	['2019-07-31T16:51:21.018201-05:00', '2019-07-31T16:51:21.018201-05:00']	['70ffe2f4-febf-5f98-8c0d-447195ca474e', 'd5c8ae36-fb2f-5639-ab71-8de5f3c702c3']	['TCGA-BT-A0S7_treatment_1', 'TCGA-BT-A0S7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:54:18.915644-05:00', '']	01	Primary	a9b73851-4609-4df7-8eb8-45a56f4b2dd6	Primary Tumor	Not Reported	1210.0	910.0	OCT	FF162E4D-8399-4DD8-BCD6-7D4D701CD7E2	true	Solid Tissue	False	Tumor
TCGA-R3-A69X-01A	692a6ced-0246-4e5e-ad2f-20450073f335	Transitional Cell Papillomas and Carcinomas	692a6ced-0246-4e5e-ad2f-20450073f335	TCGA-R3-A69X	Bladder	2.6301369863013697	Not Reported	48.0	white	male	not hispanic or latino	Alive	70	-25576.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	dd8ffcd7-1b24-57cd-b13c-d959f37241df	R3	CHI-Penrose Colorado	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	433.0	25576.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T3a	25576.0	70.07123287671233	['2019-07-31T16:51:29.709845-05:00', '2019-07-31T16:51:29.709845-05:00']	['42bb4fda-6798-5dde-8d17-016064b73030', '8c4313d8-6748-5304-8e58-9373bb8f20c1']	['TCGA-R3-A69X_treatment_1', 'TCGA-R3-A69X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:54:26.558390-05:00', '']	01	Primary	311ccb15-c5d3-4e70-850a-bdf75779238c	Primary Tumor	Not Reported	448.0	420.0	Unknown	65FF34F8-65D4-4DC8-80D8-FED4DB244F4B	false	Solid Tissue	False	Tumor
TCGA-GU-A762-01A	6a1eee8d-cf62-47e9-9322-c18633cb3ee9	Transitional Cell Papillomas and Carcinomas	6a1eee8d-cf62-47e9-9322-c18633cb3ee9	TCGA-GU-A762	Bladder		Not Reported		white	male	not hispanic or latino	Dead	87	-31812.0	1925.0	232.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	62.0	31812.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31812.0	87.15616438356165	['2019-07-31T16:51:32.745443-05:00', '2019-07-31T16:51:32.745443-05:00']	['182770d7-a2eb-58e7-b5ed-45150a42e27f', '745bdc22-2687-5afe-ae2e-40620a9ffeae']	['TCGA-GU-A762_treatment', 'TCGA-GU-A762_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:29.089903-05:00']	01	Primary	e70bf0b1-0e0e-4484-93f2-e312aa575f98	Primary Tumor	Not Reported	386.0	120.0	OCT	3EDC13B8-36AF-4C66-B4A2-38EC382FF39A	true	Solid Tissue	False	Tumor
TCGA-GC-A3RD-01A	6a2155b3-915c-41b1-b730-32e55e0c1fbd	Transitional Cell Papillomas and Carcinomas	6a2155b3-915c-41b1-b730-32e55e0c1fbd	TCGA-GC-A3RD	Bladder		Not Reported		white	female	not hispanic or latino	Alive	83	-30529.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder	428.0	30529.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported		30529.0	83.64109589041095	['2019-07-31T16:51:35.921841-05:00', '2019-07-31T16:51:35.921841-05:00']	['02c12f75-3025-5e49-8bf7-a3463c3db508', 'a399a98b-217b-5d7f-810a-fccc5eae6dad']	['TCGA-GC-A3RD_treatment', 'TCGA-GC-A3RD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:31.739898-05:00']	01	Primary	1c60f60e-a3c6-43a1-a56e-ba68801d2d90	Primary Tumor	Not Reported	77.0	70.0	OCT	4C037ABC-7731-4DD8-A6CC-0F871C09D16F	true	Solid Tissue	False	Tumor
TCGA-CF-A8HY-01A	6a3e87d7-e360-44c5-9764-4b630df383e6	Transitional Cell Papillomas and Carcinomas	6a3e87d7-e360-44c5-9764-4b630df383e6	TCGA-CF-A8HY	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	59	-21636.0	1954.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	345.0	21636.0	Transitional cell carcinoma	no	2013.0	No	6th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21636.0	59.276712328767125	['2019-07-31T16:51:39.004023-05:00', '2019-07-31T16:51:39.004023-05:00']	['5737cca9-002d-55f6-b7af-d0f79654051f', '6c1af1ac-e226-57bc-9dff-5a75be01161d']	['TCGA-CF-A8HY_treatment', 'TCGA-CF-A8HY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:34.233280-05:00']	01	Primary	e8a0dd0b-abd7-4e8e-a9e8-46876d2f99de	Primary Tumor	Not Reported	119.0	360.0	OCT	A2BA1C88-630C-42B0-97E2-B58E22AC8EB3	true	Solid Tissue	False	Tumor
TCGA-LT-A8JT-01A	6aa72ca1-b378-4db4-b4ef-b12386683d1f	Transitional Cell Papillomas and Carcinomas	6aa72ca1-b378-4db4-b4ef-b12386683d1f	TCGA-LT-A8JT	Bladder	4.109589041095891	Not Reported	75.0	white	female	not hispanic or latino	Alive	69	-25498.0	1944.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	2ad17b10-e87e-5a1d-91bc-bd4856c1f3c3	LT	Gundersen Lutheran Health System	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	641.0	25498.0	Papillary transitional cell carcinoma	no	2013.0	No	7th	T2a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25498.0	69.85753424657534	['2019-07-31T16:51:42.161993-05:00', '2019-07-31T16:51:42.161993-05:00']	['99a49678-a35a-52cd-9f51-3ddb65107a08', 'ca375034-8bdf-56c3-a24c-2aa9efa47ea3']	['TCGA-LT-A8JT_treatment_1', 'TCGA-LT-A8JT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:54:36.790997-05:00', '']	01	Primary	a85b114d-2f7b-4678-8508-e3bc04552093	Primary Tumor	Not Reported	303.0	220.0	OCT	69E369C4-2BAA-4E33-9EB9-D9E0487C990B	true	Solid Tissue	False	Tumor
TCGA-XF-A9SI-01A	6b0c8e8d-8aba-413d-85ed-631653f00ca9	Transitional Cell Papillomas and Carcinomas	6b0c8e8d-8aba-413d-85ed-631653f00ca9	TCGA-XF-A9SI	Bladder		Not Reported		asian	female	not hispanic or latino	Alive	73	-26719.0	1933.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2423.0	26719.0	Papillary transitional cell carcinoma	no	2006.0	No	6th	T2b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26719.0	73.2027397260274	['2019-07-31T16:51:45.007603-05:00', '2019-07-31T16:51:45.007603-05:00']	['f0657b09-4a6c-5be3-844b-029de56a30e9', 'faf230b4-c00e-5467-aad5-648e5571aa78']	['TCGA-XF-A9SI_treatment', 'TCGA-XF-A9SI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:39.209282-05:00']	01	Primary	864eca46-7b3f-4ca5-9606-df53bd704130	Primary Tumor	Not Reported	2855.0	950.0	OCT	BB424BA5-5E43-410B-B27C-EFBBDE18DA00	true	Solid Tissue	False	Tumor
TCGA-FJ-A3Z7-01A	6b2d63f2-f390-4601-9640-f769f6e91bf4	Transitional Cell Papillomas and Carcinomas	6b2d63f2-f390-4601-9640-f769f6e91bf4	TCGA-FJ-A3Z7	Bladder		Not Reported		white	male	not hispanic or latino	Alive	76	-28052.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4581f940-fb84-5a4a-ab36-d998d0575df0	FJ	BLN - Baylor	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	945.0	28052.0	Transitional cell carcinoma	yes	2010.0	Yes	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28052.0	76.85479452054794	['2019-07-31T16:51:48.482443-05:00', '2019-07-31T16:51:48.482443-05:00']	['a6252e63-e9b9-5571-aeae-ef3249fb99d1', 'eaddd95a-5e1e-5565-951d-1fb8d4330e21']	['TCGA-FJ-A3Z7_treatment_1', 'TCGA-FJ-A3Z7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:54:41.836956-05:00', '']	01	Primary	59c94c10-41dc-4599-aa18-ae37f3715134	Primary Tumor	Not Reported	539.0	120.0	OCT	67B47EFA-A6C9-40B6-AF17-8A4E1FF6656B	true	Solid Tissue	False	Tumor
TCGA-FD-A5BX-01A	6bd85ae2-9d27-4285-a280-4469dd2a8b0a	Transitional Cell Papillomas and Carcinomas	6bd85ae2-9d27-4285-a280-4469dd2a8b0a	TCGA-FD-A5BX	Bladder	6.082191780821918	Not Reported	111.0	white	male	not hispanic or latino	Dead	82	-30276.0	1930.0	173.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Posterior wall of bladder		30276.0	Transitional cell carcinoma	yes	2012.0	No	7th	T3b	8120/3	N1	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		30276.0	82.94794520547946	['2019-07-31T16:51:51.630884-05:00', '2019-07-31T16:51:51.630884-05:00']	['31d9019c-c9d0-5f34-b926-1e67d203f368', '4da4e88b-363f-596a-808c-4673d246d380']	['TCGA-FD-A5BX_treatment', 'TCGA-FD-A5BX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:44.333956-05:00']	01	Primary	0ac8e522-3c64-42f2-a66f-bd40530a328a	Primary Tumor	Not Reported	146.0	310.0	OCT	0D074A99-0D21-4430-B82F-28E56A0D4242	true	Solid Tissue	False	Tumor
TCGA-DK-A3X1-01A	6bddafde-7004-49b6-80cf-8081cd4b7d44	Transitional Cell Papillomas and Carcinomas	6bddafde-7004-49b6-80cf-8081cd4b7d44	TCGA-DK-A3X1	Bladder	1.095890410958904	Not Reported	20.0	white	female	not hispanic or latino	Alive	78	-28757.0	1931.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Dome of bladder	2009.0	28757.0	Transitional cell carcinoma	yes	2009.0	No	6th	T3	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		28757.0	78.78630136986301	['2019-07-31T16:51:54.460482-05:00', '2019-07-31T16:51:54.460482-05:00']	['2457ebe6-5bc0-5301-a6e3-4eaa6958f68b', 'afc46aee-8b13-58e6-9c7f-3dd602274246']	['TCGA-DK-A3X1_treatment', 'TCGA-DK-A3X1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:46.641519-05:00']	01	Primary	3d440a83-214e-432f-89d2-b523bfe7c6ef	Primary Tumor	Not Reported	1157.0	480.0	OCT	45B099D5-2E5F-4B70-9B17-D37BC5CA0D40	true	Solid Tissue	False	Tumor
TCGA-GD-A76B-01A	6c1ffaf7-fdae-4ab0-8dd1-6738937357ba	Transitional Cell Papillomas and Carcinomas	6c1ffaf7-fdae-4ab0-8dd1-6738937357ba	TCGA-GD-A76B	Bladder		Not Reported		white	female	not hispanic or latino	Dead	86	-31571.0	1927.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4ef80a37-1ea0-5817-98e8-6b6d730448f5	GD	ABS - IUPUI	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	224.0	31571.0	Transitional cell carcinoma	no	2013.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2a	31571.0	86.4958904109589	['2019-07-31T16:51:57.825764-05:00', '2019-07-31T16:51:57.825764-05:00']	['2cfbd09d-d5ae-5590-b056-2d65e2498137', 'a7337e6f-8354-5062-98f7-8f69f255d05c']	['TCGA-GD-A76B_treatment', 'TCGA-GD-A76B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:49.214357-05:00']	01	Primary	575339db-e63d-4778-8386-6d08831d318b	Primary Tumor	Not Reported	121.0	210.0	Unknown	89C0C498-8414-4CF3-A1BE-3AF53C6DE610	false	Solid Tissue	False	Tumor
TCGA-ZF-AA52-01A	6c5f09f0-2019-4440-8554-e8912bce5e98	Transitional Cell Papillomas and Carcinomas	6c5f09f0-2019-4440-8554-e8912bce5e98	TCGA-ZF-AA52	Bladder	0.1095890410958904	Not Reported	2.0	white	male	not hispanic or latino	Dead	70	-25579.0	1939.0	1077.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder		25579.0	Transitional cell carcinoma	no	2009.0	No	6th	T3a	8120/3	NX	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	25579.0	70.07945205479452	['2019-07-31T16:52:00.689330-05:00', '2019-07-31T16:52:00.689330-05:00']	['6d3c57fd-c09c-53d7-90f9-e769209531ad', '9eb6a287-45ed-5126-9ca4-c1a56521e376']	['TCGA-ZF-AA52_treatment', 'TCGA-ZF-AA52_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:54:51.493848-05:00']	01	Primary	1b16d49d-4db7-472c-86be-4be3a1c68624	Primary Tumor	Not Reported	1543.0	130.0	OCT	85DADBA7-A561-4282-B405-9906A8D3678E	true	Solid Tissue	False	Tumor
TCGA-FD-A3SJ-01A	6d8d8169-0c1a-4cdb-be6f-9761c981a369	Transitional Cell Papillomas and Carcinomas	6d8d8169-0c1a-4cdb-be6f-9761c981a369	TCGA-FD-A3SJ	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	59	-21615.0	1951.0	739.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Lateral wall of bladder		21615.0	Transitional cell carcinoma	yes	2010.0	No	7th	T2b	8120/3	N2	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		21615.0	59.21917808219178	['2019-07-31T16:52:03.781368-05:00', '2019-07-31T16:52:03.781368-05:00']	['4e1f536f-1694-5e44-bbc3-ae07b3eb528a', '92817873-291e-534d-83b4-cd002a7e0e0b']	['TCGA-FD-A3SJ_treatment', 'TCGA-FD-A3SJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:54:53.890472-05:00']	01	Primary	491a8898-7cc5-45d9-9502-fd24399c239d	Primary Tumor	Not Reported	785.0	670.0	OCT	58C20FBF-E737-4DA9-9602-AAF4D483371A	true	Solid Tissue	False	Tumor
TCGA-YC-A9TC-01A	6ee03f14-14ac-4cb9-bd23-b69704176301	Transitional Cell Papillomas and Carcinomas	6ee03f14-14ac-4cb9-bd23-b69704176301	TCGA-YC-A9TC	Bladder		Not Reported		white	male	not hispanic or latino	Dead	71	-26283.0	1942.0	20.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	872ae826-350b-59bd-b492-a58ff8eb21ab	YC	Spectrum Health	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		26283.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3		M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	26283.0	72.00821917808219	['2019-07-31T16:52:06.532355-05:00', '2019-07-31T16:52:06.532355-05:00']	['95a83a20-ef3f-5801-830f-86845070cec9', 'e4435263-4cec-577d-9626-05ea66a2f7b1']	['TCGA-YC-A9TC_treatment_1', 'TCGA-YC-A9TC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:54:56.267840-05:00', '']	01	Primary	639fcf4e-d039-4913-b992-ce73aedf87c3	Primary Tumor	Not Reported	39.0	490.0	Unknown	DA4F1C21-0B25-452C-BBC4-B27ECE0216F5	false	Solid Tissue	False	Tumor
TCGA-XF-A9T6-01A	6ee18b9a-3f45-491f-9535-502820cfcf46	Transitional Cell Papillomas and Carcinomas	6ee18b9a-3f45-491f-9535-502820cfcf46	TCGA-XF-A9T6	Bladder		Not Reported		white	female	not hispanic or latino	Alive	88	-32207.0	1920.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	64.0	32207.0	Papillary transitional cell carcinoma	yes	2008.0	No	6th	T3b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		32207.0	88.23835616438356	['2019-07-31T16:52:09.894970-05:00', '2019-07-31T16:52:09.894970-05:00']	['0828ce8d-0404-5a48-9f44-6b7dccb353ac', '1fc2565c-5993-5622-8f28-7e7b79da8a69']	['TCGA-XF-A9T6_treatment', 'TCGA-XF-A9T6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:54:58.749284-05:00']	01	Primary	3ef041c5-ffd2-497e-89b6-0e5c552d279c	Primary Tumor	Not Reported	2044.0	620.0	OCT	84E24E42-02F8-471F-B8A4-B50D89056CA2	true	Solid Tissue	False	Tumor
TCGA-E7-A7DU-01A	6f30b069-c8f5-424c-9fb5-f7dba508cb8b	Transitional Cell Papillomas and Carcinomas	6f30b069-c8f5-424c-9fb5-f7dba508cb8b	TCGA-E7-A7DU	Bladder		Not Reported		white	male	not hispanic or latino	Alive	73	-27000.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Trigone of bladder	28.0	27000.0	Transitional cell carcinoma	yes	2013.0	No	7th	T3	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported		27000.0	73.97260273972603	['2019-07-31T16:52:13.623686-05:00', '2019-07-31T16:52:13.623686-05:00']	['a1b69d08-b4f5-5df8-a98c-5a7bce3023fb', 'dd1331a3-a7ff-5437-ae02-56f1cdb23934']	['TCGA-E7-A7DU_treatment', 'TCGA-E7-A7DU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'not reported']	['', '2019-04-28T09:55:01.457698-05:00']	01	Primary	784e85bb-9c4c-44b4-8bfc-3b2dbc1406c8	Primary Tumor	Not Reported	149.0	1470.0	OCT	BEB0E95C-EDF2-40A5-BB95-588D07369CEE	true	Solid Tissue	False	Tumor
TCGA-FD-A3SR-01A	72d6e9aa-4a99-4fc9-a67b-4631e95fb043	Transitional Cell Papillomas and Carcinomas	72d6e9aa-4a99-4fc9-a67b-4631e95fb043	TCGA-FD-A3SR	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	68	-24979.0	1942.0	602.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Posterior wall of bladder		24979.0	Transitional cell carcinoma	yes	2010.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		24979.0	68.43561643835616	['2019-07-31T15:19:29.004201-05:00', '2019-07-31T15:19:29.004201-05:00']	['add66cd2-36f8-508e-bba8-98a60dce574e', 'c172e428-ff07-57b9-96ad-09a76e9fdc3a']	['TCGA-FD-A3SR_treatment', 'TCGA-FD-A3SR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T08:39:46.941678-05:00']	01	Primary	8e9683f4-52b4-4646-921e-7bf89f56774a	Primary Tumor	Not Reported	569.0	340.0	OCT	04E024F2-1D17-446A-868D-DCC2C2564103	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7R-01A	72fe54b5-c1c8-468a-954a-09992429512a	Transitional Cell Papillomas and Carcinomas	72fe54b5-c1c8-468a-954a-09992429512a	TCGA-4Z-AA7R	Bladder		Not Reported		black or african american	male	not reported	Dead	73	-26781.0	1937.0	522.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Trigone of bladder	493.0	26781.0	Papillary transitional cell carcinoma	no	2010.0	No	7th	T4b	8130/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T2a	26781.0	73.37260273972603	['2019-07-31T17:18:05.495186-05:00', '2019-07-31T17:18:05.495186-05:00']	['4e34466a-176a-5363-9859-75025b6cffe4', '55d666e0-5a46-5643-8077-da40c2fca2a0']	['TCGA-4Z-AA7R_treatment', 'TCGA-4Z-AA7R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:16:18.892302-05:00']	01	Primary	b168a02c-205b-47bf-9a2a-7f951974bc66	Primary Tumor	Not Reported	1189.0	350.0	OCT	0E7DC845-C56F-4179-9972-B1F51F00937D	true	Solid Tissue	False	Tumor
TCGA-FJ-A3Z9-01A	72ff655f-bb08-40ed-b4c3-e9497d4da108	Transitional Cell Papillomas and Carcinomas	72ff655f-bb08-40ed-b4c3-e9497d4da108	TCGA-FJ-A3Z9	Bladder	0.7123287671232876	Not Reported	13.0	white	male	not hispanic or latino	Dead	72	-26515.0	1940.0	385.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4581f940-fb84-5a4a-ab36-d998d0575df0	FJ	BLN - Baylor	Bladder Urothelial Carcinoma	NCH															No		0	not reported	Lateral wall of bladder	217.0	26515.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	TX	8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T3	26515.0	72.64383561643835	['2019-07-31T16:52:20.847347-05:00', '2019-07-31T16:52:20.847347-05:00']	['3227e359-705a-5c1f-9d24-e3a851adba7c', 'b5a31169-b3c3-5c13-91ed-77d9b5b7a926']	['TCGA-FJ-A3Z9_treatment_1', 'TCGA-FJ-A3Z9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:06.338649-05:00', '']	01	Primary	3ac90ddf-5007-4a45-a543-ea942949e030	Primary Tumor	Not Reported	110.0	240.0	OCT	7AE1E138-C824-4547-AA87-F126748DA14D	true	Solid Tissue	False	Tumor
TCGA-BT-A3PK-01A	73041fcf-f3b6-4851-b34d-1d62a1fcf6fe	Transitional Cell Papillomas and Carcinomas	73041fcf-f3b6-4851-b34d-1d62a1fcf6fe	TCGA-BT-A3PK	Bladder		Not Reported		white	male	not hispanic or latino	Dead	80	-29314.0	1931.0	303.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Posterior wall of bladder	63.0	29314.0	Transitional cell carcinoma	yes	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2b	29314.0	80.31232876712329	['2019-07-31T16:52:23.628214-05:00', '2019-07-31T16:52:23.628214-05:00']	['a460f205-853f-5d4e-8100-ba4b8932d76d', 'b308997e-99f9-524f-bef7-ced2aeba31c8']	['TCGA-BT-A3PK_treatment', 'TCGA-BT-A3PK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:08.671942-05:00']	01	Primary	f09e1eeb-bcd5-4dba-92f0-7d4b34b81ce7	Primary Tumor	Not Reported	58.0	300.0	OCT	AD597E1C-BC15-46A3-9B7C-324250540B05	true	Solid Tissue	False	Tumor
TCGA-CF-A9FF-01A	736e8cdf-e2d7-4141-86a9-45c34178a1c8	Transitional Cell Papillomas and Carcinomas	736e8cdf-e2d7-4141-86a9-45c34178a1c8	TCGA-CF-A9FF	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	52	-19195.0	1961.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	361.0	19195.0	Papillary transitional cell carcinoma	no	2013.0	No	6th	T2	8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		19195.0	52.58904109589041	['2019-07-31T16:52:26.825352-05:00', '2019-07-31T16:52:26.825352-05:00']	['74540392-de0a-5fc3-87e2-20f40c4bcc87', 'bcc7e3a1-4ba9-5f28-a70a-2b7d85ae7145']	['TCGA-CF-A9FF_treatment', 'TCGA-CF-A9FF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:11.082855-05:00']	01	Primary	286d1a8d-f384-4a49-a612-8511c5e9a8af	Primary Tumor	Not Reported	106.0	320.0	OCT	6B1308E3-4C23-43B7-9608-1EA6D435525D	true	Solid Tissue	False	Tumor
TCGA-DK-A6B0-01A	73bc18a4-3600-409e-a2b5-e09e2b3f040d	Transitional Cell Papillomas and Carcinomas	73bc18a4-3600-409e-a2b5-e09e2b3f040d	TCGA-DK-A6B0	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Alive	61	-22439.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	2330.0	22439.0	Transitional cell carcinoma	no	2007.0	No	6th	T2b	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		22439.0	61.47671232876712	['2019-07-31T16:52:29.452140-05:00', '2019-07-31T16:52:29.452140-05:00']	['6d69e5ae-943f-5704-bec0-afa338cba815', '878c658d-4418-55fd-a9da-acda29d0e3c8']	['TCGA-DK-A6B0_treatment_1', 'TCGA-DK-A6B0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:55:13.493038-05:00', '']	01	Primary	834bca7a-b13c-4618-b089-be975723a196	Primary Tumor	Not Reported	2115.0	240.0	OCT	39DA362A-CFF2-4A9B-AAC9-963AA207AB37	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RN-01A	73db40ce-2ba7-4a56-aef2-b78d2c744be1	Transitional Cell Papillomas and Carcinomas	73db40ce-2ba7-4a56-aef2-b78d2c744be1	TCGA-ZF-A9RN	Bladder		Not Reported		white	female	not hispanic or latino	Dead	67	-24795.0	1943.0	615.0	2011.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder		24795.0	Transitional cell carcinoma	no	2010.0	No	7th	T3b	8120/3	NX	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T3b	24795.0	67.93150684931507	['2019-07-31T16:52:32.169139-05:00', '2019-07-31T16:52:32.169139-05:00']	['3db8813e-f38f-5a47-b389-cbc46402ff06', 'f5055d28-b051-595c-adfb-75254467b5da']	['TCGA-ZF-A9RN_treatment_1', 'TCGA-ZF-A9RN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:16.196984-05:00', '']	01	Primary	34a093d9-85bd-4e22-814c-60e74b97998b	Primary Tumor	Not Reported	1184.0	260.0	OCT	BA6EAB50-FDB2-4E63-AD3E-E60236ABA7F7	true	Solid Tissue	False	Tumor
TCGA-FD-A62P-01A	741311b6-cb15-498f-932d-ca282e1db10d	Transitional Cell Papillomas and Carcinomas	741311b6-cb15-498f-932d-ca282e1db10d	TCGA-FD-A62P	Bladder		Not Reported		white	male	not hispanic or latino	Dead	76	-27843.0	1936.0	191.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder		27843.0	Transitional cell carcinoma	no	2012.0	Yes	7th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27843.0	76.28219178082192	['2019-07-31T16:52:35.452284-05:00', '2019-07-31T16:52:35.452284-05:00']	['21591f16-c583-5c32-bc7b-b8e29c0433cd', '3dac9e84-839e-50e7-9463-2518a9b5cf35']	['TCGA-FD-A62P_treatment_1', 'TCGA-FD-A62P_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:55:18.704088-05:00', '']	01	Primary	670f42fc-c213-4ba5-bde8-3855c4868168	Primary Tumor	Not Reported	120.0	680.0	OCT	491E768C-1E7C-4461-BFF7-BA846758B39F	true	Solid Tissue	False	Tumor
TCGA-E7-A519-01A	74216d58-9e34-4a2b-b4af-886c4a3dc079	Transitional Cell Papillomas and Carcinomas	74216d58-9e34-4a2b-b4af-886c4a3dc079	TCGA-E7-A519	Bladder	2.73972602739726	Not Reported	50.0	white	male	not hispanic or latino	Alive	72	-26427.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	508.0	26427.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	NX	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26427.0	72.40273972602739	['2019-07-31T16:52:38.654174-05:00', '2019-07-31T16:52:38.654174-05:00']	['17e1e28b-f48a-5950-9683-822fc25fafb2', 'e1a789a7-6dce-509b-a099-c87287e6d7bb']	['TCGA-E7-A519_treatment', 'TCGA-E7-A519_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:21.145427-05:00']	01	Primary	a7760929-71ca-4792-9828-2fddff3fca3c	Primary Tumor	Not Reported	125.0	550.0	OCT	6CF5659C-C6A7-4019-B368-86A6525D4035	true	Solid Tissue	False	Tumor
TCGA-BT-A20J-01A	74b1e72d-fdd0-4d84-8858-3bb32d58ff7e	Transitional Cell Papillomas and Carcinomas	74b1e72d-fdd0-4d84-8858-3bb32d58ff7e	TCGA-BT-A20J	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	75	-27646.0	1924.0	579.0	2000.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder		27646.0	Transitional cell carcinoma	no	1999.0	No	5th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2b	27646.0	75.74246575342465	['2019-07-31T16:52:41.976934-05:00', '2019-07-31T16:52:41.976934-05:00']	['1ce323bd-8e43-5143-92c1-00047ba71e2c', 'e4fb368d-e9ce-51ef-940f-b61c0232a18b']	['TCGA-BT-A20J_treatment', 'TCGA-BT-A20J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:23.526846-05:00']	01	Primary	ad4e36cd-0036-4f63-bb06-d32b51acac7a	Primary Tumor		4466.0	300.0	OCT	74E5CF6B-F334-44D7-944E-8E59879AAE90	true	Solid Tissue	False	Tumor
TCGA-BT-A20J-11A	74b1e72d-fdd0-4d84-8858-3bb32d58ff7e	Transitional Cell Papillomas and Carcinomas	74b1e72d-fdd0-4d84-8858-3bb32d58ff7e	TCGA-BT-A20J	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	75	-27646.0	1924.0	579.0	2000.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder		27646.0	Transitional cell carcinoma	no	1999.0	No	5th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2b	27646.0	75.74246575342465	['2019-07-31T16:52:41.976934-05:00', '2019-07-31T16:52:41.976934-05:00']	['1ce323bd-8e43-5143-92c1-00047ba71e2c', 'e4fb368d-e9ce-51ef-940f-b61c0232a18b']	['TCGA-BT-A20J_treatment', 'TCGA-BT-A20J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:23.526846-05:00']	11	Not Applicable	c53a13ef-44cd-49af-b69c-82c5c11a3ab4	Solid Tissue Normal		4466.0	240.0	OCT		true	Solid Tissue	False	Normal
TCGA-GC-A3I6-01A	74cbb078-9aae-422a-a7af-dd29ebca949e	Transitional Cell Papillomas and Carcinomas	74cbb078-9aae-422a-a7af-dd29ebca949e	TCGA-GC-A3I6	Bladder		Not Reported		white	male	not hispanic or latino	Dead	45	-16504.0	1966.0	630.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	68.0	16504.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		16504.0	45.21643835616438	['2019-07-31T16:52:45.110601-05:00', '2019-07-31T16:52:45.110601-05:00']	['346e6ce9-6157-52ff-bc9c-07b76be25a36', '7cc5140f-6384-50c6-a588-fc60dfb0616b']	['TCGA-GC-A3I6_treatment_1', 'TCGA-GC-A3I6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:25.915275-05:00', '']	01	Primary	db9442f6-38f2-4092-9e85-f5ec0c924025	Primary Tumor	Not Reported	132.0	320.0	Unknown	FFC0F91A-AC95-4E02-BE22-EBDAE89AB5EA	false	Solid Tissue	False	Tumor
TCGA-XF-A9SP-01A	76388364-eb01-4b16-a2b9-0b6c05b4b386	Transitional Cell Papillomas and Carcinomas	76388364-eb01-4b16-a2b9-0b6c05b4b386	TCGA-XF-A9SP	Bladder	3.6164383561643834	Not Reported	66.0	white	male	not hispanic or latino	Dead	59	-21776.0	1945.0	454.0	2005.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		21776.0	Transitional cell carcinoma	yes	2004.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21776.0	59.66027397260274	['2019-07-31T15:59:04.302091-05:00', '2019-07-31T15:59:04.302091-05:00']	['5ed9b063-ea22-5508-bdd5-7028fc6580c1', '955032ec-165f-5463-93bd-af2a6c858408']	['TCGA-XF-A9SP_treatment_1', 'TCGA-XF-A9SP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:13:16.313235-05:00', '']	01	Primary	51998fd1-4a8a-4014-853f-faaeb0bce6f0	Primary Tumor	Not Reported	3382.0	430.0	OCT	E5DD1503-9CED-449F-8312-3BD96D9ED951	true	Solid Tissue	False	Tumor
TCGA-S5-A6DX-01A	76400a3d-45c4-47f8-bd81-0a345a949a1f	Transitional Cell Papillomas and Carcinomas	76400a3d-45c4-47f8-bd81-0a345a949a1f	TCGA-S5-A6DX	Bladder	3.835616438356164	Not Reported	70.0	white	male	not hispanic or latino	Dead	83	-30594.0	1930.0	56.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	91e46035-31fd-5ade-839f-9b75517a3add	S5	 University of Oklahoma HSC	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		30594.0	Transitional cell carcinoma	no	2013.0	No	7th	T4a	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	30594.0	83.81917808219178	['2019-07-31T16:52:48.242047-05:00', '2019-07-31T16:52:48.242047-05:00']	['61beb81f-4a84-5d1c-87b7-9c6e1c954226', 'ff18f3bd-7ce4-5c7e-9605-6a44e9cc5cc7']	['TCGA-S5-A6DX_treatment', 'TCGA-S5-A6DX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:28.565254-05:00']	01	Primary	bfe6a8b9-7c89-471d-b728-e9b34fabf4db	Primary Tumor	Not Reported	113.0	340.0	OCT	8CDBA39E-6DF0-4EDA-BEF9-0864B0AE5B42	true	Solid Tissue	False	Tumor
TCGA-FD-A43S-01A	77236911-d9e0-4b85-829a-a98f1e4b92d2	Transitional Cell Papillomas and Carcinomas	77236911-d9e0-4b85-829a-a98f1e4b92d2	TCGA-FD-A43S	Bladder	8.219178082191782	Not Reported	150.0	white	female	not hispanic or latino	Alive	71	-25993.0	1941.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	455.0	25993.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T2	25993.0	71.21369863013699	['2019-07-31T16:52:51.508299-05:00', '2019-07-31T16:52:51.508299-05:00']	['bd87a0ad-0aa6-524a-a363-06f0b61c5c49', 'd1e2ed7a-9e7d-5d91-86c3-f25a052f7812']	['TCGA-FD-A43S_treatment', 'TCGA-FD-A43S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:55:31.565017-05:00']	01	Primary	6eb06b71-55d3-4356-8198-bb2643c29e45	Primary Tumor	Not Reported	127.0	1040.0	OCT	E9828A9C-1DD0-45ED-A033-32140DB0C2A2	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7N-01A	7934bd8c-0822-44a3-88a4-a3135a448f2b	Transitional Cell Papillomas and Carcinomas	7934bd8c-0822-44a3-88a4-a3135a448f2b	TCGA-4Z-AA7N	Bladder		Not Reported		white	male	not reported	Dead	65	-24090.0	1945.0	1367.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	655.0	24090.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	24090.0	66.0	['2019-07-31T16:52:57.391148-05:00', '2019-07-31T16:52:57.391148-05:00']	['3714e097-47dd-5210-916a-bfecc294ca1f', '95cf3cca-0268-5fe2-bd58-6688b701b6ef']	['TCGA-4Z-AA7N_treatment_1', 'TCGA-4Z-AA7N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:55:36.412292-05:00', '']	01	Primary	8d9b8713-9cd7-484b-9e71-6f381d00c5c3	Primary Tumor	Not Reported	1347.0	70.0	OCT	2CC89A9F-1F30-4232-B960-D8F54E7C57D4	true	Solid Tissue	False	Tumor
TCGA-4Z-AA83-01A	7976dbb0-57b0-463e-a766-126e23825743	Transitional Cell Papillomas and Carcinomas	7976dbb0-57b0-463e-a766-126e23825743	TCGA-4Z-AA83	Bladder		Not Reported		white	male	not reported	Alive	52	-19280.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	2024.0	19280.0	Papillary transitional cell carcinoma	no	2009.0	No	7th	T2a	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	19280.0	52.821917808219176	['2019-07-31T16:53:00.497434-05:00', '2019-07-31T16:53:00.497434-05:00']	['21e511ea-6776-5538-b8e8-5860789e4dc9', 'f1a00dcb-4646-5547-b5f9-fa19d2fb2146']	['TCGA-4Z-AA83_treatment_1', 'TCGA-4Z-AA83_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:55:38.716268-05:00', '']	01	Primary	ffa67234-ec2a-4e86-a4d8-d35c5266d985	Primary Tumor	Not Reported	1701.0	340.0	OCT	C177DD54-DBBB-44F1-9476-D5D1E543DE04	true	Solid Tissue	False	Tumor
TCGA-BT-A2LA-01A	797a71ee-372d-41e5-aeee-5ab3c4661110	Transitional Cell Papillomas and Carcinomas	797a71ee-372d-41e5-aeee-5ab3c4661110	TCGA-BT-A2LA	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Alive	54	-20032.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Dome of bladder	522.0	20032.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T3a	20032.0	54.88219178082192	['2019-07-31T16:53:04.386639-05:00', '2019-07-31T16:53:04.386639-05:00']	['4c23359d-908e-5cd5-a1c6-79dcc1b87e59', 'c653406a-ba51-5d81-8677-3bce7f5fbf0e']	['TCGA-BT-A2LA_treatment_1', 'TCGA-BT-A2LA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:41.195205-05:00', '']	01	Primary	6ed52558-8039-4658-a245-78a29968ce2f	Primary Tumor	Not Reported	257.0	160.0	OCT	872A05BE-966A-4757-9FED-9FD4FFA460CC	true	Solid Tissue	False	Tumor
TCGA-BT-A2LA-11A	797a71ee-372d-41e5-aeee-5ab3c4661110	Transitional Cell Papillomas and Carcinomas	797a71ee-372d-41e5-aeee-5ab3c4661110	TCGA-BT-A2LA	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Alive	54	-20032.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Dome of bladder	522.0	20032.0	Transitional cell carcinoma	no	2010.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T3a	20032.0	54.88219178082192	['2019-07-31T16:53:04.386639-05:00', '2019-07-31T16:53:04.386639-05:00']	['4c23359d-908e-5cd5-a1c6-79dcc1b87e59', 'c653406a-ba51-5d81-8677-3bce7f5fbf0e']	['TCGA-BT-A2LA_treatment_1', 'TCGA-BT-A2LA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:41.195205-05:00', '']	11	Not Applicable	f12723ef-51a8-4071-b612-b47a14c2b459	Solid Tissue Normal	Not Reported	257.0	200.0	OCT		true	Solid Tissue	False	Normal
TCGA-CU-A5W6-01A	7a7fcdd3-cce9-47cf-a26f-cc6ff34ecd9a	Transitional Cell Papillomas and Carcinomas	7a7fcdd3-cce9-47cf-a26f-cc6ff34ecd9a	TCGA-CU-A5W6	Bladder	2.0273972602739727	Not Reported	37.0	white	male	not hispanic or latino	Dead	70	-25706.0	1942.0	56.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c6e76462-00bf-53a7-a71b-dca5944c4690	CU	UNC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		25706.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25706.0	70.42739726027398	['2019-07-31T16:53:09.999009-05:00', '2019-07-31T16:53:09.999009-05:00']	['267e8e72-081d-5980-a9b5-fcbd7e31ee44', 'aba40ce7-6e6f-5bb6-a43f-2102128b0303']	['TCGA-CU-A5W6_treatment', 'TCGA-CU-A5W6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:45.940546-05:00']	01	Primary	ca04ec9f-df17-4a7c-ac61-3f9ac4d8e546	Primary Tumor	Not Reported	133.0	300.0	Unknown	16450945-2661-4167-84D2-9469077B4CDD	false	Solid Tissue	False	Tumor
TCGA-FT-A61P-01A	7c698a35-7694-47f0-b681-f08840b95c02	Transitional Cell Papillomas and Carcinomas	7c698a35-7694-47f0-b681-f08840b95c02	TCGA-FT-A61P	Bladder	0.2191780821917808	Not Reported	4.0	white	male	not hispanic or latino	Alive	76	-28082.0	1937.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	02efc747-0acd-56a7-9da3-e8c2358cd50b	FT	BLN - University of Miami	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	337.0	28082.0	Transitional cell carcinoma	yes	2013.0	No	7th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28082.0	76.93698630136986	['2019-07-31T16:53:16.039323-05:00', '2019-07-31T16:53:16.039323-05:00']	['a700bc82-0e14-5a9f-af4b-2bc01f0f0576', 'b535ad56-1f6a-5e66-9769-5943b6f191ff']	['TCGA-FT-A61P_treatment', 'TCGA-FT-A61P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:55:50.868850-05:00']	01	Primary	871de767-c6af-41a7-87cd-641cf2f59aa4	Primary Tumor	Not Reported	83.0	250.0	OCT	F2B10F1A-5A97-4FAE-8DF5-153FFBDE2C35	true	Solid Tissue	False	Tumor
TCGA-SY-A9G5-01A	7d198ee2-d80a-4759-804f-a7ef85971843	Transitional Cell Papillomas and Carcinomas	7d198ee2-d80a-4759-804f-a7ef85971843	TCGA-SY-A9G5	Bladder		Not Reported		white	male	not hispanic or latino	Alive	66	-24260.0	1945.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6761081a-af3f-57f8-bd98-4243cfb8c9e9	SY	Mayo Clinic Arizona	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1186.0	24260.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	24260.0	66.46575342465754	['2019-07-31T16:53:19.208905-05:00', '2019-07-31T16:53:19.208905-05:00']	['ce492c4e-b9ca-51e7-8752-d6b68b2995ff', 'e80ade62-e2c6-5d16-a489-a4e04e5d198a']	['TCGA-SY-A9G5_treatment_1', 'TCGA-SY-A9G5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:55:53.395376-05:00', '']	01	Primary	d3afd0db-926a-4df8-9499-af5523e243e3	Primary Tumor	Not Reported	805.0	90.0	OCT	9D1D2500-3E1D-4FDB-B2BC-3B215FB7F9C6	true	Solid Tissue	False	Tumor
TCGA-ZF-A9RM-01A	7d71945a-b81a-405c-bb17-cec9b1d7592c	Transitional Cell Papillomas and Carcinomas	7d71945a-b81a-405c-bb17-cec9b1d7592c	TCGA-ZF-A9RM	Bladder	0.4383561643835616	Not Reported	8.0	white	male	not hispanic or latino	Alive	70	-25642.0	1940.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1455.0	25642.0	Transitional cell carcinoma	no	2010.0	No	7th	T0	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	25642.0	70.25205479452055	['2019-07-31T16:53:22.353170-05:00', '2019-07-31T16:53:22.353170-05:00']	['172b8f16-70f8-5a60-8e13-36588d85721b', '3293ddcb-fcf4-554f-8b00-ac90c3b96c87']	['TCGA-ZF-A9RM_treatment_1', 'TCGA-ZF-A9RM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:55:55.768836-05:00', '']	01	Primary	6167b47f-c0ed-4aaf-af10-271eef31b663	Primary Tumor	Not Reported	1133.0	230.0	OCT	F5403E2C-C4B0-4F82-A4E8-E210017FC34B	true	Solid Tissue	False	Tumor
TCGA-CF-A27C-01A	7fee9d6f-c0ea-43c2-89c2-66d965a077a8	Transitional Cell Papillomas and Carcinomas	7fee9d6f-c0ea-43c2-89c2-66d965a077a8	TCGA-CF-A27C	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	52	-19270.0	1959.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	425.0	19270.0	Papillary transitional cell carcinoma	no	2011.0	No	6th	T3	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19270.0	52.794520547945204	['2019-07-31T17:18:09.404619-05:00', '2019-07-31T17:18:09.404619-05:00']	['3dcb878e-7949-5e2f-b15b-a0c682f97402', '6d153018-de4f-535d-a9da-ec95638a9887']	['TCGA-CF-A27C_treatment', 'TCGA-CF-A27C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:16:21.337466-05:00']	01	Primary	ead6792b-4e52-4c28-891c-6d8696873a13	Primary Tumor		79.0	430.0	OCT	F8FF65C1-F032-4CED-A0EA-FFDBA1E25DC2	true	Solid Tissue	False	Tumor
TCGA-XF-A9SG-01A	80fd5a84-4d82-49ab-ba78-9636f1989fca	Transitional Cell Papillomas and Carcinomas	80fd5a84-4d82-49ab-ba78-9636f1989fca	TCGA-XF-A9SG	Bladder		Not Reported		not reported	male	hispanic or latino	Alive	81	-29825.0	1925.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1479.0	29825.0	Transitional cell carcinoma	no	2006.0	No	6th	T2a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29825.0	81.71232876712328	['2019-07-31T16:53:25.375371-05:00', '2019-07-31T16:53:25.375371-05:00']	['57df13a0-2ccd-5e98-9d47-517cbcefa9da', 'c3560c87-6710-563e-9feb-42f295a010eb']	['TCGA-XF-A9SG_treatment_1', 'TCGA-XF-A9SG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:55:58.517595-05:00', '']	01	Primary	72036b48-88b3-4046-8335-b92134372302	Primary Tumor	Not Reported	2834.0	660.0	OCT	FD5739DB-DC2E-4291-ADBD-12C12EFCACCF	true	Solid Tissue	False	Tumor
TCGA-XF-AAMR-01A	818f5a45-4deb-49e4-9a73-55ef4269de4c	Transitional Cell Papillomas and Carcinomas	818f5a45-4deb-49e4-9a73-55ef4269de4c	TCGA-XF-AAMR	Bladder		Not Reported		white	male	not hispanic or latino	Alive	48	-17670.0	1958.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	2790.0	17670.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		17670.0	48.41095890410959	['2019-07-31T16:53:31.405957-05:00', '2019-07-31T16:53:31.405957-05:00']	['67021d3f-f533-512a-a069-7305d3d54245', 'dd3cda01-4a6e-5b47-90c9-248b2cbe6c38']	['TCGA-XF-AAMR_treatment', 'TCGA-XF-AAMR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:56:03.222617-05:00']	01	Primary	91b24777-efd1-42ed-8fa3-c873d8b79ab0	Primary Tumor	Not Reported	2686.0	750.0	OCT	907112FF-1E09-4BD1-97BE-01E9BAC0E4D9	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7W-01A	821b99bc-7e14-45b9-898d-6e8e149bc8a7	Transitional Cell Papillomas and Carcinomas	821b99bc-7e14-45b9-898d-6e8e149bc8a7	TCGA-4Z-AA7W	Bladder		Not Reported		white	male	not reported	Alive	55	-20424.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	840.0	20424.0	Transitional cell carcinoma	no	2012.0	No	7th	T2a	8120/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2a	20424.0	55.95616438356164	['2019-07-31T16:53:34.240742-05:00', '2019-07-31T16:53:34.240742-05:00']	['37fa6ea0-add8-50f8-8207-36f41abe5306', 'cde4559d-0b86-541a-9dee-6e205e65d4b3']	['TCGA-4Z-AA7W_treatment', 'TCGA-4Z-AA7W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:05.525690-05:00']	01	Primary	b6ff3630-077b-4878-b4fc-731600c6368d	Primary Tumor	Not Reported	518.0	140.0	OCT	07E6E6FB-7E6B-4439-937A-9D479EFC7515	true	Solid Tissue	False	Tumor
TCGA-CF-A47X-01A	82d5f37f-5a1b-49d8-b990-ac222b4e1c1d	Transitional Cell Papillomas and Carcinomas	82d5f37f-5a1b-49d8-b990-ac222b4e1c1d	TCGA-CF-A47X	Bladder	1.095890410958904	Not Reported	20.0	asian	male	not hispanic or latino	Alive	60	-22200.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	384.0	22200.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	22200.0	60.821917808219176	['2019-07-31T16:53:37.170307-05:00', '2019-07-31T16:53:37.170307-05:00']	['a86b9241-b6d0-595e-86ca-0582536586bd', 'c0965845-3404-5d44-b027-1e6d3d1326fb']	['TCGA-CF-A47X_treatment', 'TCGA-CF-A47X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:56:08.095036-05:00']	01	Primary	3571832f-968e-48cb-adbf-67f1f8e95b52	Primary Tumor	Not Reported	151.0	460.0	OCT	F3D1CD04-8E47-455D-9DA3-30CA82805AFB	true	Solid Tissue	False	Tumor
TCGA-XF-AAMQ-01A	82f4c181-e022-4799-9f7f-01abcdc3803e	Transitional Cell Papillomas and Carcinomas	82f4c181-e022-4799-9f7f-01abcdc3803e	TCGA-XF-AAMQ	Bladder	0.6575342465753424	Not Reported	12.0	white	female	not hispanic or latino	Alive	59	-21660.0	1947.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	2177.0	21660.0	Papillary transitional cell carcinoma	no	2006.0	No	6th	T2a	8130/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		21660.0	59.342465753424655	['2019-07-31T16:53:40.202135-05:00', '2019-07-31T16:53:40.202135-05:00']	['45157245-c2a3-556d-8cf1-9b98b95b3c4a', '7feaa00d-51cc-5496-8783-1c336c1fb8c6']	['TCGA-XF-AAMQ_treatment', 'TCGA-XF-AAMQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:10.446560-05:00']	01	Primary	6b4530dd-edd5-4bf5-b6b2-d58177ae6082	Primary Tumor	Not Reported	2785.0	570.0	OCT	6A895DCD-0417-4FC1-AE0C-CB72BE55E889	true	Solid Tissue	False	Tumor
TCGA-4Z-AA7O-01A	835084d6-9f1e-408b-a58c-9d60493bbc6a	Transitional Cell Papillomas and Carcinomas	835084d6-9f1e-408b-a58c-9d60493bbc6a	TCGA-4Z-AA7O	Bladder		Not Reported		black or african american	male	not reported	Alive	64	-23645.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	512.0	23645.0	Papillary transitional cell carcinoma	no	2013.0	No	7th	T2a	8130/3	N0	M0	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		23645.0	64.78082191780823	['2019-07-31T16:53:43.378395-05:00', '2019-07-31T16:53:43.378395-05:00']	['441b2968-a6fb-5942-ab36-9aa868a7bd5c', 'ebcae0d5-8709-5b2f-bfc8-d1d2e64db234']	['TCGA-4Z-AA7O_treatment_1', 'TCGA-4Z-AA7O_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:12.863096-05:00', '']	01	Primary	ce2b1693-5b06-436a-8cde-7d7ee48a84e1	Primary Tumor	Not Reported	189.0	380.0	OCT	1B91CBCE-11F7-4B83-BF5B-CBA6F9CEB799	true	Solid Tissue	False	Tumor
TCGA-CF-A9FH-01A	83a369ae-003b-432b-a7b2-c630805b43c1	Transitional Cell Papillomas and Carcinomas	83a369ae-003b-432b-a7b2-c630805b43c1	TCGA-CF-A9FH	Bladder	4.383561643835616	Not Reported	80.0	asian	male	not hispanic or latino	Alive	85	-31236.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	-64.0	31236.0	Papillary transitional cell carcinoma	no	2013.0	No	6th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31236.0	85.57808219178082	['2019-07-31T16:53:46.464554-05:00', '2019-07-31T16:53:46.464554-05:00']	['1dfbf1c2-173e-5790-9acb-28127248e419', '84fe61c4-54b3-57e0-822a-5fbe7397425c']	['TCGA-CF-A9FH_treatment_1', 'TCGA-CF-A9FH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:15.277103-05:00', '']	01	Primary	8688b33d-76b7-4223-b647-d9b893d94041	Primary Tumor	Not Reported	97.0	270.0	OCT	3F6B75DD-B8BE-42A1-AF6A-73B030EDD6FD	true	Solid Tissue	False	Tumor
TCGA-BT-A20U-11A	83b41d35-69b1-4218-be1a-8821d8a6899c	Transitional Cell Papillomas and Carcinomas	83b41d35-69b1-4218-be1a-8821d8a6899c	TCGA-BT-A20U	Bladder		Not Reported		white	female	not hispanic or latino	Dead	70	-25761.0	1938.0	455.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder		25761.0	Transitional cell carcinoma	no	2008.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	25761.0	70.57808219178082	['2019-07-31T16:53:49.537692-05:00', '2019-07-31T16:53:49.537692-05:00']	['e6d75ded-bbbe-5eb0-a903-366350d0ee5e', 'fff71c42-024a-520e-98b6-0660f578163e']	['TCGA-BT-A20U_treatment_1', 'TCGA-BT-A20U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:17.660271-05:00', '']	11	Not Applicable	996ee634-a7f1-4273-80d2-adbd68d5a1ce	Solid Tissue Normal		1174.0	260.0	OCT		true	Solid Tissue	False	Normal
TCGA-BT-A20U-01A	83b41d35-69b1-4218-be1a-8821d8a6899c	Transitional Cell Papillomas and Carcinomas	83b41d35-69b1-4218-be1a-8821d8a6899c	TCGA-BT-A20U	Bladder		Not Reported		white	female	not hispanic or latino	Dead	70	-25761.0	1938.0	455.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Trigone of bladder		25761.0	Transitional cell carcinoma	no	2008.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	25761.0	70.57808219178082	['2019-07-31T16:53:49.537692-05:00', '2019-07-31T16:53:49.537692-05:00']	['e6d75ded-bbbe-5eb0-a903-366350d0ee5e', 'fff71c42-024a-520e-98b6-0660f578163e']	['TCGA-BT-A20U_treatment_1', 'TCGA-BT-A20U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:17.660271-05:00', '']	01	Primary	d29e555f-8467-45c8-9124-0e6a757b1adf	Primary Tumor		1174.0	160.0	OCT	F1C2F8C6-C3F6-4E69-90FE-E55A44571779	true	Solid Tissue	False	Tumor
TCGA-XF-A8HE-01A	841b4582-a268-4a55-a9a2-47c7e5c3b69f	Transitional Cell Papillomas and Carcinomas	841b4582-a268-4a55-a9a2-47c7e5c3b69f	TCGA-XF-A8HE	Bladder		Not Reported		white	male	not hispanic or latino	Alive	47	-17212.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	3817.0	17212.0	Transitional cell carcinoma	no	2004.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		17212.0	47.156164383561645	['2019-07-31T16:53:52.473761-05:00', '2019-07-31T16:53:52.473761-05:00']	['20b3a9f9-1ef1-5385-a32b-a78d81468a85', '7ec79a1c-39c3-50fa-855f-b4f73c67448a']	['TCGA-XF-A8HE_treatment_1', 'TCGA-XF-A8HE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:19.968510-05:00', '']	01	Primary	fc7aeb8e-4258-47d0-b53b-aa4c358252ad	Primary Tumor	Not Reported	3457.0	810.0	OCT	AC201676-ED94-488A-BCC3-A9302FDF1D48	true	Solid Tissue	False	Tumor
TCGA-E7-A8O8-01A	854e5236-f2d6-4681-be62-0bead955c926	Transitional Cell Papillomas and Carcinomas	854e5236-f2d6-4681-be62-0bead955c926	TCGA-E7-A8O8	Bladder	0.7123287671232876	Not Reported	13.0	asian	male	not hispanic or latino	Alive	59	-21629.0	1954.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	13.0	21629.0	Transitional cell carcinoma	no	2013.0	No	7th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	21629.0	59.25753424657534	['2019-07-31T16:53:55.479097-05:00', '2019-07-31T16:53:55.479097-05:00']	['25419b08-023c-5122-af4b-f70e46e536c9', 'bf42ebfd-d3bb-53cb-baa2-25af74a3af88']	['TCGA-E7-A8O8_treatment', 'TCGA-E7-A8O8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'not reported']	['', '2019-04-28T09:56:22.244634-05:00']	01	Primary	c867c28d-635d-4074-a148-04c4b29fc410	Primary Tumor	Not Reported	105.0	620.0	OCT	F6B4EF0F-8E4C-4B07-B946-3D55CB975799	true	Solid Tissue	False	Tumor
TCGA-XF-A8HF-01A	8573e114-ac20-4113-a942-01f2d1562a7b	Transitional Cell Papillomas and Carcinomas	8573e114-ac20-4113-a942-01f2d1562a7b	TCGA-XF-A8HF	Bladder	0.0547945205479452	Not Reported	1.0	white	male	not hispanic or latino	Dead	80	-29288.0	1924.0	2954.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1709.0	29288.0	Transitional cell carcinoma	no	2004.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		29288.0	80.24109589041096	['2019-07-31T16:53:58.620891-05:00', '2019-07-31T16:53:58.620891-05:00']	['ce70576b-591c-5840-96b9-d1077c7d3555', 'f4b58e89-8402-5f9c-a7ff-86a34247f9b2']	['TCGA-XF-A8HF_treatment', 'TCGA-XF-A8HF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:24.450887-05:00']	01	Primary	c9772460-2d06-4e6b-8804-b9a227311d58	Primary Tumor	Not Reported	3418.0	150.0	OCT	1276CC52-8D49-40E9-A365-3E065E1B77EA	true	Solid Tissue	False	Tumor
TCGA-DK-A1AD-01A	88a521ce-a5e9-4c6f-83d4-ec36a62fedb6	Transitional Cell Papillomas and Carcinomas	88a521ce-a5e9-4c6f-83d4-ec36a62fedb6	TCGA-DK-A1AD	Bladder		Not Reported		white	male	not reported	Alive	69	-25317.0	1933.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	3420.0	25317.0	Transitional cell carcinoma	no	2002.0	No	5th	T3b	8120/3	N2	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25317.0	69.36164383561643	['2019-07-31T15:19:16.867916-05:00', '2019-07-31T15:19:16.867916-05:00']	['9f078494-a8c6-5b4f-91e3-868c353aa864', 'b738bbc2-921d-5077-b872-0a092b469b8b']	['TCGA-DK-A1AD_treatment', 'TCGA-DK-A1AD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'not reported']	['', '2019-04-28T08:39:37.143225-05:00']	01	Primary	c79f4327-675d-4651-994d-e683096df9c3	Primary Tumor	Not Reported	3101.0	210.0	OCT	E4D38398-CB3D-431A-8A1A-192565082A98	true	Solid Tissue	False	Tumor
TCGA-FD-A3B4-01A	899f8d52-4c3a-4371-90eb-1f106001eddc	Transitional Cell Papillomas and Carcinomas	899f8d52-4c3a-4371-90eb-1f106001eddc	TCGA-FD-A3B4	Bladder	1.643835616438356	Not Reported	30.0	black or african american	female	not hispanic or latino	Dead	55	-20379.0	1956.0	510.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	477.0	20379.0	Transitional cell carcinoma	no	2011.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported	T2	20379.0	55.83287671232877	['2019-07-31T16:54:04.564378-05:00', '2019-07-31T16:54:04.564378-05:00']	['9a0379a9-9932-5e69-a447-c4a33db66e12', 'f3e2800a-2bda-5eab-ba7e-ff282e9dff13']	['TCGA-FD-A3B4_treatment_1', 'TCGA-FD-A3B4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:56:29.300991-05:00', '']	01	Primary	6895a68f-0efd-4b0e-8cf2-9195833dbba1	Primary Tumor	Not Reported	141.0	310.0	Unknown	164CD26F-CF77-4490-BFD5-BDA5B81AC30E	false	Solid Tissue	False	Tumor
TCGA-XF-A9SY-01A	8a83f744-8469-41ef-a4cd-e983f849383f	Transitional Cell Papillomas and Carcinomas	8a83f744-8469-41ef-a4cd-e983f849383f	TCGA-XF-A9SY	Bladder	2.191780821917808	Not Reported	40.0	white	female	not hispanic or latino	Alive	60	-22212.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	640.0	22212.0	Transitional cell carcinoma	yes	2006.0	No	6th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		22212.0	60.85479452054795	['2019-07-31T17:18:12.184448-05:00', '2019-07-31T17:18:12.184448-05:00']	['5d4d9508-8d5f-5a67-8d76-50b3602c494f', 'c21979e0-34c6-5b74-8085-dce625bfe110']	['TCGA-XF-A9SY_treatment_1', 'TCGA-XF-A9SY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T10:16:23.756671-05:00', '']	01	Primary	dc0fdf8b-079e-423d-b27e-471582e1c0cf	Primary Tumor	Not Reported	2734.0	360.0	OCT	FACDA2AA-EE41-4EF5-8599-E72249E4B715	true	Solid Tissue	False	Tumor
TCGA-K4-A4AB-01B	8b7556ed-2dab-4180-af5b-0e113e26b36e	Transitional Cell Papillomas and Carcinomas	8b7556ed-2dab-4180-af5b-0e113e26b36e	TCGA-K4-A4AB	Bladder		Not Reported		white	male	not hispanic or latino	Not Reported	76	-27922.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	84.0	27922.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27922.0	76.4986301369863	['2019-07-31T16:54:10.553599-05:00', '2019-07-31T16:54:10.553599-05:00']	['78abc62d-cff9-5fb6-969c-e6b09428c01c', 'dece9062-45c0-5243-a964-104df97854e2']	['TCGA-K4-A4AB_treatment', 'TCGA-K4-A4AB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:33.767621-05:00']	01	Primary	01ce305a-0181-4485-8860-f5b13851a22e	Primary Tumor	Not Reported	189.0	130.0	OCT	A23011FA-CE59-4D74-8EBC-7B02AA30E1D1	true	Solid Tissue	False	Tumor
TCGA-FD-A3N6-01A	8c1dd7f7-b74a-4fa2-b6a7-86f0348d2567	Transitional Cell Papillomas and Carcinomas	8c1dd7f7-b74a-4fa2-b6a7-86f0348d2567	TCGA-FD-A3N6	Bladder	0.4520547945205479	Not Reported	8.25	black or african american	female	not hispanic or latino	Alive	43	-15758.0	1968.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Anterior wall of bladder	851.0	15758.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		15758.0	43.172602739726024	['2019-07-31T16:54:13.683809-05:00', '2019-07-31T16:54:13.683809-05:00']	['73ce33a6-0230-5ebf-b684-ab77ed722095', 'd86dcd3a-21f6-5be9-86eb-556afcf779f9']	['TCGA-FD-A3N6_treatment_1', 'TCGA-FD-A3N6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:56:36.220373-05:00', '']	01	Primary	6cd6d1f4-d8e4-47f9-812f-eb7fec925f8d	Primary Tumor	Not Reported	181.0	280.0	OCT	66C80EC0-37D4-4F88-9988-2CA3D652C8C3	true	Solid Tissue	False	Tumor
TCGA-BT-A42E-01A	8d434cfb-2414-4d93-bf79-7b957bf040db	Transitional Cell Papillomas and Carcinomas	8d434cfb-2414-4d93-bf79-7b957bf040db	TCGA-BT-A42E	Bladder	2.73972602739726	Not Reported	50.0	white	male	not hispanic or latino	Alive	74	-27045.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Posterior wall of bladder	1108.0	27045.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T3a	8130/3	N0	M0	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported	T3a	27045.0	74.0958904109589	['2019-07-31T16:54:19.317486-05:00', '2019-07-31T16:54:19.317486-05:00']	['56ed2159-601d-5c96-9d77-e7d86bc3d4a5', 'a61220d0-456c-546e-be0d-d9eba36d5925']	['TCGA-BT-A42E_treatment_1', 'TCGA-BT-A42E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:56:41.276393-05:00', '']	01	Primary	b19a7c0e-bcf9-46f4-899d-1e68407a206b	Primary Tumor	Not Reported	143.0	240.0	OCT	5613DDA8-5440-428C-B12B-C4A8814139F2	true	Solid Tissue	False	Tumor
TCGA-FD-A5BY-01A	8da76432-3004-47e5-a474-bd94bd4c0b33	Transitional Cell Papillomas and Carcinomas	8da76432-3004-47e5-a474-bd94bd4c0b33	TCGA-FD-A5BY	Bladder		Not Reported		white	female	not hispanic or latino	Alive	63	-23080.0	1949.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder	251.0	23080.0	Transitional cell carcinoma	yes	2012.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		23080.0	63.23287671232877	['2019-07-31T16:54:22.315796-05:00', '2019-07-31T16:54:22.315796-05:00']	['157e5c2b-41d8-5f55-b056-c25b3a683a84', '30cf21eb-0d6a-5ed0-b4a6-8b9c40d6db91']	['TCGA-FD-A5BY_treatment', 'TCGA-FD-A5BY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:43.611089-05:00']	01	Primary	e01fb843-d86d-42a6-81a5-30d678a17588	Primary Tumor	Not Reported	90.0	540.0	OCT	DE874063-9AE8-4855-8CD2-D30F71E3C167	true	Solid Tissue	False	Tumor
TCGA-XF-AAMJ-01A	8f10e006-531a-49ac-b51b-df3fdcb20929	Transitional Cell Papillomas and Carcinomas	8f10e006-531a-49ac-b51b-df3fdcb20929	TCGA-XF-AAMJ	Bladder		Not Reported		asian	male	not hispanic or latino	Dead	70	-25838.0	1936.0	1670.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		25838.0	Transitional cell carcinoma	yes	2006.0	No	6th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25838.0	70.78904109589041	['2019-07-31T16:54:25.180484-05:00', '2019-07-31T16:54:25.180484-05:00']	['11313e7b-1a7b-51cf-a04c-242d28988fe5', '5e540cb3-830e-5584-8e2a-d01e24de808e']	['TCGA-XF-AAMJ_treatment', 'TCGA-XF-AAMJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:56:46.039426-05:00']	01	Primary	8bc818a8-8828-43db-b37e-d364f69ac6d6	Primary Tumor	Not Reported	2914.0	480.0	OCT	40212BF3-FE4C-4B89-8583-76C73560DD2C	true	Solid Tissue	False	Tumor
TCGA-XF-A8HB-01A	90bf49b7-6710-4665-82df-30ecc22c59a3	Transitional Cell Papillomas and Carcinomas	90bf49b7-6710-4665-82df-30ecc22c59a3	TCGA-XF-A8HB	Bladder	1.095890410958904	Not Reported	20.0	not reported	female	hispanic or latino	Alive	50	-18544.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	1370.0	18544.0	Papillary transitional cell carcinoma	no	2006.0	No	6th	T2b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		18544.0	50.8054794520548	['2019-07-31T17:18:18.076402-05:00', '2019-07-31T17:18:18.076402-05:00']	['0be26d76-c476-56a1-beeb-2c717045f5ba', 'a773c3cc-f24d-5f37-9303-e6be02b78164']	['TCGA-XF-A8HB_treatment', 'TCGA-XF-A8HB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:16:28.714694-05:00']	01	Primary	23790892-a2b5-4e06-af1d-248e0f0def4f	Primary Tumor	Not Reported	2731.0	740.0	OCT	AEEB69FF-8CC6-4E22-AD71-A55B11595314	true	Solid Tissue	False	Tumor
TCGA-FJ-A3ZE-01A	917961e2-78ad-4182-9cdb-5efb09808111	Transitional Cell Papillomas and Carcinomas	917961e2-78ad-4182-9cdb-5efb09808111	TCGA-FJ-A3ZE	Bladder	1.36986301369863	Not Reported	25.0	white	male	not hispanic or latino	Dead	65	-23866.0	1947.0	324.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4581f940-fb84-5a4a-ab36-d998d0575df0	FJ	BLN - Baylor	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	106.0	23866.0	Transitional cell carcinoma	no	2012.0	No	7th		8120/3	N3	M1	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	23866.0	65.38630136986302	['2019-07-31T16:54:28.019353-05:00', '2019-07-31T16:54:28.019353-05:00']	['3080ee0f-5bd2-56ef-9bcb-e220ab3e9f9e', '7169ccba-4600-5803-882b-1bd5b47b76df']	['TCGA-FJ-A3ZE_treatment_1', 'TCGA-FJ-A3ZE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:56:48.383723-05:00', '']	01	Primary	7f7de45f-a8cb-4273-82db-fb3dc7e080a7	Primary Tumor	Not Reported	42.0	230.0	OCT	A6FF1E82-2C6B-40F5-9F5E-96562F8EE796	true	Solid Tissue	False	Tumor
TCGA-E7-A4XJ-01A	92495a89-9974-4f75-99e0-28bd11114460	Transitional Cell Papillomas and Carcinomas	92495a89-9974-4f75-99e0-28bd11114460	TCGA-E7-A4XJ	Bladder	1.095890410958904	Not Reported	20.0	asian	male	not hispanic or latino	Dead	66	-24279.0	1946.0	68.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	16.0	24279.0	Transitional cell carcinoma	no	2012.0	No	7th	T2	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	24279.0	66.51780821917808	['2019-07-31T16:54:30.855327-05:00', '2019-07-31T16:54:30.855327-05:00']	['057c04b8-56b1-5a5d-bcb4-3a2438eb7fc8', '209913c7-0149-55c9-840a-a5a28b0da0af']	['TCGA-E7-A4XJ_treatment', 'TCGA-E7-A4XJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:56:50.929487-05:00']	01	Primary	d3950f7b-a687-419e-9ad4-ea36c7de4c5d	Primary Tumor	Not Reported	82.0	860.0	OCT	BF8490C7-4535-4EFF-9785-887C7B58CC75	true	Solid Tissue	False	Tumor
TCGA-E7-A6MD-01A	92d27fec-30c2-4496-965d-df509d869eaa	Transitional Cell Papillomas and Carcinomas	92d27fec-30c2-4496-965d-df509d869eaa	TCGA-E7-A6MD	Bladder		Not Reported		white	male	not hispanic or latino	Alive	66	-24180.0	1946.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Anterior wall of bladder	129.0	24180.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N1	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	24180.0	66.24657534246575	['2019-07-31T16:54:36.704783-05:00', '2019-07-31T16:54:36.704783-05:00']	['2a59841e-7584-5733-87cb-f0d3f270dfd5', '45ec9771-2093-58c4-abc0-59cdfe5a4544']	['TCGA-E7-A6MD_treatment', 'TCGA-E7-A6MD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T09:56:55.624915-05:00']	01	Primary	a42eb242-f16d-4195-b5cf-7b274acfdea1	Primary Tumor	Not Reported	221.0	890.0	OCT	9BDC33BB-1DF1-4B0E-A39C-1A173AC0C2CF	true	Solid Tissue	False	Tumor
TCGA-BT-A3PH-01A	932bcdd4-5145-49e8-9a95-8a546396f572	Transitional Cell Papillomas and Carcinomas	932bcdd4-5145-49e8-9a95-8a546396f572	TCGA-BT-A3PH	Bladder		Not Reported		white	male	not hispanic or latino	Dead	76	-28030.0	1934.0	142.0	2010.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		28030.0	Transitional cell carcinoma	no	2010.0	No	7th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3b	28030.0	76.79452054794521	['2019-07-31T16:54:42.663633-05:00', '2019-07-31T16:54:42.663633-05:00']	['b5f0b9b7-15a9-5f09-8505-a066e5000b8f', 'e8d76e63-144b-5026-9f8e-9b880d3312d8']	['TCGA-BT-A3PH_treatment', 'TCGA-BT-A3PH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:00.380576-05:00']	01	Primary	33a83e54-3be5-4a68-8ab0-d31d0bcd3b67	Primary Tumor	Not Reported	427.0	200.0	OCT	25DF244E-6548-4304-A720-4CC31BDCB305	true	Solid Tissue	False	Tumor
TCGA-4Z-AA86-01A	939b73d8-39fd-410e-aeae-53080ea99618	Transitional Cell Papillomas and Carcinomas	939b73d8-39fd-410e-aeae-53080ea99618	TCGA-4Z-AA86	Bladder		Not Reported		black or african american	male	not reported	Dead	66	-24465.0	1943.0	311.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1181dcad-6ef1-5739-afb7-e2babfddfe21	4Z	Barretos Cancer Hospital	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Dome of bladder	270.0	24465.0	Transitional cell carcinoma	no	2009.0	No	7th	T3a	8120/3	N1	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported	T2	24465.0	67.02739726027397	['2019-07-31T16:54:45.423970-05:00', '2019-07-31T16:54:45.423970-05:00']	['4ebf66e3-c70e-525f-baf3-44c4293367d9', 'df585b7d-ed2a-591d-b7aa-1035b0970489']	['TCGA-4Z-AA86_treatment', 'TCGA-4Z-AA86_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:02.746008-05:00']	01	Primary	c14a0121-4f7b-4980-9194-94574dc6fecc	Primary Tumor	Not Reported	1466.0	120.0	OCT	B0958D4E-B2F8-4D76-96E7-714662E3B677	true	Solid Tissue	False	Tumor
TCGA-XF-AAMF-01A	93fbe302-a2e0-4cf4-a638-312786f547c2	Transitional Cell Papillomas and Carcinomas	93fbe302-a2e0-4cf4-a638-312786f547c2	TCGA-XF-AAMF	Bladder	1.7534246575342465	Not Reported	32.0	white	male	not hispanic or latino	Dead	68	-25023.0	1936.0	329.0	2004.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		25023.0	Transitional cell carcinoma	yes	2004.0	No	6th	T4	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		25023.0	68.55616438356165	['2019-07-31T16:54:48.375625-05:00', '2019-07-31T16:54:48.375625-05:00']	['6f9eb6e5-7421-58b4-82cb-597f64eeda6d', 'e003a4e6-ca84-5a6c-a993-26b273749e87']	['TCGA-XF-AAMF_treatment_1', 'TCGA-XF-AAMF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:57:05.113256-05:00', '']	01	Primary	577d5a35-60a0-4bdb-9b26-70d72266d6cf	Primary Tumor	Not Reported	3362.0	830.0	OCT	1F998F05-1055-4BBB-B3CF-BF07C0066A26	true	Solid Tissue	False	Tumor
TCGA-FD-A3SO-01A	94809fbf-4895-42c0-a7c6-f39ee1a41f1a	Transitional Cell Papillomas and Carcinomas	94809fbf-4895-42c0-a7c6-f39ee1a41f1a	TCGA-FD-A3SO	Bladder	1.643835616438356	Not Reported	30.0	white	male	not hispanic or latino	Dead	68	-25147.0	1944.0	168.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Lateral wall of bladder		25147.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N1	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		25147.0	68.8958904109589	['2019-07-31T16:54:51.191348-05:00', '2019-07-31T16:54:51.191348-05:00']	['387c60ae-d1d2-5fff-98c4-330058453f7f', 'e723b632-6455-52ac-a69a-0f43d49d951b']	['TCGA-FD-A3SO_treatment', 'TCGA-FD-A3SO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T09:57:07.552723-05:00']	01	Primary	869e3d55-cad8-436e-b6a8-7ed90ad0a535	Primary Tumor	Not Reported	66.0	700.0	OCT	9F88F244-C30A-409F-BA44-94BEA0177116	true	Solid Tissue	False	Tumor
TCGA-YC-A89H-01A	95520295-90d3-4b4e-86b6-4bd856723315	Transitional Cell Papillomas and Carcinomas	95520295-90d3-4b4e-86b6-4bd856723315	TCGA-YC-A89H	Bladder	1.726027397260274	Not Reported	31.5	white	female	not hispanic or latino	Alive	78	-28741.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	872ae826-350b-59bd-b492-a58ff8eb21ab	YC	Spectrum Health	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	573.0	28741.0	Transitional cell carcinoma	no	2013.0	No	7th		8120/3		MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	28741.0	78.74246575342465	['2019-07-31T16:54:54.187514-05:00', '2019-07-31T16:54:54.187514-05:00']	['71e2b230-3f88-5165-98b7-2d50a40e302d', '85594e79-ca9e-5e7f-a51e-82085e1d6997']	['TCGA-YC-A89H_treatment', 'TCGA-YC-A89H_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:57:09.944782-05:00']	01	Primary	e02f0582-9183-4e63-bfd5-48f7c1565daf	Primary Tumor	Not Reported	205.0	380.0	Unknown	0E633B83-3C48-4D53-B7BF-EFE0BDF73DED	false	Solid Tissue	False	Tumor
TCGA-CF-A9FL-01A	96292f0e-5d09-4c44-8dfc-73ebde6bf137	Transitional Cell Papillomas and Carcinomas	96292f0e-5d09-4c44-8dfc-73ebde6bf137	TCGA-CF-A9FL	Bladder		Not Reported		asian	male	not hispanic or latino	Dead	85	-31099.0	1928.0	565.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	84.0	31099.0	Papillary transitional cell carcinoma	yes	2013.0	No	6th	T3b	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		31099.0	85.2027397260274	['2019-07-31T16:54:57.124242-05:00', '2019-07-31T16:54:57.124242-05:00']	['8a020d0f-6fee-58dd-ad9e-1a4b20c846a5', '8e15272f-cec5-5f04-8a48-8d3a319a4227']	['TCGA-CF-A9FL_treatment_1', 'TCGA-CF-A9FL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:12.319011-05:00', '']	01	Primary	fa832ba6-9d24-40ba-a7e9-0b426b8b402a	Primary Tumor	Not Reported	294.0	350.0	OCT	1B45E29B-BFF5-4A16-A378-3ECD312DFE2F	true	Solid Tissue	False	Tumor
TCGA-5N-A9KM-01A	9743e684-25dd-4dd9-9b84-6ae9518d1818	Transitional Cell Papillomas and Carcinomas	9743e684-25dd-4dd9-9b84-6ae9518d1818	TCGA-5N-A9KM	Bladder	1.643835616438356	Not Reported	30.0	white	female	not hispanic or latino	Dead	73	-26906.0	1939.0	530.0	2013.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	740c5228-5133-53ab-a6c0-75a167b9f894	5N	University Hospital Erlangen	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS		26906.0	Transitional cell carcinoma	no	2012.0	No	7th	T4a	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T4a	26906.0	73.71506849315068	['2019-07-31T16:55:00.073471-05:00', '2019-07-31T16:55:00.073471-05:00']	['4cd94faf-430c-5ac7-b616-264b7b675930', 'd36f73b9-1ae6-5fd7-a0e4-c181f1b10890']	['TCGA-5N-A9KM_treatment', 'TCGA-5N-A9KM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:14.733334-05:00']	01	Primary	4ef0d483-b954-47dd-ab58-eb0f4db31b1d	Primary Tumor	Not Reported	524.0	52.0	Unknown	3DA2EAED-CD7A-4102-9871-74AA445DD4F3	false	Solid Tissue	False	Tumor
TCGA-YC-A8S6-01A	97d6568c-0a89-4327-8988-71e81ee8dae6	Transitional Cell Papillomas and Carcinomas	97d6568c-0a89-4327-8988-71e81ee8dae6	TCGA-YC-A8S6	Bladder		Not Reported		white	male	not hispanic or latino	Alive	71	-26130.0	1942.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	872ae826-350b-59bd-b492-a58ff8eb21ab	YC	Spectrum Health	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage II	0	not reported	Bladder, NOS	293.0	26130.0	Papillary transitional cell carcinoma	yes	2013.0	No	7th	T2a	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26130.0	71.58904109589041	['2019-07-31T16:55:02.957049-05:00', '2019-07-31T16:55:02.957049-05:00']	['0f50cad3-29b4-545d-8500-ff912af4fb99', '303abbe4-60bb-5c17-95d9-3b87b7aaf10d']	['TCGA-YC-A8S6_treatment', 'TCGA-YC-A8S6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:17.134609-05:00']	01	Primary	38a7d76d-1ec7-4469-a204-02f3ca423488	Primary Tumor	Not Reported	21.0	220.0	Unknown	9945C51F-169C-48D5-81FC-9BFEA1C276C6	false	Solid Tissue	False	Tumor
TCGA-FD-A5BU-01A	980c7214-f708-4499-818d-f3de87dc6de7	Transitional Cell Papillomas and Carcinomas	980c7214-f708-4499-818d-f3de87dc6de7	TCGA-FD-A5BU	Bladder	3.671232876712329	Not Reported	67.0	black or african american	female	not hispanic or latino	Alive	76	-27882.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Lateral wall of bladder	588.0	27882.0	Transitional cell carcinoma	no	2012.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		27882.0	76.3890410958904	['2019-07-31T16:55:05.948090-05:00', '2019-07-31T16:55:05.948090-05:00']	['4dacf0db-adc7-5924-8047-21140fe9daf8', '5079b217-c553-59d2-82d5-5bd254096209']	['TCGA-FD-A5BU_treatment_1', 'TCGA-FD-A5BU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:19.497092-05:00', '']	01	Primary	5f0353bd-0f8b-44d5-8e0f-7f99c6b9e4ba	Primary Tumor	Not Reported	153.0	780.0	OCT	A724558E-615F-4565-86B0-389FE9083D88	true	Solid Tissue	False	Tumor
TCGA-XF-AAN2-01A	987e8157-fbea-40f3-aa01-0092d6cceb97	Transitional Cell Papillomas and Carcinomas	987e8157-fbea-40f3-aa01-0092d6cceb97	TCGA-XF-AAN2	Bladder	1.095890410958904	Not Reported	20.0	white	male	not hispanic or latino	Dead	73	-26720.0	1934.0	1869.0	2012.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS		26720.0	Transitional cell carcinoma	no	2007.0	No	6th	T2b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		26720.0	73.20547945205479	['2019-07-31T16:55:08.968978-05:00', '2019-07-31T16:55:08.968978-05:00']	['481b3ba6-00d2-5ae2-83bf-29fb74f53cb2', '795695ff-0da7-5657-a560-45ff9dd15c3d']	['TCGA-XF-AAN2_treatment', 'TCGA-XF-AAN2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:21.811864-05:00']	01	Primary	41f8f766-2304-4ed4-8777-5d8b027ff9f9	Primary Tumor	Not Reported	2505.0	280.0	OCT	00D2C4D3-B209-4B54-992D-54E8048415BA	true	Solid Tissue	False	Tumor
TCGA-G2-AA3F-01A	9883c38f-87bf-4421-bfc0-1b1001f8159c	Transitional Cell Papillomas and Carcinomas	9883c38f-87bf-4421-bfc0-1b1001f8159c	TCGA-G2-AA3F	Bladder	5.917808219178082	Not Reported	108.0	white	male	not hispanic or latino	Alive	77	-28457.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	893.0	28457.0	Transitional cell carcinoma	no	2012.0	No	7th	T3	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	28457.0	77.96438356164384	['2019-07-31T16:55:11.736333-05:00', '2019-07-31T16:55:11.736333-05:00']	['78a035fb-5425-58b4-89f7-394263ff7b39', 'd7533c19-f873-5996-a1ad-fc795540189f']	['TCGA-G2-AA3F_treatment', 'TCGA-G2-AA3F_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:57:24.140390-05:00']	01	Primary	260cf40d-2f85-45c8-8dcc-689b1385fadb	Primary Tumor	Not Reported	459.0	90.0	OCT	3421B447-B005-4F3D-9FAD-50C980F90F06	true	Solid Tissue	False	Tumor
TCGA-G2-A2EO-01A	98b9ad62-76ed-43e3-91bc-b8f065d79673	Transitional Cell Papillomas and Carcinomas	98b9ad62-76ed-43e3-91bc-b8f065d79673	TCGA-G2-A2EO	Bladder		Not Reported		white	male	not hispanic or latino	Dead	69	-25440.0	1940.0	1804.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	6c2085bc-d588-5131-a7ab-87617e553c3b	G2	MD Anderson	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder	1072.0	25440.0	Transitional cell carcinoma	no	2009.0	No	6th	T3a	8120/3	N0	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		25440.0	69.6986301369863	['2019-07-31T16:55:14.804635-05:00', '2019-07-31T16:55:14.804635-05:00']	['305fe109-e1c6-55a9-be07-939d169dbb53', 'cb658e58-dc86-5969-a1ca-44c730941c71']	['TCGA-G2-A2EO_treatment', 'TCGA-G2-A2EO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:26.475210-05:00']	01	Primary	3a663626-0765-4dcb-8489-53f585e663ec	Primary Tumor	Not Reported	597.0	350.0	OCT	AB5DCF8B-A35D-4B20-A108-AB443795D3F3	true	Solid Tissue	False	Tumor
TCGA-DK-A3WY-01A	9bb5d187-033e-4e86-a76e-e1a6d20488f7	Transitional Cell Papillomas and Carcinomas	9bb5d187-033e-4e86-a76e-e1a6d20488f7	TCGA-DK-A3WY	Bladder		Not Reported		white	female	not hispanic or latino	Alive	67	-24536.0	1934.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Dome of bladder	4967.0	24536.0	Transitional cell carcinoma	no	2001.0	No	5th	T3	8120/3	N0	M0	not reported	C67.1	Dome of bladder	Not Reported	not reported		24536.0	67.22191780821917	['2019-07-31T16:55:20.979354-05:00', '2019-07-31T16:55:20.979354-05:00']	['421def04-37de-571e-868d-c2d697c15505', '5968ef5a-c726-5595-b3d4-777da5616b97']	['TCGA-DK-A3WY_treatment_1', 'TCGA-DK-A3WY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:57:31.114591-05:00', '']	01	Primary	33d579b3-198d-46ca-b2cf-574a0673e26f	Primary Tumor	Not Reported	4107.0	430.0	OCT	62654E3C-3796-43B4-A347-FF4C22EEE143	true	Solid Tissue	False	Tumor
TCGA-CF-A47Y-01A	9bcff619-f75a-4aa4-9e09-2e9aa7b59225	Transitional Cell Papillomas and Carcinomas	9bcff619-f75a-4aa4-9e09-2e9aa7b59225	TCGA-CF-A47Y	Bladder		Not Reported		asian	male	not hispanic or latino	Alive	55	-20432.0	1957.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Bladder, NOS	373.0	20432.0	Papillary transitional cell carcinoma	no	2012.0	No	7th	T2	8130/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T2	20432.0	55.97808219178082	['2019-07-31T16:55:23.771436-05:00', '2019-07-31T16:55:23.771436-05:00']	['1eaa1918-1d04-5c4e-b264-5005d83384d1', 'f0fb3033-3b8e-5f38-baab-215794dcee8e']	['TCGA-CF-A47Y_treatment_1', 'TCGA-CF-A47Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:33.458531-05:00', '']	01	Primary	9e5dc3cf-b6f8-4eca-9637-55c100a78168	Primary Tumor	Not Reported	130.0	500.0	OCT	67559C16-8825-456D-8C4B-927C1004F6E2	true	Solid Tissue	False	Tumor
TCGA-DK-A1A6-01A	9c274536-3ca1-4f0e-93a8-1688074d862f	Transitional Cell Papillomas and Carcinomas	9c274536-3ca1-4f0e-93a8-1688074d862f	TCGA-DK-A1A6	Bladder	3.287671232876712	Not Reported	60.0	white	male	not reported	Alive	53	-19554.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	2020.0	19554.0	Transitional cell carcinoma	no	2008.0	No	6th	T2a	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19554.0	53.57260273972603	['2019-07-31T16:55:26.581201-05:00', '2019-07-31T16:55:26.581201-05:00']	['51b3472f-52aa-50f3-b879-628927d48dd8', 'f57320c7-d630-5945-9191-2c153a18cf9e']	['TCGA-DK-A1A6_treatment', 'TCGA-DK-A1A6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:35.789935-05:00']	01	Primary	7ad1cd01-0ea2-4fa4-9b05-c280bd256546	Primary Tumor	Not Reported	874.0	160.0	OCT	EFF72FEC-98DC-42F0-B209-17625E653246	true	Solid Tissue	False	Tumor
TCGA-DK-A1A6-06A	9c274536-3ca1-4f0e-93a8-1688074d862f	Transitional Cell Papillomas and Carcinomas	9c274536-3ca1-4f0e-93a8-1688074d862f	TCGA-DK-A1A6	Bladder	3.287671232876712	Not Reported	60.0	white	male	not reported	Alive	53	-19554.0	1955.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	314fdb3f-96cc-5782-9c1a-5d9bee096ec0	DK	Memorial Sloan Kettering	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	2020.0	19554.0	Transitional cell carcinoma	no	2008.0	No	6th	T2a	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19554.0	53.57260273972603	['2019-07-31T16:55:26.581201-05:00', '2019-07-31T16:55:26.581201-05:00']	['51b3472f-52aa-50f3-b879-628927d48dd8', 'f57320c7-d630-5945-9191-2c153a18cf9e']	['TCGA-DK-A1A6_treatment', 'TCGA-DK-A1A6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:35.789935-05:00']	06	Metastatic	f7f74a2b-5299-424d-b9a7-2b313dc7823c	Metastatic	Not Reported	1971.0	90.0	OCT	FA3A7697-0E2C-4C79-B486-0AAE52065BE3	true	Unknown	False	Tumor
TCGA-GU-A42Q-01A	9c46846e-7f66-4936-af97-50a7b8189d84	Transitional Cell Papillomas and Carcinomas	9c46846e-7f66-4936-af97-50a7b8189d84	TCGA-GU-A42Q	Bladder	3.1232876712328768	Not Reported	57.0	white	male	not hispanic or latino	Dead	67	-24534.0	1945.0	344.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	48ca65d8-7ae8-5645-b421-2a437cea2a29	GU	BLN - UT Southwestern Medical Center at Dallas	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	231.0	24534.0	Transitional cell carcinoma	no	2012.0	No	7th	T3b	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		24534.0	67.21643835616439	['2019-07-31T16:55:29.693487-05:00', '2019-07-31T16:55:29.693487-05:00']	['144d1e07-39c1-5a11-abdb-78c5177f2f23', 'a6841f8c-e4f0-56c9-80ba-805dbc4e07a0']	['TCGA-GU-A42Q_treatment_1', 'TCGA-GU-A42Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:38.234315-05:00', '']	01	Primary	40957a46-c3ef-4a77-8a43-755918ecd6c6	Primary Tumor	Not Reported	191.0	80.0	OCT	7A1C2B15-348F-484B-A15E-CD39996517E2	true	Solid Tissue	False	Tumor
TCGA-GV-A3JZ-01A	9cc92795-7a24-4875-87f0-3efccbfcc970	Transitional Cell Papillomas and Carcinomas	9cc92795-7a24-4875-87f0-3efccbfcc970	TCGA-GV-A3JZ	Bladder	0.821917808219178	Not Reported	15.0	white	male	not hispanic or latino	Alive	55	-20420.0	1956.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	12619fdb-d678-5951-903f-5a45c1a5efc2	GV	BLN - Cleveland Clinic	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	603.0	20420.0	Transitional cell carcinoma	yes	2011.0	No	7th	T4a	8120/3	N3	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		20420.0	55.945205479452056	['2019-07-31T16:55:33.339317-05:00', '2019-07-31T16:55:33.339317-05:00']	['85a4d910-32f6-5e77-a441-6b5301f85fa6', 'd5b4b775-f626-57cd-9053-cfe030c19a8d']	['TCGA-GV-A3JZ_treatment', 'TCGA-GV-A3JZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:57:40.706993-05:00']	01	Primary	449e18fb-cbc0-4365-aeec-edc6a6b276bd	Primary Tumor	Not Reported	132.0	170.0	OCT	A1CF42EF-92A6-4214-BB25-7C71F665EFDC	true	Solid Tissue	False	Tumor
TCGA-XF-AAMY-01A	9d2b19eb-bd61-490e-982b-fadf2c4aadf7	Transitional Cell Papillomas and Carcinomas	9d2b19eb-bd61-490e-982b-fadf2c4aadf7	TCGA-XF-AAMY	Bladder		Not Reported		white	male	not hispanic or latino	Alive	78	-28509.0	1928.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS	3011.0	28509.0	Papillary transitional cell carcinoma	yes	2006.0	No	5th	T3b	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28509.0	78.10684931506849	['2019-07-31T16:55:36.313037-05:00', '2019-07-31T16:55:36.313037-05:00']	['04db0b7e-0f32-51d4-8ce4-47d2196dd368', '2b260fa5-511a-5f30-82de-a84e5d4f2fb9']	['TCGA-XF-AAMY_treatment', 'TCGA-XF-AAMY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:57:43.030117-05:00']	01	Primary	288048a5-f521-4bc9-8c3a-dac39bf946b7	Primary Tumor	Not Reported	2758.0	1090.0	OCT	AEF3C925-7B93-42F8-921B-9A2D3912DE99	true	Solid Tissue	False	Tumor
TCGA-XF-AAN7-01A	9d7fbdeb-ea3d-4e07-8527-23c5997d77cf	Transitional Cell Papillomas and Carcinomas	9d7fbdeb-ea3d-4e07-8527-23c5997d77cf	TCGA-XF-AAN7	Bladder	2.191780821917808	Not Reported	40.0	white	male	not hispanic or latino	Dead	60	-21951.0	1948.0	565.0	2009.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS		21951.0	Transitional cell carcinoma	yes	2008.0	No	5th	T3a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21951.0	60.13972602739726	['2019-07-31T16:55:39.351882-05:00', '2019-07-31T16:55:39.351882-05:00']	['05e13db9-7c4f-5594-97d2-0ca55d56a739', '6909f581-7eb7-5bca-8b66-40795f1c8c1c']	['TCGA-XF-AAN7_treatment_1', 'TCGA-XF-AAN7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:57:45.362150-05:00', '']	01	Primary	c1f6f709-4c79-465a-90d4-17e08dfa96cd	Primary Tumor	Not Reported	2087.0	1300.0	OCT	B680364D-6FEC-45A5-95FC-1055E37DFCE2	true	Solid Tissue	False	Tumor
TCGA-KQ-A41O-01A	9dd41965-7a62-464d-8a23-5c3f9565dd91	Transitional Cell Papillomas and Carcinomas	9dd41965-7a62-464d-8a23-5c3f9565dd91	TCGA-KQ-A41O	Bladder		Not Reported		not reported	male	not reported	Alive	84	-30774.0	1927.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Bladder, NOS	1538.0	30774.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3	8120/3	N1	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	TX	30774.0	84.31232876712329	['2019-07-31T16:55:42.383343-05:00', '2019-07-31T16:55:42.383343-05:00']	['b92ca137-77e7-5364-baa1-d1fe29ee4de4', 'e8a3a966-f972-5146-90d6-224b7bed7fb9']	['TCGA-KQ-A41O_treatment', 'TCGA-KQ-A41O_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:47.706952-05:00']	01	Primary	4d1b5d93-e1af-4c6b-b4f6-b327a6a82ae6	Primary Tumor	Not Reported	475.0	800.0	OCT	F8254DB1-B345-4799-9A39-56F06EB8DFF5	true	Solid Tissue	False	Tumor
TCGA-BT-A2LD-01A	9dd97821-7afd-4982-8b1d-f14f845b79f7	Transitional Cell Papillomas and Carcinomas	9dd97821-7afd-4982-8b1d-f14f845b79f7	TCGA-BT-A2LD	Bladder		Not Reported		white	female	not hispanic or latino	Dead	78	-28673.0	1933.0	623.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	1539cc6c-f9b9-5c29-b68b-883fa0b52494	BT	University of Pittsburgh	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage IV	0	not reported	Trigone of bladder	111.0	28673.0	Transitional cell carcinoma	yes	2011.0	No	7th	T3a	8120/3	N1	M0	not reported	C67.0	Trigone of bladder	Not Reported	not reported	T3a	28673.0	78.55616438356165	['2019-07-31T16:55:45.586218-05:00', '2019-07-31T16:55:45.586218-05:00']	['9584ed90-4281-5340-a355-818b81e61daa', '9ffca01b-7a1e-5a72-b746-79ae83e6a687']	['TCGA-BT-A2LD_treatment_1', 'TCGA-BT-A2LD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T09:57:50.099248-05:00', '']	01	Primary	aeb379d5-b157-4bce-82c5-0cd0077db01f	Primary Tumor	Not Reported	49.0	200.0	OCT	69B3EA67-CD1F-4B86-989C-DEE4FEFA7906	true	Solid Tissue	False	Tumor
TCGA-UY-A9PD-01A	9ef9e328-ac74-4c8a-9990-347b87cf7764	Transitional Cell Papillomas and Carcinomas	9ef9e328-ac74-4c8a-9990-347b87cf7764	TCGA-UY-A9PD	Bladder		Not Reported		white	male	not hispanic or latino	Alive	80	-29565.0				Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	f3c09fe2-d7ae-5e7f-a8a2-6cc763c815fc	UY	University of California San Francisco	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Anterior wall of bladder	542.0	29565.0	Transitional cell carcinoma	no		No	7th	T3a	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		29565.0	81.0	['2019-07-31T16:55:51.614804-05:00', '2019-07-31T16:55:51.614804-05:00']	['2f03c787-8aac-5468-a286-e0a23d7cf27a', 'd94e359c-2286-5688-85fa-94079d48a86f']	['TCGA-UY-A9PD_treatment_1', 'TCGA-UY-A9PD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:57:55.054485-05:00', '']	01	Primary	5a1b7ff4-0966-4fa1-a91e-03196eff112d	Primary Tumor	Not Reported		160.0	OCT	0698B674-4D6D-4FEF-8129-F66DF28A45F9	true	Solid Tissue	False	Tumor
TCGA-E7-A6ME-01A	9f00847c-bd1f-4cd0-99f9-d51d638c0795	Transitional Cell Papillomas and Carcinomas	9f00847c-bd1f-4cd0-99f9-d51d638c0795	TCGA-E7-A6ME	Bladder	0.821917808219178	Not Reported	15.0	asian	male	not hispanic or latino	Alive	75	-27670.0	1938.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	35cbcc1d-ede6-5172-a524-ce95a5b29652	E7	Asterand	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Anterior wall of bladder	731.0	27670.0	Transitional cell carcinoma	no	2013.0	No	7th	T2b	8120/3	NX	M0	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported	T2	27670.0	75.8082191780822	['2019-07-31T16:55:54.819010-05:00', '2019-07-31T16:55:54.819010-05:00']	['a51b2eac-209e-5b58-a644-4b83d8cf2ada', 'cd833256-0a3c-5441-92ab-d3b07d393c85']	['TCGA-E7-A6ME_treatment', 'TCGA-E7-A6ME_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:57:57.431106-05:00']	01	Primary	fe3e0288-c9bd-4d2a-a6a7-86404b22d005	Primary Tumor	Not Reported	93.0	1200.0	OCT	491F83D0-4A70-4076-9BDF-1A266925116C	true	Solid Tissue	False	Tumor
TCGA-KQ-A41Q-01A	a21bdd7e-f3cf-4826-9967-7eaffc0d035a	Transitional Cell Papillomas and Carcinomas	a21bdd7e-f3cf-4826-9967-7eaffc0d035a	TCGA-KQ-A41Q	Bladder		Not Reported		white	male	not hispanic or latino	Alive	89	-32511.0	1920.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	c3b77518-8a0f-57f2-a0d7-60683fd4783d	KQ	Cornell Medical College	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Anterior wall of bladder	361.0	32511.0	Transitional cell carcinoma	yes	2009.0	No	7th	T3b	8120/3	N0	MX	not reported	C67.3	Anterior wall of bladder	Not Reported	not reported		32511.0	89.07123287671233	['2019-07-31T16:56:03.514366-05:00', '2019-07-31T16:56:03.514366-05:00']	['85ee9f61-704f-52d8-9e9b-07052d761a42', 'd954d05f-fd68-5ccb-80e6-39e00e97191a']	['TCGA-KQ-A41Q_treatment', 'TCGA-KQ-A41Q_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:58:04.291297-05:00']	01	Primary	a52db352-836e-4ba4-8f84-4760e4bf0e39	Primary Tumor	Not Reported	1294.0	480.0	OCT	5047D01C-1425-4EE5-BB6F-5DD484C9E030	true	Solid Tissue	False	Tumor
TCGA-PQ-A6FN-01A	a3c849f2-c006-4368-950d-998a26cd368b	Transitional Cell Papillomas and Carcinomas	a3c849f2-c006-4368-950d-998a26cd368b	TCGA-PQ-A6FN	Bladder	1.5342465753424657	Not Reported	28.0	white	female	not hispanic or latino	Alive	78	-28546.0	1933.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	2b2b5abf-f65c-5e03-9fee-258ac742453e	PQ	University of Colorado Denver	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Lateral wall of bladder	507.0	28546.0	Transitional cell carcinoma	no	2011.0	No	7th	T3a	8120/3	N0	MX	not reported	C67.2	Lateral wall of bladder	Not Reported	not reported		28546.0	78.20821917808219	['2019-07-31T16:56:06.378557-05:00', '2019-07-31T16:56:06.378557-05:00']	['25b1b3b5-ba71-5a9a-b81a-f3a5387ca1f8', 'b9ec1324-e7be-50fb-9544-3c50b0783b10']	['TCGA-PQ-A6FN_treatment', 'TCGA-PQ-A6FN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:06.460582-05:00']	01	Primary	7503e8e8-68c0-4243-93f2-399e0f4d9d10	Primary Tumor	Not Reported	562.0	30.0	OCT	33979746-6DCE-434E-86D4-16005FD5502F	true	Solid Tissue	False	Tumor
TCGA-S5-AA26-01A	a540fcec-58a1-4e58-8e0a-8bf73b78e30d	Transitional Cell Papillomas and Carcinomas	a540fcec-58a1-4e58-8e0a-8bf73b78e30d	TCGA-S5-AA26	Bladder		Not Reported		black or african american	male	not hispanic or latino	Alive	46	-16972.0	1967.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	91e46035-31fd-5ade-839f-9b75517a3add	S5	 University of Oklahoma HSC	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	503.0	16972.0	Papillary transitional cell carcinoma	no	2013.0	No	7th	T3a	8130/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		16972.0	46.4986301369863	['2019-07-31T16:56:09.348299-05:00', '2019-07-31T16:56:09.348299-05:00']	['1659d8b0-c245-5191-aa07-daac8be2cee4', '683aaccc-e26b-5d23-bb83-e9a87b75aa0b']	['TCGA-S5-AA26_treatment', 'TCGA-S5-AA26_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:08.933748-05:00']	01	Primary	4fa5a2e9-e3b5-4179-a6b5-5f57d4415614	Primary Tumor	Not Reported	31.0	130.0	OCT	1EE92799-E860-4C6B-B525-0C238D8B2E2F	true	Solid Tissue	False	Tumor
TCGA-XF-A9SX-01A	a648d9bf-cf37-41fc-9515-e8f5ac85fcd4	Transitional Cell Papillomas and Carcinomas	a648d9bf-cf37-41fc-9515-e8f5ac85fcd4	TCGA-XF-A9SX	Bladder	2.191780821917808	Not Reported	40.0	white	female	not hispanic or latino	Dead	63	-23349.0	1943.0	719.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS		23349.0	Transitional cell carcinoma	no	2006.0	No	6th	T3b	8120/3	N2	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		23349.0	63.96986301369863	['2019-07-31T16:56:12.511959-05:00', '2019-07-31T16:56:12.511959-05:00']	['181a4ad7-4edd-5ab9-bb5e-ed77680ac6d7', 'd2e977e7-18c9-5427-a4fe-118b98ac83e0']	['TCGA-XF-A9SX_treatment', 'TCGA-XF-A9SX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:58:11.279122-05:00']	01	Primary	c48c874a-a34e-49ed-8ec3-6a994ab2e4ff	Primary Tumor	Not Reported	2702.0	770.0	OCT	FFF56041-E252-4438-BD4A-C7FD5295A061	true	Solid Tissue	False	Tumor
TCGA-FD-A3N5-01A	a658becf-3934-49f2-9e74-291dca61d4bb	Transitional Cell Papillomas and Carcinomas	a658becf-3934-49f2-9e74-291dca61d4bb	TCGA-FD-A3N5	Bladder	2.191780821917808	Not Reported	40.0	black or african american	male	not hispanic or latino	Dead	69	-25342.0	1942.0	685.0		Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	bd0b495d-baaa-51a0-aa47-a371544f190e	FD	BLN - University Of Chicago	Bladder Urothelial Carcinoma	NCH															No	Stage II	0	not reported	Posterior wall of bladder	363.0	25342.0	Transitional cell carcinoma	no	2011.0	No	7th	T2b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		25342.0	69.43013698630136	['2019-07-31T16:56:15.282324-05:00', '2019-07-31T16:56:15.282324-05:00']	['446e8441-ef54-587e-84fe-74d8b71fe73c', '51c365eb-37e5-5a87-94cd-ff4d1e8deed5']	['TCGA-FD-A3N5_treatment', 'TCGA-FD-A3N5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:13.580017-05:00']	01	Primary	66559b5f-ab2f-406b-9edb-0f5085eec7c5	Primary Tumor	Not Reported	260.0	330.0	OCT	9E5D7033-E1B3-47A8-9526-D45B3113A54C	true	Solid Tissue	False	Tumor
TCGA-CF-A1HS-01A	a73c0842-39c5-4c2c-aa6a-f31341a4f36e	Squamous Cell Neoplasms	a73c0842-39c5-4c2c-aa6a-f31341a4f36e	TCGA-CF-A1HS	Bladder		Not Reported		asian	female	not hispanic or latino	Alive	75	-27565.0	1935.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	554a2523-0a18-5bfd-9a10-6c49f77f514c	CF	ILSBio	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	382.0	27565.0	Squamous cell carcinoma, NOS	no	2010.0	No	6th	T3	8070/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		27565.0	75.52054794520548	['2019-07-31T16:56:18.260836-05:00', '2019-07-31T16:56:18.260836-05:00']	['388ea1dc-3aef-59da-87f5-66806d4a6a8f', '6d83faf7-520d-54b6-b050-32a76c2f5b1b']	['TCGA-CF-A1HS_treatment', 'TCGA-CF-A1HS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T09:58:15.840663-05:00']	01	Primary	0a01e5ba-5549-4027-9e84-1bbb163a8f07	Primary Tumor	Not Reported	56.0	570.0	OCT	48DB8720-833D-467C-8BF2-95EF539B4D5E	true	Solid Tissue	False	Tumor
TCGA-GC-A4ZW-01A	a9e17a7d-7ff4-44e3-b8c9-b0d2f46b6cd5	Transitional Cell Papillomas and Carcinomas	a9e17a7d-7ff4-44e3-b8c9-b0d2f46b6cd5	TCGA-GC-A4ZW	Bladder		Not Reported		white	male	not hispanic or latino	Alive	71	-25964.0	1941.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	9433201c-311d-5381-b7e4-24899b76e322	GC	International Genomics Consortium	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	15.0	25964.0	Transitional cell carcinoma	no	2012.0	No	7th	T3a	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported	T3	25964.0	71.13424657534246	['2019-07-31T17:18:21.183965-05:00', '2019-07-31T17:18:21.183965-05:00']	['ba7ea710-5084-599a-b25e-cd7e77c2e89f', 'facc7f27-2272-53d9-a781-9fc01e160760']	['TCGA-GC-A4ZW_treatment_1', 'TCGA-GC-A4ZW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T10:16:31.932616-05:00', '']	01	Primary	1daa494f-8321-4d6c-a587-df92d07b54a5	Primary Tumor	Not Reported	77.0	80.0	Unknown	577035B3-655D-401B-8316-308DE1970F66	false	Solid Tissue	False	Tumor
TCGA-XF-AAN8-01A	aa14e232-c6c6-4075-9d15-e1857373d233	Transitional Cell Papillomas and Carcinomas	aa14e232-c6c6-4075-9d15-e1857373d233	TCGA-XF-AAN8	Bladder	3.287671232876712	Not Reported	60.0	white	female	not hispanic or latino	Dead	74	-27309.0	1933.0	118.0	2007.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Posterior wall of bladder		27309.0	Transitional cell carcinoma	yes	2007.0	No	6th	T3b	8120/3	N0	MX	not reported	C67.4	Posterior wall of bladder	Not Reported	not reported		27309.0	74.81917808219178	['2019-07-31T16:56:23.898249-05:00', '2019-07-31T16:56:23.898249-05:00']	['0857c1a8-cb9a-5ad3-bd51-c12c22443e94', '6a441a50-172b-574f-b1ce-83099e4611b5']	['TCGA-XF-AAN8_treatment_1', 'TCGA-XF-AAN8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:58:20.463273-05:00', '']	01	Primary	7569d782-f14e-47e5-93bc-b58b0bd6f697	Primary Tumor	Not Reported	2275.0	1220.0	OCT	07718E82-778A-4797-BBAD-4494AAE3CAA2	true	Solid Tissue	False	Tumor
TCGA-K4-A83P-01A	aa14ffb4-a715-4636-8251-73d019dddd8c	Transitional Cell Papillomas and Carcinomas	aa14ffb4-a715-4636-8251-73d019dddd8c	TCGA-K4-A83P	Bladder	7.671232876712328	Not Reported	140.0	white	male	not hispanic or latino	Alive	77	-28463.0	1936.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	caf79304-12ae-5f5a-82ed-fc6145c8235e	K4	ABS - Lahey Clinic	Bladder Urothelial Carcinoma	NCH															No	Stage IV	0	not reported	Bladder, NOS	495.0	28463.0	Transitional cell carcinoma	no	2013.0	No	7th	T4a	8120/3	N1	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		28463.0	77.98082191780821	['2019-07-31T16:56:29.905364-05:00', '2019-07-31T16:56:29.905364-05:00']	['721aa103-f081-54ca-98c4-e110c613dd36', '8f750837-8eb2-5a4c-8224-2df8c26d5286']	['TCGA-K4-A83P_treatment_1', 'TCGA-K4-A83P_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T09:58:25.095393-05:00', '']	01	Primary	50d2886e-f232-433c-8062-c3c237fb5c09	Primary Tumor	Not Reported	104.0	220.0	OCT	B5339E3F-D046-4C1F-B3B1-8E5C20D15663	true	Solid Tissue	False	Tumor
TCGA-XF-A9T2-01A	aa6b44ab-14b1-4b5d-8679-ba958b546afa	Transitional Cell Papillomas and Carcinomas	aa6b44ab-14b1-4b5d-8679-ba958b546afa	TCGA-XF-A9T2	Bladder		Not Reported		white	male	not hispanic or latino	Dead	54	-19945.0	1953.0	575.0	2008.0	Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	4af98580-2d7b-5d27-91d4-3b13def49f2c	XF	University of Southern California	Bladder Urothelial Carcinoma	NCH															Not Reported	Stage III	0	not reported	Bladder, NOS		19945.0	Transitional cell carcinoma	yes	2007.0	No	5th	T3b	8120/3	N0	MX	not reported	C67.9	Bladder, NOS	Not Reported	not reported		19945.0	54.64383561643836	['2019-07-31T16:56:35.563993-05:00', '2019-07-31T16:56:35.563993-05:00']	['3f132ff1-276c-58a8-8af1-5c95a1551b38', 'bb23e7dd-a968-59d8-8e41-6e84a9e9e1fe']	['TCGA-XF-A9T2_treatment', 'TCGA-XF-A9T2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T09:58:29.758261-05:00']	01	Primary	3cae49a3-6deb-40f9-84cc-68b9b53543ff	Primary Tumor	Not Reported	2288.0	460.0	OCT	71F04D3B-0CA3-4CB3-9E94-E082F37C4097	true	Solid Tissue	False	Tumor
TCGA-ZF-A9R5-01A	aaa55de1-8f53-4b56-ba0a-67cff909cf81	Transitional Cell Papillomas and Carcinomas	aaa55de1-8f53-4b56-ba0a-67cff909cf81	TCGA-ZF-A9R5	Bladder	3.780821917808219	Not Reported	69.0	white	male	not hispanic or latino	Alive	59	-21811.0	1952.0			Bladder	TCGA-BLCA	['Transitional Cell Papillomas and Carcinomas', 'Squamous Cell Neoplasms', 'Adenomas and Adenocarcinomas', 'Epithelial Neoplasms, NOS']	Bladder Urothelial Carcinoma	TCGA	ac5b3f1e-cb87-56d6-8d0c-497f8c65b872	ZF	University of Sheffield	Bladder Urothelial Carcinoma	NCH															No	Stage III	0	not reported	Bladder, NOS	1090.0	21811.0	Transitional cell carcinoma	no	2011.0	No	7th	T3	8120/3	N0	M0	not reported	C67.9	Bladder, NOS	Not Reported	not reported		21811.0	59.75616438356165	['2019-07-31T16:56:38.761251-05:00', '2019-07-31T16:56:38.761251-05:00']	['a38116fa-747e-55f0-a3c3-f818d54c155a', 'e2cd1009-8fba-5524-b214-dc376cfd4336']	['TCGA-ZF-A9R5_treatment_1', 'TCGA-ZF-A9R5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:58:32.143869-05:00', '']	01	Primary	1ad5ffd6-8cc7-4638-9915-0d1a69311c9e	Primary Tumor	Not Reported	743.0	60.0	OCT	5871BCC6-E728-4DFD-B2F2-C5C1C2E43B4C	true	Solid Tissue	False	Tumor
